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Abstract 
 
 
 
n Chapter 1. A Review of Sulfonate-Containing NHC Ligands in Copper-Catalyzed 
Enantioselective Transformations—Maneuvering Selectivities in Tight Space. A 
comprehensive review of enantioselective copper-catalyzed transformations, which are 
promoted by a chiral N-heterocyclic carbene metal complex that features a unique 
sulfonate motif, is provided in this chapter. Reactions have been categorized into four 
sets: allylic substitutions conjugate additions, Cu-B additions alkenes and 
multicomponent reactions. The mechanistic scenarios provided by DFT calculations 
accounts for their uniquely reaction profile in enantioselective allylic substitutions (EAS), 
enantioselective conjugate additions (EAS) and enantioselective Cu-B additions to 
alkenes. Mechanistic investigations (density functional theory calculations and deuterium 
labeling) point to a bridging function for an alkali metal cation connecting the sulfonate 
anion and a substrate’ s phosphate group to form the branched addition products as the 
 
	
dominant isomers via Cu(III) π -allyl intermediate complexes in EAS reactions. 
Sulfonate-bearing NHC ligand with different substitution patterns promote EAS reactions 
with different reactivity and enantioselectivity. We also developed a guideline to follow 
to choose the proper sulfonate-based NHC ligands according to the combination of the 
substrates and the nucleophiles. 
 
 
n Chapter 2. NHC–Cu-Catalyzed Enantioselective Allylic Substitutions with Silyl-
protected Propargyl Boron Reagent to Generate Tertiary and Quaternary Carbon 
Stereogenic Centers. Catalytic allylic substitution reactions involving a propargylic 
nucleophilic component are presented; reactions are facilitated by 5.0 mol % of a catalyst 
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derived from a chiral N-heterocyclic carbene (NHC) and a copper chloride salt. A silyl-
containing propargylic organoboron compound, easily prepared in multi-gram quantities, 
serves as the reagent. Aryl- and heteroaryl-substituted disubstituted alkenes within allylic 
phosphates and those with an alkyl or a silyl group can be used. Functional groups 
typically sensitive to hard nucleophilic reagents are tolerated, particularly in the additions 
to disubstituted alkenes. Reactions may be performed on the corresponding trisubstituted 
alkenes, affording quaternary carbon stereogenic centers. Incorporation of the propargylic 
group is generally favored (vs allenyl addition; 89:11 to >98:2 selectivity); 1,5-enynes 
can be isolated in 75−90% yield, 87:13 to >98:2 SN2′:SN2 (branched/linear) selectivity 
and 83:17−99:1 enantiomeric ratio. Utility is showcased by conversion of the alkynyl 
group to other useful functional units. Application to stereoselective synthesis of the 
acyclic portion of antifungal agent plakinic acid A, containing two remotely positioned 
stereogenic centers, by sequential use of two different NHC−Cu-catalyzed 
enantioselective allylic substitution (EAS) reactions further highlights utility.  
 
 
 
n Chapter 3. NHC–Cu-Catalyzed Enantioselective Allylic Substitutions with 
Methylenediboron to Generate Tertiary and Quaternary Carbon Stereogenic 
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Centers. A catalytic EAS method for the site- and enantioselective addition of 
commercially available di-B(pin)-methane to disubstituted allylic phosphates is 
introduced. Transformations are facilitated by a sulfonate-containing NHC–Cu complex 
and products are obtained in 63–95% yield, 88:12 to >98:2 SN2’/SN2 selectivity, and 
85:15–99:1 enantiomeric ratio. The utility of the approach is highlighted by its 
application to the formal synthesis of the cytotoxic natural product rhopaloic acid A, in 
an all-catalytic-method synthesis route. Catalytic EAS methods of the di-B(pin) methane 
to Z-trisubstituted allylic phosphates are also disclosed and DFT calculations provide 
insights to the stereochemical models for those transformations and rationales for the 
choice of Z-trisubstituted allylic phosphates as the starting materials. 
 
 
n Chapter 4. Enantioselective NHC–Cu-Catalyzed Prenyl Conjugate Additions to 
Enoates to Generate Tertiary Carbon Stereogenic Centers. An efficient catalytic 
protocol for generation of prenyl-bearing tertiary carbon stereogenic centers from aryl-
substituted enoates was achieved in the presence of a chiral alkoxy-based NHC−Cu 
complex. A range of aryl and heteroaryl-substituted substrate were suitable substrates, the 
corresponding prenyl conjugate addition products were generated in up to 94% yield and 
95:5 enantioselectivity. The utility of the current method has been shown in the 
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application to the synthesis of a selective integrin antagonist. DFT calculations provided 
a stereochemical model for the ECA reaction employing alkoxy-containing NHC−Cu 
catalyst. 
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Chapter One 
A Review of Sulfonate-Containing NHC Ligands 
in Copper-Catalyzed Enantioselective 
Transformations—Maneuvering Selectivities in 
Tight Space   
 
1.1. Introduction 
Copper-catalyzed enantioselective allylic substitution (EAS) 1  and conjugate 
additions (ECA) 2  are two extensively-explored reactions for the construction of 
enantiomerically enriched compounds. Such transformations afford either a stereogenic 
center adjacent to an alkene, or at the β-position to a carbonyl group. These motifs can be 
found in natural products and pharmaceuticals, and are amenable to further manipulations 
                                                
(1) For reviews on allylic substitution reactions catalyzed by other transition metals and with “soft” 
nucleophiles, see: (a) Trost, B. M.; Lee, C. In Catalytic Asymmetric Synthesis; Oijima, I., Ed.; Wiley-
VCH: Weinheim, Germany, 2000; Chapter 8E. (b) Trost, B. M.; Crawley, M. L. Chem. Rev. 2003, 103, 
2921–2944. (c) Stanley, L. M.; Hartwig, J. F. Acc. Chem. Res. 2010, 43, 1461–1475. (d) Trost, B. M. Org. 
Process Res. Dev. 2012, 16, 185–194. (e) Tosatti, P.; Nelson, A.; Marsden, S. P. Org. Biomol. Chem. 2012, 
10, 3147– 3163. For reviews on Cu-catalyzed allylic alkylation reactions that involve “hard” alkyl- or 
arylmetal-based reagents, see: (f) Hoveyda, A. H.; Hird, A. W.; Kacprzynski, M. A. Chem. Commun. 2004, 
1779–1785. (g) Yorimitsu, H.; Oshima, K. Angew. Chem., Int. Ed. 2005, 44, 4435–4439. (h) Falciola, C. 
A.; Alexakis, A. Eur. J. Org. Chem. 2008, 3765–3780. (i) Alexakis, A.; Bäckvall, J.-E.; Krause, N.; Pàmies, 
O.; Diéguez, M. Chem. Rev. 2008, 108, 2796‒2823. (j) Harutyunyan, S. R.; den Hartog, T.; Geurts, K.; 
Minnaard, A. J.; Feringa, B. L. Chem. Rev. 2008, 108, 2824‒2852. (k) Lu, Z.; Ma, S. Angew. Chem., Int. 
Ed. 2008, 47, 258‒297. (l) Langlois, J. -B.; Alexakis, A. Topics in Organometallic Chemistry 2012, 38, 
235‒268. 
(2) (a) Krause, N.; Hoffmann-Röder, A. Synthesis 2001, 171–196. (b) Alexakis, A.; Benhaim, C. Eur. J. 
Org. Chem. 2002, 3221–3236. (c) Feringa, B. L.; Naasz, R.; Imbos, R.; Arnold, L. A. In Modern 
Organocopper Chemistry, Krause, N. Ed.; Wiley–VCH, Weinheim, 2002, pp. 224–258. (d) Alexakis, A.; 
Bäckvall, J. E.; Krause, N.; Pámies, O.; Diéguez, M. Chem. Rev. 2008, 108, 2796–2823. (e) Quasdorf, K. 
W.; Overman, L. E. Nature, 2014, 516, 181–191. 
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that yield higher desirable structural units, such as alkylboranes24, carboxylic acids3.  
Ever since the first example of enantioselective allylic substitutions utilizing 
Grignard reagents was reported by Bäckvall et al,4 the field has received a tremendous 
amount of interest in the past two decades. As the interest in enantioselective catalysis 
grows, a number of catalyst systems have also been devised to address problems in Cu-
catalyzed EAS reactions. Phosphine-5 and amino acid-6 based copper complexes are two 
of the most prominent catalyst classes in promoting EAS reactions with alkyl Grignard or 
zinc reagents. Additionally, over the last decade, N-heterocyclic carbenes (NHC), have 
been introduced as chiral ligands for Cu to facilitate EAS reactions and have been of 
great interest ever since.  
In 2004 and 2005, our group developed two types of phenoxide-based NHC 
ligands, derived from binol7 or with an optically pure biphenylethylene diamine as the 
backbone (Scheme 1.1). 8 The corresponding copper complexes exhibited superior 
reactivity and selectivity profiles compared to those that contain an amino acid-based 
chiral ligand. Another type of carbene containing an alkoxy chelating group was reported 
by Mauduit et al9 with its application as a monodentate NHC−Cu complex capable of 
                                                
(3) May, T. L.; Dabrowski, J. A.; Villaume, M. T.; Hoveyda, A. H. Angew. Chem., Int. Ed. 2013, 52, 
8156−8159. 
(4) van Klaveren, M.; Persson, E. S. M.; Grove, D. M.; Bäckvall, J. E.; van Koten, G. Tetrahedron Lett. 
1995, 36, 3059‒3062. 
(5) ref. 1(f)-(l). For an additional review dedicated to widely used phosphoramidite ligands, see: (b) 
Teichert, J. F.; Feringa, B. L. Angew. Chem., Int. Ed. 2010, 49, 2486‒ 2528. 
(6) (a) Luchaco-Cullis, C.; Mizutani, H.; Murphy, K. E.; Hoveyda, A. H. Angew. Chem., Int. Ed. 2001, 40, 
1456‒1460. (b) Murphy, K. E.; Hoveyda; A. H. J. Am. Chem. Soc. 2003, 125, 4690–4691. (c) Kacprzynski, 
M. A.; Hoveyda, A. H. J. Am. Chem. Soc. 2004, 126, 10676‒10681. (d) Murphy, K. E.; Hoveyda, A. H. 
Org. Lett. 2005, 7, 1255‒1258. 
(7) Larsen, A. O.; Leu, W.; Oberhuber, C. N.; Campbell, J. E.; Hoveyda, A. H. J. Am. Chem. Soc. 2004, 
126, 11130‒11131. 
(8) Van Veldhuizen, J. J.; Campbell, J. E.; Guidici, R. E.; Hoveyda, A. H. J. Am. Chem. Soc. 2005, 127, 
6877‒6882. 
(9) (a) Martin, D.; Kehrli, S.; d’Augustin, M.; Clavier, H.; Mauduit, M.; Alexakis, A. J. Am. Chem. Soc. 
2006, 128, 8416‒8417. (b) Germain, N.; Magrez, M.; Kehrli, S.; Mauduit, M.; Alexakis, A. Eur. J. Org. 
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promoting EAS reactions with alkyl Grignard or zinc reagents. In 2007, we introduced a 
new type of NHC ligand bearing a sulfonate group (Scheme 1.1), which has 
demonstrated exceptional reactivity and selectivity for EAS reactions and ECA reactions.  
1.2. Catalytic Enantioselective Allylic Substitutions  
1.2.1 Catalytic Enantioselective Allylic Substitutions with Zn- and Al-Based 
Reagents 
In 2007, we explored EAS reactions utilizing our sulfonate-based NHC ligands to 
achieve high efficiency in EAS reactions with alkyl nucleophiles. We highlighted the 
unique reactivity of our sulfonate-based NHC using the performance of our phenoxide-
based NHC ligands as a benchmark.10 As shown in Scheme 1.1a, when we employed 
diethylzinc as the nucleophile, product 1.2 was generated in high efficiency, high SN2’ 
selectivity and high enantioselectivity for both phenoxide- and sulfonate-based NHC 
ligands.11 However, a drastic increase in reactivity was observed utilizing sulfonate-base 
NHC ligand 1.5 compared with phenoxide-based ligand 1.4 when we turned to a much 
underexplored class of substrates for Cu-catalyzed EAS reactions: a trisubstituted allylic 
phosphate bearing a β-alkyl substituent, 1.6. As shown in Scheme 1.1b, Me3Al, a more 
reactive nucleophile, was then examined in Cu-catalyzed EAS reactions. (Preliminary 
studies showed that no conversion of substrate 1.6 was observed with dimethylzinc under 
                                                                                                                                            
Chem. 2012, 5301‒5306. (c) Magrez, M.; Le Guen, Y.; Baslé, O.; Crévisy, C.; Mauduit, M. Chem. Eur. J. 
2013, 19, 1199‒1203. 
(10) Kacprzynski, M. A.; May, T. L.; Kazane, S. A.; Hoveyda, A. H. Angew. Chem., Int. Ed. 2007, 46, 
4554‒4558. 
(11)  NHC−Ag complexes were employed in the reaction instead of their corresponding imidazolinium 
salts due to inefficient formation of NHC−Cu catalyst with the use of alkyl Zn reagents. The deprotonation 
of imidazolinium salt with organozinc and organoaluminum reagents is not efficient for the formation of 
NHC−Cu complexes. 
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the previously reported catalytic system.12) We found that NHC−Cu complexes derived 
from phenoxide ligand 1.4 delivered the desired product 1.7 in only 15% conversion with 
a 9:1 ratio of 1.7:1.8. The low conversion suggests a possible match/mismatch scenario 
between the stereogenic centers on the substrate and chiral catalyst. However, sulfonate 
NHC 1.5 promoted the generation of 1.7 more efficiently: 95% conversion of 1.1 to 1.7 
was observed with >20:1 SN2’: SN2 selectivity, with a 1.5:1 ratio of 1.7:1.8 and 94.5:5.5 
er of 1.7.  
 
As shown in Scheme 1.2, when we applied these EAS reaction conditions en 
route to the synthesis of baconipyrone C, we found that NHC−Ag complex 1.5 delivers 
                                                
(12) Gillingham, D. G.; Hoveyda, A. H. Angew. Chem., Int. Ed. 2007, 46, 3860‒3864. 
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the desired methyl addition product 1.12 in 61% yield and >98:2 er. The stereoselective 
synthesis of 1.12 was followed by deprotection and oxidative cleavage of the double 
bond to generate 1.13, which can be further elaborated to the natural product 
baconipyrone C. The application demonstrated the utility of the EAS method. Sulfonate-
based NHC ligands promoted the EAS reactions with a sterically-demanding 
electrophiles, enabling the formation of two stereogenic center in one step. 
 
The majority of previous reports deal primarily with alkyl, and to a lesser extent 
aryl, metal reagent, as nucleophiles. EAS reactions with alkenyl nucleophiles are far less 
prevalent.  
Our group started to explore alkenyl aluminum reagents as nucleophiles due to 
their ease of accessibility and functional group tolerance (compared to organolithium13 
and Grignard reagents). In 2009, we reported the formation of tertiary stereogenic centers 
through the addition of E-alkenyl aluminum reagent to trisubstituted allylic.14 As shown 
in Scheme 1.3, neither the use of different copper salts or varying the amount of the 
copper salt lead to the efficient formation of desired product. Moreover, the use of 
                                                
(13) Teichert, J. F.; Feringa, B. L. Angew. Chem., Int. Ed. 2010, 49, 2486‒2528. 
(14) Lee, Y.; Akiyama, K.; Gillingham, D. G.; Brown, M. K.; Hoveyda, A. H. J. Am. Chem. Soc. 2008, 
130, 446–447. 
Scheme 1.2. Cu-Catalyzed EAS reactions with Trimethylaluminum and Application to the Synthesis of Baconipyrone C
OPO(OEt)2
1.9
EtOEt
OPO(OEt)2 7.5 mol % 1.5
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NHC−Cu complex derived from copper salt and either NHC−Ag complex 1.18 or 1.4 led 
to <2% detection of the desired product. Only when the reaction was performed in the 
presence of a sulfonate-containing NHC−Cu complex, generated in situ from NHC−Ag 
complex 1.5 and CuCl2•H2O, was 1.15 obtained in over 87% yield with >98% SN2’ 
selectivity and >99:1 enantiomeric ratio.  This case exhibited the uniquely high reactivity 
of sulfonate-containing NHCs in promoting the formation of the desired branched 
product in enantioselective allylic substitutions.  
 
 
Alkyl-substituted alkenylaluminums can be prepared by reaction of alkynes with 
dibal−H15 and used in EAS reactions directly. However, the generation of aryl-substituted 
reagents suffer from competitive alkyne deprotonation, affording significant amounts of 
                                                
(15) For a review on hydroaluminations of alkynes and alkenes, see: Eisch, J. J. In ComprehensiVe Organic 
Synthesis; Trost, B. M., Fleming, I., Schreiber, S. L., Eds.; Pergamon, Oxford, 1991; Vol. 8, pp 733. 
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the corresponding alkynylaluminums; the alkynyl metal reagent may lead to the 
formation of the undesired alkynyl addition product in EAS reactions. To address this 
issue, our group developed a Ni-catalyzed method to promote the stereoselective 
synthesis of aryl-substituted alkenylaluminum reagents.16 As shown in Scheme 1.4, with 
3.0 mol % of monodentate Ni(PPh3)2Cl2 and dibal−H, phenylacetylene undergoes 
hydroalumination in two hours at 22 ºC with 93:7 β:α selectivity, and no detectable 
amount of the corresponding alkynylaluminum reagent is formed. 1.19 can then be used 
directly in allylic substitution reactions to generate skipped diene products with high 
efficiency, site-, and enantioselectivity. Switching to a bidentate nickel catalyst, 
Ni(dppp)Cl2, the α-isomer 1.20 can be formed with complete site selectivity (>98:2 α:β). 
The utility of the method was illustrated in the synthesis of bakuchiol. 17 
Alkenylaluminum 1.22 was afforded under the reported conditions and employed in an 
EAS reactions with geraniol derived allylic phosphate 1.24 to generate a quaternary 
carbon stereogenic center, catalyzed by NHC−Cu complex derived from NHC−Ag 
complex 1.23 containing an ortho-substituted N-aryl group. After demethylation, the 
EAS product furnished bakuchiol. 
                                                
(16) Gao. F.; Hoveyda, A. H. J. Am. Chem. Soc. 2010, 132, 10961–10963. 
(17) Gao, F.; McGrath, K. P.; Lee, Y.; Hoveyda, A. H. J. Am. Chem. Soc. 2010, 132, 14315−14320. 
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At this stage, we turned to X-ray crystallography in an effort to elucidate the 
unique behavior of the sulfonate-containing NHC−Cu complex. However, the X-ray 
crystal structure of the sulfonate-based NHC−Cu(I) complex could not be obtained, 
instead crystallographic analysis was carried out using Zn and Al-based analogs 1.25 and 
1.26 (Figure 1.1).18 Unexpectedly, in both complexes, NHC serves as a bidentate ligand 
in which the sulfonate coordinates to the metal center, and the sulfonate group and 
adjacent phenyl group on the backbone are in a syn orientation. It appears that chelation 
of the sulfonate with the Zn center in 1.25 causes tilting of the N-aryl unit 
(Ccarbene−N−C−C dihedral angle = 49.5°) such that the ortho unit of the same substituent 
                                                
(18) Lee, Y.; Li, B.; Hoveyda, A. H. J. Am. Chem. Soc. 2009, 131, 11625–11633. 
1.3 equiv dibal–H, 22 °C, 2 h
Ph Al(i-Bu)2
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93% β,  <2% alkynyl–Al
3.0 mol % Ni(dppp)Cl2
>98% α,  <2% alkynyl–Al
1.3 equiv dibal–H, 22 °C, 2 h
MeO
1.3 equiv dibal–H,
thf, 4 °C, 12 h
Al(i-Bu)2
MeO
Me OPO(OEt)2
Me Me
Me
Me Me
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72% overall yield, >98% SN2’,
>98% E, 91:9 er
HO
2. MeMgI
5.0 mol % CuCl2•2H2O,
thf, –15 °C, 6 h
2.0 mol %
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Scheme 1.4. EAS Reaction to Generate A Quaternary Stereogenic Center and Synthesis of Bakuchiol
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(H1 in 1.25, Scheme 2) and the backbone of the N-heterocyclic carbene (H2 in 1.25) are 
brought into close proximity, which is supported by the NOE studies. 
  
 
A model shown in Figure 1.2 was proposed based on the X-ray crystallography 
data.17 Chelation of the cationic aluminum species (Al(i-Bu)2+) counter to the equatorial 
oxygen of the sulfonate and phosphate of the substrate serves to increase the 
electrophilicity of the phosphate and facilitate substrate binding to allow for maximum 
orbital overlap. However, in the minor mode of addition, copper coordinates to the 
opposite face of the olefin, engendering steric repulsion between the large aryl ring of the 
substrate (RL) and the ortho substituent (i-Pr group) on the N-aryl group. As a result, the 
aluminum chelation is absent in this pathway which leads to a less organized transition 
state, due to geometric constraints. 
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1.2.2 Catalytic Enantioselective Allylic Substitutions with Boron-Based 
Reagents 
Despite the advances provided by the EAS methods developed in our laboratory, 
there are still fundamental limitations employing organoaluminum reagents: 1) EAS 
reactions involving this class of nucleophiles normally require cryogenic temperatures, 
limiting the industrial utility of current methods; 2) the reagent must be generated in situ 
and is not stable to prolonged storage; 3) alkenylaluminums are not compatible with 
several functional groups, such as carboxylic aldehydes and esters. 
To remedy these limitations, we decided to employ alkenyl boron-based reagents 
in catalytic EAS reactions. However, this design raised a few questions. One issue relates 
to the relatively low reactivity of organoborons. For example, organoaluminum as 
nucleophiles allows EAS reactions to be performed at lower temperatures, leading to an 
improvement of enantioselectivity. However, reactions utilizing organoboron might 
require high temperature to achieve efficient formation of the products. The second 
problem is that the alkenyl−Cu species might not be efficiently generated with a 
substantially less nucleophilic organoboron. 
We surmised the presence of a metal alkoxide, such as NaOMe19, should allow 
efficient formation of NHC−Cu−allene via alkenylboron. We found that imidazolinium 
salts can be deprotonated in the presence of NaOMe and thus can be employed to 
generate the corresponding sulfonate NHC−Cu complex in situ. 5.0 mol % of sulfonate-
containing NHC−Cu catalyst derived from 1.30 promotes the formation of a quaternary 
carbon stereogenic center, affording skipped diene 1.29 in 87% yield, over 98% site-
                                                
(19) Ohishi, T.; Nishiura, M.; Hou, Z. Angew. Chem., Int. Ed. 2008, 47, 5792–5795. 
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selectivity with 73:27 er at 60 °C for 24 h.20 We found that incorporation of another 
phenyl substituent on the NHC backbone as in 1.31,  caused the N-aryl ring to rotate 
away from the proximal phenyl group to avoid the steric interaction between the phenyl 
group and the ortho substituent. This conformational change of NHC ligand improved the 
enantioselectivity of product to 90:10 er as in 1.31. EAS reactions furnished the desired 
product in 86% yield, 98% SN2’ selectivity with >98% enantioselectivity when increasing 
the size of the ortho substituent on the N-aryl ring of NHC ligand from Me to i-Pr group 
as in 1.32. Of note, EAS reactions catalyzed by NHC−Cu complexes derived from non-
sulfonate-based NHCs also favored the formation of branched product, despite with 
lower site- and enantioselectivities (Scheme 1.5, 1.33). The utility of this method is 
illustrated through the synthesis of Pummerer ketone utilizing organoboron reagent 1.34. 
The corresponding organoaluminum reagent is not easily accessible, thus highlighting the 
robustness of this class of nucleophiles. 
                                                
(20) Gao, F.; Carr, J. L.; Hoveyda, A. H. Angew. Chem. Int. Ed. 2012, 51, 6613–6617. 
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As shown above, the degree of enantioselectivity can be tuned by changing the 
substitution pattern of the backbone or increasing the size of the ortho substituent. 
However, this strategy did not apply to all the cases. For example, when we sought to 
establish EAS reactions utilizing disubstituted allylic phosphates in order to generate 
tertiary carbon stereogenic centers21 with alkenylboron reagents, NHC ligands with ortho 
substitution pattern no longer delivered the product in high enantioselectivity. As shown 
in Scheme 1.6, reactions delivered skipped diene 1.38 with less than 70% 
enantioselectivity in the presence of ortho-substituted NHC−Cu complex derived from 
the 1.31 or 1.32. However, 1.38 was furnished with an increase in enantioselectivity by 
employing a new class of sulfonate-based NHC ligand with meta-substitution pattern on 
the N-aryl group (91:9 vs. 34:66 er, 1.39 vs. 1.32). The NHC−Cu complex derived from 
sulfonate-containing imidazolinium salt 1.40 with meta-substitution delivered the highest 
                                                
(21) Gao, F.; Carr, J. L.; Hoveyda, A. H. J. Am. Chem. Soc. 2014, 136, 2149−2161. 
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enantioselectivity. Of note, the meta-substituted NHC ligands (Scheme 1.6, 1.39 and 
1.40) promoted the generation of the (R)-enantiomer as the major product, whereas the 
reaction catalyzed by NHC ligands with 2,6-substitution afforded the (S)-enantiomer (see 
1.31, 1.32). 
  
Both meta- and ortho-substituted NHC ligands were explored in EAS reactions 
with allenyl boron reagent 1.41.22 A similar phenomenon was also observed; as shown in 
Scheme 1.7, the (S)-branched products (4:96 R:S and 33:67 R:S, 1.42 and 1.46) were 
obtained utilizing meta-substituted NHC ligand 1.40 while ortho-substituted NHC 1.31 
favored the formation of the opposite enantiomer (96:4 R:S and 67:33 R:S, 1.42 and 
1.46). Moreover, while the meta-substituted NHC ligand 1.40 was the optimal ligand for 
EAS reactions with 1,2-disubstituted allylic phosphate 1.36 (79% yield, 96% SN2’, 4:96 
R:S), reactions catalyzed by the NHC with ortho-substitution 1.31 afforded desired 
product 1.46 with quaternary carbon stereogenic centers from trisubstituted substrates 
with high enantioselectivity (96:4 R:S),. Unlike when an alkenylboron reagent was used 
as the nucleophile, only NHC−Cu complexes derived from sulfonate-containing 
                                                
 (22) Jung, B.; Hoveyda, A. H. J. Am. Chem. Soc. 2012, 134, 1490–1493. 
Ph(pin)B n-Hex
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           70% yield,
98:2 SN2':SN2, 34:66 er
          90% yield,
>98:2 SN2':SN2, 41:59 er
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2.0 equiv NaOMe, thf, 22 °C, 24 h
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Scheme 1.6. Generation of Tertiary Carbon Stereogenic Centers with an Alkenylboron Reagent
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imidazolinium salts lead to the dominant formation of branched product (SN2’ 
selectivity); non-sulfonate-containing NHC ligands favors the generation of the linear 
product (<2:>98 SN2:SN2, with 1.43, 1.44). We believe that the highly efficient 
background reaction catalyzed by free CuCl leads to dominant formation of undesired 
linear products (SN2 selectivity). Only the sulfonate-based NHC−Cu complex can 
catalyze the SN2’ reaction to outcompete the undesired background reaction.  
 
In 2015, we published the catalytic EAS reactions with di- and trisubstituted 
allylic phosphates using propargyl boron reagent 1.47 (Scheme 1.8).23 Again, only 
                                                
(23) Shi, Y.; Jung, B.; Torker, S.; Hoveyda, A. H. J. Am. Chem. Soc. 2015, 137, 8948–8964. 
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sulfonate-based NHCs promoted formation of the desired branched product 1.48 in the 
presence of an appropriate NHC−Ag complex, with meta-substituted NHC−Ag complex 
1.49 proving to be optimal (75% yield, 97% SN2’, 97:3 R:S). However, unlike cases 
utilizing alkenyl and allenyl boron-based nucleophiles, the optimal ligand to facilitate 
formation of product 1.50 with a quaternary carbon stereogenic center utilizing propargyl 
boron 1.47 is the NHC derived from 1.49 with meta-substitution (84% yield, 94% SN2’, 
92:8 R:S), instead of ortho-substituted NHC−Ag complexes. 
 
1.2.3 Mechanistic Studies Assisted by DFT Calculations 
5.5 mol % NHC-Ag complex,
10 mol % CuCl
1.5 equiv
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At this point, we wanted to elucidate the reaction mechanism. Was the model we 
proposed valid, in which sulfonate NHCs chelated to the copper and delivered the SN2’ 
product? Why in some cases did sulfonate-based NHCs bearing meta substituents 
outperform those with ortho substituents? Could we develop a set of guidelines to follow 
in order to choose the proper NHC ligand for a certain substrate and nucleophile 
combination? We envisioned that with the assistance of computational analysis, we might 
shed mechanistic insight onto the the transformation and allow the opportunity for 
rational design of catalysts. 
1.2.3.1 Elucidation of the Coordination Sphere of the Sulfonate-Based NHC−Cu 
Complexes 
First, the ground states of sulfonate-bearing NHC−Cu complexes were analyzed 
in order to evaluate our previous hypothesis (as in 1.54) which sulfonate group chelated 
to Cu center. As shown in Figure 1.3, the free energy of NHC−Cu complex 1.51 was 7.7 
kcal/mol, in which NHC served as a bidentate ligand with the anionic sulfonate syn to the 
proximal phenyl group on the NHC backbone. When NHC served as a bidentate ligand in 
which the sulfonate group was in anti orientation with the phenyl group (see 1.52), the 
relative energy dropped to 6.1 kcal/mol. The monodentate NHC−Cu complex 1.53 in 
which the sulfonate group situated anti to the proximal phenyl group was the lowest 
energy ground state. Unexpectedly, DFT calculations24 indicated that it was unlikely that 
sulfonate-containing NHC ligands served as bidentate ligands for Cu, as proposed in our 
previous model 1.54. Thus a new model 1.55 was proposed, in which the sulfonate group 
sat anti to the phenyl group and coordinated to the sodium cation instead of the copper. In 
                                                
(24) See Chapter 2, 2.5 Experimentals. 
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this new model, the sodium cation bridged between the sulfonate and the substrate 
phosphate unit.  
 
As shown in Figure 1.4, the sulfonate chelation to metal made NHC−Zn complex 
1.56 slightly higher (1.4 kcal/mol) in energy than 1.57, while for their copper 
counterparts, 1.52 was much more unstable than 1.53 (6.1 kcal/mol of free energy 
difference). The much larger energy gap of two NHC−Zn complexes 1.56 and 1.57 
compared with NHC−Cu 1.52 and 1.53 could be explained by the significantly greater 
Lewis acidity of Zn(II) vs. Cu(I). It also might account for different favorable 
coordination profiles for their sulfonate NHC−metal complexes. As we found, in 
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NHC−Ag complex 1.58, the sulfonate group also adopted an anti orientation with the 
proximal phenyl group on the NHC backbone without chelating to the metal center.  This 
X-ray data25 also indicates that the sulfonate-based NHC ligands are more likely to serve 
as a monodentate ligand for copper with the sulfonate group sitting anti to the adjacent 
phenyl substituent on the catalyst backbone as shown in 1.55, due to the similar Lewis 
acidity of Cu(I) and Ag(I). 
 
We are fully aware that the energy profiles of the ground states do not have any 
implication on the energies of the transition states. All possible transition states were 
                                                
(25) Brown, M. K.; May, T. L.; Baxter, C. A.; Hoveyda, A. H. Angew Chem. Int. Ed. 2008, 46, 1097–1100. 
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taken into consideration. As shown in Scheme 1.9, when computed in solution, the results 
indicate that it is more plausible that sulfonate-containing NHC−Cu species catalyze the 
reaction through a monodentate coordination structure. In other words, linear Cu(I) 
species I can form bent Cu(I) complex II, which can then undergo an oxidative addition 
to form III, which is consistent with the free energy profile for the group state of 
NHC−Cu complexes. A new stereochemical model II was proposed based on DFT 
calculations. The sulfonate group was oriented anti to the proximal phenyl group on the 
backbone. In this conformer, the nucleophilic group L on the copper was disfavored from 
being positioned on the back of the copper center due to steric congestion. Since L 
occupied the front binding site, the substrate could only approach the copper center from 
the rear. In order to minimize the lone pair repulsion between the sulfonate and phosphate 
groups, the sodium cation served to bridge between the two and minimize the transition 
state energy by reducing charge repulsion as well as stabilize the developing negative 
charge on the phosphate group. During oxidative insertion, as shown from II to III, the 
formation of the incipient Cu−C bond and the rupture of the C−O bond occurred anti to 
one another instead of syn, as we had previously recently proposed for NHC−Cu 
catalyzed EAS reactions with B(pin)-substituted allyl nucleophiles in 2014.26 
 
                                                
(26) Meng, F.; McGrath, K. P.; Hoveyda, A. H. Nature 2014, 513, 367–374. 
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As shown in 1.59 (Scheme 1.10), it was evident that the cation played a crucial 
role in obtaining high SN2’ selectivity, because it promotes efficient substrate binding 
through a second point of contact.24 To challenge this model, different cation metal 
species and allylic electrophiles with different leaving groups were examined under the 
EAS reaction conditions. When decreasing the Lewis acidity of the counter ion, less 
undesired linear (SN2) product was generated (NaOMe vs. KOMe, 97:3 vs. 85:15 SN2’: 
SN2 selectivity). Changing the leaving group to planar carbonate and acetate, which 
might be too rigid to participate the cation bridge, also led to much lower yield of the 
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SN2’ addition product with a drastic decrease of branched selectivity (see 1.60, 1.61). 
These findings also support the plausibility of the current model. 
 
As shown in Scheme 1.11, DFT calculation supported during oxidation insertion, 
from 1.62 to 1.63, the formation of the incipient Cu−C bond and the rupture of the C−O 
bond occurred anti to one another. We also performed deuterium-labeled experiments to 
further challenge our model with sulfonate-containing NHC ligands with meta-
substitution and ortho-substitution derived from 1.49 and 1.5. EAS reactions with the 
enantiomerically-enriched allylic phosphate 1.64 in the presence of 1.49 leads to a 96:4 
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E:Z mixture of (R)-1.66 through Cu-(III) intermediate 1.65 while the reaction catalyzed 
by NHC−Cu generated from 1.5 affords a 32:68 E:Z mixture of (S)-1.68 through Cu-(III) 
intermediate 1.67, consistent with the enantiomeric ratio gained through the usage of a 
non-deuterated substrate. (cf. 97:3 er with 1.49 and 31:69 er with 1.5 in Scheme 1.8).  
 
The sulfonate NHC afforded unique reactivity in a series of EAS reactions with a 
series of boron-based nucleophiles when compared to other NHC ligands without an 
anionic anchoring group, such as 1.71, or NHC ligands with a hydroxyl group as an 
anchoring group, like 1.72. As shown in Scheme 1.12, to promote the generation of 
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branched EAS product 1.70 containing an alkyl B(pin) group,27 we examined the EAS 
reaction with methylenediboron reagent 1.69. In this case, the sulfonate group is crucial 
for high SN2’ selectivity since 1.71 and 1.72 mainly deliver the linear SN2 product.  
From previous studies, the sulfonate group had been shown to engage in a 
secondary binding interaction with the substrate, which is believed to promote SN2’ 
reactivity. The relatively low Lewis acidity and spherical or symmetrical structure of a 
sulfonate group contributed to its unique reactivity. The greater Lewis basicity of the 
alkoxy group in 1.72 might prevent efficient formation of a bridging interaction since 
B(pin) group could compete with the sodium cation to form a B−O bond (see 1.73). The 
symmetrical geometry of the sulfonate group was crucial to the transition state since 
another oxygen could readily participate in the formation of the cation bridge if the 
interaction was disrupted.  
                                                
(27) Shi, Y.; Hoveyda, A. H. Angew. Chem. Int. Ed. 2016, 55, 3455–3458. 
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1.2.3.2 Stereochemical Models for EAS Reactions Promoted by Sulfonate-
Containing NHC Ligands with Ortho and Meta Substitution Patterns 
We sought to determine why sulfonate-based NHC ligands bearing meta- and 
ortho-substitution pattern yielded opposite enantiomers of product. We started by 
exploring the stereochemical model for EAS reactions employing a NHC−Cu complex 
with meta-substitution. In both the major and minor pathways, the sodium cation served 
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as a secondary binding site between the substrate and the copper catalyst. Additionally, in 
both pathways, disubstituted allylic phosphate 1.37 approached the copper center from 
the bottom and the rear of the complex, with its large phenyl group pointing to the left 
(1.74) or right (1.75). In the latter mode of binding, the transition state was higher in 
energy due to the strong steric repulsion between the bulky triisopropylphenyl (Trip) 
group on the meta position, while this destabilizing interaction was absent in the model 
for the major mode of addition. This rationale was supported when a decrease in the er 
was affected by reducing the size of the meta-substituent (compare 83:17 er with 1.40, 
92:8 er with 1.39, Scheme 1.6). 
 
In order to gain more insight into the reaction profile of NHC ligands with an 
ortho-substituted N-aryl group, we examined the stereochemical model for EAS with 
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trisubstituted allylic phosphates and alkenyl boron reagents (Scheme 1.14).  Similar to the 
case with the formation of tertiary stereogenic centers, the sodium cation bridge was also 
found to engage in both the major and minor mode of addition for the generation of the 
SN2’ product bearing a quaternary stereogenic center. However, in transition state 1.76 
leading to the major enantiomer, the large o-OMe-phenyl group (compared to the Me 
group) on the substrate was pointing to the right while in the transition state 1.77 
(accounting for the formation of the minor enantiomer), the o-OMe-phenyl was oriented 
to the left. Thus, the opposite enantiomer of product was obtained with the use of 
NHC−Cu complex derived from 1.32 (Scheme 1.5) in comparison to EAS reactions 
employing a meta-substituted NHC ligand as delineated in Scheme 1.5. The minor mode 
of addition 1.77 suffered from the steric interaction between the i-Pr group on the 6-
position and the methylene group on the phosphate. However, the steric strain could not 
be alleviated by rotating the N-aryl ring to the front because of steric congestion caused 
by the proximal alkenyl nucleophile R to the i-Pr group on the 2-position. Thus the 2.2 
kcal/mol free energy difference led to the high er observed in Scheme 1.5. 
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With the stereochemical models in hand, we tried to develop a method to inform 
proper selection of NHC ligands for each transformation. In most cases, in order to 
achieve high enantioselectivity, EAS reactions required the use of an NHC ligand with 
meta-substitution to generate tertiary carbon stereogenic centers; while quaternary 
stereogenic centers required an NHC−Cu complex with ortho substitution. However, this 
Scheme 1.14. Stereochemical Model for EAS Reactions with Alkenyl B(pin) Reagents to Generate Quaternary 
Stereogenic Centers
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guideline did not apply to the case of EAS methods with propargyl boron reagent 1.47. 
To furnish quaternary stereogenic centers with trisubstituted substrates with high 
enantioselectivity, meta-substituted NHC ligand required to be used in combination with 
propargyl B(pin) reagent 1.47.  
EAS with 1,2-disubstituted allylic phosphates and alkenyl boron reagents was 
studied as a starting point to understand the use of meta-substituted NHC ligand for the 
construction of tertiary stereogenic center. A simplified stereochemical model was 
proposed to explain higher enantiomeric ratios obtained with ligand 1.40 versus 1.31 
(Scheme 1.15). As been explained above, the bulky Trip group on the meta position is 
crucial to obtain the high energy gap between the two possible modes of addition, thus 
contributing to the high er observed in EAS reactions to generate tertiary carbon 
stereogenic centers. However, when the ortho-substituted 1.31 was used in alkenyl 
additions to disubstituted substrate 1.37, the previously favored mode of addition is 
destabilized due to the introduction of the steric interaction between the ortho substituent 
on the 6 position and the methylene group attached to the phosphate in 1.80. However, 
due to the absence of the methyl group on the allylic phosphate, the energy difference 
between 1.80 and 1.81 was not large enough to induce high enantioselectivity with the 
combination of the ortho-substituted ligand and the disubstituted substrate. Thus in this 
case, EAS reactions catalyzed by ligand 1.39 with meta-substitution afforded the product 
in high er.  
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To explain why an ortho-substituted NHC ligand was optimal for the construction 
of quaternary carbon stereogenic centers in EAS reactions, we applied the simplified 
model to the trisubstituted substrates as shown in Scheme 1.16. In this case, the optimal 
ligand was no longer the meta-substituted NHC (1.40) due to the undesirable interaction 
between the additional methyl group on the substrate and 5-substituent on the catalyst in 
the major pathway (1.82), which afforded to a smaller energy gap difference (compared 
to the transition state 1.83 in the minor pathway). However, when employing the ortho-
substituted ligand, the steric interaction between the methyl group with the alkenyl 
nucleophile in 1.85 caused the N-aryl ring to rotate to the rear to yield the other 
conformer 1.84. Thus, this mode of addition (1.84) suffered even more severe steric 
repulsion between the other ortho-substituent and the methylene group on the allylic 
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phosphate. In other words, the ortho-substituted NHC ligand is necessary for the 
formation of product with quaternary stereogenic centers in high enantioselectivity. 
 
It was surprising to find that in the case of propargyl additions to trisubstituted 
allylic phosphates, the optimal ligand was the meta-substituted ligand 1.49 (Scheme 
1.17), which delivered lower enantioselectivity in most cases. 92:8 er was obtained in the 
formation of product 1.50 with a quaternary stereogenic center albeit with slightly lower 
er versus the formation of tertiary stereogenic centers as in 1.48. The major mode of 
addition 1.87 is energetically favored over the minor mode of addition 1.88 due to the 
absence of the steric repulsion between the phenyl group and the substituent on the 5-
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position on N-aryl ring. However, in this case, the optimal ligand is no longer ortho-
substituted ligand 1.5. Our rationale for the lower enantiomeric ratio obtained with 1.5 is 
that the linear propargyl nucleophile is less sterically demanding (compared to the bulky 
alkenyl group), which reduces the steric strain in the front right quadrant of transition 
state 1.90. Due to the flexibility of the methylene group of the propargyl moiety, the 
ortho-substituent on the NHC is well accommodated when conformer 1.89 rotates to 
form 1.90. Thus, the energy of the transition state in the minor pathway (1.90) is not 
destabilized enough compared with 1.91, the transition state leading to the major 
enantiomer, to afford high enantioselectivity. In this way, the ortho-substituent can no 
longer deliver the highest enantioselectivity.  
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1.3. Catalytic Enantioselective Conjugate Additions 
Since DFT calculations can provide detailed mechanistic insight when used in 
combination with laboratory experiments, we attempted to gain a more complete 
understanding of the stereochemical model for sulfonate-based NHC−Cu-catalyzed 
enantioselective conjugate addition (ECA).  
1.3.1 Stereochemical Model for Cyclic Enones  
5.0 mol % CuCl
1.2 equiv NaOMe
thf, 22 °C, 6 h
OPO(OEt)2
H
R
Me3Si
B(pin)
SiMe3
R R
Me
SiMe3
75% yield, 97% SN2',
97:3 R:S
84% yield, 94% SN2',
92:8 R:S
2.75 mol %
Na+ O P(OEt)2
O
N
Ph Ph
NSO O–
O
Cu
Ph Me
H
Na+ O P(OEt)2
O
N
Ph Ph
NSO O–
O
Cu
Ph H
H
Na+ O P(OEt)2
O
N
Ph Ph
NSO O–
O
Cu
Ph Me
H
O P(OEt)2
O
N
Ph Ph
NSO O–
O
Cu
Ph
Me
H
Na+
steric pressure
easily relieved
H
Me
Ph
O
(EtO)2P
O
N
Ph Ph
NSO O–
O
Cu
Na+
less energy gap,
lower er
Scheme 1.17. Comparison of Stereochemical Models of Ortho- and Meta-N-Aryl NHC in EAS Reactions with a 
Propargylboron Reagent
1.37 or 1.45
1.47
1.48 1.50
1.87 1.88
1.89 1.90 1.91
1.49, Ar = 2,4,6-(i-Pr)3C6H2
N
Ph
S
O
N
Ag
O
O
Ag
Ph
Ar
Ar
slightly favored
or
Chapter 1, Page 33 
 
 
In 2008, our group reported the enantioselective conjugate addition of α-silyl 
alkenylaluminum reagent 1.93 to cyclic enones.28 As shown in Scheme 1.17, 1.94 was 
obtained in 76% yield with 93:7 er catalyzed by an NHC−Cu complex derived from 1.96. 
Decreasing the size of the ortho substituent to methyl groups on the N-aryl ring led to 
90:10 er (1.95), while increasing the size of the ortho substituent to isopropyl (see 1.23) 
completely eroded the enantioselectivity. Incorporation of additional phenyl group on the 
backbone of the NHC also had a detrimental effect on enantioselectivity (1.5). 
 
The stereochemical model in this reaction was also generated through DFT 
calculations. As shown in Figure 1.5, the sulfonate group again served as a secondary 
binding site for the substrate. This aluminum bridge through the sulfonate group on the 
NHC accounted for the high reactivity and enantioselectivity obtained in ECA reactions 
promoted by this type of ligand. The interaction between the aluminum species and the 
sulfonate group was covalent bond instead of an electrostatic interaction. Since cyclic 
enones, such as 1.92, were more rigid substrates as compared to allylic phosphates, the 
                                                
(28) May, T. L.; Dabrowski, J. A.; Hoveyda, A. H. J. Am. Chem. Soc. 2011, 133, 736−739. 
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secondary binding greatly limited the possible modes of approach for the substrate. In 
both modes of addition, the enone and the alkenyl group were situated in different 
quadrants, with the large silyl group on the nucleophile pointing away from the enone 
(see 1.97 and 1.98).  
It was surprising to find that, in the major pathway, the cyclic enone sits beneath 
the ortho-substituted N-aryl ring, while in the minor pathway, the substrate 
accommodates the empty space under the sulfonate-bearing N-aryl group. Initially, it 
seemed counterintuitive that the substrate would prefer to stay under the more sterically 
hindered N-aryl ring in the major pathway 1.97. However, we now believe that three 
factors contribute to the large energetic difference between the major and minor pathway. 
As shown in Figure 1.5, in the major pathway, the sulfonate N-aryl ring is oriented 
towards the rear of the complex in a configuration that favors formation of the aluminum 
bridge with the enone. This causes the aromatic ring to point away from the large silyl 
group. In the minor pathway, the sulfonate rotates upwards to accommodate the Al bridge. 
This rotation of the sulfonate phenyl ring causes the large silyl group to relocate to the 
right of the complex, where it suffers from steric repulsion with ortho-substituted N-aryl 
ring. Thus, it led to large energy gap between 1.97 and 1.98. 
The Al−O(sulfonate) bond and the two Al−Me bonds are pointing out of the plane 
of the page. The other sulfonate oxygen (O1) can donate its lone pair of electrons to the 
σ* Al−O(enone) to stabilize the transition state structure in the major pathway. Of note, 
this stabilizing interaction is absent due to the orientation of O1 in the minor pathway 
1.98. Another factor leading to the energetic difference between the major/minor 
pathways comes from the steric interaction between the Me group on the aluminum 
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bridge with the enone α-position C1. From Scheme 1.5, we can tell that there is a big 
steric effect depending on the orientation of the Al−Me group with enone C3; the A(1,3) 
interaction between the two groups raises the free energy in 1.98. 
The above model is in good agreement with the ligand screening data, which 
shows that increasing the size of the ortho substituent from Me to Et (Scheme 1.18, 1.95 
and 1.96) contributes to an increased energetic difference. This is the result of a more 
severe interaction between the silyl moiety with the ortho substituent in the minor 
pathway 1.98. However, increasing the size of the ortho substituent destabilizes the major 
transition state when an isopropyl group is installed. 
 
In the case of ECA reactions with organoaluminum reagents, the character of the 
metal cation bridge possesses covalent bonding character. As has been shown in the 
scheme above, the covalent nature of the secondary binding site leads to a more rigid 
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transition state. Thus, better differentiation between the two modes of addition affords the 
high enantioselectivity. 
1.3.2 The Bridging Metal Species is Important  
As shown in Scheme 1.19, ECA reactions to a β-ester cyclic enone 1.99 catalyzed 
by NHC−Cu complex derived from 1.5 employing diethylzinc to afford product (R)-
1.100 in 83% yield and 94:6 er.29 To our surprise, when switching the reagent to 
triethylaluminum,30 the other enantiomer (S)-1.100 was obtained in 76% yield and 
94.5:5.5 er. The complete reversal of enantioselectivity was observed when different 
organometallic metal reagents were used.  
 
As shown in Figure 1.6, when the reaction was carried out with triethylaluminum, 
DFT calculations show that the major and minor pathway 1.101 and 1.102 share a similar 
scenario as those in Figure 1.6. 1.102 suffers from the steric interaction between the alkyl 
                                                
(29) Brown, M. K.; May, T. L.; Baxter, C. A.; Hoveyda, A. H. Angew. Chem., Int. Ed. 2007, 46, 1097–
1100. 
(30) May, T. L.; Brown, M. K.; Hoveyda, A. H. Angew. Chem., Int. Ed. 2008, 47, 7358–7362. 
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substituent on Al and the enone backbone. Thus, the enone prefers to approach the Cu 
center from the rear of the complex shown in 1.102. However, when the bridging species 
is alkylzinc, the Zn bridge adopts a trigonal planar coordination sphere instead of the 
tetrahedral coordination sphere of the Al bridge due to the relatively low Lewis acidity of 
the zinc. (Organozinc species do not usually adopt a tetrahedral coordination sphere with 
one solvent molecule occupying the last coordination site, especially in tBuOMe). Thus, 
when enone 1.99 adopts a similar pathway as it does in 1.101, the Zn bridge suffers from 
the steric interaction between the phenyl group on the NHC backbone and the ortho 
substituent on the N-aryl ring of the NHC. This mode of addition 1.104 is no longer 
favored due to the absence of A(1,3) interaction in the major pathway 1.103. Thus in this 
case, the ECA reaction prefers to form the C−C bond as in mode 1.103 with the lower 
energy barrier. 
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1.4. Catalytic Enantioselective Cu−B Additions 
Our group has also explored enantioselective Cu−B additions to activated olefins 
employing sulfonate-bearing NHC ligands. In these cases, sulfonate NHC ligands afford 
uniquely high enantioselectivity. Unlike NHC−Cu catalyzed EAS and ECA reactions 
involving the use of activated olefins with a Lewis basic binding site, the substrates in 
Cu−B additions generally do not contain an additional Lewis basic binding site. 
Therefore, the stereochemical model involving a cation bridge between the substrate and 
the sulfonate is no longer relevant. DFT calculations is required to elucidate the role of 
sulfonate-based NHC in Cu−B addition reactions. 
As shown in Scheme 1.20, ligand 1.106 led to secondary alkyl B(pin) 1.107 in 
80% yield, with over 98:2 site-selectivity and 99:1 er.31 A stereochemical model was 
proposed to explain the high enantioselectivity. In this case, the sodium cation no longer 
bridges the catalyst and the substrate, instead it coordinates to the sulfonate group and the 
B(pin) nucleophile on the copper center. This facilitates the generation of a bent Cu(I) 
structure, which is crucial for the binding of the olefin. Generally, this geometric 
contortion causes the energy of the Cu(I) complex to increase by 20 kcal/mol, but is 
compensated in this case by the formation of Cu-π-complex. In the major mode of 
addition, 1.108, the B(pin) group can be easily accommodated in the rear empty space. 
However, in the minor pathway 1.109, the phenyl group on the substrate is situated to 
avoid repulsive steric interactions with the ortho substituent on the N-aryl ring. This 
leaves the B(pin) moiety beneath the large isopropyl group in the back. This destabilizing 
interaction leads to a large energetic difference, generating the high enantioselectivity. 
                                                
(31) Lee, Y.; Hoveyda, A. H. J. Am. Chem. Soc. 2009, 131, 3160−3161. 
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In 2011, we reported a method involving Cu-B addition to E-alkenyl B(pin) 1.110 
to generate 1,2-vincinal diboron product 1.111 as shown in Scheme 1.21.32 In this case 
the substrate contains another B(pin) to serve as a secondary binding site with the 
sodium. However, it was interesting to find out that only the B(pin) moiety derived from 
B2(pin)2 participates in the cationic bridge, rather than the B(pin) group on the substrate. 
 
1.5. Catalytic Enantioselective Multicomponent Reactions  
                                                
(32) Lee, Y.; Jang, H.; Hoveyda, A. H. J. Am. Chem. Soc. 2009, 131, 18234−18235. 
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As more stereochemical models have been constructed through the help of DFT 
calculations, sulfonate NHC ligands have shown to be exceptionally effective in 
promoting reactions other than EAS and ECA reactions. Recently, multicomponent 
reaction protocols involving Cu−H addition followed by allylic substitution have been 
developed in our group. In 2016, we showed that 1.113 was obtained from Cu−H addition  
to be followed by trapping with allylic phosphate 1.37.33 Product containing two 
contiguous stereogenic centers was obtained in 59% yield, 94:6 dr with 94:6 er. In this 
case, the Li cation served as the bridging species in the stereochemical model, as in 
1.114. The application to the formal synthesis of chondramide C analog has also 
demonstrated of the utility of this method. 
 
                                                
(33) Lee, J.; Sebastian. T.; Hoveyda, A. H. Angew. Chem., Int. Ed. 2017, 56, 821–826. 
N
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In 2017, our group published another multicomponent reaction to generate α-
tertiary amines containing an alkenyl−B(pin) motif (Scheme 1.23).34 The existence of the 
cationic bridge was confirmed by DFT calculations as shown in 1.118. The products are 
derived from ketimines, such as 1.116, yielding unprotected amines, such as 1.117, which 
was directly transformed with without cumbersome or low yielding deprotection 
strategies. The utility of this method had been demonstrated through the application to the 
synthesis of compound biologically active 1.119. 
 
1.6. Conclusions 
The sulfonate-bearing NHC promotes enantioselective Cu-catalyzed 
transformations of a broad scope of nucleophiles and electrophiles. Mechanistic 
investigations assisted by DFT calculations point to the existence of secondary binding 
between the substrate and the catalyst. Thus, the sulfonate bridge helps to form a well-
                                                
(34) Jang, H.; Romiti. F.; Sebastian. T.; Hoveyda, A. H. Nat. Chem. 2017, AOP. 
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organized transition state, leading to high enantioselectivity in the Cu-catalyzed reactions. 
Sulfonate-bearing NHC ligands with different substitution patterns promote EAS 
reactions with complementary reactivity and enantioselectivity. The modularity of the 
sulfonate NHC scaffold plays a pivotal role in the process to reach beyond the limitation 
of the EAS reactions.  
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Chapter Two 
NHC–Cu-Catalyzed Enantioselective Allylic 
Substitutions with a Silyl-protected Propargyl 
Boron Reagent to Generate Tertiary and 
Quaternary Carbon Stereogenic Centers 
 
2.1. Introduction 
 Catalytic enantioselective allylic substitution (EAS) reactions1 are among the most 
versatile classes of transformations in organic chemistry. Such processes deliver 
enantiomerically enriched products bearing a stereogenic center adjacent to a 
functionalizable alkene from readily accessible allylic electrophiles. Despite significant 
progress made in the past two decades, the majority of the studies in this area focused on 
the additions of an alkyl group through Cu-catalysis with the choice of proper 
nucleophilic “hard” alkyl metal reagent (Figure 2.1).2 
                                                
(1) For reviews on allylic substitution reactions catalyzed by other transition metals and with “soft” 
nucleophiles, see: (a) Trost, B. M.; Lee, C. In Catalytic Asymmetric Synthesis; Oijima, I., Ed.; Wiley-
VCH:Weinheim, Germany, 2000; Chapter 8E. (b) Trost, B. M.; Crawley, M. L. Chem. Rev. 2003 , 103 , 
2921–2944. (c) Stanley, L. M.; Hartwig, J. F. Acc. Chem. Res. 2010, 43, 1461– 1475. (d) Trost, B. M. Org. 
Process Res. Dev. 2012, 16, 185–194. (e) Tosatti, P.; Nelson, A.; Marsden, S. P. Org. Biomol. Chem. 2012, 
10, 3147–3163. 
(2) References for the Pie-Chart of Catalytic Enantioselective Allylic Substitutions generating a tertiary 
stereogenic center involving a “hard” nucleophile: Alkyl Additions: see reviews: (a) Hoveyda, A. H.; Hird, 
A.W.; Kacprzynski, M. A. Chem. Commun. 2004, 1779−1785. (b) Yorimitsu, H; Oshima, K. Angew. 
Chem., Int. Ed., 2005, 44, 4435−4439. (c) Kar, A.; Argade, N. P. Synthesis, 2005, 2995−3022. (d) Alexakis, 
A.; Malan, C.; Lea, L.; Tissot-Croset, K.; Polet, D.; Falciola, C. Chimia, 2006, 60, 124−130. (e) Falciola, 
C. A.; Alexakis, A. Eur. J. Org. Chem. 2008, 22, 3765-3780. (f) Yokobori, U.; Ohmiya, H.; Sawamura, M. 
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Organometallics, 2012, 31, 7909−7913. Aryl/Heteroaryl Additions: (aa) Jackowski, O.; Alexakis, A. 
Angew. Chem. Int. Ed. 2010, 49, 3346–3350. (ab) Falciola, C. A.; Alexakis, A. Chem. Eur. J. 2008, 14, 
10615–10627. (ac) Polet, D.; Rathgeb, X.; Falciola, C. A.; Langlois, J.-B.; Hajjaji, S. E.; Alexakis, A. 
Chem. Eur. J. 2009, 15, 1205–1216. (ad) Selim, K. B.; Matsumoto, Y.; Yamada, K.; Tomioka, K. Angew. 
Chem. Int. Ed. 2009, 48, 8733 –8735. (ae) Millet, R.; Bernardez, T.; Palais, L.; Alexakis, A. Tetrahedron 
Lett. 2009, 50, 3474–3477. (af) Selim, K. B.; Yamada, K.; Tomioka, K. Chem. Commun. 2008, 5140–5142. 
(ag) Alexakis, A.; Hajjaji, S. E.; Polet, D.; Rathgeb, X. Org. Lett. 2007, 9, 3393–3395. (ah) Selim, K. B.; 
Nakanishi, H.; Matsumoto, Y.; Yamamoto, Y.; Yamada, K.; Tomioka, K. J. Org. Chem. 2011, 76, 1398–
1408. (ai) Pérez, M.; Fańanás-Mastral, M.; Bos, P. H.; Rudolph, A.; Harutyunyan, S. R.; Feringa, B. L. Nat. 
Chem. 2011, 3, 377−381. Alkenyl Additions: (ba) Gao, F.; Carr, J. L.; Hoveyda, A. H. Angew. Chem. Int. 
Ed., 2012, 51, 6613−6617. (bb) Shintani, R.; Takatsu, K.; Takeda, M.; Hayashi, T. Angew. Chem. Int. Ed., 
2011, 50, 8656 –8659. (bc) Lee, Y.; Akiyama, K.; Gillingham, D. G.; Brown, K. M.; Hoveyda, A. H. J. 
Am. Chem. Soc. 2008, 130, 446-447. (bd) Hamilton, J. Y.; Sarlah, D.; Carreira, E. M. J. Am. Chem. Soc. 
2013, 135, 994−997. (be) Gao, F.; Hoveyda, A. H. J. Am. Chem. Soc. 2010, 132, 10961–10963. (bf) 
Akiyama, K.; Gao, F.;Hoveyda, A. H. Angew. Chem. Int. Ed. 2010, 49, 419–423. Alkynyl Additions: (ca) 
Harada, A.; Makida, Y.; Sato, T.; Ohmiya, H.; Sawamura, M. J. Am. Chem. Soc. 2014, 136, 13932−13939. 
(cb) Dabrowski, J. A.; Haeffner, F.; Hoveyda, A. H. Angew. Chem. Int. Ed. 2013, 52, 7694 –7699. (cc) 
Hamilton, J. Y.; Sarlah, D.; Carreira, E. M. Angew. Chem. Int. Ed. 2013, 52, 7532 –7535. Allenyl 
Additions: (da) Jung, B.; Hoveyda, A. H. J. Am. Chem.Soc. 2012, 134, 1490−1493. Allyl Additions: (ea) 
Le, H.; Kyne, R. E.; Brozek, L. A.; Morken, J. P. Org.Lett. 2013, 15, 1432–1435. (eb) Zhang, P.; Morken, 
J. P. J. Am. Chem. Soc. 2009, 131, 12550–12551. (ec) Ardolino, M. J.; Morken, J. P. J. Am. Chem. Soc. 
2014, 136, 7092−7100. (ed) Hamilton, J. Y.; Sarlah, D.; Carreira, E. M. J. Am. Chem. Soc. 2014, 136, 
3006–3009. (ee) Hornillos, V.; Pérez, M.; Fañanás-Mastral, M.; Feringa, B. L. J. Am. Chem. Soc. 2013, 
135, 2140–2143. (ef) Brozek, L. A.; Ardolino, M. J.; Morken, J. P. J. Am. Chem. Soc. 2011, 133, 16778–
16781. (eg) Hamilton, J. Y.; Hauser, N.; Sarlah, D.; M. Carreira, E. M. Angew. Chem. Int. Ed. 2014, 53, 
10759 –10762. (eh) Zhang, P.; Brozek, L. A.; Morken, J. P. J. Am. Chem. Soc. 2010, 132, 10686–10688. 
(ei) Meng, F.; McGrath, K. P.; Hoveyda, A. H. Nature 2014, 513, 367–374. Boryl Additions: (fa) Ito, H.; 
Ito, S.; Sasaki, Y.; Matsuura, K.; Sawamura, M. J. Am. Chem. Soc. 2007, 129, 14856−14857. (fb) A. 
Guzman-Martinez, A.; Hoveyda, A. H. J. Am. Chem. Soc., 2010, 132, 10634−10637. (fc) Park, J. K.; 
Lackey, H. H.; Ondrusek, B. A.; McQuade, D. T. J. Am. Chem. Soc. 2011, 133, 2410–2413. Yamamoto, E.; 
Takenouchi, Y.; Ozaki, T.; Miya, T.; Ito, H. J. Am. Chem. Soc. 2014, 136, 16515−16521. (fd) Park, J. K.; 
McQuade, D. T. Synthesis 2012, 44, 1485–1490. (fe) Ito, H.; Okura, T.; Kou Matsuura, K.; Sawamura, M. 
Angew. Chem. Int. Ed., 2010, 49, 560 –563. Silyl Additions: (ga) Delvos, L. B.; Vyas, D. J.; Oestreich, M. 
Angew. Chem. Int. Ed., 2013, 52, 4650–4653. (gb) Takeda, M.; Shintani, R.; Hayashi, T. J. Org. Chem. 
2013, 78, 5007−5017. Catalytic EAS reactions generating a quaternary carbon stereogenic center involving 
a “hard” nucleophile: Alkyl Additions: (ha) Luchaco-Cullis, C. A.; Mizutani, H.; Murphy, K. E.; Hoveyda, 
A. H. Angew. Chem., Int. Ed., 2001, 40, 1456–1460. (hb) Kacprzynski, M. A.; Hoveyda, A. H. J. Am. 
Chem. Soc. 2004, 126, 10676–10681. (hc) Lee, Y.; Hoveyda, A. H. J. Am. Chem. Soc., 2006, 128, 15604–
15605.  (hd) Lee, Y.; Li, B.; Hoveyda, A. H. J. Am. Chem. Soc., 2009, 131, 11625–11633. (he) Grassi, D.; 
Li, H.; Alexakis, A. Chem. Comm. 2012, 48, 11404–11406. (hf) Fańanás-Mastral, M.; Pérez, M.; Bos, P. 
H.; Rudolph, A.; Harutyunyan, S. R.; Feringa, B. L. Angew. Chem. Int. Ed. 2012, 51, 1922–1925. (hg) 
Jackowski, O.; Alexakis, A. Angew. Chem. Int. Ed. 2010, 49, 3346 –3350. (hh) Magrez, M.; Le Guen, Y.; 
Baslé, O.; Crvisy, C.; Mauduit, M. Chem. Eur. J. 2013, 19, 1199–1203. (hi) Larsen, A. O.; Leu, W.; 
Oberhuber, C. N.; Campbell, J. E.; Hoveyda, A. H. J. Am. Chem. Soc. 2004, 126, 11130–11131. (hj) J. J. 
Van Veldhuizen, J. E. Campbell, R. E. Giudici, R. E.; Hoveyda, A. H. J. Am. Chem. Soc., 2005, 127, 6877–
6882. (hk) M. A. Kacprzynski, M. A.; May, T. L.; Kazane; S. A.; Hoveyda, A. H. Angew. Chem., Int. Ed., 
2007, 46, 4554–4558. (hl) Falciola, C. A.; Alexakis, A. Chem. Eur. J. 2008, 14, 10615–10627. (hm) Grassi, 
D.; Alexakis, A. Angew. Chem. Int. Ed. 2013, 52, 13642–13646. (hn) Hojoh, K.; Shido, Y.; Ohmiya, H.; 
Sawamura, M. Angew. Chem. Int. Ed. 2014, 53, 4954–4958. Aryl/Hetereoaryl Additions: (ia) Gao, F.; 
McGrath, K. P.; Y. Lee, Y.; Hoveyda, A. H. J. Am. Chem. Soc., 2010, 132, 14315-14320. (ib) Kacprzynski, 
M. A.; May, T. L.; Kazane, S. A.; Hoveyda, A. H. Angew. Chem. Int. Ed. 2007, 46, 4554–4558. (ic) 
Takeda, M.; Takatsu, K.; Shintani, R.; Hayashi, T. J. Org. Chem. 2014, 79, 2354−2367. Alkenyl Additions: 
(ja) Gao, F.; McGrath, K. P.; Lee, Y.; Hoveyda, A. H. J. Am. Chem. Soc. 2010, 132, 14315–14320. (jb) 
Gao, F.; Carr, J. L.; Hoveyda, A. H. Angew. Chem. Int. Ed. 2012, 51, 6613–6617. Alkynyl Additions: (ka) 
Dabrowski, J. A.; Gao, F.; Hoveyda, A. H. J. Am. Chem. Soc. 2011, 133, 4778–4781. Allenyl Additions: 
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Alkynes are of high value in synthetic chemistry.3 Not only are alkynes often 
found embedded in the structures of natural products, they are also useful for installation 
of multiple functional groups. Efficient protocols for the preparation of enantiomerically 
enriched alkyne-substituted molecules is of substantial synthetic value as precursors to 
                                                                                                                                            
(la) Jung, B.; Hoveyda, A. H. J. Am. Chem. Soc. 2012, 134, 1490−1493. Allyl Additions: (ma) Zhang, P.; 
Le, H.; Kyne, R. E.; Morken, J. P. J. Am. Chem. Soc. 2011, 133, 9716–9719. Boryl Additions: (na) 
Guzman-Martinez, A.; Hoveyda, A. H. J. Am. Chem. Soc. 2010, 132, 10634–10637. Silyl Additions: (oa) 
Takeda, M.; Shintani, R.; Hayashi, T. J. Org. Chem. 2013, 78, 5007−5017. (ob) Delvos, L. B.; Hensel, A.; 
Oestreich, M. Synthesis 2014, 46, 2957–2964. 
(3) Modern Acetylene Chemistry; Stang, P. J., Diederich, F., Eds; VCH: Weinheim, 1995. 
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Figure 2.1. Moieties Introduced by Catalytic EAS Reactions (2015)
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46 
alkyl, alkenyl, allenyl and carbonyl adducts as shown in Scheme 2.1.4 We envisioned that 
the development of an EAS reaction to incorporate a stereogenic center bearing a 
propargyl group could be of synthetic utility and streamline the synthesis of natural 
products, such as plakinic acid A. from the enantiomerically-enriched alkyne product 2.1. 
However, Cu-catalyzed enantioselective propargyl additions to allylic phosphates had not 
been previously reported.  
 
2.2. Background 
In 2012, the Morken group delineated the protocol for Pd-catalyzed 
diastereoselective allylations of enantiomerically-enriched propargyl acetates. 1, 5-
Enynes, such as 2.11, were generated in up to 90% yield and 98:2 propargyl/allenyl 
selectivity and >99% ee.5 Alkyl, aryl and heteroaryl substrates with a tertiary or 
quaternary substituted stereogenic center are all suitable for the transformation. 
                                                
(4) For transformations of alkynes into various functional groups, see: (a) R. C. Larock, Comprehensive 
Organic Transformations; VCH: New York, NY, 1999. (b) Yu, S.; Ma, S. Chem. Commun. 2011, 47, 5384
−5418. 
(5) Ardolino, M. J.; Morken, J. P. J. Am. Chem. Soc. 2012, 134, 8770−8773. 
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Boron-based reagents6 have only recently been introduced as partners in Cu-
catalyzed EAS reactions, offering a more practical, tolerant and mild alternative to the 
traditional organometallic reagents. In 2012, our group disclosed a Cu-catalyzed allenyl 
addition reaction to allylic phosphates with commercially available allenyl B(pin) 2.13.7 
Installation of the stereogenic center can be achieved by employing a NHC−Cu catalyst 
derived from CuCl and imidazolinium salt 2.14. 
 
2.3. Catalytic Enantioselective Allylic Substitutions with a Silyl-Protected 
Propargyl Boron Reagent  
2.3.1 An Easily Accessible Propargyl Pinacolboron Reagent  
                                                
(6)  Cu-catalyzed EAS with aryl boron nucleophiles: (a) see ref 3bb, 3ic; with alkenyl boron nucleophiles: 
(b) see 3ba. (c) Gao, F.; Carr, J. L.; Hoveyda, A. H. J. Am. Chem. Soc. 2014, 136, 2149−2161; with alkyl 
boron nucleophiles: (d) Shido, Y.; Yoshida, M.; Tanabe, M.; Ohmiya, H.; Sawamura, M. J. Am. Chem. Soc. 
2012, 134, 18573−18576; with alkenyl boron nucleophiles: (e) Jung, B.; Hoveyda, A. H. J. Am. Chem. Soc. 
2012, 134, 1490–1493; with allyl boron nucleophiles: (f) Yasuda, Y.; Ohmiya, H.; Sawamura, M. Angew. 
Chem. Int. Ed., 2016, 55, 10816–10820. 
(7) see reference 6e. 
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 We tried to develop a protocol for Cu-catalyzed enantioselective propargyl 
additions to allylic phosphates with an unprotected propargyl B(pin) reagent 2.198, but 
only the allenyl addition product 2.18 was obtained in 38% yield and 90:10 er using 
previously reported conditions.9 This showed that 1) π-allyl isomerization between the 
allenyl−Cu and propargyl−Cu species readily interconverted following transmetalation 
and 2) the more reactive allenyl−Cu species10 undergoes transformation to afford EAS 
products. 
 
2.3.2 Synthesis of Propargyl-Substituted Tertiary Carbon Stereogenic Centers: 
Additions to Allylic Phosphates that Contain a Disubstituted Alkene 
We envisioned that a TMS-protected propargyl B(pin) 2.20 may enable selective 
addition of the propargyl group by disfavoring allenyl addition through steric control. As 
shown in Table 2.1, we found that when 2.20 was utilized under the reaction conditions, 
                                                
(8) Fandrick, D. R.; Saha, J.; Fandrick, K. R.; Sanyal, S.; Ogikubo, J.; Lee, H.; Roschangar, F.; Song, J. J.; 
Senanayake, C. H. Org. Lett. 2011, 13, 5616−5619. 
(9) Shi, Y.; Jung, B.; Torker, S.; Hoveyda, A. H. J. Am. Chem. Soc. 2015, 137, 8948–8964. 
(10) Mszar, N. W.; Haeffner, F.; Hoveyda, A. H. J. Am. Chem. Soc. 2014, 136, 3362−3365. 
 
11 mol %
10 mol % CuCl, 1.5 equiv NaOMe,
  thf, 22 oC, 24 h
(pin)B
40% conv, 38% yield
>98:<2 SN2':SN2
90:10 erpropargyl:allenyl = 88:12
NMes
Ph Ph
NSO O
O •
PhMe
Ph(EtO)2OPO
Me 11 mol %
1.5 equiv
+ NMes
Ph Ph
NSO O
O
•
PhMe
89% conv, 74% yield   
98:2 SN2':SN2
 93:7 er
•
(pin)B
+
+
Scheme 2.4. Cu-Catalyzed EAS Reaction with an Unprotected Propargylboron Reagent
Ph(EtO)2OPO
Me
1.5 equiv
+
2.16 2.13 2.17 2.18
2.16 2.19 2.17
2.18
10 mol % CuCl, 1.5 equiv NaOMe,
  thf, 22 oC, 24 h
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propargyl addition outcompete allenyl addition even in the absence of any ligands (entry 
1), albeit in SN2 selective fashion. To access the more valuable branched product 2.21, 
NHC ligands were examined under the reaction conditions. NHC−Cu complexes derived 
from both 2.25 and 2.26 led to the generation of undesired linear propargyl product 2.23 
(entry 2 and 3). Only when sulfonate-bearing NHC−Cu catalysts were employed, could 
the branched product 2.21 be generated with high SN2’ selectivity. EAS reaction 
promoted by the NHC−Cu complex derived from 2.27 bearing a meta-substituted N-aryl 
group delivered 2.21 in 68% yield, 95:5 SN2’:SN2 ratio and 90:10 enantioselectivity 
(entry 4). Increasing the size of the meta-substituent of the NHC ligand to a triisopropyl 
group improved the enantioselectivity to 97:3 er (entry 5). However, poor 
regioselectivities were observed when imidazolinium salts were used to generate the 
NHC−Cu complexes: unbound organocopper species readily facilitated an efficient 
background reaction, yielded undesired linear product. Thus, when the corresponding Ag 
complexes 2.28 and 2.29 were examined in the reaction, 2.21 was obtained with high 
regio- and enantioselectivity (entries 6 and 7).11 We found that with the use of NHC 
derived from Ag complex 2.30, 2.21 was generated in much lower enantioselectivity 
(31:69 er), and favoring formation of the opposite enantiomer (entry 8). 
                                                
 (11) The formation of NHC−Cu complex is facilitated employing NHC−Ag and CuCl since the formation 
of AgCl precipitate from the solution, driving the complexation reaction to completion. 
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As shown in Table 2.2, propargyl additions to allylic phosphates 2.12a-l afforded 
enynes 2.21a-l in >98% conversion, 75−89% yield, 87%−98% SN2’ selectivity, and 
5.0–11 mol % ligand,
10 mol % CuCl
SiMe3
(pin)B
 (1.5 equiv)
1.2 equiv NaOMe, 
thf, 22 °C, 6.0 h
NMesMesN
2.25
Cl NMesN
2.26
PF6
OH
Ph N
Ph Ph
NS
2.27 R = t-Bu
2.14 R = 2,4,6-(i-Pr)3C6H2
O O
O
R
R
N
Ph
S
O
N
Ag
O
O
Ag
O
N
N
S
O
O Ph
Ph
Ph
white solid; air stableR
R
R
R
2.28 R = t-Bu
2.29 R = 2,4,6-(i-Pr)3C6H2
2.21
entry ligand/complex conv (%);b
yield (%)c
SN2':SN2b
(2.21:2.23)
erd
1
2
3
4
5
6
7
8
none
2.25e
2.26
2.27
2.14
2.28
2.29
2.30
2.12
Ph SiMe3
(EtO)2OPO Ph
86; 67
>98; 77
86; 71
92; 68
>98; 75
>98; 70
>98; 75
>98; 74
6:94
5:95
16:84
95:5
91:9
96:4
97:3
>98:<2
na
na
nd
90:10
97:3
91:9
97:3
31:69
<2% detected in all cases
•
Ph
SiMe3
(2.21+2.23):2.24b
86:14
88:12
87:13
84:16
89:11
84:16
89:11
87:13
•
SiMe3
Ph
SiMe3
Ph
2.23
N
Ph
S
O
N
Ag
O
O
Ag
O
N
N
S
O
O Ph
Ph
Ph
Me
Me
Me
Me
Me Me
2.30
2.24
as a mixture of Z/E isomers
Table 2.1. Formation of Tertiary Carbon Centers: Examination of Different Types of NHC–Cu Complexesa
2.20
2.22
a Reactions  performed  under  N2  atm.  b Conversion  (allylic  phosphate  consumption)  and  group  (propargyl/allenyl 
addition) selectivities (±2%) were determined by analysis of 400 MHz 1H NMR spectra of product mixtures prior to 
purification. Site selectivities were determined by analysis of 400 MHz 1H NMR spectra of purified material. c Yield 
(±5%) of propargyl addition products after silica gel chromatography (includes inseparable linear isomer 2.23 but no 
allenyl  compounds).  d Enantioselectivity  (±1%)  determined  by  GC  analysis.  See  the  Supporting  Information  for 
experimental and analytical details. e Preformed NHC−Cu complex was used; see the Supporting Information for details. 
Mes, 2,4,6-(Me)3C6H2; na, not applicable; nd, not determined.
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95:5−98:2 er using 5.0 mol % of the NHC−Cu complex derived from 2.75 mol % 2.29 
and 5.0 mol % CuCl.  Notably, reactions are performed at ambient temperature in CH2Cl2 
and are generally complete in 6 h to provide both aryl- and alkyl-substituted propargyl 
addition products in high efficiency, site-selectivity and stereoselectivity. Allylic 
phosphates with an electron-donating group or halogen are compatible under the reaction 
conditions (cf. 2.12b-d, 2.12f, and 2.12g). Electron-deficient allylic phosphates 2.12h and 
2.12l proceeded with diminished site-selectivities (93:7 and 87:13 SN2’: SN2 ratio). 
Sterically hindered substrates 2.12d-e and 2.12l are suitable substrates, affording 
propargyl addition products in high yields with good regio- and enantioselectivity.  In all 
cases, allenyl addition product 2.24 was generated as the minor byproduct in 4−10% 
yield, but is readily separable. 
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1,5-Enynes possessing a heteroaromatic moiety were synthesized efficiently as 
shown in Scheme 2.5. Thienyl-substituted 2.21m was isolated in 86% yield (pure 
propargyl product) through a reaction that proceeds with 95% site selectivity and 96:4 er. 
Addition to a pyridyl substrate took place without any adverse effect by the Lewis basic 
nitrogen site on the activity of the Cu complex. Enyne 2.21n was isolated in 90% yield, 
92% site selectivity, and 96:4 er. Ester-containing substrates 2.21o-p were also 
compatible under the reaction conditions. The efficient formation of 1,5-enyne 2.21o in 
Table 2.2. EAS Reactions with Aryl-Substituted Substratesa
1
2
3
4
5
6
7
8
9
10
11
12
>98; 75
>98; 82
>98; 80
>98; 81
>98; 89
>98; 85
>98; 76
>98; 79
>98; 81
>98; 80
>98; 83
>98; 83
97:3
96:4
97:3
98:2
97:3
98:2
98:2
93:7
96:4
96:4
97:3
87:13
97:3
97:3
97:3
96:4
96:4
98:2
98:2
98:2
97:3
97:3
97:3
95:5
 
5.0 mol % CuCl2
SiMe3
(pin)B
 (1.5 equiv)
1.2 equiv NaOMe, CH2Cl2, 
22 °C, 6.0 h
2.21
Ar SiMe3
entry substrate (Ar) conv (%);b
yield (%)c
SN2':SN2b
(2.21:2.23)
erd
2.12
(EtO)2OPO Ar
2.23
(2.21+2.23):2.24b
91:9
92:8
95:5
94:6
92:8
93:7
92:8
89:11
96:4
92:8
93:7
90:10
•
SiMe3
Ar
2.24
SiMe3
Ar
2.20
2.12a (Ph)
2.12b (o-FC6H4)
2.12c (o-BrC6H4)
2.12d (o-OMeC6H4)
2.12e (o-MeC6H4)
2.12f (m-BrC6H4)
2.12g (m-MeC6H4)
2.12h (m-CF3C6H4)
2.12i (2-napthyl)
2.12j (p-ClC6H4)
2.12k (p-ClC6H4)
2.12l (p-ClC6H4)
a-d same as Table 2.1
2.75 mol %
N
Ph
S
O
N
Ag
O
O
Ag
Ph
R
R
2.29 R = 2,4,6-(i-Pr)3C6H2
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96:4 er, demonstrated the robustness and chemoselectivity of the developed method even 
in the presence of comparatively electrophilic moieties such as an acylated phenol. 
 
Propargyl additions to alkyl-substituted allylic phosphates proceeded efficiently, 
affording branched products in up to 90% yield, 96:4 propargyl/allenyl, >98:2 SN2′:SN2 
selectivity and 99:1 er (Scheme 2.6). Synthesis of allylsilane 2.35 in 90% yield, 91:9 
propargyl/allenyl, 98:2 branched/linear selectivity, and 93:7 er shows that alkenylsilanes 
are suitable substrates as well. Moreover, preparation of methyl ketone 2.36 in 59% yield, 
92:8 propargyl/allenyl, 96:4 branched/linear selectivity and 92:8 er in 2.0 h (vs 6.0 h) 
further underscores tolerance of the catalytic protocol towards electrophilic/enolizable 
units.   
2.21m
>98% conv, 86% yield,
90:10 propargyl:allenyl, 
95:5 SN2':SN2, 96:4 er
SiMe3
S
2.21n
>98% conv, 90% yield
90:10 propargyl:allenyl, 
92:8 SN2':SN2, 96:4 er
SiMe3
N
2.21o
>98% conv, 86% yield,
90:10 propargyl:allenyl, 
95:5 SN2':SN2, 96:4 er
SiMe3
2.21p
>98% conv, 82% yield,
92:8 propargyl:allenyl, 
95:5 SN2':SN2, 94:6 er
O Me
O
SiMe3
COOMe
Scheme 2.5. EAS Reactions with Heteroaryl-Substituted and Ester-Containing Substratesa
a Reactions performed under N2 atm.
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To gain additional insight into the functional group tolerance of the method, we 
performed studies with the external additives as summarized in Table 2.3. We found that 
alkyl ketone 2.37 (entry 1), aryl ester 2.39 (entry 3), phenyl cyanide 2.41 (entry 5) and 
Weinreb amide 2.42 (entry 6) were tolerated under the EAS conditions reasonably well 
(74% to >98% unreacted electrophilic additive). However, the more electrophilic ketones, 
such as acetophenone 2.38 (entry 3) and benzophenone 2.40 (entry 5), were not inert. 
Allylation of the carbonyl group occurred competitively in these cases. In all cases, 2.23a 
was generated with the same selectivity levels as in trials not employing of an additive (cf. 
entry 1, Table 2.2). 
Scheme 2.6. EAS Reactions with Alkyl-Substituted Substratesa
2.32
>98% conv, 77% yield,
93:7 propargyl:allenyl,
98:2 SN2':SN2, 95:5 er
2.33
>98% conv, 85% yield,
96:4 propargyl:allenyl, 
95:5 SN2':SN2, 99:1 er
2.34
>98% conv, 97% yield,
>97:3 propargyl:allenyl, 
>98:2 SN2':SN2, 92:8 er
SiMe3
(pin)B
2.20 (1.5 equiv)
1.2 equiv NaOMe,
CH2Cl2, 22 °C, 6.0 h
2.31
Cy SiMe3
SiMe3
OO
Me Me
SiMe3
OTBS
2.35
>98% conv, 90% yield,
91:9 propargyl:allenyl, 
98:2 SN2':SN2, 93:7 er
PhMe2Si SiMe3
(EtO)2OPO
2.36
>98% conv, 59% yield,b
92:8 propargyl:allenyl, 
96:4 SN2':SN2, 92:8 er
SiMe3
O
aReactions conditions and methods of  product  analysis  identical  to  those indicated in  Table  2.1.  Yields  (±5%) are  the lowest 
obtained  after  a  minimum  of  three  runs  and  are  of  propargyl  addition  products  (branched  and  linear).  See  the  Supporting 
Information for all experimental and analytical details. bReaction time was 2.0 h.
 
5.0 mol % CuCl2
2.75 mol %
N
Ph
S
O
N
Ag
O
O
Ag
Ph
R
R
2.29 R = 2,4,6-(i-Pr)3C6H2
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2.3.3 Synthesis of Propargyl-Substituted Quaternary Carbon Stereogenic 
Centers: Additions to Allylic Phosphates that Contain a Trisubstituted Alkene 
We then investigated the EAS process for the formation of all-carbon quaternary 
stereogenic centers using trisubstituted allylic phosphates. Preliminary catalyst screening 
(Table 2.4) revealed that the use of sulfonate-based NHC−Cu complexes was crucial to 
obtain the desired branched selectivity (compare entries 5−7 vs 1−3). Compared to the 
case of disubstituted alkenes in EAS reactions (cf. Tables 2.1), the complex derived from 
2.27 delivered 2.44a yielded poor regioselectivity (39:61 SN2′:SN2 vs 95:5 in the case of 
disubstituted allylic phosphate 2.12a). It indicated that the background reaction affording 
SiMe3
(pin)B
2.20 (1.5 equiv)
1.2 equiv NaOMe, 
CH2Cl2, 22 °C, 6.0 h
2.21a
entry additive conv (%);
yield (%)
SN2':SN2
(2.19a:2.21a)
recovery of 
additive 2.37-2.42a
1
2
3
4
5
6
2.37
2.38
2.39
2.40
3.41
2.42
2.12a
Ph SiMe3
(EtO)2OPO Ph
>98; 79
  89; 38
>98; 75
  79; 48
  95; 76
  92; 76
97:3
97:3
97:3
97:3
96:4
96:4
>98
25b
>98
41b
74
90
2.22a
<2% detected in all cases
•
Ph
SiMe3
(2.19a+2.21a:2.22a)
89:11
88:12
90:10
89:11
89:11
89:11
•
SiMe3
Ph
SiMe3
Ph
2.24a2.23a
a based on internal standard.b allyl addition to carbonyl group was observed as byproduct
Me
O
Me
O
OMe
O O
2.37 2.38 2.39 2.40
CN O
NMe
OMe
2.41 2.42
Table 2.3. Exploration of Functional Group Tolerance of Propargyl EAS Reaction
 
5.0 mol % CuCl2
2.75 mol %
N
Ph
S
O
N
Ag
O
O
Ag
Ph
R
R
2.29 R = 2,4,6-(i-Pr)3C6H2
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linear SN2 product outcompeted the desired EAS reaction. When the NHC−Cu complex 
derived from imidazolinium salt 2.17 with an ortho-substituted N-aryl group was 
employed (entry 5), the opposite enantiomer was again generated predominantly (32:68 
er); as described in Chapter 1, this observation offered considerable insight into the 
mechanism of the EAS promoted by sulfonate NHC−Cu complexes. The same selectivity 
reversal was observed in related EAS reactions with an allenyl B(pin) 2.137 with an even 
greater level of reversal (12:88 er).  Unlike transformations with an allenyl−B(pin), EAS 
using the complex derived from 2.29, afforded 2.44a in 92:8 er (entry 7, Table 2.4) as 
compared to 67:33 er (94:6 SN2′:SN2). These findings highlighted the mechanistic 
distinction between the transformations involving the allenyl B(pin) 2.13 and propargyl 
B(pin) 2.20. 
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Transformations with trisubstituted allylic phosphates proceeded to ≥ 95% 
conversion after 30 h at room temperature in thf in the presence of 5.0 mol % of catalyst 
derived from 2.29 (Table 2.5). Propargyl addition products were isolated in 78−95% 
yield after purification; the 9−11% of the allenyl byproduct (2.47a) formed was 
completely separable by silica gel chromatography. Site selectivity was comparable to 
that obtained with disubstituted allylic phosphates (cf. Table 2.2), but er values were 
5.5–11 mol % ligand,
10 mol % CuCl
entry ligand/complex;
mol % catalyst
conv (%);b
yield (%)c
SN2':SN2b
(2.44a:2.46a)
erd
1
2
3
4
5
6
7
none; 10
2.25; 10
2.26; 10
2.27; 10
2.17; 10
2.28; 5.0
2.29; 5.0
45; 35
49; 47
57; 50
93; 83
48; 31
>98; 82
>98; 84
<2:98
<2:98
3:97
39:61
85:15
91:9
94:6
na
na
nd
86:14
32:68
87:13
92:8
(2.44a+2.45a):2.47ab
82:18
92:8
91:9
89:11
85:15
92:8
88:12
Table 2.4. Formation of Quaternary Carbon Centers: Examination of Different Types of NHC–Cu Complexesa
SiMe3
(pin)B
 2.20 (1.5 equiv)
1.2 equiv NaOMe, thf, 22 °C, 24 h
2.44a
2.43a
Ph SiMe3Me
(EtO)2OPO Ph
Me
•
PhMe
SiMe3
NMes
Ph Ph
NS
2.17
O O
O
2.45a
<2% detected in all cases
•
SiMe3
Ph
SiMe3
Ph
2.47a2.46a
Me Me
a-d same as Table 2.1
NMesMesN
2.25
Cl
NMesN
2.26
PF6
OH
Ph
N
Ph Ph
NS
2.27 R = t-Bu
O O
O
R
R N
Ph
S
O
N
Ag
O
O
Ag
O
N
N
S
O
O Ph
Ph
Ph
R
R
R
R
2.28 R = t-Bu
2.29 R = 2,4,6-(i-Pr)3C6H2
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somewhat lower (83:17−94:6 er vs. 92:8−>99:1 er). The most challenging case, shown in 
entry 2 of Table 2.5, employed an ortho-substituted aryl group. In this case, the less 
hindered NHC−Cu complex derived from 2.28 proved to be the most effective. With the 
optimal ligand 2.29, there was 75% conversion, and a 60:40 ratio of branched/linear 
products was generated (vs 98% conversion and 94% SN2′ selectivity) for 2.43b. 
Aliphatic trisubstituted allylic phosphates were also effective, yielding 2.44e in 78% 
yield, >98:2 SN2′:SN2, and 94:6 er.  
 
The slower rates of EAS reactions that afford all-carbon quaternary stereogenic 
centers versus those that involve 1,2-disubstituted alkenes, render the corresponding 
conditions with reduced chemoselectivity in the presence of other electrophilic functional 
groups than was formerly illustrated (cf. Table 2.3). We found that carboxylic ester 2.39 
(1.0 equiv) were recovered in >98% yield with minimal influence on the efficiency of the 
1
2
3
4
5
2.43a (Ph)
2.43b (o-MeOC6H5)e
2.43c (m-BrC6H5)
2.43d (p-ClC6H5)
2.43e (Cy)
>98; 81
98; 95
95; 93
>98; 91
>98; 78
94:6
94:6
>98:2
96:4
>98:2
91:9
83:17
92:8
93:7
94:6
Table 2.5. Enantioselective Synthesis of Enynes with a Quaternary Carbona
5.0 mol % CuCl
SiMe3
(pin)B
2.20 (1.5 equiv)
1.2 equiv NaOMe, thf, 22 °C, 30 h
2.43
(EtO)2OPO G
Me
entry substrate (G) conv (%);b
yield (%)c
SN2':SN2b
(2.44:2.46)
erd(2.44+2.46):2.47b
89:11
91:9
89:11
90:10
90:10
2.44
G SiMe3Me
•
SiMe3
G
SiMe3
G
2.472.46
Me Me
a-d same as Table 2.1. eThe complex derived from 2.28 was used; see text for details. See the Supporting Information for all experimental and 
analytical details.
2.75 mol %
N
Ph
S
O
N
Ag
O
O
Ag
Ph
R
R
2.29 R = 2,4,6-(i-Pr)3C6H2
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EAS reaction to afford 2.44a (81% yield, 94% SN2′, 89:11 propargyl:allenyl, 91:9 er). In 
contrast, when methyl ketones 2.37 and 2.38 were added to the mixture, 2.44a was 
obtained in 67% and 29% yield, respectively, and the carbonyl additive were recovered in 
30% and 15% yield, respectively. 
2.3.4 Mechanistic Studies 
The free energy surface of a truncated model system corresponding to the EAS 
reaction that affords 2.21a (cf. entry 1, Table 2.2), obtained through DFT calculations at 
the ωB97xD/Def2TZVPPDCM(SMD) //ωB97xD/LANL2DZ level, is exhibited in Figure 2.2. 
The low-energy transition state TSiso (11.3 kcal/mol) for interconversion of the linear 
Cu(I)-propargyl (A) and the related allenyl species (B) indicates a Curtin-Hammett 
kinetic profile, consistent with complex B being 0.9 kcal/mol more stable than complex 
A and the fact that none of the chiral SN2′ addition products were generated through 
intermediacy of B (i.e., <2% formed in the studies summarized in Table 2.2). The 
significance of the large trimethylsilyl group in providing sufficient quantities of complex 
A has been previously reported and is consistent with the EAS reaction with Scheme 2.4; 
reaction with the propargyl B(pin)/allenyl B(pin) reagent mixture (2.19, 88:12) that lacks 
the silyl unit is less efficient and produces the allenyl product 2.18 exclusively, engenders 
repulsive steric interaction with the large N-aryl moiety of the Cu complex. As already 
mentioned, because of the size and mobility of the system it would be difficult to reach a 
reliable conclusion based on DFT calculations as to whether the oxidative addition or the 
reductive elimination step is turnover-limiting. Additionally, complications due to 
conformational complexity are exacerbated by the loosely associated NaOPO(OMe)2 salt 
(cf. PAA→ProdA, Figure 2.2). Nonetheless, our investigations indicate that the pathways 
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leading to allenyl addition are energetically disfavored.  
 
Figure 2.2. Energy profile regarding the origin of high site and group transfer selectivity (high SN2′:SN2 and 
propargyl/allenyl addition) derived from DFT calculations. Abbreviations: RE, reductive elimination; TS, transition state; 
OA, oxidative addition; PA, π-allyl; PC, π-complex. 
 
2.3.5 Functionalizations and Application to the Synthesis of Plakinic Acid A 
We were able to demonstrate the utility of our method by generating homoallenyl 
compounds, as represented by 2.48 in Scheme 2.7a. Treating 2.21a with (n-Bu)4NF and 
then 33 mol % CuBr, 2.0 equiv of para-formaldehyde, and 2.0 equiv of (i-Pr)2NH at 
100 °C for 4.0 h furnished the product in 93% yield in one-pot without erosion of 
enantiomeric purity and with complete chemoselectivity (<2% reaction at the alkene site). 
Figure	2.	Energy	profile	 regarding	 the	origin	of	high	site	and	group	 transfer	selectivity	(high	
SN2ʹ:SN2	and	propargyl/allenyl addition)	derived	 from
DFT	calculations.	Abbreviations:	RE,	reductive	elimination;	TS,	transition	state;	OA,	oxidative	
addition;	PA,	π-allyl;	PC,	π	complex.
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The difficulties associated with converting the product of an allyl−allyl coupling process 
to the corresponding homoallenyl compounds, and the increasing number of catalytic 
stereoselective transformations that involve monosubstituted allenes renders this 
functionalization especially striking. Another notable Cu-catalyzed process converts the 
EAS products with exclusive chemoselectivity (>98% reaction at the alkyne unit) to 
enantiomerically enriched tosylamides such as 2.49 (Scheme 2.7b). Such electronically 
activated functional units, accessible in a single step only from an alkyne unit (unlike an 
olefin), are readily amenable to further modification. The silyl alkyne group may be 
converted to the corresponding Z-alkenyl silane (see 2.50) by treatment with dibal−H at 
55 °C for 2.0 h (Scheme 2.7c).  Consistent with the cases above, chemoselectivity was 
complete (<2% by 400 MHz 1H NMR). Subsequent treatment with N-iodosuccinimide, 
30 mol % Ag2CO3, and hexafluoroisopropyl alcohol for 10 min at 0 °C led to the 
formation of the desired Z-alkenyl iodide 2.51, with ∼10% loss in alkene stereoisomeric 
purity. This latter sequence demonstrates that the silyl unit of the propargyl−B(pin) 
reagent 2.20 can impart attractive characteristics to the catalytic approach that extend far 
beyond serving as a protecting group. 
 
Scheme 2.7. Representative Functionalizations of EAS Products by Reactions that are Particularly Facile with Alkyne 
Unitsa
2. 33 mol % CuBr,
2.0 equiv HCHO,
2.0 equiv i-Pr2EtN, 
dixoane, 100 °C, 4.0 h
2.21a
(97:3 er)
2.48
93% overall yield
>98% chemoselective
a) Conversion to a homoallenyl containing compound:
2. 2.0 mol % CuI,
1.2 equiv TsN3,
1.2 equiv Et3N, H2O,
22 °C, 0.5 h
2.49
73% overall yield
>98% chemoselective
b) Conversion to a 3-amido-propyl containing compound:
1.0 equiv dibal–H,
2.21q
(obtained in 85% yield,
95:5 propargyl:allenyl
98:2 SN2':SN2, 94:6 er)
5/1 hexanes/thf,
55 °C, 2.0 h
2.50
85% yield, >98:2 Z/E,
>98% chemoselective
c) Conversion to Z-1-silyl-allyl and Z-1-iodo-allyl containing compounds:
2.51
64% yield, 90:10 Z/E
SiMe3
2.21c
(97:3 er)
SiMe3Br Br
NHTs
O
SiMe3
1.2 equiv N-iodosuccinimide
30 mol % Ag2CO3, (CF3)2CHOH,
0 °C, 10 min
•
Me3Si
I
1. 1.5 equiv (n-Bu)4NF,
thf, 22 °C, 3.0 h
1. 1.5 equiv (n-Bu)4NF,
thf, 22 °C, 3.0 h
>98% es in all cases
aYields (±5%) are the lowest obtained after a minimum of three runs and are for propargyl addition products after silica gel chromatography (includes inseparable linear isomers but no 
allenyl compounds). See the Supporting Information for details. es = enantiospecificity (product enantiomeric excess/substrate enantiomeric excess) by 100.
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 As shown in Scheme 2.8, exposure of 2.52 to NHC−Cu-catalyzed EAS 
conditions resulted in complete consumption and formation of trimethylsilyl-substituted 
2.53, which is volatile and cannot be easily isolated in high yield. Accordingly, we 
treated the unpurified mixture containing 2.53 to mildly basic methanol to remove the 
silyl unit, followed by NHC−Cu-catalyzed protoboryl addition of the resulting terminal 
alkyne to furnish β-alkenyl B(pin) 2.55 in 41% overall yield over 3 steps with 95% β 
selectivity, >98% E selectivity, and 91:9 er. β–substituted styrene 2.56 was prepared in 
98% yield by means of phosphine−Pd-catalyzed cross-coupling with iodobenzene. 
Alkenylboron derivatives such as 2.55 may not be accessed with the same ease and 
efficiency through the use of dienyl products obtained from EAS reactions that 
incorporate an allyl moiety, since differentiation of two alkene units would be less 
straightforward than that of an alkyne and an olefin [e.g., by site- and stereoselective 
cross-metathesis with vinyl−B(pin)]. This is particularly the case with a relatively 
diminutive methyl group at the allylic site. 
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1.2.2 Application to the Synthesis of Plakinic Acid A 
We envisioned that if we could transform the alkyne to an alkenyl B(pin), the 
product could be used in another EAS reaction to facilitate formation of another 
stereogenic center with a 1,5-relationship. To demonstrate the feasibility of this protocol 
further and highlight its complementary relationship with other catalytic and 
stereoselective processes, we undertook a diastereo- and enantioselective synthesis of the 
acyclic segment of antifungal natural product plakinic acid A (Scheme 2.9). The route 
commenced with NHC−Cu-catalyzed EAS involving methyl-substituted allylic 
phosphate 2.52 and tri(isopropylsilyl)-substituted propargyl−B(pin) reagent 2.57. Enyne 
2.58 was isolated in quantitative yield with complete control of group selectivity (<2% 
Scheme 2.8. EAS with a Key Substrate and Conversion to 1,5-Dienes
5.0 mol % CuCl, 1.0 equiv B2(pin)2,
20 mol % NaOt-Bu,
thf, 22 °C, 24 h
2.55
41% overall yield (3 steps),
95:5 β:α, >98:2 E:Z,
91:9 er
2.56
98% yield, >98:2 E:Z
NAdAdN
2.54
BF42. 5.0 mol %
5.0 mol % Pd(PPh3)4
1.1 equiv PhI, 2.0 equiv NaOH,
dioxane, 100 °C, 3.0 h
Me
B(pin)
Me
Ph
1. 1.2 equiv K2CO3, MeOH, 6.0 h
2.52
(EtO)2OPO Me
SiMe3
(pin)B
2.20 (1.5 equiv)
1.2 equiv NaOMe, 
CH2Cl2, 22 °C, 6.0 h
2.53
(volatile; not purified)
Me SiMe3 5.0 mol % CuCl2
2.75 mol %
N
Ph
S
O
N
Ag
O
O
Ag
Ph
R
R
2.29 R = 2,4,6-(i-Pr)3C6H2
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allenyl product) in 97:3 SN2′:SN2 selectivity and in 90:10 er. Cross-metathesis with 
styrene in the presence of 5.0 mol % of a molybdenum alkylidene 2.59 delivered enyne 
2.60 in 80% yield with retention of isomeric purity of the olefin (>98:2 E/Z) and, 
importantly, without reaction at the alkynylsilane site (<2% enyne cross-metathesis). The 
next objective was to transform the acetylene moiety into an alkenylboron unit to be 
utilized in an NHC− Cu-catalyzed EAS that would generate the other methyl-substituted 
stereogenic center. Removal of the silyl group followed by site- and stereoselective 
NHC−Cu-catalyzed protoboryl addition to the resulting terminal alkyne, which proceeded 
with >98% chemoselectivity (<2% reactions at the styrenyl group), afforded E-β-alkenyl 
B(pin) intermediate 2.61 in 81% yield, >98:2 E/Z and 95:5 β:α selectivity. Treatment of 
2.61 with 5.0 mol % enantiomerically pure imidazolinium salt 2.26, 5.0 mol % CuCl, and 
2.0 equiv of allylic phosphate 2.52 generated triene 2.62 in 56% yield, with complete 
branched selectivity (>98% SN2′) and in 76:24 diastereomeric ratio (dr; 82:18 
selectivity).6c Site-selective hydroboration of the monosubstituted alkene afforded 
primary alcohol 2.63 in >98% yield (Scheme 2.9). 
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2.4 Development of New Sulfonate-Containing NHC Ligands Assisted by DFT 
Calculations−Α New NHC Ligand Bearing a 2,5-Disubstituted N-Aryl Group 
Despite developing a model to explain the role of the sulfonate group and the 
substitution pattern on the NHC−Cu complexes with the aid of  DFT calculations,12 there 
were cases that showed the limitations of our current ligand system: as shown in Scheme 
2.9, EAS reaction with allylic phosphate 2.52 in combination with relatively large alkenyl 
B(pin) reagent 2.61 led to only moderate stereoselectivity (82:18) promoted by an 
NHC−Cu complex derived from 2.14. Therefore, we applied the insight we obtained 
from mechanistic studies to rationally design new NHC ligands to achieve high 
selectivity. We settled on a new type of sulfonate-containing NHC ligand with 2,5-
                                                
(12) see Chapter 1. 
Scheme 2.9. Application to Stereoselective Synthesis of the Diene Fragment of Plakinic Acid A
2.52 2.58
>98% conv, >98% yield,
>98:2 propargyl:allenyl addn,
97:3 SN2':SN2, 90:10 er
2.5 mol % 2.29,
5.0 mol % CuCl
Si(i-Pr)3
(pin)B
2.57 (1.5 equiv)
1.2 equiv NaOMe,
CH2Cl2, 22 °C, 6 h
2.60
>98% conv, 80% yield,
>98:2 E:Z
Mo
N
i-Pr i-Pr
O
O
CF3F3C
PhF3C
F3C
5.0 mol %
10 equiv styrene,
C6H6, 22 °C, 35 torr, 10 h
Ph
Me Si(i-Pr)3Me Si(i-Pr)3
(EtO)2OPO Me
Ph
Me
B(pin)Ph
Me Me
Ph
Me Me
OH
1. 1.5 equiv (n-Bu)4NF,
thf, 22 °C, 1 h; 95% yield
2. 10 mol % 2.54, 10 mol % CuCl,
20 mol % NaOt-Bu, 1.1 equiv B2(pin)2,
2.0 equiv MeOH, thf, 22 °C, 24 h
2.61
>98% conv, 81% yield,
>98:2 E:Z, 95:5 β:α
2.62
>98% conv, 56% yield,
>98:2 SN2':SN2, 76:24 dr
(82:18 stereoselectivity)
5.0 mol % CuCl,
2.0 equiv 2.52, 2.0 equiv NaOMe,
thf, 22 °C, 24 h
N
Ph Ph
NS
2.14
Ar = 2,4,6-iPr3C6H2
O O
O
Ar
5.0 mol %
1.0 equiv 9-BBN, 
thf, 22 °C, 8 h;
3.0 equiv NaBO3•4H2O, 
1/1 thf/H2O, 22 °C, 2 h
Ph
Me Me
2.63
>98% conv, >98% yield
OO
CO2H
Me Me
plakinic acid A
2.59
NHC–Cu-catalyzed
EAS	with	a
propargyl–B(pin)
NHC–Cu-catalyzed
β-	and	E-selective
protoboration
NHC–Cu-catalyzed
EAS	with	an
alkenyl–B(pin)
Ar
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disubstituted N-aryl ring that allowed for new protocols to streamline synthesis of several 
natural products and pharmaceuticals. 
2.4.1 Development of a New NHC Ligand with a 2,5-Substitution Pattern for 
EAS Reactions Employing 1,2-Disubstituted Allylic Phosphates  
Our goal was to develop a new ligand to improve the selectivity of the second 
EAS step towards plakinic acid A.  With our previously proposed stereochemical model, 
we proceeded to search for the reason behind lower enantioselectivity when the 
nucleophile was switched from propargyl to alkenyl. As shown in Figure 2.3, in transition 
state 2.65 leading to the minor enantiomer, there existed a strong steric repulsion between 
the large triisopropylphenyl group on the catalyst and the phenyl group on the substrate; 
while this penalizing interaction was absent in transition state 2.64 (leading to the major 
enantiomer). The large energy gap between the two modes of additions (4.0 kcal/mol) 
contributed to the high enantioselectivity observed with the NHC−Cu complex bearing 
3,5-substitution. In both transition states, the propargyl nucleophile is pointing towards 
the top; this is due to the linear geometry of the propargyl group and flexibility of the 
C(sp3)-hybridized methylene unit. However, as shown by the transition states leading to 
the major and minor enantiomers of 2.66 and 2.67 in Figure 2.4, incorporation of the 
alkenyl group induces a penalizing interaction with the methyl group of the substrate, 
which raises the energy of the major pathway, consequently lowering the energy 
difference between 2.66 and 2.67 (Figure 2.4), leading to lower enantioselectivity. This 
destabilizing interaction is due to the increased size of the nucleophile and the rigidity of 
the sp2 hybridized alkenyl group. 
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We postulated that removing the 3-substituent on the N-aryl group and 
incorporating a substituent at the 2-position as shown in Figure 2.4, the possible 
transition states leading to the major and minor enantiomer (2.69 and 2.70) could be 
better differentiated. We hypothesized that in the case of the minor pathway, the rigidity 
of the alkenyl group might lead to the rotation of the N-aryl ring to the back right 
quadrant which would induce a steric clash between the substituent on the 5-position with 
the methyl allylic phosphate, raising the energy of this pathway. Thus, the NHC−Cu 
complex derived from a imidazolinium salt 2.68 might induce higher enantioselectivity.  
The development of this new type of NHC with a 2,5-disubstituted N-aryl group proved 
to be critical for the synthesis of plakinic acid A. 
H
i-Pr
N
Ph Ph
NSO O–
O
Cu
O
P(OMe)2
O
i-Pr
H
favored
Na+
TMS
Na+
i-Pr
N
Ph Ph
NSO O–
O
Cu
H
O P(OMe)2
O
i-Pr
H
steric 
interaction
disfavored
ΔGrel= 4.0 kcal/mol
Performed	at	DFT	calculations		at	ω-B97XD/Def2TZVPPCH2Cl2(SMD)//ω-B97XD/LANL2DZ	level
TMS
Figure 2.3. Stereochemical Model for the EAS Reactions with a Propargyl B(pin) Reagent
2.64 2.65
steric 
interaction
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Our hypothesis was also supported by the EAS method of alkenyl B(pin) 
additions to disubstituted allylic phosphates published in 2014 (Scheme 2.10),6c NHC−Cu 
complex derived from 2.71 promoted the formation of alkenyl addition product 2.72 with 
>98% SN2’ selectivity and 91:9 er, while only 82:12 enantioselectivity was obtained by 
the use of NHC−Cu complex derived from 2.14. The improvement of diastereoselectivity 
yielded the conclusion that an NHC with a 2,5-disubstituted N-aryl group provided 
optimal result as compared to an NHC with a 3,5-disubstituted N-aryl ring, when a large 
alkenyl nucleophile is utilized in EAS reactions with a disubstituted allylic phosphate. 
Na+
Me
i-Pr
N
Ph Ph
NSO O–
O
Cu
H
O P(OMe)2
O
i-Pr
H
steric interaction
disfavored
steric
interaction
Performed at M06L/Def2SVP level
i-Pr
N
Ph Ph
NSO O–
O
Cu
O
P(OMe)2
O
i-Pr
Me
Na+
R
steric
interaction
R
N
Ph Ph
NSO O
O
Cu
CH2O
P(OMe)2
O
Me
R
G
Na+ Na
+
Me
i-Pr
N
Ph Ph
NSO O–
O
Cu
H
O P(OMe)2
O
i-Pr
H
steric 
interaction
disfavored
R
G
Figure 2.4. Hypothesis for an NHC Ligand with a 2,5-Disubstituted N-Aryl Group to Improve Enantioselectivity
slightly favored
more favored
2.66 2.67
2.69 2.70
N
Ph Ph
NSO O
O
Ar
G
+–
2.68
Ar = 2,4,6-(i-Pr)3C6H2
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From the previous case, we envisioned that triene 2.62 could be synthesized in 
higher diastereoselectivity assisted by an NHC ligand with an even larger substitution on 
the 5-position (larger than t-butyl group in 2.73). Thus imidazolinium salt 2.70 with 2,5-
disubstitution bearing a 5-triisopropylphenyl group was synthesized and examined in the 
EAS reaction for the synthesis of plakinic acid A. To our delight, this new ligand yielded 
improved selectivity for the formation of triene 2.62 as shown in Scheme 2.11. The facial 
selectivity was improved from 82:18 to 90:10, which further supports our hypothesis as 
delineated in Figure 2.4.  
B(pin)
Cy Ph
74:26 SN2', 74:26 er
(EtO)2OPO Cy
78% yield,
>98% SN2', 91:9 er
5.0 mol % CuCl, 2.0 equiv NaOMe,
thf, 22 °C, 24 h
N
Ph Ph
NS
Ar = 2,4,6-(i-Pr)3C6H2
O O
O
Ar
5.0 mol %
Ar
5.0 mol % CuCl, 2.0 equiv NaOMe,
thf, 22 °C, 24 h
5.0 mol %
N
Ph Ph
NSO O
O
t-Bu
Ph
+
+–
–
Ph
Cy Ph
Scheme 2.10. EAS with an Alkenyl B(pin) Reagent catalyzed by an NHC-Cu complex derived from a 
imidazolinium salt with a 2,5-disubstituted N-aryl group
2.14
2.31
2.71
2.72
2.722.73
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The utility of this new ligand was also showcased in the synthesis of semburin. As 
shown in Scheme 2.12, 6c cyclic alkenyl boron 2.74 was utilized in EAS reaction with 
allylic phosphate 2.75 to incorporate a pyran group at the stereogenic center.  The EAS 
product 2.76 can be further elaborated to semburin. The low enantioselectivity (83:17 er) 
was observed in EAS reactions requiring the addition of a large alkenyl nucleophile. The 
EAS reaction catalyzed by NHC-Cu complex derived from the newly-synthesized 
imidazolinium salt 2.70 furnished skipped diene 2.76 in higher enantioselectivity (97:3 
er).  
Ph
Me
B(pin)
Ph
Me Me
78% yield,
>98% SN2', 76:24 dr
(82:18 stereoselectivity)(EtO)2OPO Me
90:10 er, >98:2 E:Z
Ph
Me Me
92% yield,
>98% SN2', 80:20 dr
(90:10 stereoselectivity)
5.0 mol % CuCl, 2.0 equiv NaOMe,
thf, 22 °C, 24 h
N
Ph Ph
NS
Ar = 2,4,6-(i-Pr)3C6H2
O O
O
Ar
5.0 mol %
Ar
5.0 mol % CuCl, 2.0 equiv NaOMe,
thf, 22 °C, 24 h
Ar = 2,4,6-(i-Pr)3C6H2
5.0 mol %
N
Ph Ph
NSO O
O
Ar
Ph
+
+–
–
Ph
Me Me OO
CO2H
Me Me
plakinic acid A
Scheme 2.11. Introduction of a New Sulfonate-containing NHC Ligand with 2,5-Disubstitution
2.52
2.61
2.14 2.62
2.70
2.62
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2.4.2 Application of the New NHC Ligand with 2,5-Substitution for 
Enantioselective SN2’’Addition to Alkenyl-Substituted Allylic Phosphates 
Recently, we disclosed an enantioselective SN2’’ addition of allkenyl B(pin) 2.13 
to alkenyl allylic phosphates such as 2.77, furnishing the propargyl addition product 2.78 
bearing a tertiary carbon stereogenic center adjacent to a diene as shown in Scheme 
2.13.13 Ligand screening showed that sulfonate-containing NHC−Cu complex derived 
from 2.14 with a 2,5-substitution pattern promoted the generation of 2.78 in 90:10 er. 
Again, the sulfonate NHC ligand with a meta substitution pattern delivered the product in 
a less stereoselective fashion (85:15 er). Of note, the of sulfonate-bearing NHC is crucial 
for the observed high enantioselectivity; the SN2’’ addition reaction catalyzed by non-
sulfonate-containing NHC ligands or phosphine ligands led to the formation of racemic 
2.78. 
                                                
(13) Unpublished data.  
92% yield,
>98% SN2', 83:17 er
5.0 mol % CuCl, 2.0 equiv NaOMe,
thf, 22 °C, 24 h
N
Ph Ph
NSO O
O5.0 mol %
t-Bu
5.0 mol % CuCl, 2.0 equiv NaOMe,
thf, 22 °C, 24 h
Ar = 2,4,6-(i-Pr)3C6H2
5.0 mol %
N
Ph Ph
NSO O
O
Ar
Ph
O semburin
98% yield,
>98% SN2', 97:3 er
+
+–
–
(EtO)2OPO
OTBS
OTBS
O
O
B(pin)
OTBS
O
Ph
Scheme 2.12. Application of the New NHC Ligand to the Synthesis of Semburin
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DFT calculations not only provided insight into the mechanism of the SN2’’ 
additions, but informed design of this new NHC ligand as well. In this case, the cationic 
sodium bridge also plays an important role in the transition states leading to both the 
major and minor enantiomers as shown in Figure 2.5. The sulfonate group served as the 
secondary binding site of the substrate-catalyst complex, rendering a well-defined 
transition state leading to the SN2’’ addition. The allenyl−Cu species bound to the double 
bond of 2.77 close to the leaving group and then the Cu−π complex underwent a 3,3’ 
elimination followed by the cleavage of the C−O bond between the carbon and 
phosphate. As depicted in Figure 2.5, in order for the 3,3’-elimination to occur in the 
minor pathway, the allenyl group had to rotate to the right to approach the C1 position of 
the distal olefin on the allylic phosphate. Thus, it would induce a steric strain between the 
allenyl moiety and the substituent on the 2-position of N-aryl group. However, the N-aryl 
ring could not rotate to the back to alleviate the strain due to the steric pressure between 
75% yield,
93:4:3 SN2’’:SN2’:SN2, 
95:5 E:Z
85:15 er
5.0 mol % CuCl, 1.5 equiv NaOMe,
CH2Cl2, 22 °C, 16 h
N
Ph Ph
NSO O
O5.0 mol %
Ar
5.0 mol % CuCl, 2.0 equiv NaOMe,
CH2Cl2, 22 °C, 16 h
Ar = 2,4,6-(i-Pr)3C6H2
5.0 mol %
N
Ph Ph
NSO O
O
Ar
Ph
75% yield,
88:7:5 SN2’’:SN2’:SN2, 
90:10 E:Z
90:10 er
+
+–
–
(EtO)2OPO
Ph
• B(pin)
Ph
Ar
Ar = 2,4,6-(i-Pr)3C6H2
Ph
Scheme 2.13. Enantioselective SN2’’ Reaction Promoted by an NHC Ligand with 2,5-Disubstitution
2.13
2.77
2.14
2.70
2.78
2.78
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the triisopropylphenyl group on the 5-position on the N-aryl ring and the alkenyl 
substituent on the electrophile. From the model, we could see that the sulfonate group and 
the 2,5-substitution on the NHC ligand were essential for this SN2’’ reaction to occur in a 
stereoselective fashion. 
 
2.5 Conclusions 
We have developed a method for the allylic substitution of TMS-substituted 
propargyl B(pin) to a variety of di- and trisubstituted allylic phosphates to generate 
tertiary and quaternary carbon centers. Reactions are catalyzed by an NHC–Cu complex 
derived from a sulfonate-containing NHC–Ag complex with a 3,5-disubstituted N-aryl 
group. 1,5-Enynes can be isolated in 75−90% yield, 87:13 to >98:2 SN2′:SN2 
(branched/linear) selectivity and 83:17−99:1 enantiomeric ratio. Products can be 
elaborated to rapidly form allenyl, Z-alkenyl iodide, and alkenyl B(pin) containing 
compounds that are of high synthetic value. An application of the current method has 
been shown in the formal synthesis of plakinic acid A. DFT calculations provided a 
stereochemical model accounting for the high levels of enantioselectivity observed, and 
PhPh
O O
O
H
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O
Cu
CH2O
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O
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Figure 2.5. Stereochemical Model for the New NHC ligand with 2,5-Substitution in Enantioselective SN2’’ reaction
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based on that, informed design of a new imidazolinium salt with a 2,5-substituted N-aryl 
ring.  
2.6 Experimentals 
General. Infrared (IR) spectra were recorded on a Bruker FT-IR Alpha (ATR mode) 
spectrophotometer, λmax in cm−1. Bands are characterized as broad (br), strong (s), 
medium (m), and weak (w). 1H NMR spectra were recorded on a Varian Unity INOVA 
400 (400 MHz) or Varian Unity INOVA 500 (500 MHz) spectrometer. Chemical shifts 
are reported in ppm from tetramethylsilane with the solvent resonance as the internal 
standard (CDCl3: δ 7.26 ppm). Data are reported as follows: chemical shift, integration, 
multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, br = broad, m = multiplet), 
and coupling constant (Hz). 13C NMR spectra were recorded on a Varian Unity INOVA 
400 (100 MHz) spectrometer with complete proton decoupling. Chemical shifts are 
reported in ppm from tetramethylsilane with the solvent resonance as the internal 
standard (CDCl3: δ 77.16 ppm). High-resolution mass spectrometry was performed on a 
JEOL AccuTOF DART (positive mode) at the Mass Spectrometry Facility, Boston 
College. Enantiomer ratios were determined by GC analysis (Alltech Associated 
Chiraldex B-DM (30 m x 0.25 mm), Chiraldex G-TA (30 m x 0.25 mm), and Betadex 
120 column (30 m x 0.25 mm)), or HPLC analysis (Chiral Technologies Chiralpak AZ–H 
(4.6 x 250 mm), Chiralcel OD–H (4.6 x250 mm) and Chiralcel OJ–H (4.6 x 250 mm) in 
comparison with authentic racemic materials. Specific rotations were measured on an 
ATAGO® AP-300 Automatic Polarimeter or a Rudolph Research Analytical Autopol IV 
Polarimeter. Melting points were measured on a Thomas Hoover capillary melting point 
apparatus and are uncorrected. 
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Unless otherwise noted, all reactions were carried out with distilled and degassed 
solvents under an atmosphere of dry N2 in oven- (135 °C) or flame-dried glassware with 
standard dry box or vacuum-line techniques. Solvents were purified under a positive 
pressure of dry argon by a modified Innovative Technologies purification system: toluene, 
benzene and hexanes were purified through a copper oxide and alumina column; CH2Cl2 
and Et2O were purged with Ar and purified by passage through two alumina columns. 
Tetrahydrofuran (Aldrich Chemical Co.) was purified by distillation from sodium 
benzophenone ketyl immediately prior to use unless otherwise specified. All work-up and 
purification procedures were carried out with reagent grade solvents (purchased from 
Fisher Scientific, Inc.) in air.  
Reagents 
N-benzyl-N,N-diethylethanaminium dichloroiodate was prepared according to a 
previously reported procedure.14 
Bis(pinacolato)diboron (B2(pin)2) was purchased from Frontier Scientific, Inc. and 
recrystallized from pentane. 
1,3-Bis(1-adamantyl)imidazolinium tetrafluoroborate was purchased from Aldrich 
and used as received. 
1,3-Bis(2,4,6-trimethylphenyl)imidazolinium chloride (SIMes) was purchased from 
Aldrich and used as received. 
(E)-4-[(tert-Butyldimethylsilyloxy)but-2en-1-yl] diethyl phosphate (substrate for 
14)15 
1-Bromo-4-nitrobenzene was purchased from Aldrich and used as received. 
Calcium (II) carbonate (CaCO3) was purchased from Strem and used as received. 
Copper (I) bromide (CuBr) was purchased from Strem and used as received. 
Copper (I) chloride (CuCl) was purchased from Strem and used as received. 
Copper (II) chloride (CuCl2) was purchased as CuCl2•2H2O from Aldrich and dried 
over P2O5 under vacuum at 80 °C overnight.  
                                                
(14) Kosynkin, D. V.; Tour, J. M. Org. Lett. 2001, 3, 991–992. 
(15) Delvos, L. B.; Vyas, D. J.; Oestreich, M. Angew. Chem., Int. Ed. 2013, 52, 4650–4653. 
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Copper (I) iodide was purchased from Strem and used as received. 
(E)-Diethyl 3-(3-bromophenyl)but-2-enyl phosphate (2.43c)16 
(E)-Diethyl 3-(2-bromophenyl)prop-2-enyl phosphate (2.12c)17 
(E)-Diethyl 3-(3-bromophenyl)prop-2-enyl phosphate (2.12f)18 
(E)-Diethyl 3-(4-chlorophenyl)but-2-enyl phosphate (2.43d)19 
(E)-Diethyl 3-(4-chlorophenyl)prop-2-enyl phosphate (2.12j)18 
(E)-Diethyl 3-cyclohexylbut-2-enyl phosphate (2.43e)19 
(E)-Diethyl 3-cyclohexylprop-2-enyl phosphate (2.32)18 
(E)-Diethyl 3-(2-fluorophenyl)prop-2-enyl phosphate (2.12b)17 
(E)-Diethyl 3-(2-methoxyphenyl)but-2-enyl phosphate (2.43b)16 
(E)-Diethyl 3-(2-methoxyphenyl)prop-2-enyl phosphate (2.12d)18 
(E)-Diethyl 3-(2-methylphenyl)prop-2-enyl phosphate (2.12e)18 
(E)-Diethyl 3-(3-methylphenyl)prop-2-enyl phosphate (2.12g)17 
(E)-Diethyl 3-(4-methylphenyl)prop-2-enyl phosphate (2.12k)18 
(E)-Diethyl 3-(2-naphthyl)prop-2-enyl phosphate (2.12i)20 
(E)-Diethyl 3-(4-nitrophenyl)prop-2-enyl phosphate (2.12l)21 
(E)-Diethyl 3-phenylbut-2-enyl phosphate (2.43a)20 
(E)-Diethyl 3-phenylprop-2-enyl phosphate (2.12a)16 
(E)-Diethyl 3-(3-trifluoromethylphenyl)prop-2-enyl phosphate (2.12h)17 
Diisobutylaluminum hydride (dibal–H) was purchased neat from Aldrich and used as 
received.  
Diisopropyl amine was purchased from Aldrich and used as received.  
Dimethylmethylideneammonium iodide (Eschenmoser’s salt) was purchased from 
Aldrich and used as received. 
(E)-3-[Dimethyl(phenyl)silyl]prop-2-enyl diethyl phosphate (substrate for 2.35)20 
(–)-(S,S)-Diphenylethylenediamine (99% purity) was purchased from Ivy Chemical 
Company and used as received. 
Glacial acetic acid was purchased from Aldrich and used as received. 
Hexafluoro-2-propanol (HFIP) was purchased from Aldrich and used as received.  
                                                
(16) Gao, F.; McGrath, K. P.; Lee, Y.; Hoveyda, A. H. J. Am. Chem. Soc. 2010, 132, 14315–14320. 
(17) Jung, B.; Hoveyda, A. H. J. Am. Chem. Soc. 2012, 134, 1490–1493. 
(18) Akiyama, K.; Gao, F.; Hoveyda, A. H. Angew. Chem., Int. Ed. 2010, 49, 419–423. 
(19) Dabrowski, J. A.; Gao, F.; Hoveyda, A. H. J. Am. Chem. Soc. 2011, 133, 4778–4781. 
(20) Kacprzynski, M. A.; Hoveyda, A. H. J. Am. Chem. Soc. 2004, 126, 10676–10681. 
(21) Luchaco-Cullis, C. A.; Mizutani, H.; Murphy, K. E.; Hoveyda, A. H. Angew. Chem., Int. Ed. Engl. 
2001, 40, 1456–1460. 
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Imidazolinium salts 2.26, 2.27 and 2.14 were prepared previously reported methods 
according to previously reported procedures.22  
Isoamyl nitrite was purchased form TCI America and used as received. 
Isobutyl 2-bromobenzenesulfonate was prepared according to a previously reported 
procedure.23 
Methanol was purchased from Acros and purified by distillation from Na (Aldrich) prior 
to use.  
4-Methylbenzenesulfonyl azide was prepared according to a previously reported 
procedure.24  
NHC–Ag complex 2.28 and 2.29 were prepared according to a previously reported 
procedure.25  
N-Iodosuccinimide (NIS) was purchased from Aldrich and re-crystallized under 1,4-
dioxane/CCl4 at 4 °C without light.  
Paraformaldehyde was purchased from Aldrich and used as received. 
Palladium (II) acetate (Pd(OAc)2) was purchased from Strem and used as received. 
Silver carbonate was purchased from Aldrich and used as received. 
Sodium borohydride (NaBH4) was purchased from Aldrich and used as received.  
Sodium t-butoxide (NaOt-Bu) was purchased from Strem and used as received. 
Sodium perborate tetrahydrate (NaBO3•4H2O) was purchased from Aldrich and used 
as received. 
Sodium methoxide (NaOMe) was purchased from Strem and used as received. 
Tetrabutylammonium fluoride (TBAF) was purchased as a 1.0 M solution in thf from 
Fisher and used as received.  
Tetrakis(triphenylphosphine)palladium was purchased from Strem and used as 
received. 
Tin (II) chloride (SnCl2) was purchased from Aldrich and used as received. 
(2,4,6-Triisopropylphenyl)boronic acid was purchased from Combi-blocks and used as 
received.  
3-(Trimethylsilyl)-2-propyn-1-ylboronic acid pinacol ester (2.57) was prepared 
according to a previously reported procedure.26  
                                                
(22) (a) Van Veldhuizen, J. J.; Campbell, J. E.; Guidici, R. E.; Hoveyda, A. H. J. Am. Chem. Soc. 2005, 
127, 6877–6882. (b) Lee, K.-S.; Hoveyda, A. H. J. Org. Chem. 2009, 74, 4455–4462.  
(23) Brown, M. K.; May, T. L.; Baxter, C. A.; Hoveyda, A. H. Angew. Chem., Int. Ed. 2007, 46, 1097–
1100. 
(24) Serwinski, P. R.; Esat, B.; Lahti, P. M.; Liao, Y.; Walton, R.; Lan, J. J. Org. Chem. 2004, 69, 5247–
5260. 
(25) May, T. L.; Brown, M. K.; Hoveyda, A. H. Angew. Chem., Int. Ed. 2008, 47, 7358–7362. 
(26) Fandrick, D. R.; Reeves, J. T.; Song J. J. International Patent WO 2010/141328 A2. 
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Triethylamine (Et3N) was purchased from Fisher Scientific, Inc. and distilled over CaH2 
prior to use. 
 
Synthesis 
Characterization Data for Previouly Unreported Allylic Phosphates 
(E)-Diethyl (3-(thiophen-3-yl)allyl) phosphate (2.12m) 
2.12m was synthesized according to a previously reported procedure.17 IR (neat): 
3455(br,w), 3087 (w), 2983 (w), 2934 (w), 2908 (w), 1657 (w), 1444 (w), 1393 (w), 1370 
(w), 1261 (s), 1164 (w), 1101 (w), 1007 (s), 964 (s), 859 (m), 824 (m), 772 (s), 627 (w), 
549 (w) cm−1; 1H NMR (CDCl3, 400 MHz): δ 7.28–7.26(1H, m), 7.21–7.20 (2H, m), 
6.68 (1H, d, J = 16.0 Hz), 6.15 (1H, dt, J = 16.0, 6.4 Hz), 4.65 (2H, t, J = 7.6 Hz), 4.16–
4.08 (4H, m), 1.33 (6H, t, J = 6.8 Hz; 13C NMR (CDCl3, 100 MHz): δ 138.8, 128.3, 
126.4, 125.1, 123.5 (d, JCP = 6.8 Hz), 123.4, 67.8 (d, JCP = 5.3 Hz), 63.8 (d, JCP = 6.1 Hz), 
16.1 (d, JCP = 6.9 Hz). HRMS (ESI+): Calcd for C11H18O4PS [M+H]+: 277.0663; Found: 
277.0657. 
 
(E)-Diethyl (3-(pyridin-3-yl)allyl) phosphate (2.12n) 
2.12n was synthesized according to a previously reported procedure.17 IR (neat): 
3474(br,w), 2984 (w), 2933 (w), 1648 (w), 1587 (w), 1570 (w), 179 (w), 1260 (m), 1165 
(w), 1097 (w), 1011 (s), 966 (s), 883 (w), 824 (m), 795 (m), 747 (w), 708 (m), 555 (w) 
cm−1; 1H NMR (CDCl3, 400 MHz): δ 8.62 (1H, d, J = 2.4 Hz), 8.51 (1H, d, J = 4.8 Hz), 
7.16 (1H, dt, J = 8.0, 1.6 Hz), 7.29–7.26 (1H, m), 6.69 (1H, d, J = 15.6 Hz), 3.84 (1H, dt, 
J = 15.6, 6.0 Hz), 4.73 (1H, dd, J = 6.0, 1.6 Hz), 4.71 (1H, dd, J = 6.0, 1.6 Hz), 4.19–4.12 
(4H, m), 1.36 (6H, t, J = 7.2 Hz); 13C NMR (CDCl3, 100 MHz): δ 149.3, 148.6, 133.2, 
131.8, 129.9, 126.2, 126.1, 123.6, 67.4 (d, JCP = 5.3 Hz), 64.0 (d, JCP = 6.1 Hz), 16.2 (d, 
JCP = 6.1 Hz). HRMS (ESI+): Calcd for C12H18NO4P [M+H]+: 272.1052; Found: 
272.1053. 
 
 
HO
HO
OH Me Me
MeO OMe
5.0 mol % p-TsOH•H2O,
CH2Cl2, 22 °C, 14 hS1
O
O
OH
S2
63% yield
Me
Me 2. (EtO)2POCH2CO2Et,
NaH, thf, 22 °C, 4 h
O
O
Me
Me
1. (COCl)2, DMSO, –78 °C;
Et3N, CH2Cl2, –78 → 0 °C
S3
55% yield, >98:2 E /Z
CO2Et
O
O
Me
Me
S4
81% yield
OH
O
O
Me
Me
S5
97% yield
OPO(OEt)2
PO(OEt)2Cl, Et3N, DMAP
CH2Cl2, 0 → 22 °C, 3 h dibal–H, thf,
–78 → 22 °C, 3 h
Scheme S1. Preparation of an Allylic Phosphate
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(E)-Diethyl 3-(2,2-dimethyl-[1,3]dioxin-5-yl)prop-2-enyl phosphate (S5, substrate for 
2.33)  
IR (neat): 3487 (br,w), 2988 (w), 2923 (w), 2857 (w), 1479 (w), 1455 (w), 1371 (w), 
1273 (m), 1196 (m), 1161 (m), 1022 (s), 972 (s), 940 (s), 831 (m), 802 (m), 754 (w), 702 
(w), 518 (m) cm−1; 1H NMR (CDCl3, 400 MHz): δ 5.75–5.62 (2H, m), 4.49 (1H, d, J = 8 
Hz), 4.48 (1H, d, J = 8 Hz), 4.15–4.07 (4H, m), 3.87 (1H, d, J = 4.4 Hz), 3.84 (1H, d, J = 
4.4 Hz), 3.73 (1H, d, J = 9.6 Hz), 3.70 (1H, d, J = 9.6 Hz), 2.62–2.53 (1H, m), 1.44 (3H, 
d, J = 0.8 Hz), 1.41 (3H, d, J = 0.8 Hz), 1.34 (3H, t, J = 7.2 Hz), 1.33 (3H, t, J = 7.2 Hz); 
13C NMR (CDCl3, 100 MHz): δ 131.5, 127.4 (d, JCP = 6.7 Hz), 97.8, 77.3, 67.5 (d, JCP = 
5.2 Hz), 64.0, 63.9 (d, JCP = 6.0 Hz), 37.8, 27.5, 20.5, 16.3 (d, JCP = 6.7 Hz); HRMS 
(ESI+): Calcd for C13H26O6P1 [M+H]+: 309.1467; Found: 309.1472. 
 
 
(S,E)-Diethyl (3-phenylallyl-1-d) phosphate (S10, cf. 1.64 in Chapter 1) 
IR (neat): 3408 (br, w), 2983 (w), 2909 (w), 1449 (w), 1393 (w), 1369 (w), 1261 (m), 
1020 (s), 966 (s), 863 (m), 747 (m), 693 (m), 552 (w) cm−1; 1H NMR (CDCl3, 500 
MHz): δ 7.39 (2H, d = 9.0 Hz), 7.34–7.31 (2H, m), 7.28–7.25 (1H, m), 6.68 (1H, d = 
16.5 Hz), 6.30 (1H, dd, J = 16.0, 6.5 Hz), 4.68 (1H, t, J = 6.5 Hz), 4.16–4.10 (4H, m), 
1.34 (1H, t, J = 6.5 Hz); 13C NMR (CDCl3, 100 MHz): δ 136.2, 134.1, 128.8, 128.7, 
128.3, 126.8, 123.7 (d, JCP = 6.8 Hz), 67.7 (dt, JCP(d) = 4.5 Hz, JCD(t) = 22.0 Hz), 63.9 (d, 
JCP = 6.1 Hz), 16.3 (d, JCP = 6.9 Hz; HRMS (ESI+): Calcd for C13H19DO4P [M+H]+: 272. 
1162; Found: 272.1159. Specific rotation: [α]D20.0  0.0 (c 1.17, CHCl3) for an 
enantiomerically enriched sample of >98:2 er.  
Enantiomeric purity was determined by 1H NMR, 19F NMR analysis of the mosher’s ester 
for S9. 
 
(S,E)-3-Phenylallyl-1-d (R)-3,3,3-trifluoro-2-methoxy-2-phenylpropanoate (R-MTPA for 
S9) 
IR (neat): 2952 (w), 2849 (w), 1745 (s), 1495 (w), 1451 (w), 1269 (s), 1241 (s), 1167 (s), 
1122 (s), 1081 (m), 1022 (m), 995 (m), 966 (s), 765 (w), 716 (s), 693 (m), 644 (w) cm−1; 
1H NMR (CDCl3, 400 MHz): δ 7.54 (d, J = 7.0 Hz), 7.40–7.33 (7H, m), 7.32–7.26 (1H, 
m), 6.69 (1H, d, J = 15.5 Hz), 6.28 (1H, d, J = 15.5, 6.5 Hz), 4.96 (1H, d, J = 6.5 Hz), 
EtO Ph
H
(EtO)2OPO Ph
HH D
O
HO Ph
HD D
Ph
HO
D
HO Ph
HH D
7 equiv MnO2,
CH2Cl2, 50 °C, 24 h
1.3 equiv. (R)-Alpine-Borane,
thf, 22 °C, 14 h
0.8 equiv. LiAlD4,
2.67 equiv. AlCl3,
Et2O, 0 °C, 2 h
S7
63% yield
S8
75% yield
1.2 equiv. ClPO(OEt)2,
1.3 equiv. Et3N, 0.1 equiv. DMAP
CH2Cl2, 22 °C, 3 h
Scheme S2. Preparation of Allylic Phosphate S10
S9
68% yield
S10
82% yield
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3.58 (3H, d, s); 13C NMR (CDCl3, 100 MHz): δ 166.5, 136.0, 132.4, 129.8, 128.8, 128.6, 
128.5, 127.4, 126.9, 123.4 (q, JCF = 286.6 Hz), 84.8 (q, JCF = 27.3 Hz), 66.6 (t, JCD = 22.7 
Hz), 55.7; 19F NMR (CDCl3): δ 81.1.  HRMS (ESI+): Calcd for C19H17DF3O3 [M+H]+: 
352.1271; Found: 352.1284. Specific rotation: [α]D20.0  –51.7 (c 0.58, CHCl3) for an 
enantiomerically enriched sample of >98:2 dr. 
 
 
(E)-Diethyl (7-oxooct-2-en-1-yl) phosphate (S15) 
IR (neat): 3495 (br, w), 2985 (w), 2937 (w), 1713 (m), 1444 (w), 1368 (w), 1262 (m), 
1163 (m), 1093 (w), 1003 (s), 968 (s), 844 (m), 801 (m), 744 (w), 517 (m), 402 (w) cm−1; 
1H NMR (CDCl3, 400 MHz): δ 5.78–5.70 (1H, m), δ 5.63–5.56 (1H, m), 4.45 (2H, t, J = 
7.6 Hz), 4.13–4.05 (4H, m), 2.42 (2H, t, J = 7.8 Hz), 2.11 (3H, s), 2.05 (2H, q, J = 7.2 
Hz), 1.66 (2H, q, J = 7.2 Hz), 1.31 (6H, t, J = 8.0 Hz); 13C NMR (CDCl3, 100 MHz): δ 
208.7, 135.3, 125.4 (d, JCP = 6.8 Hz), 67.9 (d, JCP = 5.3 Hz), 63.7 (d, JCP = 6.1 Hz), 42.9, 
31.5, 30.1, 22.8, 16.2 (d, JCP = 6.8 Hz); HRMS (ESI+): Calcd for C12H23O5PNa [M+Na]+: 
301.1181; Found: 301.1181. 
 
 
 
Methyl (E)-4-(3-((diethoxyphosphoryl)oxy)prop-1-en-1-yl)benzoate (S17) 
IR (neat): 2984 (w), 2954 (w), 1717 (s), 1607 (w), 1436 (w), 1269 (s), 1179 (m), 1107 
(m), 1010 (s), 958 (s), 863 (m), 837 (m), 804 (m), 753 (m), 509 (w), 476 (w) cm−1; 1H 
NMR (CDCl3, 400 MHz): δ 7.99 (2H, d, J = 8.4 Hz), 7.44 (2H, d, J = 8.8 Hz), 6.72 (1H, 
d, J = 16.0 Hz), 6.41 (1H, dt, J = 16.0, 6.0 Hz), 4.72 (2H, t, J = 6.0 Hz), 4.18–4.12 (4H, d, 
J = 6.8 Hz), 3.91 (3H, s), 1.35 (6H, t, J = 6.8 Hz); 13C NMR (CDCl3, 100 MHz): δ 166.9, 
140.6, 132.5, 130.1, 129.7, 126.6, 126.5 (d, JCP = 6.8 Hz), 67.6 (d, JCP = 5.3 Hz), 64.0 (d, 
JCP = 5.3 Hz), 52.6, 16.3 (d, JCP = 6.8 Hz); HRMS (ESI+): Calcd for C15H22O6P [M+H]+: 
329.1154; Found: 329.1169. 
OH
0.33 equiv CuBr
2.0 equiv (CH2O)n
2.0 equiv i-Pr2NH
dioxane, 80 °C, 18 h
OH•
(EtO)2OPO
•
O
OEt
• OHOH
O
1. 2.0 equiv SO3•Py, 3.0 equiv EtNi-Pr2,
6.0 equiv DMSO, CH2Cl2, 0 °C, 1 h
2. 1.1 equiv NaH,
1.2 equiv EtOOCCH2PO(OEt)2
thf, 0 °C to 22 °C, 3 h
2.5 equiv dibal-H
thf, −78 °C to 22 °C, 3 h
84% yield
42% yield in 2 step
78% yield
O 1.2 equiv. ClPO(OEt)2,
1.3 equiv. Et3N, 0.1 equiv. DMAP,
CH2Cl2, 22 °C, 3 h 5.0 mol % CuCl, 1.0 equiv B2(pin)2,
20 mol % NaOt-Bu, 2.0 equiv. MeOH,
thf, 22 °C, 24 h
NAdAdN
7b BF4
 5.0 mol %
Scheme S3. Preparation of Allylic Phosphate S15
S11
S12
S13S14S15
81% yield92% yield
OMe
O
I
5 mol % Pd(OAc)2,10 mol % PPh3,
1.0 equiv AgOAc, DMF, 70 °C, 16 h
OMe
O
OH
HO2.0 equiv
OMe
O
(EtO)2OPO
35% yield
1.2 equiv. ClPO(OEt)2,
1.3 equiv. Et3N, 0.1 equiv. DMAP,
CH2Cl2, 22 °C, 3 h
S16 S17
89% yield
Scheme S4. Preparation of Allylic Phosphate S17
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Characterization Data for the Propargyl B(pin) Reagent 
Triisopropyl(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)prop-1-yn-1-yl)silane (2.59) 
 This compound was prepared previously reported methods4:IR (neat): 2942 (m), 2892 
(w), 2865 (m), 2167 (w), 1494 (w), 1381 (m), 1342 (s), 1184 (w), 1143 (m), 1031 (w), 
994 (w), 967 (w), 882 (m), 845 (w), 859 (m), 675 (m) cm−1; 1H NMR (CDCl3, 400 
MHz): δ 1.87 (2H, s) 1.26 (12H, s), 1.08–1.02 (21H, m); 13C NMR (CDCl3, 100 MHz): 
δ 104.9, 84.1, 79.1, 24.9, 18.8, 11.5, –7.7. HRMS (ESI+): Calcd for C18H36BO2Si 
[M+H]+: 323.2578; Found: 323.2566. 
 
Preparation of Imidazolinium Salt 2.70 
 
 
2,4,6-Triisopropyl-4'-nitro-1,1'-biphenyl (S18) 
In a nitrogen-filled glove-box, to a solution of Pd(PPh3)4 (163 mg, 0.141 mmol) in 1,4-
dioxane (12 mL) was added 1-bromo-4-nitrobenzene (570 mg, 2.82 mmol), an aqueous 
solution of Ba(OH)2•8H2O (1.78 g, 5.64 mmol) and (2,4,6-triisopropylphenyl)boronic 
acid (700 mg, 2.82 mmol). The mixture was allowed to warm to at 80 °C for 24 h under 
nitrogen atmosphere. The solvents were removed in vacuo, and the resulting brown solid 
residue was dissolved in CH2Cl2 and was washed with a 1N solution of HCl (10 mL). 
The aqueous layer was washed with CH2Cl2 (3 x 12 mL) and the combined organic layers 
were washed with brine (10 mL), water (10 mL), dried over MgSO4, filtered and 
concentrated in vacuo. The yellow solid residue was purified by silica gel 
chromatography (100% hexanes, Rf = 0.65) to afford 761 mg (2.34 mmol, 83% yield) of 
S18 as pale yellow solid. Mp = 213–215 °C. IR (neat): 2956 (m), 2926 (m), 2867 (m), 
1592 (m), 1567 (w), 1509 (s), 1459 (m), 1382 (w), 1362 (w), 1342 (s), 1282 (m), 1170 
Scheme S5. Synthesis of Imidazolinium Salt 2.76
i-Pr
i-Pr
B(OH)2
i-Pr
NO2
Br
+
(1.0 equiv)
    5 mol % Pd(PPh3)4,
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5 equiv SnCl2
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    80 °C, 24 h
NH2
Ar
79% yield
1.05 equiv NBnEt3ICl2
2.0 equiv CaCO3,
2:1 DCM/MeOH, 
22 °C, 3 h
NH2
Ar
I
83% yield
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C6H6, 80 °C, 1 h
Ph
Ar
I
 2.0 equiv NaOt-Bu,
  tol., 110 °C, 24 h
H2N NH2
Ph Ph
1.2 equiv
45% yield
H2N HN
Ph Ph
EtOH, 65 °C, 16 h
 2.0 equiv. NaOt-Bu,
tol., 110 °C, 24 h
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1.2 equiv SO3i-Bu
S18 S19
2. 5.0 equiv Me2NCH2I,
15 equiv AcOH, 110 °C, 1 h
S20
S21
S22
45% overall yield 64% yield
N
Ph Ph
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Ar = 2,4,6-(i-Pr)3C6H2
O O
O
Ar
Ph
Ar 10 mol % Pd(OAc)2,
  20 mol % binap,1. 6 mol % Pd2(dba)3, 18 mol % binap,
Chapter 2, Page  
 
 
82 
(w), 1099 (m), 1071 (m), 1057 (m), 1005 (m), 966 (m), 945 (s), 881 (s), 761 (m), 707 (s), 
487 (m) cm−1; 1H NMR (CDCl3, 400 MHz): δ 8.28 (2H, app. d, J = 8.8 Hz), 7.37 (2H, 
app. d, J = 8.8 Hz), 7.08 (2H, s), 2.98–2.91 (1H, m), 2.51–2.41 (2H, m), 1.31 (6H, d, J = 
7.2 Hz), 1.08 (12H, d, J = 7.2 Hz); 13C NMR (CDCl3, 100 MHz): δ 149.2, 148.8, 147.0, 
146.1, 134.9, 130.9, 123.4, 121.0, 34.5, 30.6, 24.2. HRMS (ESI+): Calcd for C21H28NO2 
[M+H]+: 326.2120; Found: 326.2135. 
 
2',4',6'-Triisopropyl-(1,1'-biphenyl)-4-amine (S19) 
A 100-mL round bottom flask was charged with S18 (325 mg, 1.00 mmol), SnCl2 (948 
mg, 5.00 mmol), and ethanol (20.0 mL). The round bottom flask was fitted with a reflux 
condenser, and the mixture was allowed to warm to 65 °C with stirring. The resulting 
homogeneous solution was kept at 65 °C for 15 h before careful addition of a saturated 
solution of NaHCO3. The aqueous layer was washed with EtOAc (3 x 100 mL). The 
organic layers were combined, dried over MgSO4, and the volatiles were removed in 
vacuo. The white oil residue was purified by silica gel chromatography (2:1 
hexanes/EtOAc, Rf 0.80) to afford S19 as off-white solid (285 mg, 0.771 mmol, 79% 
yield). Mp = 149–150 °C. IR (neat): 3439 (w), 3359 (w), 2957 (s), 2925 (m), 2863(m), 
1619 (s), 1607 (s), 1565 (w), 1519 (s), 1459 (s), 1430 (w), 1380 (m), 1360 (m), 1336 (w), 
1316 (m), 1273 (s), 1247(w), 1236(w), 1178(m), 1168 (w), 1125(w), 1099(m), 1069 (m), 
1056 (m), 1002(w), 958 (w), 939 (w), 921 (w), 879(s), 835 (s), 815 (m), 782(m), 741 (m), 
685 (w), 653 (s), 623 (m),582 (m), 554 (s), 540 (s), 508 (s), 492(s) (s), 2927 (m), 2868 
(m), 1606 (w), 1567 (w), 1401 (m), 1382 (m), 1361 (m), 1317 (w), 939 (s), 762 (s), 748 
(m), 650 (m) cm−1; 1H NMR (CDCl3, 400 MHz): δ 7.03 (2H, s), 6.95 (2H, d, J = 8.4 Hz), 
6.72 (2H, d, J = 8.4 Hz), 3.68 (2H, s), 2.96–2.89 (1H, m), 2.74–2.68 (2H, m), 1.30 (6H, d, 
J = 7.2 Hz), 1.07 (12H, d, J = 7.2 Hz); 13C NMR (CDCl3, 100 MHz): δ 147.6, 147.2, 
144.7, 137.3, 131.1, 130.7, 120.5, 114.9, 34.4, 30.3, 24.4, 24.2. HRMS (ESI+): Calcd for 
C21H30N [M+H]+: 296.2378; Found: 296.2367. 
 
3-Iodo-2',4',6'-triisopropyl-(1,1'-biphenyl)-4-amine (S20) 
Aniline S19 (134 mg, 0.45 mmol) was dissolved in CH2Cl2 (5 mL) and MeOH (2.5 mL). 
To this solution were added benzyltriethylammonium dichloroiodate (184 mg, 0.47 mmol) 
and CaCO3 (100 mg, 1.0 mmol). The suspension was allowed to stir at 22 °C for 1 h. The 
reaction mixture was filtered through a bed of celite and was concentrated in vacuo to 
approximately 1/3 volume. The red residue was washed with 5% NaHSO3 solution (1 ml), 
saturated NaHCO3 solution (1 ml), water (1 ml), and brine (1 ml). The organic layer was 
dried over MgSO4, filtered, and concentrated to afford red solid. Purification by silica gel 
chromatography (85:15 hexanes/EtOAc, Rf 0.40) furnished S20 (157 mg, 83% yield) as 
orange solid. Mp = 210–212 °C. IR (neat): 3464 (w), 3369 (w), 2955 (m), 2922 (w), 
2864 (w), 1610 (m), 1500 (m), 1459 (w), 1429 (w), 1381 (w), 1360 (m), 1337 (w), 1315 
Chapter 2, Page  
 
 
83 
(w), 1301 (w), 1291 (w), 1264 (w), 1243 (w), 1156 (w), 1069 (w), 1010 (w), 881 (m), 
830 (w), 740 (w), 693 (w), 663 (w) cm−1; 1H NMR (CDCl3, 400 MHz): δ 7.50 (1H, d, J 
= 2.0 Hz), 7.04 (2H, s), 6.97 (1H, dd, J = 8.0, 2.0 Hz), 6.79 (1H, d, J = 8.0 Hz), 4.12 (2H, 
s), 2.97–2.90 (1H, m), 2.73–2.67 (2H, m), 1.31 (6H, d, J = 6.8 Hz), 1.11 (6H, d, J = 6.4 
Hz), 1.09 (6H, d, J = 6.8 Hz); 13C NMR (CDCl3, 100 MHz): δ 148.1, 147.2, 145.2, 139.8, 
135.7, 132.7, 130.9, 120.6, 114.3, 84.1, 34.4, 30.4, 24.4, 24.3, 24.2. HRMS (ESI+): 
Calcd for C21H29IN [M+H]+: 422.1345; Found: 422.1327. 
 
3'-Iodo-2,4,6-triisopropyl-1,1':4',1''-terphenyl (S21) 
To a solution of aniline S20 (421 mg, 1.0 mmol) in benzene (4 ml) was added 200µl of 
isoamyl nitrite (176 mg, 1.5 mmol). The mixture was allowed to heat at 80 °C for 1 h. 
After cooling to 22 °C, the solution was concentrated in vacuo and purified by silica gel 
chromatography (100% hexanes, Rf 0.70) to afford 217 mg (0.45 mmol, 45% yield) of 
S21 as white solid. Mp = 135–137 °C. IR (neat): 3058 (w), 3025 (w), 2959 (s), 2868 (m), 
2926 (m), 2867 (m), 1607 (w), 1567 (w), 1526 (w), 1462 (m), 1443 (w), 1382 (w), 1364 
(w), 1338 (w), 1102 (w), 1065 (w), 1031 (w), 1004 (w), 877 (w), 840 (w), 817 (w), 763 
(m), 735 (w), 700 (m), 682 (w), 660 (w), 648 (w) cm−1; 1H NMR (CDCl3, 400 MHz): δ 
7.81 (1H, d, J = 1.6 Hz), 7.47–7.45 (4H, m), 7.45–7.40 (1H, m), 7.32 (1H, d, J = 7.6 Hz), 
7.21 (1H, dd, J = 8.0, 1.6 Hz), 7.07 (2H, s), 2.98–2.91 (1H, m), 2.70–2.63 (2H, m), 1.31 
(6H, d, J = 6.8 Hz) 1.15 (6H, d, J = 6.4Hz), 1.11 (6H, d, J = 7.2 Hz); 13C NMR (CDCl3, 
100 MHz): δ 148.5, 146.7, 144.7, 144.1, 141.8, 140.7, 135.2, 129.8, 129.6, 129.5, 128.1, 
127.7, 120.8, 98.2, 34.5, 30.5, 24.5, 24.3, 24.2. HRMS (ESI+): Calcd for C27H32I 
[M+H]+: 483.1549; Found: 483.1544. 
 
(1S,2S)-1,2-Diphenyl-N1-(2'',4'',6''-triisopropyl-[1,1':4',1''-terphenyl]-2'-yl)ethane-1,2-
diamine (S22) 
(–)-(S,S)-1,2-Diphenylethylenediamine (254 mg, 1.2 mmol), aryl iodide S21 (482 mg, 1.0 
mmol), Pd(OAc)2 (22.4 mg, 0.10 mmol), rac-BINAP (125 mg, 0.20 mmol) and NaOt-Bu 
(192 mg, 2.0 mmol) were weighed out into a flame-dried 100-mL two-neck round-bottom 
flask under a N2 atmosphere in a glove box. The flask was equipped with a reflux 
condenser and removed from the glove box. Toluene (20 mL) was added through syringe 
and the resulting mixture was allowed to stir at 110 °C for 24 h. The mixture was allowed 
to cool to 22 °C and the volatiles were removed in vacuo affording deep red oil, which 
was dissolved in toluene and purified by silica gel chromatography (5:1 hexanes/EtOAc, 
Rf 0.20) to afford 362 mg (0.64 mmol, 64% yield) of S22 as orange oil. IR (neat): 3402 
(w), 3059 (w), 3026 (w), 2958 (m), 2925 (w), 2866 (w), 1607 (m), 1556 (m), 1517 (m), 
1491 (m), 1453 (m), 1414 (m), 1381 (w), 1361 (w), 1319 (w), 1302 (w), 1272 (w), 1227 
(w), 1169 (w), 1129 (w), 1099 (w), 1070 (w), 1029 (w), 1008 (w), 994 (w), 944 (w), 909 
(s), 876 (m), 858 813 768 (m), 732 (s), 701 (s), 650 (w), 573 (w), 510 (w), 426 (w) cm−1; 
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1H NMR (CDCl3, 400 MHz): δ 7.58–7.57 (4H, m), 7.49–7.46 (1H, m), 7.30–7.25 (5H, 
m), 7.24–7.21 (5H, m), 7.07 (1H, d, J = 8.0 Hz), 7.03 (1H, d, J = 1.6 Hz), 6.94 (1H, d, J = 
2.0 Hz), 6.46 (1H, dd, J = 8.0, 2.0 Hz), 6.11 (1H, d, J = 1.6 Hz), 5.43 (1H, d, J = 7.6 Hz), 
4.55 (1H, dd, J = 7.6, 4.0 Hz), 4.33 (1H, d, J = 3.6 Hz), 2.97–2.90 (1H, m), 2.77–2.70 
(1H, m), 2.42–2.35 (1H, m), 1.32–1.30 (8H, m), 1.12 (6H, dd, J = 6.8, 4.8 Hz), 0.96 (3H, 
d, J = 6.8 Hz), 0.56 (3H, d, J = 7.2 Hz; 13C NMR (CDCl3, 100 MHz): δ 147.2, 146.6, 
146.4, 143.2, 142.7., 140.8, 140.7, 139.8 137.6, 129.7, 129.3, 128.7, 128.4, 128.1, 127.2, 
127.0, 126.8, 125.9, 120.3, 120.2, 118.4, 113.3, 63.1, 60.7, 34.2, 30.0, 29.8, 24.6, 24.3, 
24.1, 24.0, 23.9. HRMS (ESI+): Calcd for C41H47N2 [M+H]+: 567.3739; Found: 
567.3743. Specific rotation: [α]D23.1 –51.0 (c 0.98, CHCl3). 
 
Imidazolinium salt 2.70 
Diamine S22 (1.19 g, 2.1 mmol), Pd2(dba)3 (115 mg, 0.13 mmol), rac-BINAP (235 mg, 
0.38 mmol) and NaOt-Bu (404 mg, 4.2 mmol) were weighed out into a flame-dried 100-
mL two-neck round-bottom flask under a N2 atmosphere in a glove box. The flask was 
equippd with a reflux condenser and removed from the glove box. A solution of iso-
butyl-2-bromobenzenesulfonate (739 mg, 2.5 mmol) in toluene (40 mL) was added 
through syringe and the resulting mixture was allowed to stir at 110 °C for 24 h. The 
mixture was allowed to cool to 22 °C and the volatiles were removed in vacuo affording 
dark red oil. The oil was dissolved in toluene, loaded on top of a column containing silica 
gel, and purified by silica gel chromatography (9:1 hexanes/Et2O, Rf 0.18) to afford 
brown liquid, which was transferred into a screw cap vial (2 x 8 cm), which was sealed 
with a septum and purged with N2. Acetic acid (1.80 mL, 31.5 mmol) followed by 
Eschenmoser’s salt (1.94 g, 10.5 mmol) was added to the mixture. The vial was sealed 
with a screw cap and allowed to stir at 110 °C (the mixture becomes dark brown-
homogeneous solution). After 1 h, the mixture was allowed to cool to 22 °C and diluted 
with CH2Cl2 (10 mL) and water (10 mL). The solution was neutralized by the slow 
addition of a saturated aqueous K2CO3 solution until gas evolution ceased. The aqueous 
layer was washed with CH2Cl2 (4 x 30 mL) and the combined organic layers were dried 
over MgSO4, filtered and concentrated in vacuo, which was purified by silica gel 
chromatography (3:1 hexanes/EtOAc to 5:1 CH2Cl2/Acetone, Rf 0.30 in 3:1 
hexanes/EtOAc) to afford 692 mg (0.95 mmol, 45% overall yield) of 2.70 as pale yellow 
solid (Note: This material was obtained in pale yellow powder form by trituration from 
CH2Cl2/hexanes bilayer). Mp = >300 °C. IR (neat): 3060 (w), 2960 (m), 2927 (w), 2868 
(w), 1623 (m), 1587 (w), 1552 (w), 1493 (w), 1458 (w), 1399 (w), 1383 (w), 1362 (w), 
1277 (w), 1222 (m), 1140 (w), 1091 (w), 1057 (w), 1022 (w), 1009 (w), 877 (w), 843 (w), 
753 (w), 719 (w), 701 (w), 666 (w), 612 (w), 564 (w), 539(w); 1H NMR (CDCl3, 400 
MHz): δ 9.13 (1H, s), 8.25 (1H, dd, J = 7.8, 1.2 Hz), 7.72–7.68 (3H, m), 7.63–7.59 (1H, 
m), 7.54–7.52 (2H, m), 7.40–7.34 (3H, m), 7.32–7.28 (4H, m), 7.26–7.20 (3H, m), 7.21 
(1H, dd, J = 8.0, 1.6 Hz), 7.06–7.01 (5H, m), 6.43 (1H, dd, J = 8.1, 1.2 Hz), 5.93 (1H, d, 
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J = 11.2 Hz), 4.79 (1H, d, J = 11.2 Hz), 2.97–2.90 (1H, m), 2.53–2.46 (1H, m), 2.15–2.08 
(1H, m), 1.32 (6H, d, J = 6.4 Hz), 1.15 (3H, d, J = 6.8 Hz), 1.07 (3H, d, J = 6.8 Hz), 1.06 
(3H, d, J = 7.2 Hz), 0.93 (3H, d, J = 6.8 Hz); 13C NMR (CDCl3, 100 MHz): δ 158.4, 
148.8, 146.3, 146.1, 143.8, 143.0, 138.3, 135.7, 135.0, 134.4, 133.1, 132.0, 131.6, 130.9, 
130.7, 130.4, 130.2, 130.0, 129.9, 129.8, 129.6, 129.4, 129.3, 129.2, 129.0, 128.8, 127.4, 
121.0, 120.9, 75.1, 34.5, 30.7, 20.2, 24.6, 24.4, 24.3, 24.2. HRMS (ESI): Calcd for 
C48H49N2O3S [M+H]+: 733.3464; Found: 733.3470. Specific rotation: [α]D22.4 +89.2 (c 
0.56, CHCl3). 
NHC−Cu Catalyzed Enantioselective Propargyl Addition to Disubstituted Allylic 
Phosphates 
 
Representative Procedure 
An oven-dried 1-dram vial equipped with a stir bar was charged with 
imidazolinium salt 2.29 (4.8 mg, 5.0 µmol), NaOMe (6.5 mg, 150 µmol), and CuCl2 
(0.67 mg, 5.0 µmol) in a nitrogen-filled glove box. The vial was sealed with a cap 
(phenolic open top cap with a red PFTE/white silicon septum) and electrical tape, and 
removed from the glove box. CH2Cl2 (0.80 mL) was added and the mixture was allowed 
to stir for 1 h under N2 at 22 °C (the mixture became bright-yellow solution). The 
solution of allylic phosphate 2.12a (28 mg, 0.10 mmol) and propargyl–B(pin) reagent 
2.20 (40 µL, 0.15 mmol) in thf (2 mL) was added to the mixture slowly through a syringe. 
The resulting mixture was allowed to stir at 22 °C for 6 h. The mixture was passed 
through a short plug of silica gel (4 cm x 1 cm) and eluted with Et2O. The organic layer 
was concentrated in vacuo, resulting in a yellow oily residue, which was purified by silica 
gel chromatography (50:1 hexanes/Et2O, Rf 0.53) to afford 17.1 mg of the desired product 
2.21a and SN2 product (97:3 SN2’/SN2) as colorless oil (0.075 mmol, 75% yield).  
 
Characterization Data for Enynes with a Tertiary Carbon Stereogenic Center 
(R)-Trimethyl(4-phenylhex-5-en-1-yn-1-yl)silane (2.21a) 
IR (neat): 3084 (w), 3030 (w), 2959 (w), 2901 (w), 2177 (w), 1638 (w), 1602 (w), 1494 
(w), 1453 (w), 1412 (w), 1249 (m), 917 (w), 837 (s), 757 (s), 697 (s), 640 (m) cm−1; 1H 
NMR (CDCl3, 400 MHz): δ 7.33–7.28 (2H, m), 7.24–7.20 (3H, m), 6.07 (1H, ddd, J = 
17.2, 10.0, 6.8 Hz), 5.15–5.08 (2H, m), 3.52 (1H, app. q, J = 7.2 Hz), 2.67–2.55 (2H, m), 
0.11 (9H, s); 13C NMR (CDCl3, 100 MHz): δ 142.8, 140.1, 128.5, 127.9, 126.8, 115.5, 
105.5, 86.7, 48.6, 26.9, 0.2. HRMS (ESI+): Calcd for C15H20Si [M+H]+: 229.1413; 
Found: 229.1404. Specific rotation: [α]D25.2 +0.83 (c 1.33, CHCl3) for an 
enantiomerically enriched sample of 97:3 er.  
Enantiomeric purity was determined by GC analysis in comparison with authentic 
racemic material; CD-GTA column, 75 °C, 15 psi. 
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Retention Time Area Area% Retention Time Area Area% 
149.350 574.27655 54.873 146.718 100.99387 3.343 
153.905 472.27371 45.127 151.791 2920.43774 96.657 
	
(R)-(4-(2-Fluorophenyl)hex-5-en-1-yn-1-yl)trimethylsilane (2.21b) 
IR (neat): 2959 (w), 2177 (w), 1490 (m), 1456 (w), 1249 (m), 1230 (m), 1036 (w), 993 
(w), 920 (w), 838 (s), 752 (s), 698 (w), 667 (w), 642 (w), 554 (w) cm−1; 1H NMR 
(CDCl3, 400 MHz): δ 7.26-7.18 (2H, m), 7.09 (1H, td, J = 7.6, 1.2 Hz), 7.02 (1H, ddd, J 
= 9.6, 7.6, 1.2 Hz), 6.09 (1H, dddd, J = 17.2, 10.4, 6.8, 1.2 Hz), 5.16–5.09 (2H, m), 3.87 
(1H, q, J = 7.6 Hz), 2.69–2.58 (2H, m), 0.09 (9H, s); 13C NMR (CDCl3, 100 MHz): δ 
160.8 (d, JCF = 244.1 Hz), 138.7, 129.3 (d, JCF = 5.3 Hz), 128.3 (d, JCF = 8.4 Hz), 124.1 
(d, JCF = 3.1 Hz), 116.0, 115.6 (d, JCF = 22.4 Hz), 105.0, 86.7, 42.0, 25.7, 0.3, 0.1. 
HRMS (ESI+): Calcd for C15H20FSi [M+H]+: 247.1317; Found: 247.1318. Specific 
rotation: [α]D20.0  –1.01 (c 2.26, CHCl3) for an enantiomerically enriched sample of 97:3 
er. 
Enantiomeric purity was determined by GC analysis in comparison with authentic 
racemic material; CD-GTA column, 75 °C, 15 psi. 
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(R)-(4-(2-Bromophenyl)hex-5-en-1-yn-1-yl)trimethylsilane (2.21c) 
IR (neat): 3061 (w), 2959 (w), 2900 (w), 2175 (w), 1639 (m), 1468 (w), 1436 (w), 1382 
(w), 1331 (w), 1248 (m), 1217 (w), 1143 (w), 1116 (w),  1041 (w), 1023 (m), 963 (w), 
919 (w), 837 (s), 750 (s), 697 (m), 670 (w), 641 (m) cm−1; 1H NMR (CDCl3, 400 MHz): 
δ 7.56–7.55 (1H, m), 7.29–7.25 (2H, m), 7.10–7.07 (1H, m), 6.06 (1H, ddd, J = 17.2, 
10.4, 6.8 Hz), 5.20–5.13 (2H, m), 4.12 (1H, q, J = 6.8 Hz), 2.64 (2H, d, J = 6.8 Hz), 0.10 
(9H, s); 13C NMR (CDCl3, 100 MHz): δ 141.7, 138.6, 133.0, 129.1, 128.2, 127.5, 124.9, 
116.2, 104.6, 87.0, 46.4, 25.6, 0.1. HRMS (ESI+): Calcd for C15H20BrSi [M+H]+: 
307.0518; Found: 307.0509. Specific rotation: [α]D22.1 –25.2 (c 2.51, CHCl3) for an 
enantiomerically enriched sample of 97:3 er.  
Enantiomeric purity was determined by GC analysis in comparison with authentic 
racemic material of terminal alkyne obtained after removal of the silyl group with K2CO3 
in MeOH; CD-GTA column, 90 °C, 15 psi. 
 
Retention Time Area Area% Retention Time Area Area% 
86.232 716.63605 49.33481 85.759 108.33573 2.54412 
91.934 735.96112 50.66519 90.303 4149.95020 97.45588 
	
(R)-(4-(2-Methoxyphenyl)hex-5-en-1-yn-1-yl)trimethylsilane (2.21d) 
IR (neat): 3078  (w), 2958 (w), 2901 (w), 2836 (w), 2175 (w), 1638 (w), 1599 (w), 1586 
(w), 1491 (m), 1463 (w), 1438 (w), 1289 (w), 1243 (s), 1185 (w), 1162 (w), 1109 (w), 
1051 (w), 1031 (m), 994 (w), 915 (w), 837 (s), 786 (w), 749 (s), 697 (m), 671 (w), 643 
(m) cm−1; 1H NMR (CDCl3, 400 MHz): δ 7.26–7.16 (2H, m), 6.91 (1H, t, J = 6.0 Hz), 
6.86 (1H, d, J = 6.4 Hz), 6.13 (1H, ddd, J = 13.6, 8.0, 5.6 Hz), 5.13–5.09 (2H, m), 3.96 
Retention Time Area Area% Retention Time Area Area% 
139.583 1309.44556 50.96297 140.194 37.18663 2.59156 
147.708 1259.96057 49.03703 147.708 1397.72803 97.40844 
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(1H, q, J = 5.6 Hz), 3.83 (3H, s), 2.61 (2H, app. d, J = 5.6 Hz), 0.10 (9H, s); 13C NMR 
(CDCl3, 100 MHz): δ 157.0, 139.5, 131.2, 128.6, 127.7, 120.6, 115.3, 101.7, 106.1, 86.1, 
55.5, 42.0, 25.5, 0.3, 0.2. HRMS (ESI+): Calcd for C16H23OSi [M+H]+: 259.1518; 
Found: 259.1521. Specific rotation: [α]D21.9 –30.0 (c 1.50, CHCl3) for an 
enantiomerically enriched sample of 96:4 er.  
Enantiomeric purity was determined by GC analysis in comparison with authentic 
racemic material of terminal alkyne obtained after removal of the silyl group with K2CO3 
in MeOH; CDB-DM column, 70 °C, 20 psi. 
 
Retention Time Area Area% Retention Time Area Area% 
207.363 920.28778 50.46796 210.089 51.66453 3.51910 
224.479 903.22131 49.53204 223.160 1416.45117 96.48090 
 
(R)-Trimethyl(4-(o-tolyl)hex-5-en-1-yn-1-yl)silane (2.21e) 
IR (neat): 3020 (w), 2958 (w), 2176 (w), 1637 (w), 1603 (w), 1490 (w), 1461 (w), 1409 
(w), 1380 (s), 1248 (m), 1037(w), 997 (w), 964 (w), 915 (w), 837 (s), 756 (s), 726 (m), 
697 (w), 642 (m), 578 (w) cm−1; 1H NMR (CDCl3, 400 MHz): δ 7.19–7.10 (4H, m), 6.03 
(1H, ddd, J = 17.2, 10.4, 6.8 Hz), 5.12 (1H, app. dt, J = 10.4, 1.2 Hz), 5.09 (1H, app. dt, J 
= 17.2, 1.6 Hz), 3.83–3.77 (1H, m), 2.68–2.55 (2H, m), 2.37 (3H, s), 0.11 (9H, s); 13C 
NMR (CDCl3, 100 MHz): δ 140.9, 139.9, 136.1, 130.5, 126.7, 126.5, 126.2, 115.3, 105.6, 
86.3, 43.9, 26.1, 19.8, 0.2. HRMS (ESI+): Calcd for C16H23Si [M+H]+: 243.1569; Found: 
243.1577. Specific rotation: [α]D23.0 –20.4 (c 2.16, CHCl3) for an enantiomerically 
enriched sample of 96:4 er.  
Enantiomeric purity was determined by GC analysis in comparison with authentic 
racemic material of terminal alkyne obtained after removal of the silyl group with K2CO3 
in MeOH; CD-GTA column, 65°C, 20 psi. 
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Retention Time Area Area% Retention Time Area Area% 
93.211 597.78143 49.68036 93.868 61.45865 4.45704 
97.933 605.47363 50.31964 97.494 1317.45276 95.54296 
 
(R)-(4-(3-Bromophenyl)hex-5-en-1-yn-1-yl)trimethylsilane (2.21f) 
IR (neat): 3082 (w), 2959 (w), 2900 (w), 2176 (w), 1639 (w), 1593 (w), 1567 (w), 1474 
(w), 1425 (w), 1249 (m), 1073 (w), 1042 (w), 997 (w), 920 (w), 838 (s), 644 (m), 779 (m), 
758 (m), 695 (m) 642 (m) cm−1; 1H NMR (CDCl3, 400 MHz): δ 7.40–7.39 (1H, m), 7.36 
(1H, app. dt, J = 5.6, 1.6 Hz), 7.19–7.15 (2H, m), 6.03 (1H, ddd, J = 17.2, 10.4, 7.2 Hz), 
5.16 (1H, app. dt, J = 10.4, 1.2 Hz), 5.12 (1H, app. dt, J = 17.2, 1.2 Hz), 3.49 (1H, q, J = 
7.2 Hz), 2.62 (1H, dd, J = 17.2, 7.2 Hz), 2.55 (1H, dd, J = 17.2, 7.2 Hz), 0.11 (9H, s); 13C 
NMR (CDCl3, 100 MHz): δ 145.1, 139.3, 131.2, 130.0, 129.9, 126.6, 122.5, 115.7, 116.0, 
104.7, 87.3, 48.1, 26.8, 0.1. HRMS (ESI+): Calcd for C15H20BrSi [M+H]+: 307.0518; 
Found: 307.0513. Specific rotation: [α]D22.0 +6.22 (c 2.41, CHCl3) for an 
enantiomerically enriched sample of 98:2 er.  
Enantiomeric purity was determined by GC analysis in comparison with authentic 
racemic material; β-dex column, 140 °C, 15 psi. 
 
Retention Time Area Area% Retention Time Area Area% 
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92.713 43034.6 49.96801 92.784 99082.0 97.77670 
993.898 43089.7 50.03199 93.904 2252.97705 2.22330 
	
(R)-Trimethyl(4-(m-tolyl)hex-5-en-1-yn-1-yl)silane (2.21g) 
IR (neat): 2959 (w), 2901 (m), 2176 (w), 1638 (w), 1606 (w), 1589 (w), 1489 (w), 1413 
(w), 1249 (m), 1094 (w), 1041 (w), 915 (w), 838 (s), 783 (m), 758 (s), 701 (m), 675 (w), 
643 (w), 439 (w) cm−1; 1H NMR (CDCl3, 400 MHz): δ 7.20 (1H, t, J = 7.2 Hz), 7.05–
7.02 (3H, m), 6.07 (1H, ddd, J = 17.2, 10.0, 7.2 Hz), 5.14–5.09 (2H, m), 3.49 (1H, app. q, 
J = 7.2 Hz), 2.65–2.55 (2H, m), 2.34 (3H, s), 0.12 (9H, s); 13C NMR (CDCl3, 100 MHz): 
δ 142.8, 140.1, 138.0,  128.6, 128.4, 127.5, 124.8, 115.3, 105.6, 86.6, 48.6, 26.9, 21.6, 0.2. 
HRMS (ESI+): Calcd for C16H23Si [M+H]+: 243.1569; Found: 243.1578. Specific 
rotation: [α]D21 +3.53 (c 4.13, CHCl3) for an enantiomerically enriched sample of 98:2 er.  
Enantiomeric purity was determined by GC analysis in comparison with authentic 
racemic material; CDB-DM column, 95 °C, 20 psi. 
 
Retention Time Area Area% Retention Time Area Area% 
114.657 1611.58154 49.67230 114.217 2875.35107 97.627332 
120.546 1632.84521 50.32770 121.736 69.88090 2.37268 
 
(R)-Trimethyl(4-(3-(trifluoromethyl)phenyl)hex-5-en-1-yn-1-yl)silane (2.21h) 
IR (neat): 2961 (w), 2177 (w), 1728 (w), 1640 (w), 1596 (w), 1491 (w), 1448 (w), 1326 
(s), 1250 (m), 1163 (s), 1125 (s), 1096 (w), 1073 (s), 1043 (w), 1002 (w), 963 (w), 920 
(w), 895 (w), 839 (s), 800 (s), 759 (s), 701 (s), 653 (w), 638 (w), 456 (w) cm−1; 1H NMR 
(CDCl3, 400 MHz): δ 7.52–7.49 (2H, m), 7.45–7.42 (2H, m), 6.06 (1H, ddd, J = 17.2, 
10.4, 6.0 Hz), 5.18 (1H, app. dt, J = 10.4, 1.2 Hz), 5.13 (1H, app. dt, J = 17.2, 1.2 Hz), 
3.59 (1H, q, J = 6.8 Hz), 2.70–2.56 (2H, m), 0.9 (9H, s); 13C NMR (CDCl3, 100 MHz): δ 
143.6, 139.2, 131.4, 130.7 (q, JCF = 31.8 Hz), 128.9, 124.9 (q, JCF = 3.8 Hz), 124.7 (q, 
JCF = 3.8 Hz), 124.4 (q, JCF = 270.9 Hz), 116.2, 104.4, 87.5, 48.2, 26.8, 0.0. HRMS 
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(ESI+): Calcd for C16H20F3Si [M+H]+: 297.1286; Found: 297.1296. Specific rotation: 
[α]D22.5 +6.33 (c 2.40, CHCl3) for an enantiomerically enriched sample of 98:2 er.  
Enantiomeric purity was determined by GC analysis in comparison with authentic 
racemic material; CDB-DM column, 100 °C, 15 psi. 
 
Retention Time Area Area% Retention Time Area Area% 
61.995 275.15036 49.89705 61.969 263.74844 97.91413 
63.947 276.28577 50.10295 63.993 5.61864 2.08587 
 
(R)-Trimethyl(4-(naphthalen-2-yl)hex-5-en-1-yn-1-yl)silane (2.21i) 
IR (neat): 3056 (w), 2958 (w), 2900 (w), 2175 (w), 1634 (w), 1600 (w), 1508 (w), 1413 
(w), 1368 (w), 1248 (m), 1042 (w), 1018 (w), 991 (w), 962 (w), 917 (w), 888 (w), 838 (s), 
815 (s), 758 (s), 744 (s), 698 (w), 642 (m), 580 (s), 475 (w) cm−1; 1H NMR (CDCl3, 400 
MHz): δ 7.83–7.79 (3H, m), 7.69 (1H, s), 7.49–7.43 (2H, m), 7.38 (1H, d, J = 8.8 Hz), 
6.18 (1H, ddd, J = 17.2, 10.4, 7.2 Hz), 5.21–5.14 (2H, m), 3.71 (1H, q, J = 7.6 Hz), 2.78–
2.66 (2H, m), 0.11 (9H, s); 13C NMR (CDCl3, 100 MHz): δ 140.3, 140.0, 133.3, 132.6, 
128.1, 127.9, 127.7, 126.42, 126.37, 126.1, 125.6, 115.7, 105.4, 86.9, 48.6, 26.7, 0.2. 
HRMS (ESI+): Calcd for C19H23Si [M+H]+: 279.1569; Found: 279.1568. Specific 
rotation: [α]D22.0 –1.78 (c 6.76, CHCl3) for an enantiomerically enriched sample of 97:3 
er.  
Enantiomeric purity was determined by GC analysis in comparison with authentic 
racemic material; CDB-DM column, 130 °C, 15 psi. 
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Retention Time Area Area% Retention Time Area Area% 
258.350 457.46024 49.67670 258.044 2728.52002 97.28204 
263.707 463.41470 50.32330 263.994 76.23190 2.71796 
 
(R)-(4-(4-Chlorophenyl)hex-5-en-1-yn-1-yl)trimethylsilane (2.21j) 
IR (neat): 2959 (w), 2176 (w), 1491 (w), 1407 (w), 1249 (m), 1092 (w), 1043 (w), 1015 
(w), 919 (w), 838 (s), 780 (w), 758 (s), 722 (w), 698 (w), 637 (w), 578 (w), 540 (w) cm−1; 
1H NMR (CDCl3, 400 MHz): δ 7.28–7.24 (2H, m), 7.16–7.13 (2H, m), 6.01 (1H, ddd, J 
= 17.2, 10.4, 6.8 Hz), 5.13 (1H, app. d, J = 10.4 Hz), 5.07 (1H, app. d, J = 17.2 Hz), 3.48 
(1H, q, J = 7.2 Hz), 2.60 (1H, dd, J = 16.8, 7.2 Hz), 2.53 (1H, dd, J = 16.8, 7.2 Hz) ), 
2.47 (3H, s), 0.09 (9H, s); 13C NMR (CDCl3, 100 MHz): δ 141.2, 139.6, 132.5, 129.3, 
128.6, 115.8, 104.9, 87.1, 47.8, 26.8, 0.1. HRMS (ESI+): Calcd for C15H20ClSi [M+H]+: 
263.1023; Found: 263.1015. Specific rotation: [α]D21.7 +8.1 (c 7.04, CHCl3) for an 
enantiomerically enriched sample of 97:3 er.  
Enantiomeric purity was determined by GC analysis in comparison with authentic 
racemic material; CDB-DM column, 120 °C, 15 psi. 
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Retention Time Area Area% Retention Time Area Area% 
77.612 2653.32788 49.80742 78.419 868.27985 97.36540 
82.605 2673.84570 50.19258 84.343 23.49470 2.63460 
 
(R)-Trimethyl(4-(p-tolyl)hex-5-en-1-yn-1-yl)silane (2.21k) 
IR (neat): 2959 (w), 2922 (w), 2176 (w), 1638 (w), 1513 (w), 1411 (w), 1248 (m), 1111 
(w), 1042 (w), 1020 (w), 996 (w), 965 (w), 915 (w), 838 (s), 814 (s), 758 (s), 720 (w), 
698 (w), 640 (m), 581 (w), 551 (w) cm−1; 1H NMR (CDCl3, 400 MHz): δ 7.12–7.11 (4H, 
m), 6.06 (1H, ddd, J = 17.2, 10.4, 7.2 Hz), 5.12 (1H, d, J = 10.4 Hz), 5.09 (1H, d, J = 
17.2 Hz), 3.49 (1H, q, J = 7.2 Hz), 2.61 (1H, dd, J = 16.8, 7.2 Hz), 2.56 (1H, dd, J = 16.8, 
7.2 Hz), 0.12 (9H, s); 13C NMR (CDCl3, 100 MHz): δ 140.2, 139.9, 136.3,129.2, 127.7, 
115.3, 105.6, 86.6, 48.2, 27.0, 21.2, 0.2. HRMS (ESI+): Calcd for C16H23Si [M+H]+: 
243.1569; Found: 243.1569. Specific rotation: [a]D21.5 +1.6 (c 6.33, CHCl3) for an 
enantiomerically enriched sample of 97:3 er. 
Enantiomeric purity was determined by GC analysis in comparison with authentic 
racemic material; CDB-DM column, 110 °C, 20 psi. 
 
Retention Time Area Area% Retention Time Area Area% 
52.845 278.36212 49.81978 52.657 1244.00635 96.74387 
54.980 280.37601 50.18022 55.000 41.86985 3.25613 
 
(R)-Trimethyl(4-(4-nitrophenyl)hex-5-en-1-yn-1-yl)silane (2.21l) 
IR (neat): 3081 (w), 2959 (w), 2901 (w), 2176 (w), 1928 (w), 1639 (w), 1598 (s), 1519 
(s), 1411 (w), 1343 (s), 913 (m), 1249 (m), 1182 (w), 1041 (w), 1015 (w), 922 (w), 838 
(s), 758 (m), 700 (m), 642 (m) 576 (w), 531 (w) cm−1; 1H NMR (CDCl3, 500 MHz): δ 
8.17 (2H, app. d, J = 9.0 Hz), 7.41 (2H, app. d, J = 9.0 Hz), 6.04 (1H, ddd, J = 17.0, 10.0, 
6.5 Hz), 5.21 (1H, app. d, J = 10.0 Hz), 5.13 (1H, app. d, J = 17.0 Hz), 4.76 (1H, q, J = 
7.0 Hz), 2.68 (1H, dd, J = 16.5, 6.5 Hz), 2.60 (1H, dd, J = 16.5, 6.5 Hz), 0.08 (9H, s); 13C 
NMR (CDCl3, 100 MHz): δ 150.2, 147.0, 138.6, 128.9, 126.7, 123.7, 116.8, 103.9, 87.8, 
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48.2, 26.5, 0.2. HRMS (ESI+): Calcd for C15H20NO2Si [M+H]+: 274.1263; Found: 
274.1267. Specific rotation: [α]D23.2 +13.0 (c 3.70, CHCl3) for an enantiomerically 
enriched sample of 95:5 er.  
Enantiomeric purity was determined by GC analysis in comparison with authentic 
racemic material; CDB-DM column, 140 °C, 15 psi. 
 
Retention Time Area Area% Retention Time Area Area% 
132.498 876.06970 49.94657 132.264 1200.43970 95.00835 
140.502 877.94415 50.05343 141.888 63.06999 4.99165 
 
(R)-Trimethyl(4-(thiophen-3-yl)hex-5-en-1-yn-1-yl)silane (2.21m) 
IR (neat): 3081 (w), 2959 (w), 2901 (w), 2176 (w), 1639 (w), 1530 (w), 1411 (w), 1329 
(w), 1249 (m), 1153 (w), 1082 (w), 1042 (w), 1016 (w), 963 (w), 918 (w), 837 (s), 779 
(s), 758 (s), 698 (w), 639 (m), 536 (w), 469 (w) cm−1; 1H NMR (CDCl3, 400 MHz): δ 
7.26 (1H, dd, J = 4.8, 1.2 Hz), 7.06–7.04 (1H, m), 7.00 (1H, dd, J = 4.8, 1.2 Hz), 6.02 
(1H, ddd, J = 17.6, 10.0, 7.2 Hz), 5.14–5.08 (2H, m), 3.63 (1H, q, J = 7.2 Hz), 2.62 (1H, 
dd, J = 17.2, 6.8 Hz), 2.57 (1H, dd, J = 17.2, 7.2 Hz), 0.13 (9H, s); 13C NMR (CDCl3, 
100 MHz): δ 143.4, 139.7, 127.4, 125.4, 120.7, 115.6, 105.3, 86.8, 44.2, 26.8, 0.2. 
HRMS (ESI+): Calcd for C13H19SSi [M+H]+: 235.0977; Found: 235.0982. Specific 
rotation: [α]D23.7 –27.1 (c 1.75, CHCl3) for an enantiomerically enriched sample of 97:3 
er.  
Enantiomeric purity was determined by GC analysis in comparison with authentic 
racemic material; CDB-DM column, 100 °C, 15 psi.  
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Retention Time Area Area% Retention Time Area Area% 
90.737 739.93762 51.21501 90.392 1201.81348 96.93385 
95.984 704.82959 48.78499 97.090 38.01496 3.06615 
 
(R)-3-(6-(Trimethylsilyl)hex-1-en-5-yn-3-yl)pyridine (2.21a) 
IR (neat): 2976 (w), 2176 (w), 1577 (w), 1518 (w), 1474 (m), 1456 (m), 1428 (w), 1371 
(w), 1335 (w), 1249 (m), 1218 (w), 1148 (m), 1105 (w), 1043 (w), 1029 (w), 1008 (w), 
984 (w), 951 (w), 923 (w), 839 (s), 759 (m), 713 (m), 699 (m), 676 (m), 642 (w), 578 (w), 
519 (w), 495 (w) cm−1; 1H NMR (CDCl3, 400 MHz): δ 8.49–8.47 (2H, m), 7.55 (1H, dt, 
J = 8.0, 2.0 Hz), 7.26–7.22 (1H, m), 6.05 (1H, ddd, J = 17.2, 10.0, 6.4 Hz), 5.18 (1H, dt, 
J = 10.4, 1.2 Hz), 5.11 (1H, dt, J = 17.2, 1.2 Hz), 3.55 (1H, q, J = 6.8Hz), 2.66 (1H, dd, J 
= 16.8, 6.8 Hz), 2.58 (1H, dd, J = 16.8, 7.6 Hz), 0.08 (9H, s); 13C NMR (CDCl3, 100 
MHz): δ 149.7, 148.2, 138.9, 138.0, 135.3, 123.3, 116.3, 104.3, 87.6, 45.9, 26.6, 0.1; 
HRMS (ESI+): Calcd for C14H20NSi [M+H]+: 230.1365; Found: 230.1374; specific 
rotation: [α]D23.8 +13.9 (c 2.31, CHCl3) for an enantiomerically enriched sample of 98:2 
er.  
Enantiomeric purity was determined by GC analysis in comparison with authentic 
racemic material; CDB-DM column, 120 °C, 20 psi. 
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Retention Time Area Area% Retention Time Area Area% 
38.513 332.63416 50.50012 38.536 365.13907 97.85404 
40.722 326.04584 49.49988 40.961 8.00758 2.14596 
		
(R)-4-(6-(Trimethylsilyl)hex-1-en-5-yn-3-yl)phenyl acetate (2.21o) 
IR (neat): 2959 (w), 2924 (w), 2175 (w), 1763 (m), 1506 (m), 1369 (w), 1249 (m), 1195 
(s), 1166 (m), 1042 (w), 1017 (m), 910 (m), 838 (s), 759 (m), 697 (w), 683 (w), 643 (w) 
cm−1; 1H NMR (CDCl3, 500 MHz): δ 7.23 (2H, d, J = 8.4 Hz), 7.02 (2H, d, J = 8.4 Hz), 
6.04 (1H, ddd, J = 17.2, 10.0, 7.2 Hz), 5.14−5.08 (2H, m), 3.52 (1H, q, J = 7.2 Hz), 2.62 
(1H, dd, J = 16.8, 7.2 Hz), 2.56 (1H, dd, J = 16.8, 7.2 Hz), 0.11 (9H, s); 13C NMR 
(CDCl3, 100 MHz): δ 169.7, 149.4, 140.3, 139.8, 128.9, 121.5, 115.6, 105.2, 87.0, 47.9, 
26.9, 21.3, 0.2. HRMS (ESI+): Calcd for C17H23O2Si [M+H]+: 287.1467; Found: 
287.1459. Specific rotation: [α]D20.0  = 8.9 (c 2.24, CHCl3) for an enantiomerically 
enriched sample of 95:5 er.  
Enantiomeric purity was determined by GC analysis in comparison with authentic 
racemic material; CDB-DM column, 140 °C, 20 psi. 
 
Retention Time Area Area% Retention Time Area Area% 
60.216 343.15967 48.992 60.316 979.913 96.273 
61.879 357.26868 51.007 61.900 37.928 3.726 
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Methyl (R)-4-(6-(trimethylsilyl)hex-1-en-5-yn-3-yl)benzoate (2.21p) 
IR (neat): 2955 (w), 2901 (w), 2176 (w), 1722 (s), 1639 (w), 1435 (m), 1275 (s), 1248 
(s), 1180 (m), 1106 (m), 837 (s), 758 (s), 708 (m), 640 (m) cm−1; 1H NMR (CDCl3, 600 
MHz): δ 7.98 (2H, d, J = 8.4 Hz), 7.30 (1H, d, J = 8.4 Hz), 6.05 (1H, ddd, J = 15.0, 9.0, 
6.6 Hz) 5.17–5.09 (2H, m), 3.91 (3H, s), 3.58 (1H, q, J = 7.2 Hz), 2.67–2.57 (2H, m), 
0.09 (9H, s); 13C NMR (CDCl3, 100 MHz): δ 167.2, 148.0, 139.3, 129.8, 128.7, 128.0, 
116.1, 104.7, 87.2, 52.2, 48.5, 26.6, 0.1. HRMS (ESI+): Calcd for C17H23O2Si [M+H]+: 
287.1467; Found: 287.1453. Specific rotation: [α]D20.0 3.9 (c 1.13, CHCl3) for an 
enantiomerically enriched sample of 94:6 er.  
Enantiomeric purity was determined by GC analysis in comparison with authentic 
racemic material; CDB-DM column, 120 °C, 200 min, 120 °C to 140 °C for 1 °C/min, 
140 °C, 15 psi. 
 
Retention Time Area Area% Retention Time Area Area% 
254.432 793.34583 48.83541 254.561 726.83624 94.23787 
259.145 831.18396 51.16459 259.679 44.44210 5.76213 
 
(R)-(4-Cyclohexylhex-5-en-1-yn-1-yl)trimethylsilane (2.32) 
IR (neat): 3076 (w), 2922 (m), 2852 (m), 2175 (m), 1639 (w), 1449 (w), 1248 (s), 1042 
(w), 999 (w), 965 (w), 913 (m), 885 (w), 837 (s), 758 (s), 697 (m), 644 (m), 579 (w), 487 
(w), 433 (w) cm−1; 1H NMR (CDCl3, 400 MHz): δ 5.68 (1H, dt, J = 17.2, 5.6 Hz), 5.03 
(1H, app. d, J = 10.8 Hz), 4.99 (1H, app. d, J = 17.6 Hz), 2.33 (1H, dd, J = 16.8, 6.0 Hz), 
2.27 (1H, dd, J = 16.8, 6.8 Hz), 2.04–1.97 (1H, m), 1.74–1.63 (5H, m), 1.47–1.38 (1H, 
m), 1.29–1.05 (3H, m), 1.03–0.84 (2H, m), 0.14 (9H, s); 13C NMR (CDCl3, 100 MHz): δ 
139.9, 115.7, 106.3, 85.9, 48.8, 40.2, 31.1, 29.7, 26.7, 26.6, 23.2, 0.3. HRMS (ESI+): 
Calcd for C12H13 [M+H]+: 235.1882; Found: 235.1882. Specific rotation: [α]D23.8 +6.4 (c 
1.86, CHCl3) for an enantiomerically enriched sample of 95:5 er.  
Enantiomeric purity was determined by GC analysis in comparison with authentic 
racemic material; CDB-DM column, 100 °C, 15 psi. 
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Retention Time Area Area% Retention Time Area Area% 
61.304 265.12756 49.66117 61.195 613.54254 94.94081 
65.289 268.74539 50.33883 65.702 32.69436 5.05919 
	
(R)-4-(2,2-Dimethyl-[1,3]dioxin-5-yl)-1-trimethylsilyl-hex-5-en-1-yne (2.33) 
IR (neat): 3078 (w), 2991 (m), 2959 (m), 2866 (m), 2174 (m), 1640 (w), 1454 (w), 1420 
(w), 1369 (m), 1331 (w), 1248 (s), 1196 (s), 1133 (m), 1067 (m), 1034 (m), 996 (m), 966 
(m), 918 (m), 834 (s), 758 (s), 731 (m), 698 (m), 639 (m), 519 (m) cm−1; 1H NMR 
(CDCl3, 400 MHz): δ 5.69 (1H, ddd, J = 18.2, 9.0, 8.8 Hz), 5.09 (1H, dd, J = 9.0, 1.6 Hz), 
5.07 (1H, dd, J = 18.2, 1.6 Hz), 3.93 (1H, ddd, J = 11.4, 4.6, 1.6 Hz), 3.83 (1H, ddd, J = 
11.4, 4.6, 1.6 Hz), 3.68 (1H, dd, J = 26, 8.8 Hz), 3.65 (1H, dd, J = 26, 8.8 Hz), 2.31 (1H, 
d, J = 1.2 Hz), 2.30 (1H, d, J = 1.2 Hz), 2.21–2.13 (1H, m), 1.92–1.89 (1H, m), 1.39 (6H, 
s), 0.13 (9H, s); 13C NMR (CDCl3, 100 MHz): δ 138.2, 116.9, 104.1, 97.8, 87.0, 63.03, 
63.00, 42.3, 35.9, 26.8, 23.2, 21.2, 0.2. HRMS (ESI+): Calcd for C15H27O2Si1 [M+H]+: 
267.1780; Found: 267.1772. Specific rotation: [α]D21.0 –27.3 (c 2.92, CHCl3) for an 
enantiomerically enriched sample of 99:1 er.  
Enantiomeric purity was determined by GC analysis in comparison with authentic 
racemic material; CD-GTA column, 90 °C, 15 psi. 
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Retention Time Area Area% Retention Time Area Area% 
132.610 95.04 48.293 132.613 12.27 1.065 
136.606 101.75 51.707 135.589 1140.2 98.935 
 
(R)-4-(tert-Butyldimethylsilyloxymethyl)-1-trimethysilyl-hex-5-en-1-yne (2.34) 
IR (neat): 2956 (m), 2929 (m), 2899 (w), 2857 (m), 2175 (m), 1642 (w), 1471 (w), 1421 
(w), 1387 (w), 1361 (w), 1336 (w), 1249 (s), 1102 (s), 1064 (w), 1031 (m), 1004 (w), 917 
(w), 833 (s), 774 (s), 758 (s), 696 (m), 665 (m), 642 (m), 571 (w) cm−1; 1H NMR (CDCl3, 
400 MHz): δ 5.82–5.74 (1H, m), 5.11 (1H, overlapped with other H), 5.07 (1H, 
overlapped with other H), 3.64–3.62 (2H, m), 2.42–2.32 (3H, m), 0.89 (9H, s), 0.14 (9H, 
s), 0.05 (6H, s); 13C NMR (CDCl3, 100 MHz): δ 138.3, 116.1, 105.5, 85.9, 64.8, 45.0, 
26.0, 21.8, 18.4, 0.2, –5.2. HRMS (ESI+): Calcd for C16H33O1Si2 [M+H]+: 297.2069; 
Found: 297.2055. Specific rotation: [α]D22.0 +3.17 (c 3.15, CHCl3) for an 
enantiomerically enriched sample of 92:8 er. 
Enantiomeric purity was determined by GC analysis in comparison with authentic 
racemic material of primary alcohol obtained after removal of the silyl group; β-dex 
column, 50 °C, 15 psi). 
 
Retention Time Area Area% Retention Time Area Area% 
287.223 39281.0 49.618 284.676 94880.4 92.207 
327.094 39885.1 50.382 330.477 8018.30469 7.793 
 
(R)-(4-(Simethyl(phenyl)silyl)hex-5-en-1-yn-1-yl)trimethylsilane (2.35) 
IR (neat): 3070 (w), 2958 (w), 2899 (w), 2173 (w), 1626 (w), 1487 (w), 1427 (w), 1411 
(w), 1317 (w), 1248 (m), 1112 (m), 1040 (w), 998 (w), 942 (w), 899 (w), 836 (s), 813 (s), 
778 (m), 758 (s), 723 (s), 697 (s), 642 (m), 548 (w), 469 (m) cm−1; 1H NMR (CDCl3, 500 
MHz): δ 7.53–7.50 (2H, m), 7.37–7.34 (3H, m), 5.76 (1H, ddd, J = 17.0, 10.5, 9.0 Hz), 
4.96 (1H, app. d, J = 10.5 Hz), 4.88 (1H, app. d, J = 17.5 Hz), 2.38 (1H, dd, J = 17.0, 5.5 
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Hz), 2.30 (1H, dd, J = 17.5, 8.0 Hz), 1.99–1.95 (1H, m), 0.35 (3H, s), 0.34 (3H, s), 0.13 
(9H, s); 13C NMR (CDCl3, 100 MHz): δ 138.2, 137.2, 134.2, 129.3, 127.9, 113.2, 107.2, 
85.6, 33.5, 0.3, –4.1, –4.4. HRMS (ESI+): Calcd for C17H27Si2 [M+H]+: 287.1651; 
Found: 287.1654. Specific rotation: [α]D22.1 +18.3 (c 2.49, CHCl3) for an 
enantiomerically enriched sample of 93:7 er.  
Enantiomeric purity was determined by GC analysis in comparison with authentic 
racemic material; column, 99:1 hexanes/ iPrOH, 1.0 mL/min, 220 nm.  
 
Retention Time Area Area% Retention Time Area Area% 
37.334 4406370 49.618 35.189 830996 6.911 
46.262 4792130   50.382 42.463 11193122 93.089 
	
(R)-9-(Trimethylsilyl)-6-vinylnon-8-yn-2-one (2.36) 
IR (neat): 3025 (m), 2956 (s), 2927 (s), 2854 (s), 1603 (w), 1538 (w), 1496 (m), 1437 (s), 
1267 (s), 1258 (s), 1134 (s), 1080 (w), 1031 (s), 975 (s), 880 (s), 811 (s), 766 (s), 736 (s), 
698 (s) cm−1; 1H NMR (CDCl3, 400 MHz): δ 5.69–5.60 (1H, m), 5.07–5.02 (2H, m), 
2.44–2.40 (2H, m), 2.27–2.25 (2H, m), 2.23–2.19 (1H, m), 2.13 (3H, s), 1.66–1.48  (2H, 
m), 1.37–1.26 (2H, m), 0.14 (9H, s); 13C NMR (CDCl3, 100 MHz): δ 209.0,140.9,115.5, 
105.5, 86.2, 43.8,42.8, 33.1, 30.0, 25.9, 21.5, 0.3. HRMS (ESI+): Calcd for C14H25OSi 
[M+H]+: 237.1675; Found: 237.1673. Specific rotation: [α]D20.0  8.8 (c 0.97, CHCl3) for 
an enantiomerically enriched sample of 92:8 er.  
Enantiomeric purity was determined by GC analysis in comparison with authentic 
racemic material; CDB-DM column, 60°C, 90 min, 60 °C to 70 °C for 1°C/min, 70 °C, 
90 min, 70 °C to 80 °C for 1°C/min, 15 psi. 
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Retention Time Area Area% Retention Time Area Area% 
429.490 150.90643 47.52756 428.581 366.26157 91.68601 
434.576 166.60707 52.47244 434.119 33.21220 8.31399 
 
(R)-trimethyl(4-(naphthalen-1-yl)hex-5-en-1-yn-1-yl)silane (2.21q) 
IR (neat): 3049 (w), 2959 (w), 2924 (w), 2854 (w), 2175 (w), 1637 (w), 1598 (w), 1510 
(w), 1396 (w), 1249 (m), 1166 (w), 1094 (w), 1022 (m), 917 (w), 840 (s), 796 (s), 776 (s), 
759 (s), 731 (w), 698 (w), 650 (w), 637 (w), 551 (w), 509 (w), 477 (w), 441 (w), 423 (w) 
cm−1; 1H NMR (CDCl3, 500 MHz): δ 8.13 (1H, d, J = 8.5 Hz), 7.87 (1H, d, J = 8.5 Hz), 
7.73 (1H, d, J = 7.0 Hz), 7.54–7.51(1H, m), 7.50–7.47 (1H, m), 7.47 (1H, d, J = 7.5 Hz) 
7.40 (1H, dd, J = 7.5, 1.5 Hz), 6.22 (1H, ddd, J = 17.0, 10.5, 6.5 Hz), 5.21 (1H, app. d, J 
= 10.5 Hz), 5.18 (1H, app. d, J = 17.5 Hz), 4.41 (1H, q, J = 7.0 Hz), 2.81 (1H, dd, J = 
16.5, 7.0 Hz), 2.78 (1H, dd, J = 16.5, 6.5 Hz), 0.08 (9H, s); 13C NMR (CDCl3, 100 
MHz): δ 139.8, 138.8, 134.1, 131.7, 129.1, 127.4, 126.0, 125.6, 125.5, 124.6, 123.5, 
115.9, 105.5, 86.8, 43.2, 26.3, 0.1. HRMS (ESI+): Calcd for C19H23Si [M+H]+: 279.1569; 
Found: 279.1554. Specific rotation: [α]D22.5  –14.2 (c 1.14, CHCl3) for an 
enantiomerically enriched sample of 94:6 er.  
Enantiomeric purity was determined by HPLC analysis in comparison with authentic 
racemic material obtained from the derived alcohol, which was prepared through 
oxidative cleavage of the olefin then reduction of the derived aldehyde with NaBH4; 
Chiralpak OD–H column, 99:1 hexanes/ i-PrOH, 1.0 mL/min, 220 nm. 
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Retention Time Area Area% Retention Time Area Area% 
6.284 15169967 49.477 6.382 2454609 5.552 
7.557 15490935 50.523 7.704 41760529 94.448 
 
(R,E)-Trimethyl(4-phenylhex-5-en-1-yn-1-yl-6-d)silane (cf. 1.66 in Chapter 1) 
IR (neat): 3030 (w), 2959 (w), 2176 (w), 1496 (w), 1248 (m), 1075 (w), 1039 (w), 837 
(s), 758 (s), 697 (s), 654 (m), 645 (m) cm−1; 1H NMR (CDCl3, 400 MHz): δ 7.33 (1H, d, 
J = 8.5 Hz), 7.87 (1H, d, J = 8.5 Hz), 7.73 (1H, d, J = 7.0 Hz), 7.33–7.29 (2H, m), 7.24–
7.20 (3H, m), 6.08 (1H, dd, J = 17.2, 7.2 Hz), 5.11 (3 mol % Z-diastereomer, 1H, dd, J = 
6.0, 1.6 Hz)), 5.09 (97 mol % E-diastereomer, 1H, dd, J = 17.2, 1.6 Hz), 3.53 (1H, qd, J = 
7.2, 1.2 Hz), 2.67–2.53 (2H, m), 0.11 (9H, s); 13C NMR (CDCl3, 100 MHz): δ 142.8 (d, 
JCD = 1.5 Hz), 128.5, 127.9, 126.8, 126.7, 115.2 (t, JCD = 24.4 Hz), 105.5 (d, JCD = 1.5 
Hz), 86.7(d, JCD = 1.5 Hz), 48.6, 26.9, 0.2. HRMS (ESI+): Calcd for C15H20DSi [M+H]+: 
230.1475; Found: 230.1473. Specific rotation: [α]D20.0  0.76 (c 0.58, CHCl3) for an 
enantiomerically enriched sample of 96:4 dr.  
 
Proof of Stereochemistry for Products with a Tertiary Carbon Stereogenic Center  
 
 
An oven-dried vial (4 mL, 17 x 38 mm) equipped with a stir bar was charged with 
TMS-protected alkyne 2.21q (28.0 mg, 100 µmol) and thf (1 mL). Tetrabutylammonium 
fluoride (0.15 mL of 1.0 M thf solution, 150 µmol) was added to the mixture and the 
mixture was allowed to stir at 22 °C for 3 h. The reaction was quenched upon the 
addition of a saturated solution of ammonium chloride (1 mL), washed with Et2O (3 x 2 
S23
93% overall yield
Scheme S6. Preparation of 1,5-Diene S23
2.21q
SiMe3
1. 1.5 equiv (n-Bu)4NF, thf, 22 °C, 3 h
2. 2.0 equiv dibal-H, hexanes, 22 °C, 12 h
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mL). The combined organic layers were filtered through a short plug of celite/MgSO4 (4 
cm x 1 cm) and eluted with Et2O. The filtrate was concentrated in vacuo to provide a pale 
yellow oily residue, which was used for next step without further purification. An oven-
dried vial (4 mL, 17 x 38 mm) equipped with a stir bar was charged with the terminal 
alkyne and hexanes (1 mL). Dibal-H (36 µL, 200 µmol) was added to the mixture 
through a syringe and the reaction mixture was allowed to stir at 22 °C for 12 h. The 
reaction was quenched upon the addition of a saturated solution of sodium potassium 
tartrate (0.5 mL) and stired under N2. After allowing the mixture to stir at 22 °C for an 
additional 2 h, the aqueous solution was washed with pentane (3 x 1 mL) and the 
combined organic layers were passed through a short plug of silica gel (3 cm x 1 cm) 
eluting with pentane. The organic layer was concentrated in vacuo and purified by silica 
gel chromatography (100% pentane, Rf 0.70) to afford 19.4 mg of the desired product S23 
as colorless oil (93 µmol, 93% yield). Specific rotation: [α]D22.0 –21.2 (c 0.83, CHCl3). 
Based on reported optical rotation value ([α]D20 +26.6 (c 0.89, CHCl3), the absolute 
stereochemistry of the major enantiomer is assigned to be R.27 
NHC−Cu Catalyzed Enantioselective Propargyl Addition to Trisubstituted Allylic 
Phosphates 
 
Representative Procedure  
An oven-dried 2-dram vial equipped with a stir bar was charged with NHC–Ag 
complex 2.29 (24 mg, 12.5 µmol), NaOMe (32 mg, 0.6 mmol), and CuCl (2.47 mg, 25 
µmol) in a nitrogen-filled glove box. The vial was sealed with a septum and electrical 
tape, and removed from the glove box. Thf (3 mL) was added and the mixture was 
allowed to stir for 1 h under N2 at 22 °C (The mixture became bright-yellow solution). 
The solution of allylic phosphate 2.43a (142 mg, 0.5 mmol) and propargyl–B(pin) 
reagent 2.20 (0.2 mL, 0.75 mmol) in thf (2 mL) was added to the mixture slowly through 
a platic syringe. The resulting mixture was allowed to stir at 22 °C for 30 h and quenched 
by passing through a short plug of silica gel (4 cm x 1 cm) and eluted with Et2O. The 
organic layer was concentrated in vacuo, resulting in yellow oil, which was purified by 
silica gel chromatography (100% hexanes, Rf 0.32) to afford 97 mg of inseparable 
mixture of 2.44a and SN2 product (94:6 SN2’/SN2) as colorless oil (0.40 mmol, 81% 
yield). 
 
 
                                                
(14) Zhang, P.; Brozek, L. A.; Morken, J. P. J. Am. Chem. Soc. 2010, 132, 10686–10688. 
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Characterization Data for Enynes with a Quaternary Carbon Stereogenic Center 
(R)-4-Methyl-4-phenyl-1-trimethylsilyl-hex-5-en-1-yne (2.44a) 
IR (neat): 3085 (w), 3059 (w), 2960 (m), 2900 (w), 2175 (m), 1636 (w), 1600 (w), 1494 
(w), 1445 (w), 1410 (w), 1372 (w), 1248 (s), 1075 (w), 1026 (m), 1000 (w), 915 (m), 837 
(s), 758 (s), 696 (s), 646 (s), 595 (w), 555 (w) cm−1; 1H NMR (CDCl3, 400 MHz): δ 
7.37–7.34 (2H, m), 7.32–7.28 (2H, m), 7.23–7.18 (1H, m), 6.09 (1H, dd, J = 17.6, 10.8 
Hz), 5.15 (1H, dd, J = 10.8, 0.8 Hz), 5.09 (1H, dd, J = 17.6, 0.8 Hz), 2.64 (1H, s), 2.63 
(1H, s), 1.51 (3H, s), 0.09 (9H, s); 13C NMR (CDCl3, 100 MHz): δ 146.0, 145.3, 128.1, 
126.8, 126.3, 112.7, 104.9, 87.4, 44.4, 32.6, 25.3, 0.1. HRMS (ESI+): Calcd for 
C16H23Si1 [M+H]+: 243.1569; Found: 243.1563. Specific rotation: [α]D20.9 +10.0 (c 1.56, 
CHCl3) for an enantiomerically enriched sample of 93:7 er.  
Enantiomeric purity was determined by GC analysis in comparison with authentic 
racemic material; CDB-DM column, 100 °C, 15 psi. 
 
Retention Time Area Area% Retention Time Area Area% 
85.277 3270.46729 50.05367 85.683 411.96298 92.84269 
87.782 3263.45312 49.94633 88.694 31.75853 7.15731 
 
(R)-4-Methyl-4-(2-methoxyphenyl)-1-trimethylsilyl-hex-5-en-1-yne (2.44b) 
IR (neat): 2958 (w), 2900 (m), 2834 (w), 2173 (m), 1635 (w), 1598 (w), 1580 (w), 1489 
(m), 1462 (m), 1434 (m), 1409 (w), 1369 (w), 1286 (w), 1237 (s), 1179 (w), 1121 (w), 
1071 (w), 1028 (s), 912 (m), 837 (s), 789 (m), 747 (s), 697 (m), 670 (m), 646 (s), 573 (w) 
cm−1; 1H NMR (CDCl3, 400 MHz): δ 7.29 (1H, dd, J = 7.6, 1.6 Hz), 7.24–7.19 (1H, m), 
6.91 (1H, dd, J = 7.6, 1.6 Hz), 6.87–6.86 (1H, m), 6.28 (1H, dd, J = 17.4, 10.8 Hz), 5.04 
(1H, dd, J = 10.8, 1.2 Hz), 4.97 (1H, dd, J = 17.4, 1.2 Hz), 3.80 (3H, s), 2.86 (1H, s), 2.85 
(1H, s), 1.55 (3H, s), 0.04 (9H, s); 13C NMR (CDCl3, 100 MHz): δ 158.1, 145.4, 134.0, 
128.3, 127.8, 120.3, 111.8, 111.7, 106.1, 86.5, 55.3, 44.1, 30.6, 24.4, 0.2. HRMS (ESI+): 
Calcd for C17H25O1Si1 [M+H]+: 273.1674; Found: 273.1684. Specific rotation: [α]D20 
+19.9 (c 2.00, CHCl3) for an enantiomerically enriched sample of 83:17 er.  
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Enantiomeric purity was determined by GC analysis in comparison with authentic 
racemic material of the ketone derivative obtained through protoboration/oxidative work-
up after removal of the silyl group; CDB-DM column, 90 °C, 60 min, then 0.05 °C /min 
to 100 °C, 15 psi. 
 
Retention Time Area Area% Retention Time Area Area% 
264.429 151.93213 49.21451 264.558 62.55266 16.98042 
267.640 156.78194 50.78549 267.933 305.82843 83.01958 
 
(R)-4-Methyl-4-(3-bromophenyl)-1-trimethylsilyl-hex-5-en-1-yne (2.44c) 
IR (neat): 3084 (w), 2960 (m), 2899 (w), 2175 (m), 1637 (w), 1592 (m), 1563 (m), 1475 
(m), 1415 (m), 1372 (m), 1299 (w), 1248 (s), 1205 (w), 1068 (w), 1033 (m), 1015 (m), 
996 (m), 918 (m), 837 (s), 781 (s), 758 (s), 696 (s), 646 (s) cm−1; 1H NMR (CDCl3, 400 
MHz): δ 7.50 (1H, dd, J = 2.0, 2.0 Hz), 7.35–7.33 (1H, m), 7.29–7.26 (1H, m), 7.19–7.15 
(1H, m), 6.04 (1H, dd, J = 17.6, 10.8 Hz), 5.18 (1H, dd, J = 10.8, 0.8 Hz), 5.10 (1H, dd, J 
= 17.6, 0.8 Hz), 2.59 (2H, s), 1.48 (3H, s), 0.09 (9H, s); 13C NMR (CDCl3, 100 MHz): δ 
148.4, 144.6, 130.2, 129.6, 129.4, 125.6, 122.3, 113.3, 104.2, 87.9, 44.4, 32.6, 25.3, 0.1; 
HRMS (ESI+): Calcd for C16H22Br1Si1 [M+H]+: 321.0674; Found: 321.0680. Specific 
rotation: [α]D21.3 +21.4 (c 1.40, CHCl3) for an enantiomerically enriched sample of 92:8 
er.  
Enantiomeric purity was determined by GC analysis in comparison with authentic 
racemic material; CDB-DM column, 110 °C, 15 psi. 
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Retention Time Area Area% Retention Time Area Area% 
220.652 128.77628 49.46294 220.215 4622.51953 91.91237 
226.092 131.57272 50.53706 225.621 406.74847 8.08763 
	
(R)-4-Methyl-4-(4-chlorophenyl)-1-trimethylsilyl-hex-5-en-1-yne (2.44d) 
IR (neat): 3085 (w), 2961 (m), 2900 (w), 2176 (m), 1636 (w), 1596 (w), 1493 (m), 1460 
(w), 1411 (w), 1372 (w), 1298 (w), 1248 (s), 1096 (m), 1033 (m), 1012 (s), 917 (m), 838 
(s), 823 (s), 758 (s), 742 (m), 722 (m), 697 (m), 646 (m), 594 (w), 532 (m) cm−1; 1H 
NMR (CDCl3, 400 MHz): δ 7.28–7.26 (4H, m), 6.04 (1H, dd, J = 17.2, 10.8 Hz), 5.15 
(1H, dd, J = 10.8, 0.8 Hz), 5.07 (1H, dd, J = 17.2, 0.8 Hz), 2.60 (1H, s), 2.59 (1H, s), 1.48 
(3H, s), 0.08 (9H, s); 13C NMR (CDCl3, 100 MHz): δ 145.0, 144.5, 132.2, 128.4, 128.2, 
113.1, 104.4, 87.8, 44.2, 32.7, 25.4, 0.1. HRMS (ESI+): Calcd for C16H22Cl1Si1 [M+H]+: 
277.1179; Found: 277.1177. Specific Rotation: [α]D21.2 +20.0 (c 1.50, CHCl3) for an 
enantiomerically enriched sample of 93:7 er.  
Enantiomeric purity was determined by GC analysis in comparison with authentic 
racemic material; CDB-DM column, 115 °C, 15 psi. 
 
Retention Time Area Area% Retention Time Area Area% 
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126.496 81.00266 49.79742 125.768 82.78249 6.63908 
129.626 81.66171 50.20258 127.913 1164.11401 93.36092 
 
(R)-4-Cyclohexyl-4-methyl-1-trimethylsilyl-hex-5-en-1-yne (2.44e) 
IR (neat): 3082 (w), 2923 (m), 2852 (m), 2173 (m), 1636 (w), 1449 (m), 1414 (m), 1374 
(w), 1294 (s), 1248 (w), 1131 (w), 1036 (m), 1004 (m), 911 (m), 890 (w), 837 (s), 758 (s), 
698 (m), 646 (s) cm−1; 1H NMR (CDCl3, 400 MHz): δ 5.80 (1H, dd, J = 17.6, 10.8 Hz), 
5.03 (1H, dd, J = 10.8, 1.6 Hz), 4.93 (1H, dd, J = 17.6, 1.6 Hz), 2.23 (1H, s), 2.22 (1H, s), 
1.81-1.62 (6H, m), 1.42-1.37 (1H, m), 1.22-1.04 (2H, m), 1.00 (3H, s), 0.99-0.83 (2H, m), 
0.14 (9H, s); 13C NMR (CDCl3, 100 MHz): δ 144.9, 112.5, 105.5, 86.6, 44.8, 42.3, 31.7, 
30.3, 27.8, 27.3, 27.2, 26.7, 20.0, 0.3. HRMS (ESI+): Calcd for C16H29Si1 [M+H]+: 
249.2038; Found: 249.2045. Specific rotation: [α]D21.6 +13.0 (c 1.20, CHCl3) for an 
enantiomerically enriched sample of 94:6 er.  
Enantiomeric purity was determined by GC analysis in comparison with authentic 
racemic material; β-dex column, 100 °C, 15 psi.  
 
Retention Time Area Area% Retention Time Area Area% 
173.646 25598.5 50.28299 171.170 10988.5 94.23493 
177.637 25310.4 49.71701 175.563 6722.48779 5.76507 
 
Proof of Stereochemistry for Products with a Quaternary Carbon Stereogenic Center 
 
 
An oven-dried vial (4 mL, 17 x 38 mm) equipped with a stir bar was charged with 
TMS-protected alkyne 2.44e (19 mg, 76 µmol) and thf (1 mL). Tetrabutylammonium 
S24
67% overall yield
Scheme S7. Preparation of 1,5-Diene S24
2.45e
SiMe3
1. 1.5 equiv (n-Bu)4NF, thf, 22 °C, 3 h
2. 2.0 equiv dibal-H, hexanes, 22 °C, 12 hMe
Me
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fluoride (0.12 mL of 1.0 M thf solution, 0.12 mmol) was added to the mixture, which was 
allowed to stir at 22 °C for 3 h. The reaction was quenched upon the addition of a 
saturated solution of ammonium chloride (1 mL), washed with Et2O (3 x 2 mL). The 
combined organic layers were filtered through a short plug of celite/MgSO4 (4 cm x 1 cm) 
and eluted with Et2O. The filtrate was concentrated in vacuo to provide yellow oily 
residue, which was used without purification. An oven-dried vial (4 mL, 17 x 38 mm) 
equipped with a stir bar was charged with the terminal alkyne and hexanes (1 mL). Dibal-
H (27 µL, 150 µmol) was added to the mixture through the syringe and the reaction 
mixture was allowed to stir at 22 °C for 12 h. The reaction was quenched upon the 
addition of a saturated solution of sodium potassium tartrate (0.5 mL) and allowed to stir 
at 22 °C for an additional 2 h, the aqueous solution was washed with pentane (3 x 1 mL) 
and the combined organic layers were passed through a short plug of silica gel (3 cm x 1 
cm) and eluted with pentane. The organic layer was concentrated in vacuo, resulting in 
colorless oil that was purified by silica gel chromatography (100% pentane, Rf  = 0.82) to 
afford 9.3 mg of the desired product S24 as colorless oil (52 µmol, 67% yield). Specific 
rotation: [α]D22 +7.02 (c 0.83, CHCl3). Based on reported optical rotation value ([α]D20 
+6.85 (c 0.96, CHCl3)), the absolute stereochemistry of the major enantiomer is assigned 
to be R enantiomer.28 
Further Functionalization of Propargyl Addition Products (cf. Schemes 2.7−2.9) 
 
(S)-5-Phenyl-1,2,6-heptatriene (2.48) 
An oven-dried vial (4 mL, 17 x 38 mm) equipped with a stir bar was charged with 
TMS-protected alkyne 2.21a (46 mg, 0.20 mmol) and thf (1 mL). Tetrabutylammonium 
fluoride (0.30 mL of 1.0 M thf solution, 0.30 mmol) was added to the mixture, which was 
allowed to stir at 22 °C for 3 h. The reaction was quenched upon the addition of a 
saturated solution of ammonium chloride (1 mL), washed with Et2O (3 x 2 mL). The 
combined organic layers were filtered through a short plug of celite/MgSO4 (4 cm x 1 cm) 
and eluted with Et2O. The filtrate was concentrated in vacuo to provide pale yellow oil, 
which was used for next step without further purification. An oven-dried round bottom 
flask (5 mL) equipped with a reflux condenser and a magnetic stir bar was charged with 
the unpurified mixture, paraformaldehyde (12 mg, 0.40 mmol), CuBr (9.4 mg, 0.066 
mmol), diisopropylamine (0.054 mL, 0.40 mmol) and 1,4-dioxane (1 mL) under N2 
atmosphere. The resulting mixture was allowed to stir at 100 °C for 4 h and the reaction 
was quenched by addition of a saturated aqueous solution of Na2CO3 (5 mL). The 
aqueous layer was washed with Et2O (3 × 3 mL) and the combined organic layers were 
washed with brine (5 mL), dried over MgSO4, filtered and concentrated in vacuo. The 
residue was purified by silica gel chromatography (100% hexanes, Rf 0.56) to afford the 
                                                
(15) Zhang, P.; Le, H.; Kyne, R. E.; Morken, J. P. J. Am. Chem. Soc. 2011, 133, 9716–9719. 
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desired product 2.48 (31 mg, 0.186 mmol, 93% overall yield) as colorless oil. (S)-5-
Phenyl-1,2,6-heptatriene (2.48): IR (neat): 3081 (w), 3061 (w), 3027 (w), 2979 (w), 
2912 (w), 1954 (m), 1636 (w), 1600 (w), 1492 (m), 1451 (m), 1414 (w), 1303 (w), 1241 
(w), 1180 (w), 1075 (w), 1028 (m), 992 (w), 965 (w), 914 (s), 841 (s), 782 (w), 753 (s), 
697 (s), 676 (m), 608 (w), 514 (m) cm−1; 1H NMR (CDCl3, 400 MHz): δ 7.32–7.29 (2H, 
m), 7.22–7.19 (3H, m), 5.99 (1H, ddd, J = 17.3, 10.2, 7.2 Hz), 5.08 (1H, d, J = 7.2 Hz), 
5.06 (1H, d, J = 17.3 Hz), 5.03 (1H, tt, J = 14.4, 6.8 Hz), 4.63–4.59 (2H, m), 3.39 (1H, td, 
J = 7.4, 7.2 Hz), 2.48–2.42 (2H, m); 13C NMR (CDCl3, 100 MHz): δ 209.2, 143.6, 141.4, 
128.5, 127.8, 126.5, 114.8, 88.0, 74.7, 49.7, 34.5. HRMS (ESI+): Calcd for C13H15 
[M+H]+: 171.1173; Found: 171.1175. Specific rotation: [α]D22.8 +4.16 (c 3.00, CHCl3) for 
an enantiomerically enriched sample of 97:3 er.  
 
N-[(S)-4-(2-Bromophenyl)-5-hexenoyl]-4-methylbenzenesulfonamide (2.49) 
An oven-dried vial (4 mL, 17 x 38 mm) equipped with a stir bar was charged with 
TMS-protected alkyne 2.21c (74 mg, 0.24 mmol) and thf (1 mL). Tetrabutylammonium 
fluoride (0.36 mL of 1.0 M thf solution, 0.36 mmol) was added to the mixture, which was 
allowed to stir at 22 °C for 3 h. The reaction was quenched upon the addition of a 
saturated solution of ammonium chloride (1 mL), washed with Et2O (3 x 2 mL). The 
combined organic layers were filtered through a short plug of celite/MgSO4 (4 cm x 1 cm) 
and eluted with Et2O. The filtrate was concentrated in vacuo to provide an oily residue 
that was purified by silica gel chromatography (100% pentane, Rf 0.77) to afford 57 mg 
of terminal alkyne as colorless oil (0.24 mmol, 98% yield). An opened vial (4 mL, 17 x 
38 mm) equipped with a stir bar was charged with the terminal alkyne obtain from last 
step (50 mg, 0.21 mmol), CuI (0.8 mg, 4.2 µmol), TsN3 (49 mg, 0.25 mmol) and H2O 
(0.5 mL). Et3N (35 µL, 0.25 mmol) was slowly added to the mixture through syringe and 
the reaction mixture was allowed to stir at 22 °C for 30 min in air. The mixture was 
diluted with CH2Cl2 (2 mL) and the reaction was quenched upon the addition of a 
saturated solution of ammonium chloride (1 mL). The aqueous solution was washed with 
CH2Cl2 (3 x 1 mL) and the combined organic layers were passed through a short plug of 
silica gel (3 cm x 1 cm) and eluted with CH2Cl2. The organic layer was concentrated in 
vacuo, resulting in yellow oil that was purified by silica gel chromatography (30:1 
EtOAc/CH2Cl2, Rf 0.27) to afford 66 mg of the desired product 2.49 as yellow oil (0.156 
mmol, 74% yield). (S)-4-(2-Bromophenyl)hex-5-en-1-yne: IR (neat): 3299 (m), 3081 
(w), 3008 (w), 2981 (w), 2913 (w), 2119 (w), 1637 (w), 1589 (w), 1566 (w), 1468 (s), 
1437 (m), 1415 (m), 1276 (w), 1243 (w), 1161 (w), 1119 (w), 1021 (s), 994 (m), 919 (s), 
861 (w), 822 (w), 779 (w), 750 (s), 734 (s), 724 (s), 630 (s), 546 (w), 513 (w), 447 (m) 
cm−1; 1H NMR (CDCl3, 400 MHz): δ 7.56–7.54 (1H, m), 7.29–7.23 (2H, m), 7.10–7.06 
(1H, m), 6.03 (1H, ddd, J = 17.2, 10.6, 6.8 Hz), 5.19 (1H, dd, J = 10.6, 1.6 Hz), 5.16 (1H, 
dd, J = 17.2, 1.6 Hz), 4.10 (1H, td, J = 8.0, 6.8 Hz), 2.62–2.60 (2H, m), 1.9 (1H, t, J = 2.8 
Hz); 13C NMR (CDCl3, 100 MHz): δ 141.5, 138.4, 133.1, 128.8, 128.3, 127.6, 124.8, 
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116.4, 82.0, 70.1, 46.3, 24.0. HRMS (ESI+): Calcd for C12H12Br1 [M+H]+: 235.0122; 
Found: 235.0117. Specific rotation: [α]D21.7 –4.99 (c 5.00, CHCl3) for an 
enantiomerically enriched sample of 97:3 er.  
N-[(S)-4-(2-Bromophenyl)-5-hexenoyl]-4-methylbenzenesulfonamide (2.49): IR 
(neat): 3243 (br), 3064 (w), 2925 (w), 1697 (m), 1636 (w), 1596 (w), 1468 (m), 1435 (s), 
1339 (s), 1307 (m), 1292 (m), 1265 (m), 1215 (m), 1188 (m), 1168 (s), 1140 (s), 1117 (s), 
1084 (s), 1045 (m), 1020 (s), 995 (m), 920 (m), 853 (s), 813 (s), 750 (m), 703 (s), 660 (s), 
545 (s), 482 (m) cm−1; 1H NMR (CDCl3, 400 MHz): δ 7.91 (2H, d, J = 8.4 Hz), 7.51 (1H, 
d, J = 8.0 Hz), 7.36 (2H, s), 7.32 (2H, d, J = 8.4 Hz), 7.25–7.22 (1H, m), 7.13 (1H, d, J = 
8.0 Hz), 7.07–7.03 (1H, m), 5.82 (1H, ddd, J = 17.2, 10.4, 7.2 Hz), 5.07 (1H, d, J = 10.4 
Hz), 5.05 (1H, d, J = 17.2 Hz), 3.67 (1H, td, J = 7.6, 7.2 Hz), 2.44 (3H, s), 2.30–2.22 (1H, 
m), 2.20–2.12 (1H, m), 2.09–2.00 (1H, m), 1.96–1.87 (1H, m); 13C NMR (CDCl3, 100 
MHz): δ 170.0, 145.3, 141.9, 139.5, 133.1, 129.7, 128.6, 128.5, 128.4, 128.2, 128.0, 
124.8, 116.0, 46.7, 34.0, 29.0, 21.8. HRMS (ESI+): Calcd for C19H21Br1N1O3S1 [M+H]+: 
422.0425; Found: 422.0408. Specific rotation: [α]D21.6 +7.50 (c 6.00, CHCl3) for an 
enantiomerically enriched sample of 97:3 er.  
 
(R,Z)-Trimethyl(4-(naphthalen-1-yl)hexa-1,5-dien-1-yl)silane (2.50) 
A 50-mL flask equipped with a stir bar was charged with enyne 2.21q (278 mg, 
1.0 mmol), hexanes (10 mL) and thf (2.0 mL). Dibal-H (360 µL, 2.0 mmol) was added to 
the solution through the syringe and the mixture was allowed to stir at 55 °C for 2 h. The 
reaction was quenched upon the addition of a saturated solution of sodium potassium 
tartrate (5 mL) and allowed to stir at 22 °C for an additional 2 h, and then washed with 
Et2O (3 x 10 mL). The combined organic layers were dried over MgSO4, filtered, 
concentrated in vacuo, resulting in colorless oil that was purified by silica gel 
chromatography (100% pentane, Rf  0.65) to afford 238 mg of the desired product 2.50 as 
coloress oil. (R,Z)-Trimethyl(4-(naphthalen-1-yl)hexa-1,5-dien-1-yl)silane (2.50): IR 
(neat): 3048 (w), 2954 (w), 2897 (w), 1636 (w), 1601 (w), 1510 (w), 1396 (w), 1247 (s), 
1167 (w), 992 (w), 915 (w), 856 (s), 836 (s), 796 (s), 777 (s), 764 (m), 731 (w), 690 (w), 
560 (w), 518 (w), 422 (w) cm−1; 1H NMR (CDCl3, 400 MHz): δ 8.13 (1H, d, J = 8.0 Hz), 
7.89–7.86 (1H, m), 7.75 (1H, d, J = 7.6 Hz), 7.54–7.45 (3H, m), 7.41 (1H, dd, J = 7.2, 1.2 
Hz), 6.33 (1H, dt, J = 14.0, 7.2 Hz), 6.12 (1H, ddd, J = 17.2, 10.0, 6.8 Hz), 5.55 (1H, dt, J 
= 14.0, 1.6 Hz), 5.12 (1H, app.d, J = 9.6 Hz), 5.10 (1H, app.d, J = 17.2 Hz), 4.23 (1H, q, 
J = 7.2 Hz), 2.79–2.74 (2H, m), 0.12 (9H, s); 13C NMR (CDCl3, 100 MHz): δ 146.7, 
141.3, 139.8, 134.2, 131.8, 130.6, 129.1, 127.1, 125.9, 125.6, 125.5, 124.4, 123.6, 115.2, 
44.5, 38.7, 0.3. HRMS (ESI+): Calcd for C19H24Si [M+H]+: 281.1726; Found: 281.1732. 
Specific rotation: [α]D20.8 –45.1 (c 1.77, CHCl3) for an enantiomerically enriched sample 
of 94:6 er.  
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(R,Z)-1-(6-Iodohexa-1,5-dien-3-yl)naphthalene (2.51) 
An oven-dried vial (4 mL, 17 x 38 mm) equipped with a stir bar was charged with 
alkenyl silane 2.52 (28 mg, 0.10 mmol), Ag2CO3 (8.3 mg, 30 µmmol) and (CF3)2CHOH 
(1.0 mL). The suspension was allowed to cool to 0 °C. N-iodosuccinimide (27 mg, 0.12 
mmol) was added to the mixture, which was allowed to stir at 0 °C for 10 min. The 
reaction was quenched upon the addition of a saturated solution of NaHSO3 (0.5 mL). 
The aqueous solution was washed with Et2O (3 x 1 mL) and the combined organic layers 
were passed through a short plug of silica gel and eluted with Et2O. The organic layer 
was concentrated in vacuo, and the yellow oil was purified by silica gel chromatography 
(100% pentane, Rf 0.50) to afford 21.4 mg of the desired product 2.51 (0.064 mmol, 64% 
yield) as colorless oil. (R,Z)-1-(6-Iodohexa-1,5-dien-3-yl)naphthalene (2.51): IR (neat): 
3047 (w), 3002 (w), 2921 (w), 1636 (w), 1597 (w), 1510 (w), 1435 (w), 1412 (w), 1395 
(w), 1284 (m), 1263 (m), 1193 (w), 1167 (w), 1102 (w), 993 (w), 949 (w), 917 (m), 858 
(w), 837 (w), 797 (m), 777 (s), 751 (w), 734 (w), 691 (w), 647 (w), 560 (w), 477 (w), 427 
(w); 1H NMR (CDCl3, 400 MHz): δ 8.14 (1H, d, J = 8.4 Hz), 7.89–7.87 (1H, m), 7.76 
(1H, d, J = 8.4 Hz), 7.56–7.42 (4H, m), 6.26–6.19 (2H, m), 6.14 (1H, ddd, J = 17.2, 10.4, 
6.8 Hz), 5.18–5.12 (2H, m), 4.34 (1H, q, J = 7.2 Hz), 2.77 (2H, app. t, J = 6.8 Hz); 13C 
NMR (CDCl3, 100 MHz): δ 140.7, 139.6, 139.0, 134.2, 131.7, 129.1, 127.3, 126.1, 125.6, 
124.5, 123.5, 115.6, 83.8, 43.0, 40.1. HRMS (ESI+): Calcd for C16H16I [M+H]+: 
335.0297; Found: 335.0291. Specific rotation: [α]D23.1 –68.7 (c 1.60, CHCl3) for an 
enantiomerically enriched sample of 94:6 er. 
  
4,4,5,5-Tetramethyl-1-(4-methylhexa-1,5-dienyl)-1,3,2-dioxaborolane (2.53) 
An oven-dried 1-dram vial equipped with a stir bar was charged with NHC–Ag 
complex 2.29 (14.5 mg, 7.5 µmol), NaOMe (19.4 mg, 0.36 mmol), and CuCl (1.47 mg, 
15 µmol) in a nitrogen-filled glove box. The vial was sealed with a cap (phenolic open 
top cap with a red PFTE/white silicon septum) and electrical tape, and removed from the 
glove box. CH2Cl2 (2 mL) was added and the mixture was allowed to stir for 1 h under 
N2 at 22 °C (The solution became bright-yellow). The solution of allylic phosphate 2.52 
(62 mg, 0.3 mmol) and propargyl–B(pin) reagent 2.20 (0.12 mL, 0.45 mmol) in CH2Cl2 
(1 mL) was added to the mixture slowly through syringe. The resulting mixture was 
allowed to stir at 22 °C for 6 h after which the reaction was quenched by passing it 
through a short plug of silica gel (4 cm x 1 cm) and eluted with Et2O. The organic layer 
was concentrated in vacuo and the unpurified residue was used without further 
purification. An oven-dried 1-dram vial equipped with a stir bar was charged with the 
unpurified mixture, K2CO3 (12.4 mg, 0.09 mmol) and MeOH (0.93 mL, 18 mmol) in a 
nitrogen-filled glove box. The vial was sealed with a cap and the mixture was allowed to 
stir at 22 °C for 6 h in a nitrogen-filled glove box. To another oven-dried 1-dram vial 
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equipped with a stir bar, imidazolinium salt 2.54 (7.0 mg, 16.5 µmol), CuCl (1.48 mg, 15 
µmol) and NaOt-Bu (5.8 mg, 60 µmol) were added in a nitrogen-filled glove box. Thf 
(1.5 mL) was added and the solution was allowed to stir for at 22 °C for 1 h under N2 
atmosphere. B2(pin)2 (76 mg, 0.3 mmol) was added to the mixture, which was allowed to 
stir for an additional 30 min. A solution of the terminal alkyne in MeOH was added to the 
mixture by syringe and the mixture was allowed to stir for 24 h at 22 °C. The reaction 
was quenched by passing through a short plug of silica gel (4 cm x 1 cm) and eluted with 
Et2O. The organic layer was concentrated in vacuo and purified by silica gel 
chromatography (20:1 hexanes/Et2O, Rf 0.51) to afford 27.8 mg of alkenylboron 2.55 
(95:5 β/α) as colorless oil (0.13 mmol, 41% overall yield). (S)-4,4,5,5-Tetramethyl-1-(4-
methylhexa-1,5-dienyl)-1,3,2-dioxaborolane (2.55): IR (neat): 3079 (w), 2977 (m), 
2928 (w), 1637 (s), 1457 (w), 1396 (m), 1359 (s), 1317 (s), 1265 (w), 1236 (w), 1214 (w), 
1143 (s), 1113 (w), 994 (m), 969 (m), 909 (m), 882 (w), 849 (m), 737 (w), 674 (w), 637 
(w), 577 (w) cm−1; 1H NMR (CDCl3, 400 MHz): δ 6.58 (1H, dt, J = 18.0, 6.8 Hz), 5.76 
(1H, ddd, J = 17.2, 10.4, 6.8 Hz), 5.43 (1H, dt, J = 18.0, 1.2 Hz), 4.97 (1H, dt, J = 17.2, 
1.6 Hz), 4.93 (1H, dt, J = 10.4, 1.6 Hz), 2.30–2.19 (2H, m), 2.14–2.08 (1H, m), 1.25 (12H, 
s), 1.00 (3H, d, J = 6.8 Hz); 13C NMR (CDCl3, 100 MHz): δ 152.7, 144.0, 120.2, 112.7, 
83.1, 43.2, 36.8, 24.8, 19.6; HRMS (ESI+): Calcd for C13H24B1O2 [M+H]+: 223.1869; 
Found: 223.1861. Specific rotation: [α]D20 +9.9 (c 2.00, CHCl3) for an enantiomerically 
enriched sample of 91:9 er.  
Enantiomeric purity was determined by GC analysis in comparison with authentic 
racemic material by converting 2.53 to the desilyation product of 2.60 through formation 
of the dicobalt complex with Co2(CO)8, cross-metathesis with styrene, 
decomplexation/deprotection; CDB-DM column, 70 °C, 15 psi. 
 
Retention Time Area Area% Retention Time Area Area% 
331.684 277.73416 49.62742 316.132 3538.04248 90.84312 
344.920 281.90439 50.37258 340.621 356.63058 9.15688 
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(S)-4-Methyl-1-phenylhexa-1,5-diene (2.56) 
An oven-dried 4-dram vial equipped with a stir bar was charged with Pd(PPh3)4 
(16 mg, 0.014 mmol) and 1,4-dioxane (0.5 mL) under N2 atmosphere. A solution of the 
substrate 2.55 (60 mg, 0.27 mmol) and iodobenzene (33 µL, 0.297 mmol) in 1,4-dioxane 
(0.5 mL) was added to the mixture and 10% NaOH aqueous solution (0.22 mL, 0.54 
mmol) was added. The resulting mixture was allowed to stir for at 100 °C for 3 h and 
then cooled to 22 °C, which was quenched by the addition of water (1 mL) and the 
aqueous phase was washed with Et2O (3 x 4 mL). The combined organic layers were 
dried over MgSO4, concentrated in vacuo and purified by silica gel chromatography (100% 
hexanes, Rf 0.45) to afford 45.6 mg of the compound 2.56 as colorless oil (0.26 mmol, 98% 
yield). (S)-4-Methyl-1-phenylhexa-1,5-diene (2.56): IR (neat): 1640 (w), 1600 (w), 992 
(m), 960 (s), 908 (w) cm−1; 1H NMR (CDCl3, 400 MHz): δ 7.35‒7.33 (2H, m), 7.29 (2H, 
t, J = 7.2 Hz), 7.19 (1H, tt, J = 7.2, 1.2 Hz), 7.32‒7.29 (2H, m), 7.25‒7.23 (3H, m), 6.38 
(1H, d, J = 16.4 Hz), 6.20 (1H, dt, J = 16.4, 6.8 Hz), 5.81 (1H, ddd, J = 17.2, 10.4, 6.8 
Hz), 5.01 (1H, dt, J = 17.2, 1.2 Hz), 4.96 (1H, dt, J = 10.4, 1.2 Hz), 2.33‒2.27 (2H, m), 
2.23‒2.15 (1H, m), 1.05 (1H, d, J = 6.8 Hz); 13C NMR (CDCl3, 100 MHz): δ 144.1, 
137.9, 131.2, 129.1, 128.6, 127.0, 126.1, 112.9, 40.3, 37.9, 19.6. HRMS (ESI+): Calcd 
for C13H17 [M+H]+: 173.1330; Found: 173.1325. Specific rotation: [α]D21.4 ‒10.6 (c 1.03, 
CHCl3).  
 
Formal Synthesis of Plakinic Acid A (cf. Scheme 2.9) 
 
(R)-Triisopropyl(4-methylhex-5-en-1-yn-1-yl)silane (2.58) 
A 100-mL oven-dried vial equipped with a stir bar was charged with 
imidazolinium salt 2.29 (43 mg, 50 µmol), NaOMe (65 mg, 1.20 mmol), and CuCl (5.0 
mg, 50 µmol) in a nitrogen-filled glove box. The vial was sealed with a septum and 
electrical tape, and removed from the glove box. CH2Cl2 (8.0 mL) was added and the 
solution was allowed to stir for 1 h under N2 at 22 °C. The solution became bright yellow. 
Propargyl–B(pin) reagent 2.57 (483 mg, 0.15 mmol) and allylic phosphate 2.52 (208 mg, 
1.0 mmol) was in CH2Cl2 (2.0 mL) was transferred to the mixture through a syringe and 
the resulting solution was allowed to stir at 22 °C for 6 h. The mixture was passed 
through a short plug of silica gel and eluted with Et2O. The organic layer was 
concentrated in vacuo, affording yellow oil that was purified by silica gel 
chromatography (100% hexanes, Rf 0.80) to afford 248 mg of 2.58 (97:3 SN2’/SN2) as 
pale yellow oil (0.99 mmol, 99% yield). (R)-Triisopropyl(4-methylhex-5-en-1-yn-1-
yl)silane (2.58): IR (neat): 2958 (m), 2942 (s), 2892 (m), 2865 (s), 2173 (m), 1462 (m), 
1073 (w), 1028 (w), 994 (m), 915 (s), 882 (s), 674 (s), 660 (s), 632 (s), 456 (w) cm−1; 1H 
NMR (CDCl3, 400 MHz): δ 5.84 (1H, ddd, J = 17.2, 10.0, 6.8 Hz), 5.04 (1H, dt, J = 17.2, 
1.6 Hz), 4.97 (1H, dt, J = 10.4, 1.2 Hz), 2.42‒2.36 (1H, m), 2.34‒2.20 (2H, m), 1.19 (3H, 
d, J = 6.8 Hz), 1.07‒0.98 (21H, m); 13C NMR (CDCl3, 100 MHz): δ 142.9, 113.4, 107.3, 
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81.6, 37.2, 27.4, 19.2, 18.8, 11.5. HRMS (ESI+): Calcd for C16H31Si [M+H]+: 251.2195; 
Found: 251.2196. Specific rotation: [α]D21.7 −3.81 (c 2.62, CHCl3) for an 
enantiomerically enriched sample of 90:10 er.  
 
(R,E)-Triisopropyl(4-methyl-6-phenylhex-5-en-1-yn-1-yl)silane (2.60) 
In a nitrogen-filled glove box, a 250 mL flask with a stir bar was charged with 
enyne 2.60 (613 mg, 2.45 mmol) and styrene (2.55 g, 24.5 mmol). A solution of Mo 
complex 2.59 (0.1 M in benzene, 1.22 mL, 0.122 mmol, 5.0 mol %) was introduced and 
the mixture was allowed to stir at 22 °C for 3 h under 35 torr. After 10 h, the solution was 
exposed to air and moved out of the glove box, and concentrated in vacuo. The resulting 
green oil was passed through a short plug of activated charcoal and eluted with pentane to 
remove stilbene. The organic layer was concentrated and purified by silica gel 
chromatography (100% hexanes, Rf = 0.35) to afford 2.60 (>98:2 E/Z) as colorless oil 
(643 mg, 80% yield). (R,E)-Triisopropyl(4-methyl-6-phenylhex-5-en-1-yn-1-yl)silane 
(2.60): IR (neat): 3026 (w), 2957 (s), 2941 (s), 2864 (s), 2171 (m), 1492 (w), 1461 (m), 
1427 (w), 1381 (w), 1329 (w), 1242 (w), 1072 (w), 1028 (m), 995 (m), 963 (s), 938 (w), 
919 (w), 882 (s), 745 (s), 692 (s), 664 (s), 612 (s), 520 (m), 455 (m), 416 (m) cm−1; 1H 
NMR (CDCl3, 400 MHz): δ 7.35 (2H, d, J = 7.6 Hz), 7.29 (2H, t, J = 7.6 Hz), 7.20 (1H, t, 
J = 7.2 Hz), 6.45 (1H, d, J = 16.0 Hz), 6.22 (1H, dd, J = 16.0, 7.2 Hz), 2.61‒2.54 (1H, m), 
2.42‒2.32 (2H, m), 1.22 (3H, d, J = 6.8 Hz), 1.12‒1.01(21H, m); 13C NMR (CDCl3, 100 
MHz): δ 137.7, 134.8, 128.9, 128.6, 127.1, 126.2, 107.1, 81.9, 36.7, 27.8, 19.8, 18.8, 11.4. 
HRMS (ESI+): Calcd for C22H35Si [M+H]+: 327.2508; Found: 327.2498. Specific 
rotation: [α]D22.1 −16.6 (c 1.85, CHCl3) for an enantiomerically enriched sample of 90:10 
er.  
 
(R,E)-(3-Methylhex-1-en-5-yn-1-yl)benzene  
To a solution of enyne 2.60 (327 mg, 1.0 mmol) in thf (10 ml) was added tbaf (1.5 
mL of 1.0 M thf solution, 1.5 mmol) at 22 °C. The resulting solution was allowed to stir 
at 22 °C for 1.5 h. Then the reaction was quenched by addition of an aqueous saturated 
solution of NH4Cl (10 ml). The resulting solution was washed with Et2O (10 ml), and the 
combined organic layers was concentrated in vacuo to afford a pale yellow oily residue, 
which was purified by silica gel chromatography (50:1 hexanes/Et2O, Rf 0.30) to deliver 
the desired a terminal alkyne as colorless oil (162 mg, 0.95 mmol, 95% yield). (R,E)-(3-
Methylhex-1-en-5-yn-1-yl)benzene: IR (neat): 3301 (m), 3026 (w), 2961 (m), 2924 (m), 
1493 (m), 1449 (m), 1429 (w), 1071 (w), 1029 (w), 965 (s), 747 (s), 693 (s), 634 (s), 515 
(w) cm−1; 1H NMR (CDCl3, 400 MHz): δ 7.39–7.36 (2H, m), 7.33–7.29 (2H, m), 7.24–
7.19 (1H, m), 6.43 (1H, d, J = 16.4 Hz), 6.22 (1H, dd, J = 16.4, 7.2 Hz), 2.58 (1H, q, J = 
7.2 Hz), 2.34 (1H, ddd, J = 16.8, 7.2, 2.4 Hz), 2.27 (1H, ddd, J = 16.8, 7.2, 2.4 Hz), 2.01 
(1H, t, J = 2.4 Hz), 1.22 (3H, d, J = 6.4 Hz); 13C NMR (CDCl3, 100 MHz): δ 137.6, 
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134.4, 129.1, 128.6, 127.3, 126.3, 82.9, 69.8, 36.3, 26.3, 19.7. HRMS (ESI+): Calcd for 
C13H15 [M+H]+: 171.1174; Found: 171.1175. Specific rotation: [α]D20.9 −29.9 (c 1.56, 
CHCl3) for an enantiomerically enriched sample of 90:10 er. 
Enantiomeric purity was determined by GC analysis in comparison with authentic 
racemic material; CDB-DM column, 70 °C, 15 psi. 
  
Retention Time Area Area% Retention Time Area Area% 
331.684 277.73416 49.62742 316.132 3538.04248 90.44695 
344.920 281.90439 50.37258 340.621 356.63058 9.55305 
	
4,4,5,5-Tetramethyl-2-((R,1E,5E)-4-methyl-6-phenylhexa-1,5-dien-1-yl)-1,3,2-
dioxaborolane (2.61) 
In a nitrogen-filled glove box, an oven-dried flask equipped with a stir bar was 
charged with imidazolium salt 2.54 (37.5 mg, 0.10 mmol, 10.0 mol %), CuCl (10 mg, 
0.10 mmol, 10.0 mol%), NaOt-Bu (19 mg, 0.2 mmol, 20 mol %) and thf (3.0 mL). The 
vessel was sealed with a septum and the solution was allowed to stir at 22 °C for 1 h. 
Bis(pinacolato)diboron (279 mg, 1.1 mmol, 1.1 equiv) was added to the solution, causing 
it to turn dark brown immediately. The vial was re-sealed and removed from the glove 
box. The mixture was allowed to stir at 22 °C for 30 min under an atmosphere of N2. The 
terminal alkyne obtained from last step (170 mg, 1.0 mmol, 1.0 equiv) and MeOH (82 
µL, 2.0 mmol, 2.0 equiv) were added by syringe. The resulting solution was allowed to 
stir at 22 °C for 24 hours before the reaction was quenched by passing the mixture 
through a short plug of celite and silica gel and eluted with Et2O (3 × 20 mL). The filtrate 
was concentrated in vacuo to provide yellow oil, which was purified by silica gel 
chromatography (10:1 hexanes/Et2O, Rf 0.45) to afford alkenyl–B(pin) 2.61 255 mg as 
colorless oil (81% yield). 4,4,5,5-Tetramethyl-2-((R,1E,5E)-4-methyl-6-phenylhexa-
1,5-dien-1-yl)-1,3,2-dioxaborolane (2.61): IR (neat): 3025 (w), 2976 (m), 2927 (w), 
1637 (s), 1599 (w), 1493 (w), 1449 (w), 1396 (m), 1359 (s), 1318 (s), 1269 (m), 1231 (m), 
1214 (m), 1164 (m), 1142 (s), 1112 (w), 1072 (w), 995 (m), 966 (s), 909 (w), 882 (w), 
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848 (s),786 (w), 746 (s), 693 (s), 648 (w), 578 (w) cm−1; 1H NMR (CDCl3, 400 MHz): δ 
7.35–7.33 (2H, m), 7.31–7.26 (2H, m), 7.21–7.17 (1H, m), 6.62 (1H, dt, J = 17.6, 7.2 Hz), 
6.36 (1H, d, J = 16.0 Hz), 6.15 (1H, dd, J = 16.0, 7.2 Hz), 5.47 (1H, app. d, J = 17.6 Hz), 
2.50–2.43 (1H, m), 2.37–2.30 (1H, m), 2.24–2.17 (1H, m), 1.26 (1H, d, J = 9.2 Hz), 1.11 
(1H, d, J = 6.8 Hz); 13C NMR (CDCl3, 100 MHz): δ 152.5, 137.9, 136.1, 128.6, 128.3, 
127.0, 126.2, 83.2, 69.8, 43.6, 36.4, 24.9, 20.2. HRMS (ESI+): Calcd for C19H28BO2 
[M+H]+: 316.2448; Found: 316.2436. Specific rotation: [α]D21.4 −44.2 (c 1.13, CHCl3) for 
an enantiomerically enriched sample of 90:10 er. 
 
((1E,3R,5E,7S)-3,7-Dimethylnona-1,5,8-trien-1-yl)benzene (2.62) 
An oven-dried 1-dram vial equipped with a stir bar was charged with 
imidazolinium salt 2.70 (37 mg, 50 µmol), NaOMe (81 mg, 1.5 mmol), and CuCl (25 mg, 
250 µmol) in a nitrogenfilled glove box. The vial was sealed with septum and electrical 
tape, and removed from the glove box. Thf (8.0 mL) was added and the mixture was 
allowed to stir for 1 h under N2 at 22 °C. The mixture turned bright yellow. Alkenyl–
B(pin) 2.61 (315 mg, 1.0 mmol) was added to the solution, which was allowed to stir for 
an additional 20 min. Allylic phosphate 2.52 (208 mg, 0.10 mmol) was weighed into 
another oven-dried vial and degassed in vacuo. The substrate 2.61 in thf (2.0 mL) was 
transferred to the mixture with syringe and the resulting solution was allowed to stir for 
24 h at 22 °C. The mixture was passed through a short plug of silica gel and eluted with 
Et2O. The organic layer was concentrated in vacuo, resulting in yellow oil, which was 
purified by silica gel chromatography (100% hexanes, Rf 0.40) to afford 208 mg of 2.62 
product as colorless oil (0.92 mmol, 92% yield of a mixture of 80:20 anti:syn 
diastereomer). ((1E,3R,5E,7S)-3,7-Dimethylnona-1,5,8-trien-1-yl)benzene (2.62): IR 
(neat): 3081 (w), 3060 (w), 3025 (w), 2962 (w), 2925 (w), 2869 (w), 1636 (w), 1599 (w), 
1493 (w), 1450 (w), 1413 (w), 1371 (w), 1071 (w), 1028 (w), 992 (w), 965 (m), 911 (m), 
746 (m), 692 (m) cm−1; 1H NMR (CDCl3, 400 MHz): δ 7.38–7.35 (2H, m), 7.33–7.28 
(2H, m), 7.23–7.19 (1H, m), 6.36 (1H, d, J = 16.0 Hz), 6.16 (1H, dd, J = 16.0, 7.2 Hz), 
5.81 (1H, dddd, J = 17.2, 10.4, 6.4, 2.0 Hz), 5.45–5.42 (2H, m), 5.03–4.92 (2H, m), 2.87–
2.83(1H, m), 2.42–2.35 (1H, m), 2.20–2.14 (1H, m), 2.12–2.05 (1H, m), 1.10 (3H, d, J = 
6.4 Hz), 1.09 (3H, d, J = 6.4 Hz); 13C NMR (CDCl3, 100 MHz): δ 143.4, 138.1,136.5, 
135.9, 128.6, 128.2, 127.3, 126.9, 126.1, 40.5, 40.3, 37.4, 30.5, 20.2, 20.0. HRMS 
(ESI+): Calcd for C17H23 [M+H]+: 227.1800; Found: 227.1789. Specific rotation: [α]D23.1 
−142.7 (c 0.21, CHCl3) for an enantiomerically enriched sample of 98:2 er.  
 
(3S,4E,7R,8E)-3,7-Dimethyl-9-phenylnona-4,8-dien-1-ol (2.63) 
To an oven-dried 1-dram vial equipped with a stir bar was added was added 9-
BBN dimer (20.0 mg, 0.084 mmol) and thf (0.5 mL) under nitrogen. The solution was 
allowed to cool to 0°C and was added slowly a solution of triene 2.62 (18.4 mg, 0.084 
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mmol) in thf (0.5 mL). The solution was then allowed to warm to 22 °C and stirred for 8 
h. Then 1 mL of water and sodium perborate tetrahydrate (129 mg, 0.25 mmol) were 
added slowly. The resulting white suspension was allowed to stir for 2 h, after which 
Et2O (1 mL) was added to the mixture. The layers were separated, the aqueous phase was 
washed with Et2O (3 x 1mL), and the combined organic layers were dried over MgSO4, 
filtered and concentrated in vacuo, resulting in yellow oil that was purified by silica gel 
chromatography (2:1 hexanes/EtOAc, Rf 0.57) to afford 20.3 mg of the desired product 
2.63 as colorless oil (0.075 mmol, 98% yield of a mixture of 80:20 anti:syn diastereomer). 
(3S,4E,7R,8E)-3,7-Dimethyl-9-phenylnona-4,8-dien-1-ol (2.63): IR (neat): 3352 (br), 
3025 (w), 2957 (m), 2925 (m), 2869 (m), 1649 (w), 1598 (w), 1493 (w), 1450 (m), 1373 
(m), 1259 (w), 1216 (w), 1050 (m), 1028 (m), 964 (s), 911 (w), 848 (w), 745 (s), 692 (s), 
667 (w), 601 (w), 522 (w), 403 (w) cm−1; 1H NMR (CDCl3, 400 MHz): δ 7.36–7.34 (2H, 
m), 7.34–7.28 (2H, m), 7.21–7.17 (1H, m), 6.34 (1H, d, J = 16.4 Hz), 6.13 (1H, dd, J = 
16.4, 7.8 Hz), 5.46–5.38 (1H, m), 5.35–5.27 (1H, m), 3.63 (2H, dt, J = 6.4, 1.2 Hz), 2.40–
2.33 (1H, m), 2.29–2.22 (1H, m), 2.17–2.03 (2H, m), 1.62–1.44 (2H, m), 1.08 (3H, d, J = 
6.8 Hz), 0.99 (3H, d, J = 6.8 Hz); 13C NMR (CDCl3, 100 MHz): δ 138.0, 137.7, 136.4, 
128.6, 128.3, 127.2, 127.0, 126.1, 61.1, 40.2, 39.9, 37.4, 34.1, 21.4, 20.0. HRMS (ESI+): 
Calcd for C17H23O [M+H]+: 243.1758; Found: 243.1749. Specific rotation: [α]D23.6 −37.3 
(c 1.61, CHCl3) for an enantiomerically enriched sample of 98:2 er.  
Enantiomeric purity was determined by HPLC analysis in comparison with 
authentic racemic material; Chiralpak AZ–H column, 99.5:0.5 hexanes/ iPrOH, 0.3 
mL/min, 254 nm. 
 
 
Retention Time Area Area% Retention Time Area Area% 
56.544 7009166 25.268 59.896 7276533 7.457 
58.774 6944759 25.035 62.347 1414327 1.449 
64.748 6776719 24.429 68.629 11714748 12.005 
67.974 7009155 25.267 71.740 77179497 79.089 
 
Chapter 2, Page  
 
 
118 
The Influence of the Alkyne Substituents on the Efficiency of Cross-metathesis Reactions 
 
For the catalytic CM stage in the above sequence, use of the more sterically 
hindered silyl unit [(i-Pr)3Si in 2.58 vs Me3Si] was based on two reasons: ease of product 
isolation, as the smaller silyl unit renders the EAS product inconveniently volatile, and 
the facility of the subsequent catalytic CM step. The latter issue revealed to us a number 
of unappreciated factors regarding this important class of CM reactions.  
We first evaluated the feasibility of using triethylsilyl-substituted enyne 2.58b, 
since it is generated with similar efficiency and selectivity as 2.58, while being 
sufficiently non-volatile so that it can be purified and isolated with relative ease. Still, as 
illustrated in Scheme S8a, CM of 2.58b with styrene under the same conditions as used 
for 2.58 led to only 5–10% conv. Moreover, use of Ru-based carbene 2.7929 as catalyst 
precursor resulted in relatively facile substrate consumption but yielded an assortment of 
products among which only the identity of 1,3-diene 2.80 could be established (18%); in 
all likelihood, 2.80 is formed from reaction with ethylene generated from homocoupling 
of styrene or 2.58b.30 Further optimization revealed that, at best, with 2.0 equiv styrene at 
60 °C (open vessel), 2.60b may be obtained in 32% yield after 3.0 h (84% conv). Control 
experiments indicated that low efficiency of the aforementioned CM process is probably 
due to catalyst deactivation caused by the alkyne unit;31 this hypothesis is supported by 
the substantially higher efficiency observed with 2.58 wherein the acetylene group is 
shielded by a sterically more demanding silyl moiety. 
                                                
(29) Garber, S. B.; Kingsbury, J. S.; Gray, B. L.; Hoveyda, A. H. J. Am. Chem. Soc. 2000, 122, 8168–8179.  
(30) For a review on catalytic enyne metathesis reactions, see: Diver, S. T.; Giessert, A. J. Chem. Rev. 
2004, 104, 1317–1382. 
(31) When 0.5 equiv 2.58b is introduced in a reaction where substrate consumption is observed within h 
(>98% conv, significant amount of cyclic alkene oligomerization), the reaction becomes significantly more 
sluggish and none of the product from ring-opening/cross-metathesis process, which occurs slower than 
oxabicyclic olefin oligomerization, is formed. Intermediacy of i, leading to sequestration of the Ru complex 
offers a plausible rationale for the observed reactivity trends. 
 i
Ru
NMesMesN
Cl
Cl
O
OH
5 mol % 2.79
20 equiv
C6H6, 22 °C, 15 h
O
OH
On-Bu
On-Bu
>98% conv.,44% yield
with 0.5 euqiv 30% conv., <2% yield
Me
SiEt3
stable complex:
inhibition of catalysis
2.58b
Me SiEt3
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      While alkylidene 2.59 and carbene 2.79 can be used for CM of 2.58 and styrene, the 
former Mo complex is preferable because a significant amount of homocoupling 
byproduct remains in the mixture when the Ru carbene is employed (Scheme S5b). 
This is likely because the more active 2.59 is able to react with the relatively hindered 
internal alkene of 2.81 to re-generate 2.58 and its corresponding Mo alkylidene, which 
can then undergo transformation with styrene to generate 2.60.32 The above findings 
reveal a critical attribute of the catalytic EAS reaction: synthesis and structural 
modification of enantiomerically enriched 1,5-enynes seem to pose complications that 
do not apply to the products derived from addition of other C-based moieties. Such 
distinction originates from the strong propensity of alkynyl units to associate with 
transition metal salts, giving rise to catalyst inhibition.  
 
                                                
(32) For studies regarding the ability of Mo complex 2.59 to reverse a homocoupling reaction involving 
two terminal alkenes, see: Xu, Z.; Johannes. C. W.; Houri, A. F.; La, D. S.; Cogan, D. A.; Hofilena, G. E.; 
Hoveyda, A. H. J. Am. Chem. Soc. 1997, 119, 10302–10316. 
Scheme S8. Representative Data for Catalytic Cross-Metathesis of Enynes with Styrene
2.58
2.60
5.0 mol % Mo or Ru complex
Ph
Me Si(i-Pr)3
Me Si(i-Pr)3
2.79
Ru
Oi-Pr
NMesMesN
Cl
Cl
4.0 equiv styrene,
C6H6, 22 °C, 35 torr, 4 h
Me Si(i-Pr)3
2.81
Me(i-Pr)3Si
Mo
N
i-Pr i-Pr
O
O
CF3F3C
PhF3C
F3C
2.59
2.58b
10 mol % Mo complex 2.59
Ph
Me SiEt3Me SiEt3
10 equiv styrene,
C6H6, 22 °C, 35 torr, 3 h
2.60b
5–10% conv
with Mo complex 2.59: 75% conv, >98:2 2.60:2.81
with Ru complex 2.79: 75% conv, 66:33 2.60:2.81
2.58b
Me SiEt3
2.80
70% conv, 18% 2.80
a. Preliminary studies with (triethyl)siyl-substituted alkene 2.58b:
b. Preliminary studies with (tri-iso-propyl)siyl-substituted alkene 2.58:
10 mol % Ru complex 2.79
10 equiv styrene,
C6H6, 22 °C, 35 torr, 3 h
10 mol % Ru complex 2.79
2.0 equiv styrene,
C6H6, 60 °C,
open vessel, 3 h
Ph
Me SiEt3
2.60b
84% conv, 32% 2.60b
Ph
Me
SiEt3
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Density Functional Theory (DFT) calculations 
 
DFT33 computations were performed with the Gaussian 09 suite of programs34 employing 
the dispersion corrected ωB97XD functional.35,36 The LANL2DZ basis set was used for 
geometry optimizations and evaluation of thermal corrections to the Gibbs free energy at 
standard conditions (298.15 K, 1 atm). The nature of all stationary points was checked 
through vibrational analysis. Several of the located transition states have been verified 
through IRC calculations employing the L(ocal) Q(uadratic) A(approximation) method.37 
The geometries for model System 1  (SYS1, cf. Scheme S9 below) have further been re-
optimized with the larger Def2SVP38 basis set. Single point electronic energy (ΔEsp) 
calculations applying functionals ωB97XD and M0639 in solution (tetrahydorfuran and 
dichloromethane) with the SMD solvation model40 were performed on the gas phase 
geometries obtained with LANL2DZ or Def2SVP and the larger Def2TZVPP38 basis set. 
The single point electronic energies (ΔEsp) at the Def2TZVPP level were corrected by 
addition of thermal corrections to the Gibbs free energy (ΔGcorr) obtained at the 
corresponding LANL2DZ or Def2SVP level. Tables of electronic and free energies with 
                                                
(33) For a recent review on the application of DFT to complexes containing transition metals, see: Cramer, 
C. J.; Truhlar, D. G. Phys. Chem. Chem. Phys. 2009, 11, 10757. 
(34) Frisch, M. J.; Trucks, G. W.; Schlegel, H. B.; Scuseria, G. E.; Robb, M. A.; Cheeseman, J. R.; 
Scalmani, G.; Barone, V.; Mennucci, B.; Petersson, G. A.; Nakatsuji, H.; Caricato, M.; Li, X.; Hratchian, H. 
P.; Izmaylov, A. F.; Bloino, J.; Zheng, G.; Sonnenberg, J. L.; Hada, M.; Ehara, M.; Toyota, K.; Fukuda, R.; 
Hasegawa, J.; Ishida, M.; Nakajima, T.; Honda, Y.; Kitao, O.; Nakai, H.; Vreven, T.; Montgomery, Jr., J. A.; 
Peralta, J. E.; Ogliaro, F.; Bearpark, M.; Heyd, J. J.; Brothers, E.; Kudin, K. N.; Staroverov, V. N.; 
Kobayashi, R.; Normand, J.; Raghavachari, K.; Rendell, A.; Burant, J. C.; Iyengar, S. S.; Tomasi, J.; Cossi, 
M.; Rega, N.; Millam, J. M.; Klene, M.; Knox, J. E.; Cross, J. B.; Bakken, V.; Adamo, C.; Jaramillo, J.; 
Gomperts, R.; Stratmann, R. E.; Yazyev, O.; Austin, A. J.; Cammi, R.; Pomelli, C.; Ochterski, J. W.; Martin, 
R. L.; Morokuma, K.; Zakrzewski, V. G.; Voth, G. A.; Salvador, P.; Dannenberg, J. J.; Dapprich, S.; 
Daniels, A. D.; Farkas, Ö.; Foresman, J. B.; Ortiz, J. V.; Cioslowski, J.; Fox, D. J. Gaussian 09, Revision 
D.01, Gaussian, Inc., Wallingford CT, 2009. 
(35) Chai, J.-D.; Head-Gordon, M. Phys. Chem. Chem. Phys., 2008, 10, 6615. 
(36) For supporting mechanistic studies suggesting the use of dispersion corrected density functionals, see: 
(a) Torker, S.; Merki, D.; Chen. P. J. Am. Chem. Soc. 2008, 130, 4808. (b) Zhao, Y.; Truhlar, D. G. Org. 
Lett. 2007, 9, 1967. (c) Minenkov, Y.; Occhipinti, G.; Singstad, A.; Jensen, V. R. Dalton Trans. 2012, 41, 
5526. 
(37) (a) Page, M.; McIver Jr., J. W. J. Chem. Phys. 1988, 88, 922−935. (b) Page, M.; Doubleday Jr., C.; 
McIver Jr., J. W. J. Chem. Phys. 1990, 93, 5634−5642. 
(38) Weigend, F.; Ahlrichs, R. Phys. Chem. Chem. Phys. 2005, 7, 3297−3305. 
(39) Zhao, Y.; Truhlar, D. G. Acc. Chem. Res. 2008, 41, 157. 
(40) Marenich, A. V.; Cramer, C. J.; Truhlar, D. G. J. Phys. Chem. B, 2009, 113, 6378−6396. 
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functionals ωb97XD and M06 after geometry optimization and single point energy 
calculation and the geometries obtained with ωB97XD/ LANL2DZ or Def2SVP.  
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Model systems under investigation 
 
We have chosen vinyl addition to substrate 2.44b (cf. Table 2.5 in manuscript) 
with ligand 2.82 to derive the general stereochemical model for EAS reactions promoted 
by sulfonate-based NHC−Cu complexes containing 2,6-disubstituted aryl rings [System 1 
(SYS1) in Scheme S9].41 Likewise, propargyl and allenyl addition in presence of 2.29, 
containing a 3,5-disubstituted aryl ring, to generate products with a reversal in 
enantioselectivity was modeled as shown in [System 2 (SYS2) in Scheme S9]. Based on 
the assumption that the entire ligand structure would be crucial for enantioselectivity, 
removal of para-substituents and exchange of ethyl for methyl groups on the phosphate 
were the only truncations performed. In the following sections, the structures in the 
pathways leading to the major and minor enantiomers are denoted “major” and “minor”, 
extended by the identity of the transferred nucleophile (e.g. propargyl_major vs 
allenyl_major). 
 
 
 
 
 
 
 
 
 
 
                                                
(41) For the corresponding experimental data, see: Gao, F.; Carr, J. L.; Hoveyda, A. H. Angew. Chem., Int. 
Ed. 2012, 51, 6613–6617. 
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Scheme S9. Model systems studied computationally for EAS reactions promoted by sulfonate 
NHC−Cu complexes. 
	
Nomenclature 
 
N
Ph Ph
NS
2.27 R = t-Bu
2.14 R = 2,4,6-(i-Pr)3C6H2
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R
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In addition to the major and minor nomenclature (cf. Scheme S9) we denoted the 
type of intermediate and transition state as following (Scheme S10): CuR stands for the 
linear Cu(I) species, wherein R can be vinyl (Cu_vinyl), propargyl (Cu-propargyl = A 
in Figure 2 in manuscript) or allenyl (Cu_allenyl = B in Figure 2 manuscript). PC is used 
for π-complexes, OATS for transition states leading to oxidative addition to generate PA 
(i.e. the π-allyl complex). Through the transition state for reductive elimination (RETS) 
π-complexes between the product and Cu(I) are generated (Prod). Furthermore, TS_iso 
(= TSiso in manuscript) is used for isomerization between Cu_propargyl (= A in 
manuscript) and Cu_allenyl (= B in manuscript) in System 2 (cf. Figure 2 in manuscript). 
As mentioned below, in certain pathways, no π-allyl intermediate (PA) and hence 
reductive elimination transition state (RETS) could be located. 
 
Scheme S10. Reaction sequence for EAS reactions promoted by sulfonate NHC−Cu complexes. 
 
The role of the sulfonate group 
 
Initially we investigated the strength of the SO3−Cu interaction (Figures S1−S3). 
Calculations in gas phase predict a minimum for structure 1.51 (cf. Figure 1.3 in Chapter 
1) with a Cu−O distance of 2.49 Å (Figure S1). This structure is 7.7 kcal/mol higher in 
energy than 1.53; in the latter the sulfonate is anti to the phenyl ring on the backbone 
with a Cu−O distance of 4.44 Å. Geometry 1.52, wherein the Cu−O distance has been 
constrained to 2.30 Å, is not a minimum and 6.1 kcal/mol higher in energy than 1.53. 
Comparison of 1.57 and 1.56 with the corresponding structures of the 
(NHC−SO3)−Zn−Me2 anion (Figure S2) reveals that sulfonate dissociation from Zn1 (Erel 
= 0.0 kcal/mol) is only weakly exothermic with ω−B97XD/Def2SVP in gas phase to 
yield Zn2 (-0.7 kcal/mol) via transition state Zn12 and slightly more exothermic with the 
Def2TZVPP basis set in THF (-3.3 kcal/mol). Part of the calculated exothermicity 
originates from release of steric repulsion due to rotation of the Me2Zn fragment from 
Zn1 to Zn2. Constraining the Me−Zn−C−N angle to 32.3, 27.3, 22.3 and 17.3 ° (cf. Zn3) 
as opposed to 102.3 ° in Zn2 partly corrects for the strain release so that sulfonate 
dissociation from Zn1 becomes less exothermic (-2.4, -2.1, -1.8 and -1.4 kcal/mol, 
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respectively with ω−B97XD/Def2TZVPP in THF). This trend illustrates the significantly 
greater Lewis acidity of Zn(II) vs Cu(I). 
The propensity of the sulfonate group to stabilize Cu(III) intermediates has been 
evaluated by comparison of free energies of η1- and η3-allyl species relative to 
Cu_propargyl (= A). While calculations in gas phase with the small LANL2DZ basis set 
show that η1-allyl structures are favored due to minimal charge separation, there is a 
preference for η3-allyl species in solution (THF) and/or with the larger basis set (Figure 
S3). 
 
Sulfonate binding 1 − syn vs anti orientation in (NHC−SO3) −Cu−Me anion (cf. Scheme 
1.3 in Chapter 1) 
 
 
Figure S1. Comparison of SO3−binding in anionic NHC−Cu−Me complexes [electronic energy in 
kcal/mol with ωB97XD/Def2SVP (blue squares) and 
ω−B97XD/Def2TZVPPTHF(SMD)//ω−B97XD/Def2SVPgas-phase (red circles)].  
 
1.53  
1.52 
 
1.51 
Chapter 2, Page  
 
 
126 
Sulfonate binding 2	−	(NHC−SO3)−Cu−Me anion vs (NHC−SO3)−Zn−Me2 anion 
 
Figure S2. Comparison of SO3−binding in NHC−Cu−Me and NHC−Zn−Me2 anions (electronic 
energy in kcal/mol at various levels of theory after optimization with ωB97XD/Def2SVP in gas-
phase). For geometries see SI in Reference 8. 
Sulfonate binding 3	–	η1	vs	η3-allyl species (cf. Scheme 1.9 in Chapter 1)	
 
 
1.56 
1.57 
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Figure S3. Comparison of SO3−binding in square planar Cu(III) intermediates as a function of 
basis set and solvation (THF); two representative structures are shown (for geometries see 
reference 8. 
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Pathways investigated for system 1 (SYS1) 
In order to further test the most favorable orientation of the sulfonate group (syn 
or anti to the phenyl ring on the NHC backbone), the following pathways have been 
calculated for System 1 (SYS1, Figure S4).  
 
Figure S4. Investigated reaction pathways for system 1 (SYS1). 
 
In pathways major and minor the sulfonate anion is situated anti to the phenyl 
ring on the NHC backbone, so that the nucleophilic group R (i.e. vinyl) is in the front. 
Alternatively, in pathways syn-to-NHC_major and syn-to-NHC_minor the sulfonate is 
on the same side as the backbone phenyl ring. In these cases, a bridging interaction 
between the sulfonate and the phosphate through the sodium cation is only possible if the 
R group is in the rear. Furthermore, we investigated the possibility when the phosphate 
anion is displaced on the same side as the Cu center during oxidative addition (syn-to-
NHC_Psyn). 
The energies (at the ω−B97XD or 
M06/Def2TZVPPDCM(DCM)//ω−B97XD/LANL2DZ level) for several investigated 
rotamers (i.e. different orientation of the ortho-OMe-phenyl ring on the substrate or the 
vinyl group R) for each of the above mentioned intermediates and pathways are shown in 
Figure S5. For the corresponding geometries. For pathways syn-to-NHC_major, syn-to-
NHC_minor and syn-to-NHC_Psyn no PA intermediate could be located, resulting in 
direct collapse of the OATS structure to the product complex (Prod). 
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Figure S5. Computed free energies for several conformers of the pathways shown in Figure S4 
with different levels of theory after geometry optimization with ωB97XD/LANL2DZ. 
The energy span between the investigated conformers for OATS_major and 
OATS_minor (highlighted with round grey background in Figure S5) amounts to 5−10 
kcal/mol, which underscores the difficulty associated with accurate determination of 
reaction pathways leading to major and minor enantiomers on the order of 2−3 kcal/mol 
for systems of such size and complexity. Nonetheless, pathways syn-to-NHC_major, 
syn-to-NHC_minor and syn-to-NHC_Psyn can be excluded since the energy difference 
relative to structures OATS_major and OATS_minor exceeds the “noise level” (5−10 
kcal/mol). Plots of the free energy surfaces of the lowest energy conformers with 
different density functionals (ωB97XD and M06) and solvents (THF and DCM) predict 
similar energies for the pathways leading to major and minor enantiomers (Figure S6). 
For example, the energy difference between SYS1_OATS_major (11.8 kcal/mol) and 
SYS1_OATS_minor (12.3 kcal/mol) at the M06/Def2TZVPPDCM(SMD)//ω−B97XD/ 
LANL2DZgas-phase level of theory amounts to only 0.5 kcal/mol. 
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Figure S6. Computed free energies for the most stable conformers of the pathways shown in 
Figure S4 (except for syn-to-NHC_Psyn) with different density functionals (ωB97XD and M06) 
and solvents (THF and DCM) after geometry optimization with ωB97XD/LANL2DZgas-phase. 
We have re-optimized the structures (cf. Figure S5) with the slightly larger 
Def2SVP basis set.. Through this a larger energy difference between OATS_major and 
OATS_minor, in favor of the former, is predicted (highlighted with round grey 
background in Figure S7). For example, the energy difference between 
SYS1_OATS_major (16.9 kcal/mol) and SYS1_OATS_minor (20.2 kcal/mol) at the 
M06/Def2TZVPPDCM(SMD)//ω−B97XD/Def2SVPgas-phase level of theory amounts to 3.3 
kcal/mol (Figure S8). Due to the considerable uncertainty of the obtained energy values 
(cf. Figures S5 and S7) it is not possible at this point to make a conclusive statement on 
basis of the calculations regarding the rate-limiting barrier (OATS vs RETS). This is 
furthermore complicated due to the significant increase in conformational complexity of 
the latter (i.e. RETS) as a result of the loosely associated sodium phosphate salt (cf. PA 
→ Prod in Scheme S10). 
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Figure S7. Computed free energies for several conformers of the pathways shown in Figure S4 
with different levels of theory after geometry optimization with ωB97XD/Def2SVP. 
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Figure S8. Computed free energies for the most stable conformers of the pathways shown in 
Figure S4 (except for syn-to-NHC_Psyn) with different density functionals (ωB97XD and M06) 
and solvents (THF and DCM) after geometry optimization with ωB97XD/Def2SVPgas-phase. 
 
 
 Despite the above-mentioned difficulties, commonly occuring structural features 
in the various conformers of PC/OATS_major and PC/OATS_minor provide a hint 
regarding the stereo-controlling role of the sulfonate-based NHC ligand. Cu(dxz) → 
olefin(π*) donation rigidifies the allylic substrate, and as a consequence, the α-carbon 
atom (Cα) points towards the back isopropyl group of the 2,6-diisopropylphenyl ring in 
PC_minor (cf. Figure S9). This results in a tilt of the 2,6-diisopropylphenyl ring relative 
to the central 5-membered NHC ring (cf. side view in Figure S9). Therefore, the dihedral 
angle Cortho−Cipso−NNHC−CNHC in PC_minor (70.9 °) is significantly smaller than in 
PC_major (96.4 °). Although the π-allyl framework has to rotate during transformation 
to generate π-allyl complex PA (cf. Scheme S10), which places the α-carbon further 
away from the ortho-isopropyl group, the above-mentioned steric interaction is still 
considerably large in OATS_minor (cf. Cortho−Cipso−NNHC−CNHC = 72.6 ° in Figure S10). 
In contrast, such unfavorable proximity between the α-carbon atom and the back 
isopropyl group is avoided in OATS_major (cf. Cortho−Cipso−NNHC−CNHC = 80.4 °). 
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Figure S9. Comparison of computed structures for SYS1_PC_major and SYS1_PC_minor 
obtained at the ωB97XD/LANL2DZ level of theory. 
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Figure S10. Comparison of computed structures for SYS1_OATS_major and 
SYS1_OATS_minor obtained at the ωB97XD/LANL2DZ level of theory in comparison with 
ChemDraw drawings of SYS1_PC_major and SYS1_PC_minor. 
 
 
Pathways investigated for system 2 (SYS2) 
 
Having derived the most favorable orientation of the sulfonate group in system 1 
(anti to phenyl ring on the NHC backbone), we tested the validity of the stereochemical 
model for system 2 (SYS2), for which we have investigated the 4 pathways shown in 
Figure S11. The pathways for propargyl addition (propargyl_major and 
propargyl_minor) and allenyl addition (allenyl_major and allenyl_minor) are 
connected through low-lying transition state TS_iso (Figure S12). The corresponding 
relative free energies for Cu_propargyl (= A in manuscript), TS_iso (= TSiso in 
manuscript) and Cu_allenyl (= B in manuscript) at the M06/Def2TZVPPDCM(SMD) // 
ωB97XD/LANL2DZgas-phase level of theory are 0.0, 10.5 and −1.9 kcal/mol, respectively 
(see Figures S12, below). 
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Figure S11. Investigated reaction pathways for system 2 (SYS2). 
 
 
Figure S12. Computed structures for SYS2_Cu_propargyl (= A in manuscript), TS_iso (= TSiso 
in manuscript) and SYS2_Cu_allenyl (= B in manuscript) obtained at the ωB97XD/LANL2DZ 
level of theory. 
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Figure S13. Computed free energies for several conformers of the pathways shown in Figure S4 
with different levels of theory after geometry optimization with ωB97XD/LANL2DZ. 
 
As is the case in system 1 (SYS1), the energy difference between the various 
conformers exceeds the 2−3 kcal/mol relevant for stereodifferentiation (Figure S13). 
Although comparison of the lowest energy conformers predicts the proper order between 
OATS_propargyl_major (=OAtsA,major in manuscript)  and OATS_propargyl_minor 
(=OAtsA,minor in manuscript), in agreement with the experimental results, 
OATS_allenyl_major (=OAtsB,major in manuscript), the product of which is not observed 
experimentally, lies below the transition state leading to the minor enantiomer 
(OATS_propargyl_minor). For example, the corresponding free energies for 
OATS_propargyl_major (= OAtsA,major), OATS_propargyl_minor (= OAtsA,minor), 
OATS_allenyl_major (= OAtsB,major) and OATS_allenyl_minor (= OAtsB,minor) at the 
M06/Def2TZVPPDCM(SMD)//ω−B97XD/LANL2DZgas-phase level of theory are 10.2, 13.7, 
12.8 and 20.4 kcal/mol, respectively (Figure S14). 
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Figure S14. Computed free energies for the most stable conformers of the pathways shown in 
Figure S11 with different density functionals (ωB97XD and M06) and solvents (THF and DCM) 
after geometry optimization with ωB97XD/LANL2DZgas-phase (cf. Figure 2 in manuscript). 
  
Structural comparison of PC_propargyl_major (= PCA,major in manuscript) and 
PC_propargyl_minor (= PCA,minor in manuscript) provides a reasonable rationale for the 
experimentally observed reversal in enantioselectivity between systems 1 and 2 (Figure 
S15). Due to the absence of ortho substituents on the 3,5-disubstituted aryl ring on the 
NHC there is no severe penalty for placing the α-carbon atom on the allyl phosphate to 
the right side (PC_propargyl_major). In contrast, the further extending phenyl group on 
the allyl phosphate comes into close proximity with the isopropyl groups on the 3,5-
diaryl substituted phenyl ring in PC_propargyl_minor. Similar interactions are seen in 
the corresponding transition states for oxidative addition (OATS). 
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Figure S15. Comparison of computed structures for SYS2_PC_propargyl_major, 
SYS2_PC_propargyl_minor, SYS2_PC_allenyl_major and SYS2_PC_allenyl_minor obtained 
at the ωB97XD/LANL2DZ level of theory. 
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Chapter Three 
NHC–Cu-Catalyzed Enantioselective Allylic 
Substitutions with Methylenediboron to Generate 
Tertiary and Quaternary Carbon Stereogenic 
Centers 
 
3.1. Introduction 
Copper-catalyzed enantioselective allylic substitution (EAS) reactions1 are among 
the most versatile classes of transformations in organic chemistry: such processes deliver 
enantiomerically enriched products bearing a stereogenic center adjacent to a 
functionalizable alkene from readily accessible allylic electrophiles with “hard” 
nucleophiles. These processes may involve various organometallic reagents (e.g., Zn-, 
Mg-, or Al-based) and can be promoted by Cu complexes derived from chiral O-, N-, or 
P-based ligands or N-heterocyclic carbenes (NHCs). Several applications in total 
synthesis have demonstrated their utility.2 While the last decade has seen considerable 
                                                
(1) For reviews on Cu-catalyzed allylic substitution reactions with “hard” nucleophiles (a) Hoveyda, A. H.; 
Hird, A.W.; Kacprzynski, M. A. Chem. Commun. 2004, 1779−1785. (b) Yorimitsu, H; Oshima, K. Angew. 
Chem., Int. Ed., 2005, 44, 4435−4439. (c) Kar, A.; Argade, N. P. Synthesis, 2005, 2995−3022. (d) Alexakis, 
A.; Malan, C.; Lea, L.; Tissot-Croset, K.; Polet, D.; Falciola, C. Chimia, 2006, 60, 124−130. (e) Falciola, 
C. A.; Alexakis, A. Eur. J. Org. Chem. 2008, 22, 3765-3780. (f) Yokobori, U.; Ohmiya, H.; Sawamura, M. 
Organometallics, 2012, 31, 7909−7913. 
(2) For a recent review regarding applications of catalytic EAS reactions to natural product synthesis, see: 
Calvo, B. C.; Buter, J.; Minnaard A. J. in Copper-Catalyzed Asymmetric Synthesis, A. Alexakis, N. Krause, 
S. Woodward, Eds. Wiley-VCH, Weinheim, 2014, pp. 373–447. 
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developments in Cu-catalyzed EAS with organometallic reagents, there are still 
shortcomings that need to be addressed in order to achieve a broad scope with these 
important transformations. One major drawback is the sensitivity of common 
organometallic species to air and moisture: mandating their fresh preparation to ensure 
quality and reproducibility of the results. Additionally, the functional group compatibility 
of most organometallic reagents is poor, resulting in difficulty in incorporating many 
desired functionalities or requiring a series of cumbersome protecting group 
manipulations. 
To remedy these fundamental limitations, organoboron nucleophiles have been 
adopted in this area because of their robustness and functional group tolerance. The first 
examples of enantioselective allylic substitution involving trialkylboranes were published 
by Sawamura and co-workers in 2012. 3  As shown in Scheme 3.1, unlike previous 
reactions utilizing allylic phosphates, 4  the enantioselective variant employed 
allylchlorides as the electrophiles. Under this protocol, alkyl addition products were 
obtained in the presence of 10 mol % of an in situ generated bisphosphine−Cu complex 
derived from chiral ligand 3.3 in 83% yield and 88.5:11.5 er as a single regioisomer 
(>98:2 SN2’:SN2) after 48 h at 10 °C.  
                                                
(3) Shido, Y.; Yoshida, M.; Tanabe, M.; Ohmiya, H.; Sawamura, M. J. Am. Chem. Soc. 2012, 134, 
18573−18576. 
(4) (a) Nagao, K.; Yokobori, U.; Makida, Y.; Ohmiya, H.; Sawamura, M. J. Am. Chem. Soc. 2012, 134, 
8982−8987. (b) Ohmiya, H.; Yokobori, U.; Makida, Y.; Sawamura, M. Org. Lett. 2011, 13, 6312−6315. (c) 
Yokobori, U.; Ohmiya, H.; Sawamura, M. Organometallics 2012, 31, 7909−7913. 
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We sought to develop our own method to address these shortcomings as we 
considered synthesis of natural product rhopaloic acid A employing EAS reactions with 
alkylborane reagents (Scheme 3.2a). In each of the routes, the construction of the 
stereogenic center requires EAS reactions with allylchloride 3.7.  In route (i), preparation 
of enantiomerically enriched 3.5 called for an organoboron reagent that required site-
selective hydroboration of a somewhat sensitive dienyl aldehyde 3.6 (or an ester-
derivative). An alternative route (ii) through diene 3.9, accessible by previously reported 
EAS methods,5 would demand the differentiation of two terminal olefins, likely to result 
in the generation of difficult-to-separate isomeric mixtures. Another possible route (iii) is 
to utilize a more expensive diene 3.11 ($ 1,200/ 2.5 g) derived from farnesol. Instead, we 
turned our attention to the much less reactive, but functional group tolerant methylene 
diboron 3.13. As shown in Scheme 3.2b, we proposed a new EAS reaction protocol 
utilizing allylic phosphate 3.12 and methylene diboron 3.13. Such processes would not 
only involve an organoboron reagent as a starting material, but would deliver products 
containing a versatile C−B(pin) bond as well. We imagined a subsequent sequence 
entailing hydroboration of the EAS product 3.14 to furnish 3.15 with differentiable C−B 
bonds that could then be converted chemoselectively into 3.19 by a pair of catalytic 
                                                
(5) For example, see: (a) Tissot-Croset, K.; D. Polet, Alexakis, A. Angew. Chem. Int. Ed. 2004, 43, 2426–
2428; Angew. Chem. 2004, 116, 2480–2482. (b) Lýpez, F.; van Zijl, A. W.; Minnaard, A. J.; Feringa, B. L.; 
Chem. Commun. 2006, 409–411. 
Scheme 3.1. EAS Reaction with Alkylborane Reagents
Cl
Ph
9-BBN
MeO
MeO
+
3.1 3.2
10 mol %
5.0 mol % (CuOTf)2•toluene,1.1 equiv KOMe
dioxane/CH2Cl2, 10 °C, 48 h
Ph
3.4
MeO
MeO
83% yield, >98:2 SN2’:SN2, 
88.5:11.5 er
P
P
O
O
O
O
tBu
tBu
OMe
tBu
OMe
tBu 2
23.3
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cross-coupling reactions followed by cross metathesis with acrolein 3.18. The first cross-
coupling would chemoselectively react with the more reactive the alkylborane, and the 
second one could be directed by the neighboring hydroxy group, that could then be 
readily transformed to the pyran motif.  
 
3.2. Background 
Methylenediboron 3.13, a member of a class of compounds developed by 
OO
HO
rhopaloic acid A
(cytotoxic)
Me
Me Me Me
H
H
a. Retrosynthetic Analysis of Rhopaloic Acid A
H
PGOO
G'
i
H
PGO
ii
G' = H or OMe
Enantiomerically enriched building blocks obtained directly from an EAS process would present 
functional group compatibility, chemoselectivity issues, or suffers from expensive starting material.
b. Proposed Strategy involving Three Catalytic C-C bond Forming Processes
H
HO C1
(pin)B
H
HO
3.16
C1
(pin)B
H
PGO B(alkyl)2
(alkyl)2B-H
(pin)B
H
PGO
(pin)B B(pin)
PGO LG
chemoselective
catalytic 
cross-coupling
hydroxy-assisted
catalytic cross-coupling
3.14 3.15
deprotect
O
G'
(alkyl)2B-H
H
PGO Me
iii
Me
Me Me MeMe Me Me
(alkyl)2B-H
3.5
3.6
3.8
3.10 3.11 $ 1,200/2.5 g
Scheme 3.2. Problems Associated with the Application of Catalytic EAS to the Synthesis of Rhopaloic Acid A and an 
Alternative Route.
3.12 3.13
+
O
H
cross metathesis
rhopaloic acid A
3.19
3.7
PGO
3.7
3.7
LG
O
H
Cl
3.17
3.18
+ PGO
Cl
PGO
Cl
B(alkyl)2
3.9
+
+
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Matteson6 and co-workers, has been the focus of several studies following the pioneering 
work by Endo and Shibata. 7  Suzuki cross-coupling reactions with alkyl boronate 
compounds are known to suffer from slow transmetalation, β-hydride elimination as well 
as protodeboration. However, the Shibata group demonstrated that the Suzuki cross-
coupling of germinal diboron reagents such as 3.20, proceeds at room temperature 
without the need for a large excess of the boron reagent (Scheme 3.3). Additionally, the 
second B(pin) group does not undergo further cross-coupling even in the presence of 
excess aryl iodide. Furthermore, in the formation of 3.22, the aryl bromide reacts 
selectively with the geminal diboron over the unsubstituted alkyl−B(pin).  
 
The authors propose that the transmetalation is able to occur at lower 
temperatures in part due to the ability of the B(pin) moiety to stabilize the negative 
charge built up at the α-C in the transition state of transmetalation through 
hyperconjugation  intro the empty p orbital of the vicinal B atom.7a To probe this 
stabilizing effect, the analogous α-silyl boryl reagent 3.24 was subjected to the same 
cross-coupling conditions, but <2% conversion to the desired product 3.26 was observed 
(Scheme 3.4). DFT calculations were used to create a LUMO map for both the diboron 
                                                
(6) Matteson, D. S.; Moody, R. J. Organometallics 1982, 1, 20–28. 
(7) (a) Endo, K.; Ohkubo, T.; Hirokami, M.; Shibata, T. J. Am. Chem. Soc. 2010, 132, 11033–11035. (b) 
Endo, K.; Ohkubo, T.; Shibata, T. Org. Lett. 2011, 13, 3368–3371. (c) Endo, K.; Ohkubo, T.; Ishioka, T.; 
Shibata, T. J. Org. Chem. 2012, 77, 4826–4831. (d) Endo, K.; Ishioka, T.; Ohkubo, T.; Shibata, T. J. Org. 
Chem. 2012, 77, 7223–7231. (e) Endo, K.; Ishioka, T.; Shibata, T.  Synlett 2014, 25, 2184–2188. for related 
investigations, see: (f) Z.-Q. Zhang, C.-T. Yang, L.-J. Liang, B. Xiao, X. Lu, J.-H. Liu, Y.-Y. San, T. B. 
Marder, Y. Fu, Org. Lett. 2014, 16, 6342–6345. 
5.0 mol % Pd(Pt-Bu3)2
4.5 equiv KOH
1.0 equiv 4-bromoanisole,
 dioxane/H2O, 25 °C, 6-24 h
Me B(pin)
B(pin)
 (1.5 equiv)
Me
B(pin)
OMe
Scheme 3.3 Catalytic Suzuki Cross-Coupling with Geminal Diboron Reagents
3.20 3.21
B(pin)
3.22 B(pin)
Ph
93% yield 85% yield
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and borosilane reagents. As shown in Scheme 3.4, the LUMO of 3.27 is distributed 
across the B–C–B bonds whereas in 3.28, the LUMO is delocalized around the boron and 
silicon atoms. The distribution of the LUMO in 3.27 lowers its energy and allows for a 
more facile formation of the borate species, which then participates in transmetalation. 
11B NMR of 3.23 and 3.24 point to the formation of a borate species generated from 3.23 
when 3.0 equiv KOH is added (1:1 signals at 35.5 and –0.6 ppm), whereas 3.24 produces 
one signal at 34.6 ppm, indicating that the corresponding borate is not formed. 
 
Morken and co-workers demonstrated the first enantioselective Pd-catalyzed 
Suzuki cross-coupling of symmetric geminal diboron compounds (Scheme 3.5).8 The 
reaction, catalyzed by 5.0 mol % Pd(OAc)2 and 10 mol % of phosphoramidite ligand 3.30 
with 15 equiv KOH, allows for the enantioselective cross-coupling of diboron reagents 
with a range of aryl halides in up to 92% yield and 96:4 er. The authors proposed that the 
transmetalation occurs with inversion in a stereospecific fashion based on the results of a 
10B−labeled experiment. The Morken group also published a desymmetrization reaction 
of symmetric geminal diboron compounds with alkenyl halides leading to the formation 
                                                
(8) C. Sun, B. Potter, J. P. Morken, J. Am. Chem. Soc. 2014, 136, 6534–6537. 
5.0 mol % Pd(PtBu3)2
4.5 equiv KOH
1.0 equiv 4-bromoanisole,
 dioxane/H2O, 25 °C, 6-24 h
Ph B(pin)
X
X = B(pin), 3.23
X = SiMe3, 3.24
Ph
B(pin)
OMe
Scheme 3.4 Catalytic Suzuki Cross-Coupling with A Geminal Diboron Reagent and α-Silyl-substituted Alkyl-B(pin)
3.25
93% yield
Ph
SiMe3
OMe3.26
<2% conv
Me B
B
OO
O
O Me B
SiH3
O
O
3.27 3.28
Ph B(pin)
B(pin)
Ph B(pin)
SiMe3
11B δ = 34.8 ppm
with 3.0 equiv KOH
11B δ = 35.5, -0.6 ppm (1:1)
11B δ = 34.8 ppm
with 3.0 equiv KOH
11B δ = 34.6 ppm
3.23
3.24
performed at B3LYP/6-31G** level
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of enantiomeric enriched allylic boronate in the same year.9 
 
In 2014, the Morken group also demonstrated that a deborylation/alkylation could 
be performed with a diboron reagent in the presence of NaOt-Bu and an alkyl halide.10 In 
the same year, the Morken laboratory also published a protocol involving an 
enantioselective diboration of alkenyl boronic acid pinacol esters followed by selective  
deborylative alkylation of the tris(boronate) products to generate the vicinal diboron 
product (Scheme 3.6).11 In the presence of 3.0 mol % Pt(dba)3 and 6.0 mol % of chiral 
phosphite ligand 3.33, a range of E-alkyl-substituted alkenyl–B(pin) substrates, for 
example 3.32, undergo diboration with B2(cat)2 in 67–82% yield and up to 95:5 er. 
Deborylative/alkylation occurs in the presence of 5.0 equiv NaOt-Bu in toluene at room 
temperature with both primary and secondary alkyl halides. After oxidation, syn-diol 3.35 
was obtained in high diastereoselectivity and enantioselectivity. Of note, intramolecular 
alkylation, however, provides access to anti-diol 3.37 in good yield and high 
diastereoselectivity, suggesting the formation of the C−C bond and the vicinal C-B bond 
occurs in an anti-fashion through 3.38. 
                                                
(9) B. Potter, A. A. Szymaniak, E. K. Edelstein, J. P. Morken, J. Am. Chem. Soc. 2014, 136, 17918–17921. 
(10) Hong, K; Liu, X.; Morken, J. P. J. Am. Chem. Soc. 2014, 136, 10581–10584. 
(11) Coombs, J.R.; Zhang, L.; Morken, J. P. J. Am. Chem. Soc. 2014, 136, 16140–16143. 
5.0 mol % Pd(OAc)2
4-iodoanisole, 15 equiv KOH, 
dioxane/H2O = 1:1, 22 °C, 12 h
Ph B(pin)
B(pin)
 (1.1 equiv)
Ph
B(pin)
OMe
O
P
O
NMe2
ArAr
O
O
ArAr
Me
Me
3.30 Ar = 4-t-BuC6H4
Scheme 3.5. Catalytic Enantiotopic Suzuki Coupling with Aryl Halide
3.29 3.31
10 mol %
up to 92% yield, 96:4 er
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The Meek group reported a Cu-catalyzed enantio- and diastereoselective synthesis 
of 1,2-hydroxyboronates through methyleneboryl addition to aldehydes (Scheme 3.7).12 
Reactions are promoted by a readily available chiral monodentate phosphoramidite-Cu 
complex derived from 3.41 in the presence of an alkyl 1,1-diboron reagent 3.40. Products 
contain two contiguous stereogenic centers and are obtained in up to 91% yield, >98:2 
dr., and 98:2 er in high syn selectivity. In 2015, they also reported a method involving 
Ag-catalyzed diastereoselective synthesis of anti-1,2-hydroxyboronates.13 
 
More recently, the Cho and Fu group disclosed the NHC–Cu-catalyzed allylic 
                                                
(12) Joannou, M. V.; Moyer, B. S.; Meek, S. J.  J. Am. Chem. Soc. 2015, 137, 6176–6179. 
(13) Joannou, M. V.; Moyer, B. S.; Goldfogel, M. J.; Meek, S. J. Angew. Chem. Int. Ed. 2015, 54, 14141– 
14145; Angew. Chem. 2015, 127, 14347–14351. 
Ph B(pin)
3.0 mol % Pt(dba)3
2.0 equiv B2(cat)2, thf, 70 °C, 24 h;
pinacol, 22 °C, 14 h
Ph B(pin)
B(pin)
3.34
3.32
B(pin)
O
P
O
Ph
ArAr
O
O
ArAr
Me
Me
3.33 Ar = 3,5-i-Pr2C6H3
5.0 equiv NaOt-Bu
Ph Br
Ph
OH
OH
Ph
toluene, 22 °C, 14 h
NaOH, H2O2;
B(pin)
B(pin)
3.36
B(pin) toluene, 22 °C, 14 h;
NaOH, H2O2
Cl
OH
OH
5.0 equiv NaOt-Bu
3.35
3.37
Scheme 3.6. Enantioselective Synthesis of Tris(boronate) and Diastereoselective Alkylation
88% yield,
17:1 dr
3.38
81% yield,
94:6 er
94:6 er
67% yield,
>20:1 dr
6.0 mol %
10 mol % Cu(NCMe)4PF4,
90 mol % LiOt-Am
thf, 22 °C, 24 h
O
P
O
NMe2
Scheme 3.7. Catalytic Diastereo- and Enantioselective Formation of 1,2-Hydroxyboronates
H
O
Me(pin)B
B(pin)
3.403.39
+
3.41
Me
B(pin)
OH
92% conv, 92:8 dr, 
94:6 er
3.42
20 mol %
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substitution of geminal diboron reagents separately (Scheme 3.8).14 Reaction of allylic 
chlorides and diboron reagents, catalyzed by NHC–Cu complex 3.44, occur at 50 ºC in 
toluene to afford racemic primary alkyl–B(pin) products in 55–86% yield. After 
disclosure of our EAS method, the Niu group reported a Ir-catalyzed EAS protocol to 
form SN2’ products from allylic carbonates with diboron reagent 3.13.15 However, alkyl 
substrates suffered from poor reaction efficiency.  
 
3.3. Catalytic Enantioselective Allylic Substitutions with Methylenediboron 
3.3.1. Screening of Reaction Conditions for Methyleneboryl Additions to 1,2-
Disubstituted Allylic Phosphates  
 We sought to identify a Cu-catalyzed allylic substitution protocol with 
methylene diboron 3.13 and allylic phosphates to achieve enantioselective 
formation of 3.45.16 This product contains an alkyl–B(pin) which can be further 
elaborated to versatile functional groups (Scheme 3.9). Upon ligand screening, we 
found that NHC ligands derived from 3.48−3.50 and bisphosphine ligands 3.51 
and 3.52 all favored the formation of the undesired SN2 product 3.47. Only the 
                                                
(14) (a) Kim, J.; Park, S.; Park, J.; Cho, S. H. Angew. Chem., Int. Ed. 2016, 55, 1498–1501. (b) Zhang, Z.-
Q.; Zhang, B.; Lu, X.; Liu, J.- H.; Lu, X.-Y.; Xiao, B.; Fu, Y. Org. Lett. 2016, 18, 952−955. 
(15) Zhan, M.; Li, R.-Z.; Mou, Z.-D.; Cao, C.-G.; J Liu, J.; Chen, Y.; Niu, D. ACS Catal. 2016, 6, 3381–
3386. 
(16) Shi, Y.; Hoveyda, A. H. Angew. Chem. Int. Ed. 2016, 55, 3455–3458. 
Ph Cl
10 mol %
3.43
3.0 equiv LiOt-Bu,
toluene, 50 °C, 24 h
Ph
B(pin)
3.45
MesN NMes
CuCl
3.44
78% yield,
93:7 SN2’:SN2
Scheme 3.8. Catalytic Allylic Substitution with a Methylenediboron Reagent
2.0 equiv
3.13
(pin)B B(pin)
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sulfonate-bearing NHC ligand derived from imidazolinium salt 3.53 furnished the 
desired SN2’ product 3.45. To achieve higher regioselectivity, NHC−Ag complex 
3.54 was employed in the reaction, 3.44 was generated in 83% yield, 95:5 SN2’: 
SN2, 97:3 er. 
 
A distinct feature of the sulfonate-containing chiral NHC ligands (see 3.54 and 
3.51) is that the Cu complexes promote highly SN2’-selective reactions (see Scheme 3.9 
and Scheme 3.10). This is congruent with the most recent mechanistic and computational 
studies, revealing that the active species is likely a monodentate system wherein the 
sulfonate group, without the geometric constraints of chelation with the Cu center, is 
oriented anti to the proximal phenyl substituent on the NHC backbone (A, Scheme 3.10). 
Formation of an alkali metal bridge between the anionic tether of the chiral catalyst and 
the Lewis basic phosphate unit can engender a well-defined transition structure with the 
NMesN
PF6
OH
Ph
>98% conv, 69% yield,
<2:>98 SN2':SN2
NMesMesN
Cl
>98% conv, 73% yield,
5:95 SN2':SN2
NMes
Ph Ph
MesN
>98% conv, 54% yield,
20:80 SN2':SN2
PPh2
PPh2
80% conv, 76% yield,
2:98 SN2':SN2
56% conv, 41% yield,
7:93 SN2':SN2
N
Ph
S O NO
O
Ph
Ar
Ar
>98% conv. 77% yield
76:24 SN2':SN2, 97:3 er
BF4
Fe
PPh2
PCy2
Me
11 mol % ligand,
10 mol % CuCl
B(pin)
Ph
(EtO)2OPO Ph
(1.5 equiv)
1.2 equiv NaOMe, thf, 22 °C, 18 h
>98% conv. 83% yield
95:5 SN2':SN2, 97:3 er
Scheme 3.9. Ligand Screening
3.53 Ar = 2,4,6-i-Pr3C6H2
3.46 3.13 3.45
3.48 3.49 3.50
3.51 3.52
Ph+
3.47
(pin)B
(pin)B B(pin)
N
Ph
S
O
N
Ag
O
O
Ag
O
N
N
S
O
O Ph
Ph
Ph
Ar
Ar
Ar
Ar
3.54 Ar = 2,4,6-i-Pr3C6H2
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Cu−C bond disposed for SN2’ addition. There is indeed measurable dependence of branch 
selectivity on the identity of the base used (Scheme 3.10). With the more Lewis acidic 
lithium salt, there was >98% SN2’ selectivity, albeit at lower yield owing to solubility 
issues. More of the achiral isomer was generated with the less Lewis acidic and larger 
potassium methoxide. 
 
The method has a considerable scope (Scheme 3.11). Various aryl-substituted 
substrates, including those with an electron-donating or -withdrawing substituent, 
regardless of position (3.55a–3.55j), were converted into the corresponding primary 
alcohols in 61–95% yield (after oxidation), 88:12 to >98:2 SN2’/SN2 selectivity, and 
85:15–99:1 er. There were no complications due to other competitive electrophilic sites, 
such as the aryl ketone unit in 3.55i. Such a functional group is not compatible in NHC–
Cu-catalyzed transformations with propargyl–B(pin). 17  In that case, competitive 
propargyl addition to the reactive carbonyl group was observed.  
                                                
(17) Shi, Y.; Jung, B.; Torker, S.; Hoveyda, A. H. J. Am. Chem. Soc. 2015, 137, 8948–8964. 
M O P(OEt)2
O
N
Ph Ph
NSO O
O
Cu
G
H
–
+
G
(pin)B
SN2' addition mode
preferred
(pin)B
2.75 mol % ligand,
5.0 mol % CuCl
1.5 equiv. MOMe,
thf, 22 °C, 18 h
OPO(OEt)2Ph
(pin)B B(pin)
Ph
(pin)B
Scheme 3.10. Role of Counter Ion
M = Li
M = Na
M = K
29% conv., 29% yield, >98:2 SN2':SN2, 94:6 er
>98% conv., 83% yield, 95:5 SN2':SN2, 97:3 er
>98% conv., 45% yield, 90:10 SN2':SN2, 96:4 er
A
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As shown in Scheme 3.12, The Cu catalyst remained operative in the presence of 
Lewis basic heterocyclic moieties that can potentially deactivate the catalyst: pyridyl- and 
thienyl-substituted 3.55k and 3.55l were obtained with similar efficiency and selectivity. 
Alkyl-substituted allylic phosphates (e.g., 3.55m) were suitable. The reaction with a 1,3-
dienyl substrate was somewhat less SN2’- and enantioselective but none of the side 
products from the formation of the SN2’’ addition by-product could be detected (3.55n). 
However, employing NHC−Ag complex 3.56 (as in Scheme 3.13), 3.55n can be 
furnished in higher enantioselectivity (95:5 er). Allylsilane 3.55o can be also generated in 
75% yield, >98:2 SN2’/SN2 selectivity and 98:2 er, which may be utilized in 
5.0 mol % CuCl, 1.2 equiv NaOMe, 
thf, 22 °C, 18 h;
3.0 equiv NaBO3•4H2O
thf/H2O = 1:1, 22 °C, 3 h
3.46
HO
(EtO)2OPO G
HO HO
3.55a 3.55c
HO
3.55d
HO
3.55b
>98% conv, 83% yield, 
95:5 SN2':SN2 
97:3 er
94% conv, 80% yield, 
98:2 SN2':SN2
98:2 er
94% conv, 88% yield, 
95:5 SN2':SN2
97:3 er
94% conv, 71% yield, 
94:6 SN2':SN2
99:1 er
HO
3.55g
HO
3.55h
F3C O2N
97% conv, 61% yield, 
95:5 SN2':SN2 
97:3 er
>98% conv, 83% yield, 
93:7 SN2':SN2 
97:3 er
(pin)B B(pin)
3.13
(1.5 equiv.)
HO
3.55e
Br
G
OMe BrF
98% conv, 87% yield, 
98:2 SN2':SN2
97:3 er
HO
3.55f
Cl
>98% conv, 81% yield, 
97:3 SN2':SN2 
97:3 er
HO
3.55i
>98% conv, 78% yield, 
92:8 SN2':SN2 
97:3 er
HO
3.55j
MeOOC
>98% conv, 62% yield, 
95:5 SN2':SN2 
97:3 er
Me
O
Scheme 3.11. Scope of Catalytic EAS with a Methylenediboron Reagent
+
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S
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N
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Ar = 2,4,6-(i-Pr)3C6H2
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stereoselective synthesis. 
 
3.3.2. Application to the Synthesis of Rhopaloic Acid A 
 We then probed the feasibility of the application of this process to the synthesis 
of rhopaloic acid A (Scheme 3.13). 18  Organoboron compound 3.57 was purified by 
column chromatography on silica gel and isolated in 89% yield, >98:2 SN2’/SN2 
selectivity, and 96:4 er; in this case, the Cu complex derived from 3.56 gave higher 
enantioselectivity (84:16 er with 3.54). Improvement of enantioselectivity in EAS 
reactions with disubstituted allylic phosphates with large boron-based nucleophile was 
also observed by switching the substitution pattern of the N-aryl group on the sulfonate-
containing NHC ligands: NHC−Cu complex with 2,5-substitution delivered the EAS 
products with a tertiary stereogenic center in higher enantioselectivity than the ones with 
3,5-substitution pattern. Moreover, the utility of this sulfonate-based NHC ligand was 
also highlighted in the synthesis of plakinic acid A.19 
Hydroboration afforded diboron product 3.58, which was used crude and 
                                                
 (18) a) Yanai, M.; Ohta, S.; Ohta, E.; Ikegami, S. Tetrahedron 1998, 54, 15607–15612. b) Ohta, S.; Uno, 
M.; Yoshimura, M.; Hiraga, Y.; Ikegami, S. Tetrahedron Lett. 1996, 37, 2265–2266. For previous studies 
regarding the synthesis of rhopaloic acids, see: c) Snider, B. B.; He, F. Tetrahedron Lett. 1997, 38, 5453–
5454. d) Takagi, R.; Sasaoka, A.; Kojima, S.; Ohkata, K. Chem. Commun. 1997, 1887–1888. e) Takagi, R.; 
Sasaoka, A.; Nishitani, H.; Kojima, S.; Hiraga, Y.; Ohkata, K. J. Chem. Soc. Perkin Trans. 1 1998, 925–
934. f) Nishitani, H.; Sasaoka, A.; Tokumasu, M.; Ohkata, K. Heterocycles 1999, 50, 35–38. g) Kadota, K.; 
Ogasawara, K. Heterocycles 2003, 59, 485–490. h) Brioche, J. C. R.; Goodenough, K. M.; Whatrup, D. J.; 
Harrity, J. P. A. Org. Lett. 2007, 9, 3941–3943. i) Brioche, J. C. R.; Goodenough, K. M.; Whatrup, D. J.; 
Harrity, J. P. A. J. Org. Chem. 2008, 73, 1946–1953. 
(19) ref.17. also see discussion in Chapter 2.4.1. 
HO
3.55l
HO
3.55m
97% conv, 63% yield, 
>98:2 SN2':SN2 
96:4 er
>98% conv, 75% yield, 
93:7 SN2':SN2 
94:6 er
HO
3.55k
N
94% conv, 75% yieldb, 
95:5 SN2':SN2 
97:3 er
HO
3.55n
>98% conv, 71% yield, 
88:12 SN2':SN2 
85:15 er
HO
PhMe2Si
3.55o
>98% conv, 75% yield, 
>98:2 SN2':SN2 
98:2 er
S
Scheme 3.12. Catalytic EAS Reactions with Heteroaryl-, Alkyl-, Alkenyl- and Silyl-Substituted Allylic Phosphatesa
a Yields of isolated and purified SN2’ product. b Yield of isolated mixture of SN2’ and SN2 products.
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subjected to a Pd-catalyzed cross-coupling20 with E-alkenyl iodide 3.5921, affording 3.60 
in >98% chemoselectivity and 87% yield. Removal of the silyl ether and NHC–Cu-
catalyzed C–C bond formation with the alkyl–B(pin) moiety of 3.60 and commercially 
available allyl phosphate 3.61 delivered tetraene 3.62 in 67% overall yield. As noted 
earlier, this latter process strongly benefited from the proximal hydroxyl group: there was 
<2% C−C bond formation with silyl ether 3.60. Cross-metathesis with Ru complex 3.63 
and acrolein 3.18 led to enal 3.19 (71% overall yield). Intramolecular conjugate addition 
delivered pyran 3.64, which has previously been converted into rhopaloic acid A in 85% 
yield and 89:11 diastereomeric ratio. 
 
                                                
(20) a) Miyaura, N.; Suzuki, A. Chem. Rev. 1995, 95, 2457–2483. b) Chemler, S. R.; Trauner, D.; 
Danishefsky, S. J. Angew. Chem. Int. Ed. 2001, 40, 4544–4568; Angew. Chem. 2001, 113, 4676–4701. 
(21) a) Sulake, R. S.; Lin, H.-H.; Hsu, C.-Y.; Weng, C.-F.; Chen, C. J. Org. Chem. 2015, 80, 6044–6051. b) 
Wipf, P.; Lim, S. Angew. Chem. Int. Ed. Engl. 1993, 32, 1068–1071; Angew. Chem. 1993, 105, 1095–1097. 
See the Supporting Information for details. 
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Harrity, Org. Lett 2007, 3941
Scheme 3.13. Application to the Synthesis of Rhopaloic Acid A
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3.3.3 Screening of Reaction Conditions for Methyleneboryl Additions to 
Trisubstituted Allylic Phosphates and DFT Calculations   
As shown above, we found out 3.54 is the optimal ligand for constructing a 
tertiary stereogenic center with 1,2-disubstituted alkenes. However, when we tried to 
elaborate this protocol to generate a quaternary stereogenic center from an E-
trisubstituted olefin 3.65, it was not surprising to find out that 3.54, which afforded good 
selectivity in EAS reactions with a propargyl–B(pin),17 delivered low yield and low 
selectivity (entry 1, 48:52 SN2’:SN2 selectivity), albeit in a moderate er (20:80 er). When 
switching to NHC−Ag complexes with ortho-substitution, increasing the size of ortho-
substituted ligands led to lower enantioselectivity and more drastically lower SN2’ 
selectivity (Table 3.1, 3.68−3.70, entry 2−4). When NHC ligands with a 2,5-disubstituted 
N-aryl group, 3.71 and 3.72, were applied in the system, improved SN2’ selectivities were 
observed (entry 5, 6) albeit with low enantioselectivities. Increasing the steric bulk of the 
ligand or lowering the temperature did not yield higher enantioselectivity due to the more 
sterically-encumbered nucleophile and lower reactivity of methylenediboron (<2% 
detection of the desired product if the EAS reaction was carried out at 4 °C).  It was also 
worth mentioning that free CuCl promoted generation of the SN2 byproduct. Thus, in this 
case the use of NHC−Cu catalyst with the proper binding pocket was crucial to get high 
SN2’ selectivity and enantioselectivity at the same time.22 
We went on to explore the impact of the stereochemistry of the electrophile with 
Z-3.66. A higher enantioselectivity was observed with ligand 3.72 (90:10 er, Table 3.1, 
entry 9). By altering the N-aryl group to have a more sterically-demanding ortho 
                                                
(22) see discussions in Chapter 1. 
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substituent (3.72 vs. 3.73), EAS product 3.67 was generated more efficiently with a high 
enantiomeric ratio (80% yield, 92:8 er, entry 10). 
 
As shown in Figure 3.1, the stereochemical models obtained by DFT calculations 
provided a rationale for the higher enantiomeric ratio utilizing Z-trisubstituted substrates 
(see 3.76, 3.77) than its E counterpart (3.74, 3.75) in EAS reactions catalyzed by NHC-
Cu species derived from ligand 3.72. In all the transition states, the large B(pin) was 
oriented away from the large phenyl substituent on the allylic phosphate to avoid a 
potentially severe steric interaction. With E-3.65, the major mode of addition 3.74 
suffered from a steric interaction between the ortho substituent and the methylene–B(pin) 
group in the right front quadrant, while the methyl group on the substrate would have 
steric interaction with the meta-substituent of the N-aryl ring causing it to rotate to the 
OH
Ph
(pin)B B(pin)
1.5 equiv
 1.2 equiv NaOMePh(EtO)2OPO
thf, 22 oC, 18 h;
3.0 equiv NaBO3•4H2O
thf/H2O = 1:1, 22 oC, 3.0 h
5.0 mol % CuCl, 2.75 mol % ligand
NAr
Ph
S
O
N
Ag
O
O
N
NAr
Ph Ph
S
O
O
Ag
O
NAr
Ph Ph
S
O
N
Ag
O
O
N
NAr
Ph Ph
S
O
O
Ag
O
Me
Me(EtO)2OPO
Ph
or
+
entry ligand conv (%)
b;
yield (%)c SN2':SN2
b erd
1
2
3
4
5
6
7
8
9
10
3.54
3.68
3.69
3.70
3.71
3.72
3.54
3.71
3.72
3.73
84; 32
72; 56
79; 69
65; 25
72; 60
73; 52
72; 12
70; 36
86; 76
95; 80
48:52
93:7
93:7
39:61
98:2
98:2
19:81
57:43
93:7
98:2
20:80
84:16
81:19
68:32
62:38
64:36
54:46
76:24
90:10
92:8
substrate
Me
OH
PhMe
3.68 Ar = Mes
3.69 Ar = 2,6-Et2C6H3
3.70 Ar  = 2,4,6-iPr3C6H2
Table 3.1. EAS Reactions with Methylene Di-B(pin) to Generate Quaternary Stereogenic Centers
(E)-3.65
(Z)-3.66
3.13
(S)-3.67 (R)-3.67
3.71 Ar= 2-Me,5-tBuC6H3
3.72 Ar= 2-Ph,5-tBuC6H3
3.73 Ar= 2-(3,5-Me2C6H3),5-tBuC6H3
3.54 Ar = 3,5-(2,4,6-iPr3C6H2)2C6H3
(E)-3.65
(E)-3.65
(E)-3.65
(E)-3.65
(E)-3.65
(E)-3.65
(Z)-3.66
(Z)-3.66
(Z)-3.66
(Z)-3.66
a Reactions performed under N2 atm. b Conversion (allylic phosphate consumption) and group (propargyl/allenyl addition) selectivities (±2%) were determined by 
analysis of 400 MHz 1H NMR spectra of product mixtures prior to purification. Site selectivities were determined by analysis of 400 MHz 1H NMR spectra of purified 
material.  c Yield (±5%) of SN2’ addition products  after  silica gel  chromatography.  d Enantioselectivity (±1%) determined by HPLC analysis.  See the Supporting 
Information for experimental and analytical details.
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back in order to alleviate the steric strain in the front. Thus, this mode of addition was 
also disfavored, causing the erosion of enantioselectivity. In the minor pathway 3.75 for 
addition to E-3.65, the B(pin) group was oriented to the left to avoid a steric interaction 
with the phenyl group, thus inducing a steric strain with the sulfonate N-aryl ring. 
However, in this case, the steric strain could not be alleviated by rotating to the back due 
to hindrance from the phosphate group. The energy difference between these two modes 
of addition was not large enough to induce high er (1.9 kcal/mol). However, in the case 
with Z-3.66, there was a lack of disfavoring interactions between the catalyst and the 
substrate attributable to the different orientations of the B(pin) moiety and the phosphate 
group in the major mode of addition 3.76. However, in the minor pathway 3.75, steric 
strain between the B(pin) and ortho substituent, and also between the meta substituent 
and the methyl group on the allylic phosphate, disfavored this mode of addition. When 
increasing the size of the ortho substituent, this mode of addition suffered increased 
severe interaction between the ortho substituent and the B(pin) moiety, thus increasing 
the enantioselectivity of the product (compare 90:10 er with 3.72, 92:8 er with 3.73).  
Moreover, the large phenyl group on the substrate experienced steric repulsion with the 
sulfonate N-aryl ring due to the Z-substitution pattern of the substrate, further 
destabilizing this transition state. The large energy gap between 3.76 and 3.77 contributes 
to the higher er obtained in EAS reaction with Z-3.66. 
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Another type of NHC−Cu complex with 2,5-substitution yielded high SN2’ 
selectivity and er when we explored EAS reactions to form a tertiary stereogenic center 
employing β-ester-substituted Z-allylic phosphates with methylenediboron 3.13 as shown 
in Scheme 3.14. Sulfonate-bearing NHC−Cu catalyst derived from 3.79 delivered the 
desired product 3.80 in 75% yield, 96% branched selectivity and a 97:3 enantiomeric 
ratio.  
H
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OO P(OEt)2
O
N
Ph Ph
NSO O–
O
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Ph
Me
H
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smaller energy gap
N
Ph Ph
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N
Ph Ph
NSO O–
O
Cu
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larger energy gap
N
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N
SO O–
O
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Na+
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Figure 3.1. Stereochemical Models Account for Higher Enantioselectivity with Z- in Comparison to E-Allylic Phosphates
3.74 3.75 3.76 3.77
From (E)-3.65 From
ΔGrel= 1.9 kcal/mol                                                                              ΔGrel= 3.9 kcal/mol
Performed	at	DFT	calculations		at	ω-B97XD/Def2TZVPPTHF(SMD)//M06L/Def2DVP(density	fit)
(Z)-3.66
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The stereochemical model obtained with DFT calculations (Figure 3.2), illustrated 
that the minor pathway (3.82) suffered from the steric repulsion between the N-aryl ring 
and the phenyl substituent on the substrate. Furthermore, this mode of addition was also 
destabilized by the steric strain between the B(pin) group and ortho substituent on the N-
aryl ring. Another destabilizing interaction comes from the β-ester group and meta-
substituent. Thus high enantiomeric ratio was attributed to the large energy gap between 
the two modes of addition. 
 
OH
Ph
(pin)B B(pin)
1.5 equiv
 1.2 equiv NaOMe
thf, 22 oC, 18 h;
3.0 equiv NaBO3•4H2O
thf/H2O = 1:1, 22 oC, 3.0 h
5.0 mol % CuCl
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Scheme 3.14. EAS Reactions to Generate a Tertiary Stereogenic Center 
Employing Z-Trisubstituted Allylic Phosphates
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Figure 3.2. Stereochemical Models for EAS Reactions Employing Z-Allylic Phosphates with β-Ester Group
 ΔGrel= 2.6 kcal/mol
Performed	at	DFT	calculations		at	ω-B97XD/Def2TZVPPTHF(SMD)//bp86-631G*/Def2DVP
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The trisubstituted substrates were required to achieve a high enantioselectivity in 
EAS reactions promoted by this type of sulfonate-based NHC with 2,5-substitution. As 
shown by the stereochemical models in Figure 3.1 and 3.2, the methyl group of 3.74 and 
the β-ester group on 3.76 played an important role in the differentiation of two modes of 
addition. Consequently, only 70:30 er was obtained when disubstituted allylic phosphate 
Z-3.83 was examined in the EAS reactions catalyzed by NHC−Cu complex derived from 
3.72 (Scheme 3.15). 
 
3.4. Conclusions 
A catalytic EAS method for the site- and enantioselective addition of 
commercially available methylenediboron to disubstituted allylic phosphates was 
developed. Transformations were facilitated by a sulfonate-containing NHC–Cu complex 
and products are obtained in 63–95% yield, 88:12 to >98:2 SN2’/SN2 selectivity, and 
85:15–99:1 enantiomeric ratio. The utility of the approach is highlighted by the 
application to the formal synthesis of the cytotoxic natural product rhopaloic acid A. 
Catalytic EAS methods of methylenediboron addition to Z-trisubstituted allylic 
OH
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Scheme 3.15. The Necessity of Trisubstituted Z-Allylic Phosphates for High 
Enantioselectivity
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phosphates were also disclosed. DFT calculations provided insight to the stereochemical 
models and explain the rationales behind employing Z-trisubstituted allylic phosphates as 
the starting materials. 
3.5. Experimentals 
General 
Infrared (IR) spectra were recorded on a Bruker FT-IR Alpha (ATR mode) 
spectrophotometer, λmax in cm−1. Bands are characterized as broad (br), strong (s), 
medium (m), and weak (w). 1H NMR spectra were recorded on a Varian Unity INOVA 
400 (400 MHz) or Varian Unity INOVA 600 (600 MHz) spectrometer. Chemical shifts 
are reported in ppm from tetramethylsilane with the solvent resonance as the internal 
standard (CDCl3: δ 7.26 ppm). Data are reported as follows: chemical shift, integration, 
multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, br = broad, m = multiplet), 
and coupling constant (Hz). 13C NMR spectra were recorded on a Varian Unity INOVA 
400 (100 MHz) spectrometer with complete proton decoupling. Chemical shifts are 
reported in ppm from tetramethylsilane with the solvent resonance as the internal 
standard (CDCl3: δ 77.16 ppm). High-resolution mass spectrometry was performed on a 
JEOL AccuTOF DART (positive mode) at the Mass Spectrometry Facility, Boston 
College. Enantiomer ratios were determined by GC analysis (Alltech Associated 
Chiraldex B-DM (30 m x 0.25 mm), Chiraldex G-TA (30 m x 0.25 mm), and Betadex 
120 column (30 m x 0.25 mm)), or HPLC analysis (Chiral Technologies Chiralpak AZ–H 
(4.6 x 250 mmin comparison with authentic racemic materials. Specific rotations were 
measured on an ATAGO® AP-300 Automatic Polarimeter or a Rudolph Research 
Analytical Autopol IV Polarimeter. Melting points were measured on a Thomas Hoover 
capillary melting point apparatus and are uncorrected. 
Unless otherwise noted, all reactions were carried out with distilled and degassed 
solvents under an atmosphere of dry N2 in oven- (135 °C) or flame-dried glassware with 
standard dry box or vacuum-line techniques. Solvents were purified under a positive 
pressure of dry argon by a modified Innovative Technologies purification system: toluene, 
benzene and hexanes were purified through a copper oxide and alumina column; CH2Cl2 
and Et2O were purged with Ar and purified by passage through two alumina columns. 
Tetrahydrofuran (Aldrich Chemical Co.) was purified by distillation from sodium 
benzophenone ketyl immediately prior to use unless otherwise specified. All work-up and 
purification procedures were carried out with reagent grade solvents (purchased from 
Fisher Scientific, Inc.) in air.  
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Reagents 
Allyl phosphate was purchased from Aldrich and used as received. 
Benzoic acid (BzOH) was purchased from Aldrich and used as received. 
[1,1'-Bis(diphenylphosphino)ferrocene]palladium(II) dichloride) (PdCl2(dppf)) was 
purchased from TCI chemicals and used as received. 
Bis[(pinacolato)boryl]methane (CH2B2(pin)2) was purchased from TCI chemicals and 
used as received. 
1,3-Bis(2,4,6-trimethylphenyl)imidazolinium chloride (SIMes) was purchased from 
Aldrich and used as received. 
9-Borabicyclo[3.3.1]nonane dimer (9-BBN) was purchased from Aldrich and used as 
received. 
(E)-4-[(tert-Butyldimethylsilyloxy)but-2en-1-yl] diethyl phosphate (3.46p)23 
Copper (I) chloride (CuCl) was purchased from Strem and used as received. 
(E)-Diethyl 3-(2-bromophenyl)prop-2-enyl phosphate (3.46d)24 
(E)-Diethyl 3-(3-bromophenyl)prop-2-enyl phosphate (3.46e)25 
(E)-Diethyl 3-(4-chlorophenyl)prop-2-enyl phosphate (3.46f)25 
(E)-Diethyl 3-cyclohexylprop-2-enyl phosphate (3.46m)25 
(E)-Diethyl 3-(2-fluorophenyl)prop-2-enyl phosphate (3.46c)24 
(E)-Diethyl 3-(2-methoxyphenyl)prop-2-enyl phosphate (3.46b)25 
(E)-Diethyl 3-(4-nitrophenyl)prop-2-enyl phosphate (3.46h)26 
(E)-Diethyl 3-phenylprop-2-enyl phosphate (3.46a)27 
(E)-Diethyl (3-(pyridin-3-yl)allyl) phosphate (3.46k)27 
(E)-Diethyl (3-(thiophen-3-yl)allyl) phosphate (3.46l)27 
(E)-Diethyl 3-(4-trifluoromethylphenyl)prop-2-enyl phosphate (3.46g)24 
(E)-3-[Dimethyl(phenyl)silyl]prop-2-enyl diethyl phosphate (3.46o)27 
Imidazolinium salts 3.49, 3.50 were prepared according to previously reported 
procedures.28 
                                                
(23) L. B. Delvos, D. J. Vyas, M. Oestreich, Angew. Chem. Int. Ed. 2013, 52, 4650–4653. 
(24) B. Jung, A. H. Hoveyda, J. Am. Chem. Soc. 2012, 134, 1490–1493. 
(25) K. Akiyama, F. Gao, A. H. Hoveyda, Angew. Chem. Int. Ed. 2010, 49, 419–423. 
(26) C. A. Luchaco-Cullis, H. Mizutani, K. E. Murphy, A. H. Hoveyda, Angew. Chem. Int. Ed. Engl. 2001, 
40, 1456–1460. 
(27) Y. Shi, B. Jung, S. Torker, A. H. Hoveyda, J. Am. Chem. Soc. 2015, 127, 6877–6882. 
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(1E,5E)-1-Iodo-2,6,10-trimethylundeca-1,5,9-triene (3.59) was prepared according to 
previously reported procedures.29 
Lithium methoxide (LiOMe) was purchased from Aldrich and used as received. 
Methanol was purchased from Acros and purified by distillation from Na (Aldrich) prior 
to use.  
Methyl (E)-4-(3-((diethoxyphosphoryl)oxy)prop-1-en-1-yl)benzoate (3.46j)17 
NHC–Ag complex 3.54 and 3.56 were prepared according to a previously reported 
procedure.30 
Palladium (II) Acetate (Pd(OAc)2) was purchased from Strem and used as received. 
Potassium t-butoxide (KOt-Bu) was purchased from Strem and used as received. 
Potassium methoxide (KOMe) was purchased from Aldrich and used as received. 
Pyrrolidine was purchased from Aldrich and used as received. 
Ruthenium complex (3.63) was purchased from Aldrich and used as received. 
Sodium perborate tetrahydrate (NaBO3•4H2O) was purchased from Aldrich and used 
as received. 
Sodium methoxide (NaOMe) was purchased from Strem and used as received. 
Silver (I) Acetate (AgOAc) was purchased from Aldrich and used as received. 
p-Toluenesulfonic acid (p-TsOH) was purchased from Aldrich and used as received. 
Triethylamine (Et3N) was purchased from Fisher Scientific, Inc. and distilled over CaH2 
prior to use. 
Tripotassium phosphate (K3PO4) was purchased from Fisher Scientific, Inc. and 
distilled over CaH2 prior to use. 
 
Characterization Data for Allylic Phosphates Not Previously Reported 
 
(E)-3-(4-Acetylphenyl)allyl diethyl phosphate (3.46i): IR (neat): 2985 (w), 2932 (w), 
1681 (s), 1603 (m), 1563 (w), 1360 (w), 1266 (s), 1182 (w), 1166 (w), 1101 (w), 1028 (s), 
975 (s), 853 (w), 801 (w), 594 (w) cm−1; 1H NMR (CDCl3, 600 MHz): δ 7.90 (2H, d, J = 
                                                                                                                                            
(28) a) J. J. Van Veldhuizen, J. E. Campbell, R. E. Guidici, A. H. Hoveyda, J. Am. Chem. Soc. 2005, 127, 
6877–6882; b) K.-s. Lee, A. H. Hoveyda, J. Org. Chem. 2009, 74, 4455–4462.  
(29) R. S. Sulake, H.−H. Lin, C.−Y. Hsu, C.−F. Weng, C. Chen, J. Org. Chem. 2015, 80, 6044−6051. 
(30) T. L. May, M. K. Brown, A. H. Hoveyda, Angew. Chem. Int. Ed. 2008, 47, 7358–7362.  
Me
O
I
5 mol % Pd(OAc)2,10 mol % PPh3,
1.0 equiv AgOAc, DMF, 70 °C, 16 h
Me
O
OH
HO2.0 equiv
Me
O
(EtO)2OPO
41% yield
1.2 equiv. ClPO(OEt)2,
1.3 equiv. Et3N, 0.1 equiv. DMAP,
CH2Cl2, 22 °C, 3 h
S1 3.46i
89% yield
Scheme S1. Preparation of Allylic Phosphate 3.46i
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8.4 Hz), 7.45 (2H, d, J = 8.4 Hz), 6.70 (1H, d, J = 15.6 Hz), 6.40 (1H, dt, J = 15.6, 6.0 
Hz), 4.70 (2H, t, J = 8.4 Hz), 4.15–4.10 (4H, m), 2.57 (3H, s), 1.33 (6H, t, J = 7.2 Hz; 13C 
NMR (CDCl3, 150 MHz): δ 197.5, 140.7, 136.6, 132.3, 128.9, 126.8, 126.6 (d, JCP = 6.9 
Hz), 67.5 (d, JCP = 4.7 Hz), 64.0 (d, JCP = 5.7 Hz), 26.7, 16.2 (d, JCP = 6.9 Hz). HRMS 
(ESI+): Calcd for C15H22O5P1 [M+H]+: 313.1205; Found: 313.1217. 
 
Representative Procedure for NHC−Cu-Catalyzed Enantioselective Methylene-
Boryl Addition to Disubstituted Allylic Phosphates  
An oven-dried 1-dram vial equipped with a stir bar was charged with NHC−Ag 
complex 3.54 (4.8 mg, 5.5 µmol), NaOMe (6.5 mg, 150 µmol), and CuCl (0.5 mg, 5.0 
µmol) in a nitrogen-filled glove box. The vial was sealed with a cap (phenolic open top 
cap with a red PFTE/white silicon septum) and electrical tape, and removed from the 
glove box. Tetrahydrofuran (thf; 0.50 mL) was added and the mixture was allowed to stir 
for 2 h under N2 at 22 °C (the mixture became bright-yellow solution). The mixture of 
allylic phosphate 3.46a (28 mg, 0.10 mmol) and bis[(pinacolato)boryl]methane 1 (40 mg, 
0.15 mmol) in thf (0.5 mL) was added to the mixture slowly through a syringe. The 
resulting mixture was allowed to stir at 22 °C for 18 h. The mixture was passed through a 
short plug of silica gel (4 cm x 1 cm) and eluted with Et2O. The organic layer was 
concentrated in vacuo, resulting in a yellow oily residue, which was diluted with thf (0.5 
ml) and water (0.5 ml), then NaBO3•4H2O (78mg, 0.3 mmol) was added and the mixture 
was allowed to stir at 22 °C for 3 h. The mixture was washed with Et2O (1.0 ml) three 
times and the combined organic layers was passed through a short plug of MgSO4, 
concentrated and purified by silica gel chromatography (6:1 hexanes/Et2O, Rf  = 0.18) to 
afford 12.3 mg of the desired product 3.55a as colorless oil (0.083 mmol, 83% yield).  
 
Characterization Data for Alcohols with a Tertiary Carbon Stereogenic Center 
 
(R)-2-Phenylbut-3-en-1-ol (3.55a). IR (neat): 3353 (br, s), 2925 (w), 2873 (w), 1637 
(w), 1601 (w), 1493 (w), 1452 (w), 1051 (m), 1027 (m), 916 (m), 755 (m), 698 (s), 679 
(m), 593 (w), 537 (m) cm−1; 1H NMR (CDCl3, 400 MHz): δ 7.35–7.31 (2H, m), 7.26–
7.22 (3H, m), 6.00 (1H, ddd, J = 18.0, 10.4, 8.0 Hz), 5.22–5.15 (2H, m), 3.82 (1H, d, J = 
6.8 Hz), 3.81 (1H, d, J = 6.8 Hz), 3.52 (1H, q, J = 7.2 Hz), 1.54 (1H, s); 13C NMR 
(CDCl3, 100 MHz): δ 140.7, 138.3, 128.9, 128.1, 127.1, 117.3, 66.2, 52.7. HRMS 
(ESI+): Calcd for C10H11 [M+H-H2O]+: 131.0854; Found: 131.0861. Specific rotation: 
[α]D20.0 −36.0 (c 0.25, CHCl3) for an enantiomerically enriched sample of 97:3 e.r. Based 
on reported optical rotation value ([α]D26 +19 (c 0.81, CHCl3) for 33:67 er) , the absolute 
stereochemistry of the major enantiomer is assigned to be R.31 
                                                
(31) K. B. Selim, K. Yamada, K. Tomioka, Chem. Commun. 2008, 5140−5142. 
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Enantiomeric purity was determined by HPLC analysis in comparison with authentic 
racemic material; Chiralpak AZ–H column, 99.5:0.5 hexanes/iPrOH, 0.5 mL/min, 220 
nm. 
 
Retention Time Area Area% Retention Time Area Area% 
91.224 11050190 49.885 91.569 2846041 3.300 
105.687 120005426 50.115 102.605 83400095 96.700 
 
(R)-2-(2-Methoxyphenyl)but-3-en-1-ol (3.55b): IR (neat): 3379 (br, s), 2937 (w), 2836 
(w), 1636 (w), 1597 (w), 1585 (w), 1491 (s), 1462 (m), 1438 (m), 1288 (w), 1240 (w), 
1187 (w), 1168 (w), 1109 (w), 1051 (s), 1026 (s), 996 (m), 915 (m), 751 (s), 670 (m) 
cm−1; 1H NMR (CDCl3, 400 MHz): δ 7.26-7.21 (1H, m), 7.20 (1H, m), 6.94 (1H, t, J = 
7.6 Hz), 6.89 (1H, d, J = 8.4 Hz), 6.12–6.03 (1H, m), 5.22–5.17 (2H, m), 3.87 (1H, q, J = 
7.2 Hz), 3.86–3.80 (5H, m), 1.61 (1H, s); 13C NMR (CDCl3, 100 MHz): δ 157.3, 138.0, 
129.0, 128.5, 128.0, 120.9, 117.0, 111.0, 65.3, 55.6, 45.9. HRMS (ESI+): Calcd for 
C11H13O1 [M+H-H2O]+: 161.0966; Found: 161.0968. Specific rotation: [α]D20.0  –25.2 (c 
0.85, CHCl3) for an enantiomerically enriched sample of 99:1 e.r. 
Enantiomeric purity was determined by HPLC analysis in comparison with authentic 
racemic material; Chiralpak AZ–H column, 99.0:1.0 hexanes/iPrOH, 0.5 mL/min, 220 
nm. 
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(R)-2-(2-Fluorophenyl)but-3-en-1-ol (3.55c): IR (neat): 3358 (br, s), 2938 (w), 1638 
(w), 1583 (w), 1490 (s), 1454 (m), 1418 (w), 1228 (s), 1175 (w), 1055 (s), 1036 (s), 993 
(m), 919 (s), 824 (w), 806 (w), 665 (w), 602 (w), 479 (w) cm−1; 1H NMR (CDCl3, 400 
MHz): δ 7.27–7.20 (2H, m), 7.14–7.10 (1H, m), 7.07–7.03 (1H, m), 6.08–6.00 (1H, m), 
5.23 (1H, d, J = 10.8 Hz), 5.13 (1H, J = 17.2 Hz), 3.86 (3H, app.s), 1.58 (1H, s); 13C 
NMR (CDCl3, 100 MHz): δ 161.0 (d, JCF = 244.4 Hz), 137.0, 129.3 (d, JCF = 4.5 Hz), 
128.5 (d, JCF = 8.4 Hz), 127.7 (d, JCF = 15.2 Hz), 124.4 (d, JCF = 3.0 Hz), 117.8.0, 115.9 
(d, JCF = 22.0 Hz), 65.1, 46.2. HRMS (ESI+): Calcd for C10H10F [M+H-H2O]+: 149.0767; 
Found: 149.0773. Specific rotation: [α]D20.0 –34.2 (c 0.89, CHCl3) for an 
enantiomerically enriched sample of 98:2 er.  
Enantiomeric purity was determined by HPLC analysis in comparison with authentic 
racemic material; Chiralpak AZ–H column, 99.0:1.0 hexanes/iPrOH, 0.5 mL/min, 220 
nm 
 
Retention Time Area Area% Retention Time Area Area% 
42.201 2521279 49.764 37.938 3737434 98.073 
44.920 2545157 50.236 40.564 73451 1.927 
 
(R)-2-(2-Bromophenyl)but-3-en-1-ol (3.55d): IR (neat): 3353 (br, s), 3080 (w), 2928 
(w), 2874 (w), 1730 (w), 1637 (w), 1469 (m), 1437 (w), 1417 (w), 1373 (w), 1222 (w), 
1021 (s), 992 (s), 918 (s), 832 (w), 750 (s), 724 (m), 646 (m), 600 (w) cm−1; 1H NMR 
(CDCl3, 400 MHz): δ 7.59 (1H, J = 8.0 Hz), 7.32–7.28 (2H, m), 7.13–7.08 (1H, m), 5.99 
(1H, ddd, J = 17.6, 10.0, 6.8 Hz), 5.27 (1H, dd, J = 10.4 Hz), 5.23 (1H, d, J = 17.6 Hz), 
4.11 (1H, J = 6.8 Hz), 3.91–3.87 (2H, m), 1.56 (1H, s); 13C NMR (CDCl3, 100 MHz): δ 
139.8, 137.1, 133.4, 128.9, 128.5, 127.8, 125.3, 118.0, 65.1, 50.7. HRMS (ESI+): Calcd 
for C10H10Br [M+H-H2O]+: 208.9966; Found: 208.9964. Specific rotation: [α]D20.0 –11.9 
(c 1.33, CHCl3) for an enantiomerically enriched sample of 97:3 er.  
Retention Time Area Area% Retention Time Area Area% 
43.824 5928380 49.978 42.468 212733 1.437 
46.472 5933496 50.022 44.929 14593269 98.563 
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Enantiomeric purity was determined by HPLC analysis in comparison with authentic 
racemic material; Chiralpak AZ–H column, 99.0:1.0 hexanes/iPrOH, 0.5 mL/min, 220 
nm. 
 
Retention Time Area Area% Retention Time Area Area% 
36.168 19585946 49.867 37.549 19349954 97.161 
40.717 19690233 50.133 42.225 565421 2.839 
 
(R)-2-(3-Bromophenyl)but-3-en-1-ol (3.55e): IR (neat): 3333 (br, s), 2925 (w), 2874 
(w), 1638 (w), 1593 (m), 1566 (m), 1474 (m), 1426 (m), 1299 (w), 1187 (w), 1127 (w), 
1071 (s), 1053 (s), 1027 (s), 996 (s), 919 (s), 878 (m), 836 (w), 804 (w), 779 (s), 693 (s), 
656 (m), 435 (m) cm−1; 1H NMR (CDCl3, 400 MHz): δ 7.39–7.37 (2H, m), 7.23–7.16 
(2H, m), 5.96 (1H, ddd, J = 17.2, 9.6, 6.8 Hz), 5.24 (1H, d, J = 9.6 Hz), 5.19 (1H, d, J = 
16.8 Hz), 3.82 (2H, app. d, J = 7.2 Hz), 3.50 (1H, app. q, J = 7.2 Hz), 1.56 (1H, s); 13C 
NMR (CDCl3, 100 MHz): δ 143.2, 137.6, 131.2, 130.4, 130.2, 126.8, 122.9, 117.8, 66.0, 
52.2. HRMS (ESI+): Calcd for C10H10Br [M+H−H2O]+: 208.9966; Found: 208.9957. 
Specific rotation: [α]D20.0 –39.5 (c 1.32, CHCl3) for an enantiomerically enriched sample 
of 97:3 e.r.  
Enantiomeric purity was determined by HPLC analysis in comparison with authentic 
racemic material; Chiralpak AZ–H column, 99.0:1.0 hexanes/iPrOH, 0.5 mL/min, 220 
nm. 
 
Retention Time Area Area% Retention Time Area Area% 
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47.512 13339096 49.983 47.586 656466 3.328 
51.825 13347987 50.017 51.663 19067927 96.672 
(R)-2-(4-Chlorophenyl)but-3-en-1-ol (3.55f): IR (neat): 3345 (br, s), 2926 (w), 2876 
(w), 1637 (w), 1490 (s), 1406 (m), 1297 (w), 1181 (w), 1091 (s), 1053 (s), 1030 (s), 1014 
(s), 993 (s), 919 (s), 870 (w), 824 (w), 784 (m), 723 (m), 625 (m), 540 (s), 521 (s), 457 (w) 
cm−1; 1H NMR (CDCl3, 400 MHz): δ 7.33–7.29 (2H, m), 7.19–7.16 (2H, m), 5.97 (1H, 
ddd, J = 17.6, 10.0, 7.2 Hz), 5.23 (1H, app. dt, J = 10.4, 1.2 Hz), 5.17 (1H, app. dt, J = 
17.2, 1.2 Hz), 3.81 (2H, app. d, J = 7.2 Hz), 3.51 (1H, app. q, J = 7.2 Hz), 1.50 (1H, s); 
13C NMR (CDCl3, 100 MHz): δ 139.3, 137.8, 132.8, 129.5, 129.0, 117.6, 66.0, 51.9. 
HRMS (ESI+): Calcd for C10H10Cl [M+H−H2O]+: 165.0471; Found: 165.0470. Specific 
rotation: [α]D20.0 −49.5 (c 0.58, CHCl3) for an enantiomerically enriched sample of 97:3 
e.r.  
Enantiomeric purity was determined by HPLC analysis in comparison with authentic 
racemic material; Chiralpak AZ–H column, 99.0:1.0 hexanes/iPrOH, 0.5 mL/min, 220 
nm. 
 
Retention Time Area Area% Retention Time Area Area% 
63.483 28543632 49.950 63.194 3312871 2.896 
69.046 28600276 50.050 67.648 111076701 97.104 
 
(R)-2-(4-(Trifluoromethyl)phenyl)but-3-en-1-ol (3.55g): IR (neat): 3344 (br, s), 2923 
(m), 2853 (w), 1731 (w), 1619 (w), 1554 (w), 14612 (w), 1377 (w), 1325 (s), 1261 (w), 
1164 (m), 1124 (s), 1068 (s), 1018 (m), 922 (w), 839 (w), 738 (w), 605 (w) cm−1; 1H 
NMR (CDCl3, 400 MHz): δ 7.60 (2H, d, J = 8.0 Hz), 7.37 (2H, d, J = 8.0 Hz), 6.00 (1H, 
ddd, J = 17.6, 10.0, 7.2 Hz), 5.26 (1H, d, J = 10.0 Hz), 5.20 (1H, dd, J = 17.2, 0.8 Hz), 
3.86 (2H, d, J = 7.2 Hz), 3.60 (1H, app. q, J = 7.2 Hz), 1.57 (1H, s); 13C NMR (CDCl3, 
100 MHz): 145.0, 137.4, 129.4 (q, JCF = 31.9 Hz), 128.5, 125.8 (q, JCF = 3.8 Hz), 124.3 
(q, JCF = 270.2 Hz), 118.0, 65.9, 52.4.  HRMS (ESI+): Calcd for C11H10F3 [M+H−H2O]+: 
199.0735; Found: 199.0737. Specific rotation: [α]D20.0 11.7 (c 1.09, CHCl3) for an 
enantiomerically enriched sample of 97:3 er.  
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Enantiomeric purity was determined by HPLC analysis in comparison with authentic 
racemic material; Chiralpak AZ–H column, 99.0:1.0 hexanes/iPrOH, 0.5 mL/min, 220 
nm. 
 
Retention Time Area Area% Retention Time Area Area% 
34.311 7407524 49.802 35.486 390190 2.883 
36.835 7466527 50.198 38.085 13143231 97.117 
 
(R)-2-(4-Nitrophenyl)but-3-en-1-ol (3.55h): IR (neat): 3374 (br, s), 2927 (w), 2877 (w), 
1638 (w), 1597 (m), 1514 (s), 1411 (w), 1342 (s), 1182 (w), 1109 (w), 1052 (m), 1014 
(m), 994 (m), 923 (m), 850 (s), 827 (m), 779 (w), 751 (m), 702 (s), 535 (w) cm−1; 1H 
NMR (CDCl3, 400 MHz): δ 8.18 (2H, d, J = 8.8 Hz), 7.42 (2H, d, J = 8.8 Hz), 5.99 (1H, 
ddd, J = 17.6, 10.0, 7.2 Hz), 5.28 (1H, d, J = 10.4 Hz), 5.20 (1H, d, J = 17.2 Hz), 3.88 
(2H, d, J = 7.6 Hz), 3.65 (1H, app. q, J = 7.2 Hz), 1.86 (1H, br); 13C NMR (CDCl3, 100 
MHz): δ 148.7, 147.1, 136.8, 129.1, 124.0, 118.5, 65.7, 52.3. HRMS (ESI+): Calcd for 
C10H12O3N [M+H]+: 194.0817; Found: 194.0811. Specific rotation: [α]D20.0 −62.8 (c 
0.78, CHCl3) for an enantiomerically enriched sample of 97:3 e.r.  
Enantiomeric purity was determined by HPLC analysis in comparison with authentic 
racemic material; Chiralpak AZ–H column, 96.0:4.0 hexanes/iPrOH, 0.5 mL/min, 220 
nm. 
 
Retention Time Area Area% Retention Time Area Area% 
61.972 51297087 49.608 62.233 1853958 2.818 
71.878 52108385 50.392 71.274 63927005 97.182 
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(R)-1-(4-(1-Hydroxybut-3-en-2-yl)phenyl)ethan-1-one (3.55i): IR (neat): 3423 (br, s), 
2924 (m), 2827 (w), 1679 (s), 1605 (s), 1459 (w), 1411 (m), 1359 (m), 1307 (w), 1270 (s), 
1184 (w), 1115 (w), 1056 (m), 1017 (m), 996 (w), 959 (w), 835 (w) cm−1; 1H NMR 
(CDCl3, 400 MHz): δ 7.94–7.91 (2H, m), 7.35–7.33 (2H, m), 6.00 (1H, ddd, J = 17.6, 
10.0, 7.2 Hz), 5.25 (1H, d, J = 10.4 Hz), 5.20 (1H, d, J = 17.6 Hz), 3.86 (2H, d, J = 5.2 
Hz), 3.61 (1H, q, J = 7.2 Hz), 2.59 (3H, s), 1.59 (1H, s); 13C NMR (CDCl3, 100 MHz): δ 
197.9, 146.5, 137.5, 136.0, 128.9, 128.4, 118.0, 65.9, 52.6, 26.7. HRMS (ESI+): Calcd 
for C12H15O2 [M+H]+: 191.1072; Found: 191.1073. Specific rotation: [α]D20.0 –55.6 (c 
0.73, CHCl3) for an enantiomerically enriched sample of 97:3 e.r.  
Enantiomeric purity was determined by HPLC analysis in comparison with authentic 
racemic material; Chiralpak AZ–H column, 96.0:4.0 hexanes/iPrOH, 0.5 mL/min, 254 
nm. 
 
Retention Time Area Area% Retention Time Area Area% 
147.924 191706307 49.424 157.396 15715158 3.438 
182.114 196173222 50.576 183.499 441445152 96.562 
 
Methyl (R)-4-(1-hydroxybut-3-en-2-yl)benzoate (3.55j): IR (neat): 3419 (br, s), 2951 
(w), 2878 (w), 1718 (s), 1637 (w), 1609 (m), 1574 (w), 1436 (m), 1413 (w), 1312 (m), 
1277 (s), 1181 (m), 1110 (s), 1054 (m), 1019 (m), 996 (w), 966 (w), 920 (w), 769 (m), 
709 (m) cm−1; 1H NMR (CDCl3, 600 MHz): δ 8.01 (2H, J = 8.4 Hz), 7.32 (2H, J = 8.4 
Hz), 6.00 (1H, ddd, J = 17.4, 9.6, 7.2 Hz), 5.25 (1H, app. d, J = 10.2 Hz), 5.20 (1H, app. 
d, J = 18.0 Hz), 3.91 (3H, s), 3.85 (2H, d, J = 6.6 Hz), 3.60 (1H, q, J = 7.2 Hz) ), 1.52 
(1H, s); 13C NMR (CDCl3, 100 MHz): δ 167.1, 146.2, 137.6, 130.2, 129.0, 128.2, 117.9, 
66.0, 52.6, 52.2. HRMS (ESI+): Calcd for C12H15O3 [M+H]+: 207.1021; Found: 
207.1025. Specific rotation: [α]D20.0 –51.7 (c 1.05, CHCl3) for an enantiomerically 
enriched sample of 97:3 e.r.  
Enantiomeric purity was determined by HPLC analysis in comparison with authentic 
racemic material; Chiralpak AZ–H column, 96.0:4.0 hexanes/ iPrOH, 0.5 mL/min, 254 
nm. 
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Retention Time Area Area% Retention Time Area Area% 
88.285 13394628 50.006 91.575 489606 3.478 
109.614 13391298 49.994 112.395 13586141 96.522 
 
(R)-2-(Pyridin-3-yl)but-3-en-1-ol (3.55k): IR (neat): 3222 (br, s), 3081 (w), 2922 (w), 
2868 (w), 1638 (w), 1592 (w), 1479 (m), 1425 (m), 1369 (w), 1060 (s), 1028 (s), 994 (m), 
918 (s), 810 (m), 785 (m), 713 (s), 633 (m), 400 (m) cm−1; 1H NMR (CDCl3, 600 MHz): 
δ 8.49–8.47 (2H, m), 7.57 (1H, dt, J = 7.8, 1.8 Hz), 7.27–7.25 (1H, m), 6.00 (1H, ddd, J = 
18.0, 10.2, 7.2 Hz), 5.26 (1H, td, J = 10.2, 1.2 Hz), 5.19 (1H, td, J = 17.4, 1.2 Hz), 3.87–
3.86 (1H, m), 3.56 (1H, q, J = 7.2 Hz), 1.95 (1H, s); 13C NMR (CDCl3, 100 MHz): δ 
149.8, 148.2, 137.3, 136.7, 135.6, 123.7, 118.0, 65.8, 50.0. HRMS (ESI+): Calcd for 
C9H12NO [M+H]+: 150.0919; Found: 150.0921. Specific rotation: [α]D20.0 −20.6 (c 0.67, 
CHCl3) for an enantiomerically enriched sample of 97:3 e.r. 
Enantiomeric purity was determined by HPLC analysis in comparison with authentic 
racemic material before oxidation; Chiralpak AZ–H column, 98.0:2.0 hexanes/ iPrOH, 
1.0 mL/min, 254 nm. 
 
Retention Time Area Area% Retention Time Area Area% 
16.371 676373 49.119 16.619 51849 3.283 
17.399 700622 50.881 17.076 1527232 96.717 
(R)-2-(Thiophen-3-yl)but-3-en-1-ol (3.55l): IR (neat): 3392 (br, s), 2923 (s), 2853 (m), 
1733 (w), 1639 (w), 1461 (m), 1414 (m), 1382 (m), 1259 (m), 1156 (m), 1079 (s), 1030 
(s), 993 (s), 965 (m), 921 (s), 840 (m), 783 (s), 714 (m), 632 (m), 482 (w) cm−1; 1H NMR 
(CDCl3, 500 MHz): δ 7.32 (1H, dd, J = 5.2, 3.2 Hz), 7.08−7.07 (1H, m), 7.00 (1H, dd, J 
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= 5.2, 1.2 Hz), 5.97 (1H, ddd, J = 17.2, 10.0, 7.2 Hz), 5.24−5.17 (2H, m), 3.86−3.76 (2H, 
m), 3.65 (1H, q, J = 7.2 Hz), 1.57 (1H, s); 13C NMR (CDCl3, 100 MHz): δ 141.2, 138.0, 
127.2, 126.1, 121.3, 117.4, 65.9, 48.2. HRMS (ESI+): Calcd for C8H9S [M+H−H2O]+: 
137.0425; Found: 137.0420. Specific rotation: [α]D20.0 −13.6 (c 0.87, CHCl3) for an 
enantiomerically enriched sample of 94:6 e.r.  
Enantiomeric purity was determined by HPLC analysis in comparison with authentic 
racemic material before oxidation; Chiralpak AZ–H column, 99.0:1.0 hexanes/iPrOH, 0.5 
mL/min, 220 nm. 
 
Retention Time Area Area% Retention Time Area Area% 
63.196 8529375 50.223 65.538 552387 5.850 
68.262 8453654 49.777 70.108 8890482 94.150 
 
(R)-2-Cyclohexylbut-3-en-1-ol (3.55m): IR (neat): 3358 (br, s), 2923 (s), 2852 (m), 
1449 (w), 1055 (w), 1016 (w), 997 (w), 913 (w) cm−1; 1H NMR (CDCl3, 400 MHz): δ 
5.63 (1H, dt, J = 16.8, 10.0 Hz), 5.19 (1H, dd, J = 10.4, 2.0 Hz), 5.11 (1H, dd, J = 17.2, 
2.0 Hz), 3.70 (1H, dd, J = 10.4, 4.8 Hz), 3.44 (1H, dd, J = 10.4, 9.2 Hz), 2.07–2.00 (1H, 
m), 1.73–1.62 (5H, m), 1.43 (1H, s), 1.37–1.31 (1H, m), 1.27–1.10 (3H, m), 1.07–0.93 
(2H, m); 13C NMR (CDCl3, 100 MHz): δ 138.9, 118.3, 63.6, 53.2, 38.7, 31.3, 30.4, 26.7, 
26.6, 26.5. HRMS (ESI+): Calcd for C10H19O [M+H]+: 155.1426; Found: 155.1432. 
Specific rotation: [α]D20.0 –10.8 (c 0.65, CHCl3) for an enantiomerically enriched sample 
of 96:4 e.r.  
Enantiomeric purity was determined by HPLC analysis in comparison with authentic 
racemic material after benzoylation; Chiralpak AZ–H column, 99.0:1.0 hexanes/iPrOH, 
1.0 mL/min, 220 nm. 
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Retention Time Area Area% Retention Time Area Area% 
6.944 285485 50.394 6.956 3724875 95.615 
7.372 282018 49.606 7.348 170829 4.385 
 
(R,E)-4-Phenyl-2-vinylbut-3-en-1-ol (3.55n): IR (neat): 3349 (br, s), 3080 (w), 3059 
(w), 3025 (w), 2926 (w), 2872 (w), 1637 (w), 1598 (w), 1493 (w), 1448 (w), 1415 (w), 
1028 (m), 990 (m), 965 (s), 915 (s), 862 (w), 842 (w), 746 (s), 691 (s), 601 (w), 508 (w) 
cm−1; 1H NMR (CDCl3, 400 MHz): δ 7.38 (2H, d, J = 7.2 Hz), 7.31 (2H, app. t, J = 7.2 
Hz), 7.25–7.21 (1H, m), 6.51 (1H, d, J = 16.0 Hz), 6.14 (1H, dd, J = 16.0, 8.0 Hz), 5.89–
5.80 (1H, m), 5.25– 5.21(2H, m), 3.66 (2H, d, J = 6.8 Hz), 3.18–3.11 (1H, m), 1.59 (1H, 
s); 13C NMR (CDCl3, 100 MHz): δ 137.5, 137.1, 132.4, 128.70, 128.68, 128.63, 126.4, 
117.4, 65.4, 50.2. HRMS (ESI+): Calcd for C12H13 [M+H−H2O]+: 157.1017; Found: 
157.1014; specific rotation: [α]D20.0 –43.8 (c 0.84, CHCl3) for an enantiomerically 
enriched sample of 85:15 e.r.  
Enantiomeric purity was determined by HPLC analysis in comparison with authentic 
racemic material; Chiralpak AZ–H column, 99.0:1.0 hexanes/iPrOH, 0.5 mL/min, 254 
nm. 
 
Retention Time Area Area% Retention Time Area Area% 
42.178 3766154 49.949 41.526 12122695 85.254 
51.477 3773786 50.051 51.057 2096846 14.746 
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(S)-2-(Dimethyl(phenyl)silyl)but-3-en-1-ol (3.55o): IR (neat): 3347(br, s), 2956 (w), 
2868 (w), 1627 (w), 1427 (w), 1412 (w), 1301 (w), 1248 (m), 1111(m), 1049 (m), 993 
(m), 896 (m), 832 (s), 812 (s), 793 (s), 775 (m), 759 (m), 729 (s), 698 (s), 653 (s), 594 (w), 
469 (m), 417 (m) cm−1; 1H NMR (CDCl3, 500 MHz): δ 7.50−7.48 (2H, m), 7.39−7.33 
(3H, m), 5.69 (1H, dt, J = 17.6, 10.4 Hz), 5.08 (1H, d, J = 10.4 Hz), 5.02 (2H, 1H, d, J = 
10.4 Hz), 3.74−3.65 (2H, m), 2.15 (1H, td, J = 10.0, 4.8 Hz), 1.47 (1H, s), 0.32 (6H, s); 
13C NMR (CDCl3, 100 MHz): δ 136.84, 136.75, 134.4, 129.4, 128.0, 115.6, 62.4, 39.7, –
4.13, –4.81. HRMS (ESI+): Calcd for C12H17Si [M+H−H2O]+: 189.1100; Found: 
189.1106. Specific rotation: [α]D20.0  –4.22 (c 1.47, CHCl3) for an enantiomerically 
enriched sample of 98:2 e.r.  
Enantiomeric purity was determined by HPLC analysis in comparison with authentic 
racemic material; Chiralpak AZ–H column, 99.0:1.0 hexanes/iPrOH, 0.5 mL/min, 220 
nm. 
 
Retention Time Area Area% Retention Time Area Area% 
21.752 14471832 49.743 21.655 297603 1.900 
22.934 14621157 50.257 22.836 15364427 98.100 
 
 
Formal Synthesis of Rhopaloic Acid A 
 
NHC–Cu-Catalyzed EAS with Allylic Phosphate 3.46p  
A 100-mL oven-dried flask equipped with a stir bar was charged with NHC−Ag comlex 
3.56 (35 mg, 55 µmol), NaOMe (65 mg, 1.20 mmol), and CuCl (5.0 mg, 50 µmol) in an 
N2-filled glove box. The vial was sealed with a septum and electrical tape, and removed 
from the glove box. Tetrahydrofuran (5.0 mL) was added and the mixture was allowed to 
stir for 2 h under N2 at 22 °C. The solution became bright yellow. 
Bis[(pinacolato)boryl]methane 3.13 (400 mg, 1.5 mmol) and allylic phosphate 3.46p (338 
mg, 1.0 mmol) dissolved in thf (5.0 mL) was added through a syringe and the resulting 
solution was allowed to stir at 22 °C for 6 h. The solution was then passed through a short 
plug of silica gel and eluted with Et2O. The organic layer was concentrated in vacuo, 
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resulting in yellow oil that was purified by silica gel chromatography (20:1 hexanes/Et2O, 
Rf 0.19) to afford 290 mg of 3.57 (>98:2 SN2’/SN2) as pale yellow oil (0.89 mmol, 89% 
yield). (R)-tert-Butyldimethyl((2-((4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-
yl)methyl)but-3-en-1-yl)oxy)silane (3.57): IR (neat): 2978 (w), 2956 (w), 2929 (w), 
2888 (w), 2857(w), 1471 (w), 1407 (w), 1368 (s), 1317 (s), 1253 (s), 1213 (w), 1145 (s), 
1095 (s), 1004 (w), 969 (w), 888 (w), 834 (s), 774 (s), 667 (m) cm−1; 1H NMR (CDCl3, 
400 MHz): δ 5.78 (1H, ddd, J = 18.0, 10.4, 7.6 Hz), 5.03 (1H, app. d, J = 17.2 Hz), 4.97 
(1H, app. d, J = 10.8 Hz), 3.49 (2H, d, J = 6.4 Hz)，2.50–2.41 (1H, m), 1.23 (12H, d, J = 
2.4 Hz), 0.96 (1H, dd, J = 15.6, 10.0 Hz), 0.88 (9H, s), 0.79 (1H, dd, J = 16.0, 9.2 Hz), 
0.03 (6H, s); 13C NMR (CDCl3, 150 MHz): δ 141.7, 114.2, 83.3, 68.2, 42.1, 26.1, 25.1, 
24.9, −5.1, −5.2. HRMS (ESI+): Calcd for C17H36BO3Si [M+H]+: 327.2527; Found: 
327.2527. Specific rotation: [α]D20.0 7.89 (c 0.84, CHCl3) for an enantiomerically 
enriched sample of 96:4 e.r.  
Enantiomeric purity was determined by HPLC analysis in comparison with authentic 
racemic material after desilylation and benzoylation of the resulting alcohol; Chiralpak 
AZ–H column, 97.0:3.0 hexanes/iPrOH, 0.3 mL/min, 220 nm. 
 
Retention Time Area Area% Retention Time Area Area% 
16.025 8362169 49.258 16.013 50972 4.216 
16.641 8614075 50.742 16.632 1040246 95.784 
 
Phosphine–Palladium Catalyzed Suzuki Cross-Coupling32 with Alkenyl 
Iodide 
A 4-dram vial with a stir bar was charged with alkyl–B(pin) 3.57 (290 mg, 0.89 
mmol) and a solution of 9-BBN dimer (119 mg, 0.97 mmol) in thf (0.5 ml). After 12 h, 
the mixture was transferred to a 25 mL flask under nitrogen atmosphere containing 
PdCl2(dppf)2 (36 mg, 0.045 mmol), K3PO4 (378 mg, 1.78 mmol), alkenyl iodide 3.59 
(308 mg, 0.97 mmol) and 3 mL dmf. Then 150 µL deionized water (sparged with 
nitrogen) was transferred to the flask and the mixture was allowed to stir at 50 °C for 24 
h. At this time, the reaction was quenched by addition of a saturated solution of NH4Cl 
                                                
(32) S. R. Chemler, D. Trauner, S. J. Danishefsky, Angew. Chem. Int. Ed. 2001, 40, 4544−4568. 
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and the inorganic layer was washed with Et2O (5.0 mL, three times). The combined 
organic layer was concentrated in vacuo and purified by silica gel chromatography (20:1 
hexanes/Et2O, Rf = 0.25) to afford 3.60 as colorless oil (402 mg, 87% yield). tert-
Butyldimethyl(((R,5E,9E)-6,10,14-trimethyl-2-((4,4,5,5-tetramethyl-1,3,2-
dioxaborolan-2-yl)methyl)pentadeca-5,9,13-trien-1-yl)oxy)silane (3.60): IR (neat): 
2956 (s), 2927 (s), 2855 (s), 1447 (m), 1372 (s), 1317 (m), 1252 (m), 1146 (s), 1093 (s), 
969 (w), 8356 (s), 813 (w), 774 (s) cm−1; 1H NMR (CDCl3, 400 MHz): δ 5.14–5.07 (3H, 
m), 3.50 (1H, dd, J = 10.0, 5.6 Hz), 3.44 (1H, dd, J = 9.6, 6.4 Hz), 2.10–2.03 (4H, m), 
1.99–1.95 (6H, m), 1.77–1.71 (1H, m), 1.67 (3H, s), 1.59 (9H, s), 1.53–1.43 (2H, m), 
1.23 (12H, s), 0.88 (9H, s), 0.82–0.76 (2H, m), 0.03 (6H, s); 13C NMR (CDCl3, 100 
MHz): δ 135.0, 134.7, 131.3, 125.1, 124.6, 124.5, 82.9, 62.6, 39.90, 39.87, 36.9, 33.6, 
27.0, 26.9, 26.8, 26.1, 25.8, 25.6, 25.0, 24.9, 18.5, 17.8, 16.13, 16.10, −5.2. HRMS 
(ESI+): Calcd for C31H60BO3Si [M+H]+: 519.4405; Found: 519.4422. Specific rotation: 
[α]D20.0 2.61 (c 1.15, CHCl3) for an enantiomerically enriched sample of 96:4 e.r.  
 
Deprotection/NHC–Cu-catalyzed Allylic Substitition to Obtain 3.62 
To a solution of alkyl-B(pin) 3.60 (402 mg, 0.77 mmol) in anhydrous methanol 
(1.0 ml) was added p-TsOH (6.6 mg, 0.039 mmol) at 22 °C and the mixture was allowed 
to stir for 2 h. The resulting solution was concentrated in vacuo to remove methanol. A 4-
dram vial was charged with CuCl(19 mg, 0.19 mmol), imidazolinium salt (26 mg, 0.076 
mmol), KOtBu (129 mg, 1.2 mmol) and thf (5.0 ml) was allowed to stir at 22 °C for 2 h. 
Then the crude of desilylation and allyl phosphate (224 mg, 1.2mol) in thf (2.0 ml) was 
transferred to the vial and the reaction mixture was allowed to stir at 70 °C for 24 h. The 
reaction was then quenched by passing the solution through a short plug of silica gel, 
after which it was washed with Et2O (20 ml), concentrated in vacuo to afford a pale 
yellow oily residue, which was purified by silica gel chromatography (6:1 hexanes/Et2O, 
Rf = 0.30) to deliver alcohol 3.62 as colorless oil (165 mg, 0.51 mmol, 67% yield). 
(R,5E,9E)-2-(But-3-en-1-yl)-6,10,14-trimethylpentadeca-5,9,13-trien-1-ol (3.62): IR 
(neat): 3323 (s), 2966 (m), 2917 (s), 2855 (s), 1641 (w), 1449 (m), 1379 (m), 1202 (w), 
1107 (w), 1032 (s), 993 (s), 908 (s), 833 (m), 743 (w) cm−1; 1H NMR (CDCl3, 400 
MHz): δ 5.87 (1H, m), 5.14–5.08 (1H, m), 5.05–4.99 (1H, m), 4.95 (1H, dt, J = 10.0, 0.8 
Hz), 3.57 (2H, d, J = 4.8 Hz), ), 2.12–2.05 (6H, m), 2.03–1.95 (6H, m), 1.68 (3H, s), 1.60 
(9H, s), 1.54–1.33 (5H, m); 13C NMR (CDCl3, 100 MHz): δ 139.1, 135.4, 135.1, 131.4, 
124.6, 124.5, 124.3, 114.6, 65.5, 39.9, 39.7, 31.6, 31.3, 31.1, 30.3, 26.9, 26.8, 25.5, 25.3, 
17.8, 16.18, 16.16. HRMS (ESI+): Calcd for C22H39O [M+H]+: 319.3001; Found: 
319.3008. Specific rotation: [α]D20.0 –3.74 (c 0.80, CHCl3) for an enantiomerically 
enriched sample of 96:4 e.r. 
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Catalytic Cross-Metathesis with Acrolein33 
In a 1-dram vial with a stir bar was charged with alkene 3.62 (16 mg, 0.051 
mmol) and acrolein (67 µl, 1.02 mmol). A solution of Ru complex 3.63 (0.01 M in 
CH2Cl2, 0.5 mL, 0.005 mmol, 1.0 mol %) was introduced and the mixture was allowed to 
stir at 22 °C for 0.5 h under nitrogen atomsphere. Then the mixture was flushed through a 
short plug of silica gel with Et2O and concentrated in vacuo and purified by silica gel 
chromatography (6:1 hexanes/Et2O, Rf = 0.35 to 1:1 hexanes/Et2O) to afford α,β-
unsaturated aldehyde 3.19 (>98:2 E/Z) as colorless oil (13.5 mg, 71% yield). 
(R,2E,9E,13E)-6-(Hydroxymethyl)-10,14,18-trimethylnonadeca-2,9,13,17-tetraenal 
(3.19): IR (neat): 2962 (m), 2917 (s), 2870 (m), 2851 (m), 2184 (w), 2138 (w), 2033 (w), 
1691 (s), 1636 (w), 1449 (w), 1379 (w), 1131 (w), 1102 (w), 1035 (w), 1023 (w) cm−1; 
1H NMR (CDCl3, 400 MHz): δ 9.51 (1H, d, J = 8.0 Hz), 6.86 (1H, dt, J = 15.6, 6.4 Hz), 
6.14 (1H, ddt, J = 16.0, 8.0, 1.6 Hz), 5.13–5.07 (3H, m), 3.63 (1H, J = 10.4, 4.0 Hz), 2.37 
(2H, J = 6.0 Hz), 2.10–1.95 (10H, m), 1.68 (3H, d, J = 1.2 Hz), 1.60 (9H, s), 1.58–1.34 
(5H, m); 13C NMR (CDCl3, 100 MHz): δ 194.2, 158.8, 135.7, 135.2, 133.1, 131.5, 124.5, 
124.25, 124.20, 65.2, 39.9, 39.8, 39.7, 31.0, 30.3, 29.4, 26.9, 26.7, 25.9, 25.3, 17.8, 16.22, 
16.17. HRMS (ESI+): Calcd for C23H39O2 [M+H]+: 374.2950; Found: 374.2957. Specific 
rotation: [α]D20.0 –3.17 (c 0.80, CHCl3) for an enantiomerically enriched sample of 96:4 
e.r. 
 
Catalytic Oxa-Michael Addition34 
To a solution of aldehyde 3.19 (32.3 mg, 0.078 mmol) in CH2Cl2 (3.0 mL, 0.026 M) was 
added dropwise a 1:1 mixture of pyrrolidine/BzOH (0.28 mL, 0.054 M in CH2Cl2) at 22 
ºC. After the solution was allowed to stir for 1 h at 22 ºC, it was diluted with hexanes 
(30.0 mL), filtered through a short pad of silica gel (hexanes/EtOAc, 3/1), and 
concentrated in vacuo. The resulting residue was purified by silica gel chromatography 
(5:1 hexanes/Et2O, Rf  0.36) to afford aldehyde 3.64 (31.6 mg, diastereoisomer ratio 8:1) 
as colorless oil. 2-((2R,5S)-5-((3E,7E)-4,8,12-Trimethyltrideca-3,7,11-trien-1-
yl)tetrahydro-2H-pyran-2-yl)acetaldehyde (3.64): IR (neat): 3070 (w), 2958 (w), 2899 
(w), 2173 (w), 1626 (w), 1487 (w), 1427 (w), 1411 (w), 1317 (w), 1248 (m), 1112 (m), 
1040 (w), 998 (w), 942 (w), 899 (w), 836 (s), 813 (s), 778 (m), 758 (s), 723 (s), 697 (s), 
642 (m), 548 (w), 469 (m) cm−1; 1H NMR (CDCl3, 600 MHz): δ 9.79 (1H, t, J = 2.4 Hz), 
5.11–5.07 (3H, m), 3.94–3.91 (1H, m), 3.78–3.73 (1H, m), 3.06 (1H, t, J = 10.8 Hz), 2.58 
(1H, ddd, J = 16.8, 7.8, 3.0 Hz), 2.47 (1H, ddd, J = 16.2, 4.8, 1.8 Hz), 2.09–2.04 (4H, m), 
2.00–1.96 (6H, m), 1.68–1.67 (4H, m), 1.60 (9H, d), 1.57–1.54 (1H, m), 1.37 (1H, qd, J = 
10.8, 3.0 Hz), 1.21–1.11 (2H, m); 13C NMR (CDCl3, 150 MHz): δ 201.6, 135.5, 135.1, 
                                                
(33) Killen, J. C.;Leonard, J.; Aggarwal, V. K. Synlett. 2010, 4, 579–582.01.03.2010 
(34) Lee, K. ; Kim, H.; Hong, J. Org Lett. 2011, 13, 2722–2725. 
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131.4, 124.5, 124.29, 124.25, 73.8, 73.2, 50.1, 39.9, 39.8, 35.2, 32.7, 31.9, 30.3, 26.9, 
26.1, 25.8, 25.1, 17.8, 16.2, 16.1. HRMS (ESI+): Calcd for C17H27Si2 [M+H]+: 287.1651; 
Found: 287.1654. Specific rotation: [α]D20.0 – 1.97 (c 0.65, CHCl3) for an 
enantiomerically enriched sample of 96:4 e.r.  
 
 
1H NMR and 13C NMR Spectra 
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Chapter Four 
Enantioselective NHC–Cu-Catalyzed Prenyl 
Conjugate Additions to Enoates  
 
4.1. Introduction 
Prenyl groups are commonly occurring in biologically important natural 
products.1 Furthermore, functionalization of a prenyl unit can be performed in a number 
of ways, leading to the formation of a number of desirable derivatives (Figure 4.1). 
Prenylation of proteins is a well-known lipid modification that  plays an important role in 
promoting membrane translocation, and is crucial for protein-protein interaction and 
cellular signal transduction.2 Therefore, design and development of methods for efficient 
preparation of enantiomerically enriched prenyl-containing molecules is a compelling 
objective of research in organic chemistry. 
                                                
(1) Recent reviews: (a) Williams, R. M.; Stocking, E. M.; Sanz-Cervera, J. F. Top. Curr. Chem. 2000, 209, 
97−173. (b) Li, S. Nat. Prod. Rep. 2010, 27, 57−78. 
(2) Zhang, F. L.; Casey, P. J. Annu. Rev. Biochem. 1996, 65, 241−69. 
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Cu-catalyzed enantioselective conjugate addition (ECA)3 reactions have been 
developed as a convenient method to generate stereogenic centers at the β position to 
carbonyl groups. Cu-catalyzed ECA methods may involve the use of Grignard reagent,4 
                                                
(3) Recent reviews: (a) Copper-Catalyzed Asymmetric Synthesis; Alexakis, A.; Krause, N.; Woodward, S. 
Eds; VCH: Weinheim, 2004, pp 33−68. (b) Catalytic Asymmetric Conjugate Reactions; Córdova, A., Ed.; 
Wiley-VCH: Weinheim, Germany, 2010; pp 71−168. (c) Wang, S.-Y.; Loh, T.-P. Chem. Commun. 2009, 
46, 8694−8703. (d) Harutyunyan, S. R.; den Hartog, T.; Geurts, K.; Minnaard, A. J.; Feringa, B. L. Chem. 
Rev. 2008, 108, 2824−2852. (e) López, F.; Minnaard, A. J.; Feringa, B. L. Acc. Chem. Res. 2007, 40, 
179−188. (f) Alexakis, A.; Bäckwall, J. E.; Krause, N.;Pa mies, O.; Diéguez, M. Chem. Rev. 2008, 108, 
2796−2823. (g) Christoffers, J.; Koripelly, G.; Rösiak, A.; Rossle, M. Synthesis 2007, 1279−1300. (h) von 
Zezschwitz, P. Synthesis 2008, 1809−1831.  
(4) For recent examples, see: (a) Wilsily, A.; Lou, T.; Fillion, E. Synthesis 2009, 2066−2072. (b) Bos, P. 
H.; Macia ́, B.; Ferna ́ndez-Iba ́n ̃ez, M. A ́.; Minnaard, A. J.; Feringa, B. L. Org. Biomol. Chem. 2010, 8, 
47−49. (c) Palais, L.; Babel, L.; Quintard, A.; Belot, S.; Alexakis, A. Org. Lett. 2010, 12, 1988−1991. (d) 
Endo, K.; Ogawa, M.; Shibata, T. Angew. Chem., Int. Ed. 2010, 49, 2410−2413. (e) Superchi, S.; 
Marchitiello, V.; Pisani, L.; Scafato, P. Chirality 2011, 23, 761−767. (f) Drissi-Amraoui, S.; Morin, M. S. 
T.; Cre ́visy, C.; Basle ́, O.; de Figueiredo, R. M.; Mauduit, M.; Campagne, J.-M. Angew. Chem., Int. Ed. 
Figure 4.1. Prenylated Natural Products and Natural Products/Pharmaceuticals Derived from Prenylated 
Compounds
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an organozinc reagent, or an organoaluminum species. However, these protocols are 
typically used to introduce an alkyl moiety. Related transformations involving an alkenyl 
and aryl metal reagents5 have been developed as well. And yet, ECA of an allyl group, a 
class of valuable reactions, remains underdeveloped.4-8 Boron-based reagents8-9,12 have 
only been introduced recently as partners in Cu-catalyzed ECA, offering a more practical, 
functional group tolerant and milder alternative to the corresponding organometallic 
entities. We envisioned that if we can achieve enantioselective Cu-catalyzed prenyl 
conjugate additions to enoates, we may easily access synthetically useful motifs for the 
synthesis of natural products and pharmaceuticals (Figure 4.1). 
4.2. Background 
4.2.1 Catalytic Enantioselective Allyl Conjugate Additions to Cyclic α,β-
Unsaturated Diesters 
In 2008, Snapper and co-workers disclosed the first Cu-catalyzed enantioselective 
Hosomi-Sakurai conjugate allyl additions to cyclic unsaturated ketoesters with 
allyltrimethylsilane (Scheme 4.1).6 The desired product were obtained in high yields and 
up to >99:1 er. Cyclic enones with different substitution patterns were explored as well. 
Five- and eight-membered ring electrophiles proved to be suitable substrates, as they 
were converted to ECA products in 85:15−>98:2 er.   
                                                                                                                                            
2015, 54, 11830−11834. (g) Drissi-Amraoui, S.; Schmid, T. E.; Lauberteaux, J.; Cre ́visy, C.; Basle ́, O.; de 
Figueiredo, R. M.; Halbert, S.; Ge ́rard, H.; Mauduit, M.; Campagne, J.-M. Adv. Synth. Catal. 2016, 358, 
2519−2540. 
(5) (a) Chong, Q.; Yue, Z.; Zhang, S.; Ji, C.; Cheng, F.; Zhang, H.; Hong, X.; Meng, F. ACS Catalysis 2017, 
7, 5693−5698. Cu-catalyzed ECA protocol with aryl boron reagent involving one example of alkenyl 
addition: (b) Takatsu, K.; Shintani, R.; Hayashi, T. Angew. Chem., Int. Ed. 2011, 50, 5548−5552. 
(6) Shizuka, M.; Snapper, M. L. Angew. Chem., Int. Ed. 2008, 47, 5049−5051. 
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In 2011, Feng and co-workers reported a catalytic diastereoselective and 
enantioselective allyl conjugate addition reaction to coumarins. 7  High yields and 
stereoselectivities were obtained through a dual activation strategy: N,N’-dioxide 4.7 
used in combination with Yb(OTf)3, serves to activate the electrophile, coumarin 4.5. In 
situ transmetalation from tetraallyltin 4.6 to Cu(OTf)•tol serves to generate the more 
nucleophilic species. 
 
4.2.2 Catalytic Enantioselective Allyl Conjugate Additions to Acyclic α,β-
Unsaturated Diesters 
The Morken group pioneered the Ni-catalyzed enantioselective conjugate addition 
of allylboronic acid pinacol ester to dialkylidene ketones.8 Reactions proceeded highly 
efficiently and favors allylation at benzylidene positions with β:β’ ratios ranging from 
5.1:1 to 49:1, and in up to 97:3 er. In 2011, the same research group showed that Pd-
                                                
(7) Kuang, Y.; Liu, X.; Chang, L.; Wang, M.; Lin, L.; Feng, X. Org. Lett. 2011, 13, 3814−3817. 
(8) (a) Sieber, J. D.; Liu, S.; Morken, J. P. J. Am. Chem. Soc. 2007, 129, 2214−2215. (b) Sieber, J. D.; 
Morken, J. P. J. Am. Chem. Soc. 2008, 130, 4978−4983. 
O
CO2Me
O O
N N
Me Me
tBu tBu
11 mol %
10 mol % Cu(OTf)2
CH2Cl2, -78 °C, 45 h
4.1
TMS
5.0 equiv
+
4.2
4.3 O
CO2Me
4.4
Scheme 4.1. Enantioselective Hosomi-Sakurai Conjugate Allylation of Cyclic Unsaturated 
Ketosesters
Scheme 4.2.  Catalytic Asymmetric Conjugate Allylation of Coumarins
10 mol %
10 mol % Yb(OTf)3
10 mol % Cu(OTf)2•tol
thf, 40 °C, 48 h;
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based catalysts may be used to promote ECA reactions with methylidene ketones.9  
 
In 2011, Shibasaki et al. reported on Cu-catalyzed enantioselective conjugate 
additions of allyl cyanide to unsaturated thioamides, leading to the formation of a wide 
range of Z-alkenyl cyanide products. 10  Both aryl- and alkyl-thioamides are suitable 
substrates for the transformations. Reactions proceeded through deprotonation of allyl 
cyanide/formation of an allyl copper catalyst, followed by enantioselective additions to 
thioamides 4.13. Products were then obtained in high yield and with exceptional 
enantioselectivity. It is worth mentioning that triphenylphosphine-oxide serves as a “hard” 
Lewis base to enhance the Brønsted basicity of Li(OC6H4-pOMe) through a hard–hard 
interaction with the Li cation. 
 
4.2.3 Catalytic Enantioselective Conjugate Additions to Acyclic α,β-Unsaturated 
Diesters with Boron-Based Nucleophiles 
                                                
(9) Brozek, L. A.; Sieber, J. D.; Morken, J. P. Org. Lett. 2011, 13, 995−997. 
(10) Yanagida, Y.; Yazaki, R.; Kumagai, N.; Shibasaki, M. Angew. Chem., Int. Ed. 2011, 50, 7910 –7914. 
Scheme 4.3.  Ni-Catalyzed Enantioselective Conjugate Allylation of Activated Enones
10 mol % Ni(cod)2
tol, 22 °C, 8 h
B(pin)+
up to 81% yield,
91-94% ee
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Scheme 4.4.  Cu-Catalyzed Conjugate Additions of Allyl Cyanide to α,β-Unsaturated Thioamides
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5.0 mol % Cu(CH3CN)4PF6
5.0 mol % Li(OC6H4-pOMe)/PPh3O
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In 2016, following the development of enantioselective 1,6-conjugate propargyl 
and allyl additions to dienoates,11 we reported a multicomponent reaction protocol to 
facilitate the transformation of an in situ B(pin)-substituted allylcopper compound to α,β-
unsaturated diesters.12 Products were obtained in 45−83% yield, over 95% α selectivity 
(4.20:4.21), 94:6−99:1 er. Reactions involving butadiene and isoprene, which are 
common feedstock, enoates and B2(pin)2 were promoted by a NHC−Cu catalyst derived 
from an imidazolinium salt 4.19. A stereochemical model was proposed for this 
transformation: the sodium cation bridges the catalyst alkoxy group and the carbonyl 
groups on the substrate, which not only serves to rigidify the transition state and also 
lowers the activation barrier by stabilizing the negative charge accommodated during the 
C−C bond formation step. 
 
Very recently, Meng reported a reaction protocol regarding ECA reactions of 
allenyl−B(pin) compounds to α,β-unsaturated diesters 4.23.13 Alkyl as well as aryl-
substrated enoates are suitable substrates for this transformation. An alkoxy-based 
                                                
(11) Meng, F.; Li, X.; Torker, S.; Shi, Y.; Shen, X.; Hoveyda, A. H. Nature 2016, 537, 387−393. 
(12) Li, X.; Meng, F.; Torker, S.; Shi, Y.; Hoveyda, A. H.  Angew. Chem., Int. Ed. 2016, 55, 9997 –10002. 
(13) Chong, Q.; Yue, Z.; Zhang, S.; Ji, C.; Cheng, F.; Zhang, H.; Hong, X.; Meng F. ACS Catal. 2017, 7, 
5693−5698. 
Scheme 4.5.  Cu-Catalyzed Conjguate Additions of B(pin)-Substituted Allylcopper Compounds
Ar CO2Et
CO2Et
>98% conv. >95:5 4.20:4.21,
45-83% yield, 
70:30-77:23 4.20:4.22, 
94:6-99:1 er
(6.0 equiv)
+ 5.0 mol % CuCl
1.5 equiv B2(pin)2,
1.5 equiv NaOPh,
 thf, 22 °C, 16 h;
NaBO3•4H2O, thf/H2O = 1:1
22 °C, 2 h
Ar COOEt
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Ar COOEt
COOEt
Ar COOEt
COOEt
HO
OH
4.20 4.21
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NHC−Cu catalyst serves as the catalyst and a variety of functionalized alkenyl units were 
used. 
 
4.3. Cu-Catalyzed Enantioselective Prenyl Conjugate Additions to Acyclic α,β-
Unsaturated Diesters 
4.3.1 Catalyst Screening and Reaction Optimizations 
We decided to utilized 3,3-dimethylallyl B(pin) 4.28 to introduce the prenyl unit 
to a stereogenic center. The requisite organoboron compound (4.28) is easily accessible 
from relatively inexpensive starting materials (Scheme 4.7).  
 
As shown in Scheme 4.8, prenyl addition to enoate 4.29 affords diester  4.30 in 84% 
yield, 92:8 er with 95:5 γ:α ratio. The transformation was performed with 5.0 mol % 
NHC−Cu complex derived from 10 mol % valinol-based 4.24,  5.0 mol % CuCl and 1.5 
equivalent of sodium ethoxide in thf at 22 °C for 18 h.  10 mol % of ligand was needed to 
avoid complication arising from the generation of 4.31 presumably by background 
reaction promoted by (prenyl)CuOEt (Scheme 4.9). Switching the N-alkyl substituent of 
the NHC ligand from isopropyl group to a phenyl group 4.32 delivers the desired product 
R CO2Et
CO2Et
up to 98% yield,  
99.5:0.5 er
5.0 mol % CuCl
1.5 equiv NaOt-Bu
 thf, 22 °C, 16 h;
Ar COOEt
COOEt
4.26
4.23
NMesN
OH
PF6
4.25
R = aryl, alkyl
Scheme 4.6.  Cu-Catalyzed Conjguate Additions of Alkenyl-B(pin)
R1
B(pin)
4.24
R2
R3
R1
R2
R3
5.0 mol %
+
70% yield
4.284.27
2.0 equiv
Scheme 4.7.  Preparation of 3,3-Dimethylallyl-B(pin)
Br
1.2 equiv Mg
1.0 equiv HB(pin) B(pin)
thf, rt, 2 h
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in 89% yield, 91:9 er with slight decrease of group-selectivity (91:9 γ:α ratio). Increasing 
the size of ortho-substituent on the N-aryl ring to Et group led to a slight increase in the 
enantioselectivity (92.5:7.5 er vs 91:9 er, 4.33 vs. 4.32). However, further increasing the 
size of ortho substituent on N-aryl ring from Et to i-Pr group led to detrimental effect on 
the enantioselectivity (38:62 er vs 92.5:7.5 er, 4.34 vs. 4.33), favoring the generation of 
alternative enantiomer of the product. Switching to phenylalaninol-based NHC ligand 
4.35 cause the enantiomeric ratio to drop to 82:18 er. Desired product 4.30 with 95:5 er 
was obtained when a NHC ligand derived from tert-leucinol (R)-4.22 was used. However, 
drop of regioselectivity was also observed (cf. 82:18 vs. 91:9 γ:α selectivity, (R)-4.22 vs. 
4.32). Changing the substitution pattern of N-aryl ring from ortho to meta led to a lower 
yield, regioselectivity and enantioselectivity (cf.  88:12 er vs 95:5 er, 4.36 vs. (R)-4.22; 
73:27 er vs 91:9 er, 4.38 vs. 4.32). When NHC ligand derived from trans-1-amino-2-
indanol-based imidazolinium salt 4.39 was utilized in the reaction conditions, 4.30 was 
obtained in 92% yield with 96:4 group selectivity and 95:5 enantioselectivity. Decreasing 
the loading of 4.39 from 10 mol % to 6.0 mol %, ECA reaction afforded 4.30 in a slightly 
lower yield (85% yield vs. 92% yield) with no obvious drop of group selectivity and 
enantioselectivity.  
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Scheme 4.8.  Ligand Screening for Prenyl Conjugate Additions
10 mol % Ligand
5.0 mol % CuCl
EtO2C
1.5 equiv NaOEt, 
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 However, a drastic decrease in regio- and enantioselectivity was observed, when 
lower catalyst loading of sterically-demanding ligand 4.22 was utilized; product was 
obtained in only 78:22 γ:α ratio with 92:8 er when lowering the catalyst loading of 4.22 
to 6.0 mol %. However, product could be obtained in high regio- and enantioselectivity 
when 6.0 mol % of ligand 4.39 was used. We surmised that the bulky t-Bu group in 4.22 
might elevate the barrier complexation step, as shown in Scheme 4.10, as compared to 
the sterically less demanding phenyl unit of the indanyl group in 4.36, thus the 
background reaction (Scheme 4.9). 
 
4.3.2 Scope of Enantioselective Prenyl Conjugate Additions 
Scheme 4.9.  Formation of Regioisomer Promoted by Unbound CuOEt
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O
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O
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A range of aryl-substituted substrates with electron-donating and electron-
withdrawing group were employed in the ECA reaction conditions (Scheme 4.11). 
Conjugate addition products were obtained in higher yield, γ:α ratio and 
enantioselectivity with the use of 4.39 as compared to 4.24 or 4.22. Sterically-demanding 
substrate with an electron-donating group led to lower enantioselectivity (cf. 4.42). In this 
case, 4.22 afforded higher enantioselectivity albeit in lower yield. 
 
As shown in Scheme 4.12, enoates with an electron-donating group (see 4.46), or 
a sterically hindered aryl substituent (see 4.44) or a halogen-containing aryl group (see 
4.45) are all suitable substrates. In the case of heteroaryl substrates, high 
enantioselectivities and yields were obtained with the use of ligand 4.39; however, less 
congested heteroaryl enoates with the heteroatom at the 2-positions led to a dramatic drop 
in enantioselectivity (76:24 er and 78:22 er for 4.54 and 4.55). 
EtO2C
H
CO2Et
EtO2C
H
CO2Et
F CF3
92% conv., 97:3 γ:α
76 yield, 93.5:6.5 er
85% conv., 96:4 γ:α
69% yield, 93:7 er
93% conv., 95:5 γ:α
75% yield, 95:5 er
>98% conv., 94:6 γ:α
86% yield, 96:4 er
>98% conv., 72:28 γ:α
40% yield, 90:10 er
92% conv., 75:25 γ:α
58% yield, 94:6 er
EtO2C
H
CO2Et
EtO2C
H
CO2Et
BrMeO
>98% conv., >98:<2 γ:α
55% yield, 93:7 er
95% conv., 96:4 γ:α
80% yield, 95:5 er
84% conv., >98:<2 γ:α
68% yield, 88:12 er
>98% conv., 79:21 γ:α
42% yield, 94:6 er
>98% conv., 96:4 γ:α
93% yield, 87:13 er
>98% conv., 93:7 γ:α
90% yield, 95:5 er
Scheme 4.11.  Scope with Electron-Deficient and Electron-Donating Enoates
with 4.24
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As shown in Scheme 4.13, prenyl conjugate additions to coumarin led to the 
generation of racemic compound with >98% α selectivity (see 4.56). The complete 
formation of the undesired regioisomer is probably due to the background reaction which 
outcompete the desired reaction. ECA reactions employing alkyl-substituted substrates 
proceeded efficiently, however with lower enantioselectivities (63:37 er and 80:20 er see 
4.57 and 4.58). When alkenyl-substituted substrates were utilized in the reaction 
conditions, >98% conversion to 1,6-conjugate addition product (see 4.59 and 4.60). It is 
worth mentioning that ECA reaction with an alkyl-substituted dienoate led to product 
with near perfect enantioselective while the formation of racemic product was observed 
starting with a less sterically demanding and electronically activated aryl-substituted 
Scheme 4.12.  Scope with Aryl- and Heteroaryl-Substituted Enoates Catalyzed by NHC-Cu complex Derived from 4.39
4.44 4.45 4.46 4.47
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O
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82% yield, 94.5:5.5 er
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96% yield(γ+α), 94:6 er
80% conv., >98:<2 γ:α
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87% yield, 94:6 er
>98% conv., 69:31 γ:α,
51% yield, 91:9 er
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83% yield(97:3 γ:α), 94.5:5.5 er
>98% conv., 88;12 γ:α
54% yield, 78:22 er
96% conv., 74:26 γ:α,
55% yield, 76:24 er
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dienoates (97:3 er vs. 49:51 er, 4.60 vs. 4.59). These dramatic difference in 
enantioselectivities might be due to the faster rate of 1,6-conjugate addition promoted by 
unbound (prenyl)CuOEt with electronically-activated 4.61; while high enantioselective 
product could be obtained with less activated 4.63, promoted by NHC-Cu catalyst 
derived from the chiral ligand 4.39 (Scheme 4.14). 
 
O
O
EtO2C
EtO2C
Me
EtO2C
92% conv., 92:8 γ:α,
61% yield, 63:37 er
H EtO2C
EtO2C
>98% conv., 95:5 γ:α,
92% yield, 80:20 er
>98% conv., <2:>98 γ:α,
90% yield, >98:<2 dr, 50:50 er
Scheme 4.13.  Scope with Coumarin, Alkyl-, Alkenyl-Substituted Enoates Catalyzed 
by NHC-Cu Complex Derived from 4.39
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CO2Et
CO2Et
4.56 4.57 4.58
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H
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CO2Et
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As shown in Scheme 4.15, when prenyl B(pin) reagent 4.61 was employed in the 
ECA reaction instead of 4.28, 4.29 was obtained in only 31% yield, 95:5 er, indicating 
the inefficient transmetalation of 4.65 with CuCl in a γ-addition fashion (Scheme 4.16).14 
 
                                                
(14) Ardolino, M. J.; Morken, J. P. J. Am. Chem. Soc. 2014, 136, 7092−7100. 
Scheme 4.14.  1,6-Conjugate Addition with Alkenyl-Substituted Enoates Catalyzed by (Prenyl)CuOEt and NHC-Cu 
Complex Derived from 4.39
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4.3.3 Functionalization and Application to the Synthesis of a Selective Integrin 
Antagonist 
At this stage, we carried on the formal synthesis of 4.71 reported as a selective 
integrin antagonist.15 As shown in Scheme 4.16, ECA product 4.66 was obtained in 90% 
yield and 95:5 er in 0.7 g scale. Followed by decarboxylation, 4.67 was generated in 67% 
yield, which underwent Ru-catalyzed cross metathesis with a 1,1-disubstituted alkene 
4.68 in the presence of 15 mol % benzoquinone. It is worth mentioning the prenyl group 
is crucial for the promoting the generation of the trisubstituted olefin 4.69 by site-
selective formation of the Ru-metallacyclobutane complex following the initiation of 
cross metathesis of Ru-based catalyst with 4.68.16 Hydrogenation of 4.69 gave the desired 
product 4.70 which can be further elaborated to 4.71 as the target molecule. 
                                                
(15) De Corte, B. L.; Kinney, W. A.; Liu, L; Ghosh, S.; Brunner, L.; Hoekstra, W. J.; Santulli, R. J.; 
Tuman, R. W.; Baker, J.; Burns, C.; Proost, J. C.; Tounge, B. A.; Damiano, B. P.; Maryanoff, B. E.; 
Johnson, D. L.; Galemmo, R. A. Bio. Med. Chem. Lett. 2004, 14, 5227−5232. 
(16) Wang, Z. J.; Jackson,W. R.; Andrea J. Robinson, A. J. Org. Lett.. 2013, 15, 3006−3009. 
 
Scheme 4.16.  Transmetalation with Prenyl-B(pin) and 1,1-Dimethylallyl-B(pin)
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4.3.4 Stereochemical Models by DFT Calculations 
As shown in Figure 4.2, DFT calculations provided the rationale for the high 
enantioselectivity obtained with 4.39. During the C−C bond forming step, the copper 
center coordinated with the enoate with the alkoxy group, which served as a secondary 
binding site with the enoate through a cation metal bridge. In the major mode of addition 
4.72, the aryl group was situated beneath the N-aryl ring on the catalyst and benefited 
from the edge to face π-interaction. However, the minor mode of 4.73 suffered from the 
steric interaction between the prenyl group and the ortho-substituted N-aryl ring. The 
stereochemical model provided an explanation for the low enantioselectivity for alkyl 
substrates (63:37 er and 80:20 er, 4.57 and 4.58, Scheme 4.13) and heteroaryl cases 
(76:24 er and 73:27 er for 4.54 and 4.55, Scheme 4.12): complete or partial loss of the 
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5.0 mol % HG-II
15 mol % 
benzoquinone
2.0 equiv
NBoc
C6H6, 
100 °C, 14 h
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Scheme 4.17.  Application to the Synthesis of a Selective Integrin Inhibitor
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favoring edge to face CH−π-interaction raised the energy barrier for the major pathway, 
causing the erosion of enantioselectivity. 
 
4.4. Conclusions 
 An efficient catalytic protocol for generation of prenyl-bearing tertiary carbon 
stereogenic centers from aryl-substituted enoate was achieved in the presence of chiral 
NHC−Cu complex. A range of aryl and heteroaryl-substituted substrate were suitable 
substrates, the corresponding prenyl conjugate addition products were generated in up to 
94% yield and 95:5 enantioselectivity. The utility of the current method has been shown 
in the application to the synthesis of a selective integrin antagonist. DFT calculations 
provided a stereochemical model for the ECA reaction employing NHC−Cu catalyst 
derived from 4.39. 
Figure 4.2.  Stereochemical Model for Prenyl Conjugate Additions with 4.39
4.72 4.73
Na
NN
CuO3
MeO
O2 OMe
O1
H
Me
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Me
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CH-π interaction
Me
Me
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disfavored
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O2 OMe
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Me
Me
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ΔGrel= 2.5 kcal/mol
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4.5. Experimentals 
General. Infrared (IR) spectra were recorded on a Bruker FT-IR Alpha (ATR mode) 
spectrophotometer, λmax in cm−1. Bands are characterized as broad (br), strong (s), 
medium (m), and weak (w). 1H NMR spectra were recorded on a Varian Unity INOVA 
400 (400 MHz) spectrometer. Chemical shifts are reported in ppm from tetramethylsilane 
with the solvent resonance as the internal standard (CDCl3: δ 7.26 ppm). Data are 
reported as follows: chemical shift, integration, multiplicity (s = singlet, d = doublet, t = 
triplet, q = quartet, br s = broad singlet, m = multiplet app = apparent), and coupling 
constants (Hz). 13C NMR spectra were recorded on a Varian Unity INOVA 400 (100 
MHz) spectrometer with complete proton decoupling. Chemical shifts are reported in 
ppm from tetramethylsilane with the solvent resonance as the internal standard (CDCl3: δ 
77.16 ppm). High-resolution mass spectrometry was performed on a Micromass LCT 
ESI-MS (positive mode) at the Mass Spectrometry Facility, Boston College. Elemental 
microanalyses were performed at Robertson Microlit Laboratories (Madison, NJ). 
Enantiomeric ratios were determined by high-performance liquid chromatography 
(HPLC) with a Shimadzu chromatograph (Chiral Technologies Chiralcel OB-H (4.6 x 
250 mm), Chiral Technologies Chiralcel OJ-H (4.6 x 250 mm)) in comparison with 
authentic racemic materials. Optical rotations were measured on a Rudolph Research 
Analytical Autopol IV Polarimeter. Unless otherwise noted, all reactions were carried out 
with distilled and degassed solvents under an atmosphere of dry N2 in oven- (135 °C) or 
flame-dried glassware with standard dry box or vacuum-line techniques. 
Dichloromethane (Fisher Scientific, Inc.) was purified by being passed through two 
alumina columns under a positive pressure of dry argon by a modified Innovative 
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Technologies purification system. Tetrahydrofuran (Aldrich Chemical Co.) was purified 
by distillation from sodium benzophenone ketyl immediately prior to use unless 
otherwise specified. Methanol (Aldrich Chemical Co.) was distilled over CaH2. All work-
up and purification procedures were carried out with reagent grade solvents (purchased 
from Doe & Ingalls) under air. 
Reagents 
Copper (I) chloride: purchased from Strem Chemicals Inc. and used as received. 
Diethyl benzylidenemalonate (3.29): purchased from Aldrich Chemical Co. and used as 
received. 
Enoate (substrate for 4.40−4.55): prepared according to previously reported 
procedures.17 
Imidazolinium salts (4.32−4.38,18  4.395b): prepared according to previously reported 
procedures. 
Ruthenium complex (HG-II) was purchased from Aldrich and used as received. 
Sodium methoxide (NaOEt) was purchased from Strem and used as received. 
 
Procedure for NHC–Cu-Catalyzed Additions to Enoates (Scheme 4.8 and 
4.10): 
In an N2-filled glove box, an oven-dried vial (4 mL) with a magnetic stir bar was charged 
with imidazolinium salt 4.39 (2.8 mg, 0.0060 mmol), CuCl (0.5 mg, 0.005 mmol,), 
NaOEt (10.2 mg, 0.150 mmol) and tetrahydrofuran (thf, 1.0 mL). The vessel was sealed 
with a cap (phenolic open top cap with red PTFE/white silicone septum) and the solution 
was allowed to stir at 22 °C for 3.0 h. 1,1-Dimethylallyl−B(pin) 4.28 (29.4 mg, 0.150 
mmol) was added to the solution, causing it to turn dark brown immediately. The mixture 
was allowed to stir at 22 °C for 10 min under an atmosphere of N2. enoate 4.29 (24.8 mg, 
0.100 mmol) were added through a syringe. The vial was re-sealed with a cap (phenolic 
open top cap with red PTFE/white silicone septum) and removed from the glove box. The 
                                                
(17) Allen, C. F. H.; Spangler, F. W. Org. Syn. 1945, 25, 42. 
(18) Clavier, H.; Coutable, L.; Toupet, L.; Guillemin, J.-C.; Mauduit, M. J. J. Organomet. Chem. 2005, 690, 
5237–5254. 
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resulting solution was allowed to stir at 22 °C for 16 hours before the reaction was 
quenched by passing the mixture through a short plug of silica gel and eluted with Et2O. 
The filtrate was concentrated in vacuo to provide yellow oil, which was purified by silica 
gel chromatography (hexanes/ethyl acetate = 75:1 to 60:1) to afford the 4.30 as colorless 
oil (27.0 mg, 0.085 mmol, 85% yield). 
 
Characterization Data for Diesters with a Tertiary Carbon Stereogenic 
Center 
 
Diethyl (S)-2-(4-methyl-1-phenylpent-3-en-1-yl)malonate (4.30). IR (neat): 3030 (w), 
2980 (w), 2931 (w), 1752 (s), 1729 (s), 1496 (w), 1453 (m), 1368 (m), 1310 (m), 1248 (s), 
1175 (s), 1146 (s), 1112 (m), 1096 (m), 1031 (s), 861 (w), 757 (m), 699 (s), 574 (w) cm−1; 
1H NMR (CDCl3, 400 MHz): δ 7.30–7.27 (2H, m), 7.22–7.19 (3H, m), 4.93 (1H, t, J = 
8.0 Hz), 4.26 (2H, q, J = 7.2 Hz), 3.93–3.88 (2H, m), 3.72 (1H, d, J = 10.4 Hz), 3.44 (1H, 
td, J = 10.0, 4.4 Hz), 2.50–2.43 (1H, m), 2.36–2.29 (1H, m), 1.60 (3H, s), 1.49 (3H, s), 
1.32 (3H, t, J = 7.2 Hz), 0.96 (3H, t, J = 7.2 Hz); 13C NMR (CDCl3, 100 MHz): δ 168.7, 
168.0, 141.1, 133.8, 128.5, 128.2, 126.8, 121.0, 61.6, 61.2, 58.1, 46.0, 32.9, 25.8, 17.8, 
14.2, 13.8. HRMS (ESI+): Calcd for C19H27O4 [M+H]+: 319.1909; Found: 319.1912. 
Specific rotation: [α]D20.0 −7.89 (c 1.85, CHCl3) for an enantiomerically enriched sample 
of 95:5 e.r.  
Enantiomeric purity was determined by HPLC analysis in comparison with authentic 
racemic material; Chiralpak OZ–H column, 99.0:1.0 hexanes/iPrOH, 1.0 mL/min, 220 
nm. 
 
Retention Time Area Area% Retention Time Area Area% 
14.354 1886077 49.574 13.020 156692 5.368 
27.401 1918482 50.426 24.575 2762577 94.632 
Diethyl (S)-2-(1-(4-fluorophenyl)-4-methylpent-3-en-1-yl)malonate (4.40): IR (neat): 
2980 (w), 2931 (w), 1752 (s), 1730 (s), 1605 (w), 1509 (s), 1446 (w), 1368 (m), 1307 (m), 
1223 (s), 1175 (s), 1147 (s), 1098 (s), 1031 (s), 860 (w), 831 (s), 570 (w), 546 (w)   cm−1; 
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1H NMR (CDCl3, 400 MHz): δ 7.16–7.13 (2H, m), 6.94 (2H, t, J = 8.8 Hz), 4.87 (1H, t, 
J = 7.2 Hz), 4.23 (2H, q, J = 7.2 Hz), 3.90 (2H, qd, J = 7.2, 1.2 Hz), 3.64 (1H, d, J = 11.2 
Hz), 3.40 (1H, td, J = 10.4, 4.8 Hz), 2.45–2.38 (1H, m), 2.29–2.21 (1H, m), 1.57 (3H, s), 
1.45 (3H, s), 1.29 (3H, t, J = 7.2 Hz), 0.97 (3H, t, J = 7.2 Hz); 13C NMR (CDCl3, 100 
MHz): δ 168.5, 167.9, 161.8 (d, JCF = 243.6 Hz), 136.8 (d, JCF = 3.1 Hz), 134.1, 130.0 (d, 
JCF = 7.6 Hz), 120.7, 115.1 (d, JCF = 21.2 Hz), 61.7, 61.3, 58.1, 45.2, 33.0, 25.8, 17.8, 
14.2, 13.9. HRMS (DART +): Calcd for C19H26O4F [M+H]+: 337.1815; Found: 337.1816. 
Specific rotation: [α]D20.0  –5.66 (c 1.16, CHCl3) for an enantiomerically enriched sample 
of 95:5 e.r. 
Enantiomeric purity was determined by HPLC analysis in comparison with authentic 
racemic material; Chiralpak OZ–H column, 99.0:1.0 hexanes/iPrOH, 1.0 mL/min, 220 
nm. 
 
 
Diethyl (S)-2-(4-methyl-1-(4-(trifluoromethyl)phenyl)pent-3-en-1-yl)malonate (4.41): 
IR (neat): 2981 (w), 2931 (w), 1752 (s), 1731 (s), 1619 (w), 1447 (w), 1421 (w), 1370 
(w), 1324 (s), 1250 (s), 1162 (s), 1113 (s), 1068 (s), 1033 (s), 1018 (s), 833 (s), 732 (w), 
610 (m), 444 (w)   cm−1; 1H NMR (CDCl3, 400 MHz): δ 7.52 (2H, d, J = 8.0 Hz), 7.31 
(2H, d, J = 8.0 Hz), 4.86 (1H, t, J = 7.2 Hz), 4.24 (2H, q, J = 7.2 Hz), 3.90 (2H, q, J = 7.2 
Hz), 3.70 (1H, d, J = 10.4 Hz), 3.52−3.45 (1H, m), 2.48–2.42 (1H, m), 2.34–2.26 (1H, m), 
1.58 (3H, s), 1.44 (3H, s), 1.29 (3H, t, J = 7.2 Hz), 0.94 (3H, t, J = 7.2 Hz); 13C NMR 
(CDCl3, 100 MHz): δ 168.3, 167.7, 145.48, 148.47, 134.6, 129.2 (q, JCF = 31.9 Hz), 
128.9, 125.2 (q, JCF = 3.8 Hz), 120.3, 61.9, 61.5, 57.6, 45.7, 32.7, 25.8, 17.8, 14.2, 13.8. 
HRMS (DART +): Calcd for C20H26F3O4 [M+H]+: 387.1783; Found: 387.1782. Specific 
rotation: [α]D20.0 –11.2 (c 2.97, CHCl3) for an enantiomerically enriched sample of 96:4 
er.  
Enantiomeric purity was determined by HPLC analysis in comparison with authentic 
racemic material; Chiralpak OD–H column, 99.0:1.0 hexanes/iPrOH, 0.5 mL/min, 220 
nm 
Retention Time Area Area% Retention Time Area Area% 
10.031 1475038 50.007 9.792 103030 5.076 
11.869 1474630 49.993 11.419 1926828 94.924 
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Retention Time Area Area% Retention Time Area Area% 
13.052 7068263 50.879 13.471 16189875 96.007 
17.574 6823922 49.121 19.116 673381 3.993 
Diethyl (S)-2-(1-(2-methoxyphenyl)-4-methylpent-3-en-1-yl)malonate (4.42): IR 
(neat): 2979 (w), 2931 (w), 1752 (s), 1730 (s), 1600 (w), 1586 (w), 1493 (m), 1462 (m), 
1440 (m), 1368 (m), 1307 (s), 1242 (s), 1175 (s), 1146 (s), 1117 (m), 1096 (m), 1027 (s), 
861 (w), 751 (s), 523 (w) cm−1; 1H NMR (CDCl3, 400 MHz): δ 7.15 (1H, td, J = 7.6, 1.6 
Hz), 7.06 (1H, dd, J = 7.6, 1.6 Hz), 6.84−6.80 (2H, m), 4.92 (1H, t, J = 7.2 Hz), 4.21 (2H, 
q, J = 7.2 Hz), 4.00 (1H, d, J = 10.8 Hz), 3.91−3.85 (2H, m), 3.82 (3H, s), 3.70 (1H, td, J 
= 10.4, 4.8 Hz), 2.51–2.44 (1H, m), 2.39–2.33 (1H, m), 1.55 (3H, s), 1.44 (3H, s), 1.27 
(3H, t, J = 7.2 Hz), 0.94 (3H, t, J = 7.2 Hz); 13C NMR (CDCl3, 100 MHz): δ 169.1, 
168.5, 157.9, 133.2, 130.2, 129.0, 127.9, 121.8, 120.3, 110.8, 61.4, 61.0, 56.1, 55.4, 30.8, 
25.8, 17.7, 14.3, 13.9. HRMS (DART +): Calcd for C20H29O5 [M+H]+: 349.2015; Found: 
349.2007. Specific rotation: [α]D20.0 –5.50 (c 1.09, CHCl3) for an enantiomerically 
enriched sample of 93:7 er.  
Enantiomeric purity was determined by HPLC analysis in comparison with authentic 
racemic material; Chiralpak OD–H column, 99.0:1.0 hexanes/iPrOH, 0.5 mL/min, 220 
nm. 
 
Retention Time Area Area% Retention Time Area Area% 
14.470 10087012 50.184 14.779 12798830 92.633 
15.479 10013159 49.816 15.950 1017838 7.367 
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Diethyl (S)-2-(1-(3-bromophenyl)-4-methylpent-3-en-1-yl)malonate (4.43): IR (neat): 
2979 (w), 2931 (w), 1752 (s), 1730 (s), 1594 (w), 1567 (w), 1474 (w), 1446 (w), 1429 
(w), 1368 (m), 1302 (m), 1247 (s), 1176 (s), 1147 (s), 1112 (m), 1096 (m), 1074 (m), 
1030 (s), 997 (w), 784 (m), 662 (w), 440 (w) cm−1; 1H NMR (CDCl3, 400 MHz): δ 
7.33−7.31 (2H, m), 7.13−7.11 (2H, m), 6.84−6.80 (2H, m), 4.88 (1H, t, J = 7.2 Hz), 4.23 
(2H, q, J = 7.2 Hz), 3.92 (2H, q, J = 7.2 Hz), 3.65 (1H, d, J = 10.8 Hz), 3.38 (1H, td, J = 
10.0, 4.8 Hz), 2.45–2.39 (1H, m), 2.30–2.23 (1H, m), 1.59 (3H, s), 1.46 (3H, s), 1.29 (3H, 
t, J = 7.2 Hz), 0.97 (3H, t, J = 7.2 Hz); 13C NMR (CDCl3, 100 MHz): δ 168.4, 167.8, 
143.6, 134.5, 131.6, 130.0, 129.8, 127.3, 122.3, 120.5, 61.8, 61.4, 57.7, 45.6, 32.7, 25.8, 
17.8, 14.2, 13.9. HRMS (DART+): Calcd for C19H26BrO4 [M+H]+: 397.1014; Found: 
397.1009. Specific rotation: [α]D20.0 –12.0 (c 2.39, CHCl3) for an enantiomerically 
enriched sample of 95:5 e.r.  
Enantiomeric purity was determined by HPLC analysis in comparison with authentic 
racemic material; Chiralpak OZ–H column, 99.0:1.0 hexanes/iPrOH, 0.5 mL/min, 220 
nm. 
 
Retention Time Area Area% Retention Time Area Area% 
19.236 50220980 50.975 20.535 1346615 5.092 
24.661 48300362 49.025 26.923 25101476 94.908 
Diethyl (S)-2-(4-methyl-1-(o-tolyl)pent-3-en-1-yl)malonate (4.44): IR (neat): 2978 (w), 
2928 (w), 2856 (w), 1753 (s), 1731 (s), 1493 (w), 1464 (w), 1446 (w), 1368 (s), 1307 (s), 
1250 (s), 1175 (s), 1146 (s), 1114 (m), 1096 (m), 1032 (s), 861 (w), 756 (m), 726 (m), 
594 (w) , 455 (w)  cm−1; 1H NMR (CDCl3, 400 MHz): δ 7.13−7.12 (2H, m), 7.10−7.05 
(2H, m), 4.90 (1H, t, J = 7.2 Hz), 4.24 (2H, q, J = 7.2 Hz), 3.85 (2H, q, J = 7.2 Hz), 
3.81−3.72 (2H, m), 2.45–2.38 (1H, m), 2.35 (3H, s), 2.26–2.18 (1H, m), 1.57 (3H, s), 
1.44 (3H, s), 1.30 (3H, t, J = 7.2 Hz), 0.90 (3H, t, J = 7.2 Hz); 13C NMR (CDCl3, 100 
MHz): δ 168.8, 168.1, 139.8, 137.1, 133.9, 130.3, 126.5, 126.4, 125.9, 120.7, 61.6, 61.2, 
57.9, 40.2, 33.3, 25.8, 20.1, 17.7, 14.3, 13.7. HRMS (ESI+): Calcd for C20H29O4 [M+H]+: 
333.2066; Found: 333.2057. Specific rotation: [α]D20.0 −21.8 (c 2.17, CHCl3) for an 
enantiomerically enriched sample of 95:5 e.r.  
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Enantiomeric purity was determined by HPLC analysis in comparison with authentic 
racemic material; Chiralpak OZ–H column, 99.0:1.0 hexanes/iPrOH, 0.5 mL/min, 220 
nm. 
 
Retention Time Area Area% Retention Time Area Area% 
20.926 15224891 49.268 25.147 762174 4.894 
52.284 15677312 50.732 55.804 14810692 95.106 
Diethyl (S)-2-(1-(2-chlorophenyl)-4-methylpent-3-en-1-yl)malonate (4.45): IR (neat): 
2980 (w), 2932 (w), 1731 (s), 1476 (w), 1443 (w), 1369 (m), 1305 (m), 1247 (s), 1176 (s), 
1148 (s), 1110 (m), 1096 (m), 1035 (s), 862 (w), 754 (s), 456 (m) cm−1; 1H NMR (CDCl3, 
400 MHz): δ 7.32 (1H, d, J = 7.2 Hz), 7.20−7.17 (2H, m), 7.17−7.09 (1H, m), 4.93 (1H, 
tt, J = 7.2, 1.2 Hz), 4.24 (2H, q, J = 7.6 Hz), 3.85 (2H, q, J = 7.2 Hz), 4.10 (1H, s, br), 
3.98−3.88 (2H, m), 2.86–2.82 (1H, m), 2.48–2.38 (2H, m), 1.57 (3H, s), 1.42 (3H, s), 
1.28 (3H, t, J = 7.2 Hz), 0.98 (3H, t, J = 7.2 Hz); 13C NMR (CDCl3, 100 MHz): δ 168.4, 
167.8, 138.8, 134.8, 134.5, 129.8, 127.8, 126.7, 120.2, 61.7, 61.4, 56.6, 31.7, 29.8, 25.8, 
17.7, 14.2, 13.8.  HRMS (ESI+): Calcd for C19H26ClO4 [M+H]+: 353.1520; Found: 
353.1515. Specific rotation: [α]D20.0 −5.84 (c 1.09, CHCl3) for an enantiomerically 
enriched sample of 94:6 er.  
Enantiomeric purity was determined by HPLC analysis in comparison with authentic 
racemic material; Chiralpak OZ–H column, 99.0:1.0 hexanes/iPrOH, 0.5 mL/min, 220 
nm. 
 
Retention Time Area Area% Retention Time Area Area% 
28.916 38790432 49.511 31.679 947731 6.258 
Chapter 4, Page 353 
 
 
69.409 39556842 50.489 68.430 14196315 93.742 
Diethyl (S)-2-(1-(4-methoxyphenyl)-4-methylpent-3-en-1-yl)malonate (4.46): IR 
(neat): 2979 (w), 2933 (w), 1752 (s), 1729 (s), 1611 (w), 1512 (s), 1463 (w), 1444 (w), 
1368 (m), 1303 (m), 1246 (s), 1177 (s), 1146 (s), 1113 (s), 1096 (m), 1033 (s), 861 (w), 
828 (s), 573 (w) , 551 (m) cm−1; 1H NMR (CDCl3, 400 MHz): δ 7.10 (2H, d, J = 8.4 Hz), 
6.79 (2H, d, J = 8.8 Hz), 4.89 (1H, tt, J = 7.2, 1.2 Hz), 4.22 (2H, q, J = 7.2 Hz), 3.89 (2H, 
qd, J = 7.2, 1.6 Hz), 3.77 (3H, s), 3.63 (1H, d, J = 11.2 Hz), 3.36 (1H, td, J = 10.0, 4.8 
Hz), 2.44–2.37 (1H, m), 2.29–2.22 (1H, m), 1.58 (3H, s), 1.47 (3H, s), 1.28 (3H, t, J = 7.2 
Hz), 0.97 (3H, t, J = 7.2 Hz); 13C NMR (CDCl3, 100 MHz): δ 168.7, 168.1, 158.4, 133.7, 
133.1, 129.5, 121.2, 113.6, 61.6, 61.2, 58.3, 55.3, 45.2, 33.0, 25.8, 17.8, 14.2, 13.9. 
HRMS (ESI+): Calcd for C20H29O5 [M+H]+: 349.2028; Found: 349.2015. Specific 
rotation: [α]D20.0 −7.27 (c 1.54, CHCl3) for an enantiomerically enriched sample of 94:6 
e.r.  
Enantiomeric purity was determined by HPLC analysis in comparison with authentic 
racemic material; Chiralpak OZ–H column, 99.0:1.0 hexanes/iPrOH, 0.5 mL/min, 220 
nm. 
 
Retention Time Area Area% Retention Time Area Area% 
17.466 13665820 47.138 17.499 1007488 5.654 
19.207 15325167 52.862 19.232 16810671 94.346 
Diethyl (S)-2-(4-methyl-1-(naphthalen-2-yl)pent-3-en-1-yl)malonate (4.47): IR (neat): 
3055 (w), 2979 (w), 2931 (w), 1751 (s), 1728 (s), 1600 (w), 1508 (w), 1445 (w), 1368 
(m), 1302 (m), 1246 (s), 1174 (s), 1145 (s), 1112 (m), 1095 (m), 1029 (s), 856 (s), 817 (s), 
746 (s), 662 (w) , 477 (s) cm−1; 1H NMR (CDCl3, 400 MHz): δ 7.80−7.75 (3H, m), 7.64 
(1H, s), 7.47−7.41(2H, m), 7.36 (1H, td, J = 8.4, 1.2 Hz), 4.93 (1H, t, J = 7.2 Hz), 4.26 
(2H, q, J = 7.2 Hz), 3.87−3.78 (3H, m), 3.61 (1H, td, J = 11.2, 4.4 Hz), 2.56–2.50 (1H, 
m), 2.46–2.38 (1H, m), 1.55 (3H, s), 1.48 (3H, s), 1.31 (3H, t, J = 7.2 Hz), 0.85 (3H, t, J 
= 7.2 Hz); 13C NMR (CDCl3, 100 MHz): δ 168.6, 168.0, 138.7, 133.9, 133.4, 132.6, 
127.9, 127.7, 127.4, 126.6, 126.0, 125.6, 121.0, 61.7, 61.2, 58.1, 46.0, 32.8, 25.8, 17.9, 
14.3, 13.8. HRMS (DART+): Calcd for C23H29O4 [M+H]+: 369.2066; Found: 369.2061. 
Specific rotation: [α]D20.0 –18.6 (c 2.05, CHCl3) for an enantiomerically enriched sample 
of 95:5 e.r.  
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Enantiomeric purity was determined by HPLC analysis in comparison with authentic 
racemic material; Chiralpak OZ–H column, 99.0:1.0 hexanes/iPrOH, 1.0 mL/min, 220 
nm. 
 
Retention Time Area Area% Retention Time Area Area% 
9.033 101138991 47.768 8.341 46155405 95.138 
11.063 112778676 52.232 10.121 2358642 4.862 
Diethyl (S)-2-(1-(benzofuran-5-yl)-4-methylpent-3-en-1-yl)malonate (4.48): IR (neat): 
2979 (w), 2930 (w), 1751 (s), 1728 (s), 1468 (m), 1445 (m), 1368 (m), 1301 (m), 1248 (s), 
1175 (s), 1148 (s), 1128 (s), 1111 (s), 1096 (m), 1030 (s), 880 (m), 861 (m), 811 (m), 769 
(m), 738 (s), 650 (w), 442 (m) cm−1; 1H NMR (CDCl3, 600 MHz): δ 7.57 (1H, d, J = 2.0 
Hz), 7.42 (1H, d, J = 1.6 Hz), 7.39 (1H, d, J = 8.8 Hz), 7.13 (1H, dd, J = 8.4, 1.6 Hz), 
4.90 (1H, t, J = 7.2 Hz), 4.24 (2H, q, J = 7.2 Hz), 3.88−3.80 (2H, m), 3.72 (1H, d, J = 
10.4 Hz), 3.51 (1H, td, J = 10.0, 4.8 Hz), 2.51–2.45 (1H, m), 2.38–2.30 (1H, m), 1.56 (3H, 
s), 1.47 (3H, s), 1.29 (3H, t, J = 7.2 Hz), 0.88 (3H, t, J = 7.2 Hz); 13C NMR (CDCl3, 100 
MHz): δ 168.7, 168.1, 154.1, 145.2, 135.6, 133.7, 127.4, 124.8, 121.1, 121.0, 111.0, 
106.7, 61.6, 61.2, 58.6, 45.9, 33.3, 25.8, 17.8, 14.2, 13.8. HRMS (ESI+): Calcd for 
C21H27O5 [M+H]+: 359.1858; Found: 359.1843. Specific rotation: [α]D20.0 –12.7 (c 1.91, 
CHCl3) for an enantiomerically enriched sample of 94.5:5.5 e.r.  
Enantiomeric purity was determined by HPLC analysis in comparison with authentic 
racemic material; Chiralpak OZ–H column, 99.0:1.0 hexanes/ iPrOH, 0.5 mL/min, 254 
nm. 
 
Retention Time Area Area% Retention Time Area Area% 
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16.011 22904843 52.412 15.195 847985 5.471 
18.173 20797074 47.588 16.930 14652586 94.529 
Diethyl (S)-2-(4-methyl-1-(pyridin-4-yl)pent-3-en-1-yl)malonate (4.49): IR (neat): 
2980 (w), 2936 (w), 1728 (s), 1599 (m), 1559 (w), 1446 (m), 1416 (m), 1369 (m), 1300 
(m), 1235 (s), 1174 (s), 1148 (s), 1128 (s), 1095 (m), 1071 (s), 1028 (s), 858 (m), 821 (m), 
769 (m), 586 (m) cm−1; 1H NMR (CDCl3, 600 MHz): δ 8.48 (2H, d, J = 4.0 Hz), 7.11 
(2H, d, J = 6.4 Hz), 4.85 (1H, t, J = 7.2 Hz), 4.23 (2H, q, J = 7.2 Hz), 3.91 (2H, qd, J = 
7.2, 2.4 Hz), 3.69 (1H, d, J = 11.2 Hz), 3.40 (1H, td, J = 10.0, 4.8 Hz), 2.45–2.39 (1H, m), 
2.32–2.24 (1H, m), 1.57 (3H, s), 1.42 (3H, s), 1.28 (3H, t, J = 7.2 Hz), 0.96 (3H, t, J = 7.2 
Hz); 13C NMR (CDCl3, 100 MHz): δ 168.1, 167.5, 150.6, 149.7, 134.9, 123.9, 119.9, 
61.9, 61.6, 56.9, 45.2, 32.3, 25.8, 17.8, 14.2, 13.8. HRMS (DART+): Calcd for 
C18H26NO4 [M+H]+: 320.1862; Found: 320.1869. Specific rotation: [α]D20.0 −8.57 (c 
1.19, CHCl3) for an enantiomerically enriched sample of 94:6 e.r. 
Enantiomeric purity was determined by HPLC analysis in comparison with authentic 
racemic material; Chiralpak OZ–H column, 95.0:5.0 hexanes/ iPrOH, 1.0 mL/min, 254 
nm. 
 
Retention Time Area Area% Retention Time Area Area% 
20.414 1742577 49.997 20.319 994448 5.967 
31.033 1742767 50.003 29.930 15672649 94.033 
Diethyl (S)-2-(4-methyl-1-(pyridin-3-yl)pent-3-en-1-yl)malonate (4.50): IR (neat): 
2980 (w), 2933 (w), 1729 (s), 1572 (w), 1446 (m), 1426 (m), 1369 (m), 1302 (m), 1257 
(s), 1240 (s), 1219 (s), 1173 (s), 1147 (s), 1111 (m), 1096 (m), 1024 (s), 861 (m), 809 (m), 
715 (s), 627 (m) cm−1; 1H NMR (CDCl3, 400 MHz): δ 8.43 (2H, m), 7.22 (1H, dt, J = 
7.6, 2.0 Hz), 7.19 (1H, dd, J = 7.6, 4.8 Hz), 4.87 (1H, t, J = 7.2 Hz), 4.23 (2H, q, J = 7.2 
Hz), 3.90 (2H, qd, J = 7.2, 1.6 Hz), 3.70 (1H, d, J = 10.4 Hz), 3.44 (1H, td, J = 10.0, 4.4 
Hz), 2.48–2.41 (1H, m), 2.33–2.26 (1H, m), 1.57 (3H, s), 1.42 (3H, s), 1.28 (3H, t, J = 7.2 
Hz), 0.96 (3H, t, J = 7.2 Hz); 13C NMR (CDCl3, 100 MHz): δ 168.3, 167.7, 150.3, 148.3, 
136.6, 135.8, 134.8, 123.2, 120.1, 61.9, 61.5, 57.3, 43.4, 32.6, 25.8, 17.8, 14.2, 13.9. 
HRMS (DART+): Calcd for C18H26NO4 [M+H]+: 320.1862; Found: 320.1850. Specific 
rotation: [α]D20.0 −5.42 (c 1.61, CHCl3) for an enantiomerically enriched sample of 94:6 
e.r.  
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Enantiomeric purity was determined by HPLC analysis in comparison with authentic 
racemic material; Chiralpak OZ–H column, 95.0:5.0 hexanes/iPrOH, 1.0 mL/min, 254 
nm. 
 
Retention Time Area Area% Retention Time Area Area% 
12.652 1195002 50.277 12.408 419260 5.706 
13.731 1181826 49.723 13.279 6928379 94.294 
Diethyl (S)-2-(1-(1-(tert-butoxycarbonyl)-1H-indol-6-yl)-4-methylpent-3-en-1-
yl)malonate (4.51): IR (neat): 2979 (w), 2932 (w), 1729 (s), 1529 (w), 1480 (w), 1439 
(m), 1369 (m), 1335 (s), 1252 (s), 1211 (m), 1219 (s), 1170 (s), 1144 (s), 1128 (s), 1096 
(m), 1078 (m), 1024 (s), 908 (m), 855 (m), 818 (m), 767 (m), 729 (s), 652 (m), 466 (w) 
cm−1; 1H NMR (CDCl3, 400 MHz): δ 8.02 (1H, s), 7.53 (1H, d, J = 3.6 Hz), 7.42 (1H, d, 
J = 8.0 Hz), 7.07 (1H, d, J = 8.0 Hz), 6.49 (1H, d, J = 3.6 Hz), 4.93 (1H, t, J = 7.2 Hz), 
4.26-4.19 (2H, m) 3.86 (2H, q, J = 7.2 Hz), 3.75 (1H, d, J = 10.4 Hz), 3.55 (1H, td, J = 
10.0, 4.4 Hz), 2.52–2.46 (1H, m), 2.41–2.34 (1H, m), 1.67 (9H, s), 1.56 (3H, s), 1.48 (3H, 
s), 1.29 (3H, t, J = 7.2 Hz), 0.93 (3H, t, J = 7.2 Hz);  13C NMR (CDCl3, 100 MHz): δ 
168.8, 168.1, 149.8, 137.5, 135.4, 133.6, 129.5, 125.9, 123.6, 121.3, 120.5, 115.0, 107.2, 
83.6, 61.6, 61.2, 58.5, 46.3, 33.2, 28.3, 25.8, 17.9, 14.2, 13.8. HRMS (ESI+): Calcd for 
C26H39O6N2 [M+NH4]+: 475.2808; Found: 475.2811. Specific rotation: [α]D20.0 –8.15 (c 
2.65, CHCl3) for an enantiomerically enriched sample of 94:6 e.r.  
Enantiomeric purity was determined by HPLC analysis in comparison with authentic 
racemic material; Chiralpak OD–H column, 99.0:1.0 hexanes/iPrOH, 0.5 mL/min, 220 
nm. 
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Retention Time Area Area% Retention Time Area Area% 
11.577 5913937 50.282 11.555 19969066 93.747 
12.450 5847648 49.718 12.463 1331850 6.253 
Diethyl (S)-2-(4-methyl-1-(thiophen-3-yl)pent-3-en-1-yl)malonate (4.52): IR (neat): 
2979 (w), 2929 (w), 1751 (s), 1728 (s), 1446 (m), 1413 (w), 1368 (m), 1301 (m), 1255 (s), 
1236 (s), 1174 (s), 1145 (s), 1112 (m), 1096 (m), 1030 (s), 904 (w), 858 (m), 836 (m), 
782 (m), 657 (m), 428 (w) cm−1; 1H NMR (CDCl3, 500 MHz): δ 7.20 (1H, dd, J = 4.8, 
3.2 Hz), 6.99 (1H, d, J = 3.2 Hz), 6.96 (1H, d, J = 4.8 Hz), 4.95 (1H, t, J = 7.2 Hz), 4.21 
(2H, q, J = 7.2 Hz) 3.95 (2H, q, J = 7.2 Hz), 3.64 (1H, d, J = 10.0 Hz), 3.60−3.55 (1H, m), 
2.45−2.39 (1H, m), 2.32−2.25 (1H, m), 1.61 (3H, s), 1.48 (3H, s), 1.28 (3H, t, J = 7.2 Hz), 
1.02 (3H, t, J = 7.2 Hz); 13C NMR (CDCl3, 100 MHz): δ 168.6, 168.2, 141.8, 134.1, 
61.6, 61.3, 57.8, 41.2, 32.7, 25.9, 17.7, 14.2, 13.9. HRMS (DART+): Calcd for 
C17H25SO4 [M+H]+: 325.1474; Found: 325.1486. Specific rotation: [α]D20.0  1.21 (c 0.99, 
CHCl3) for an enantiomerically enriched sample of 91:9 e.r.  
Diethyl (S)-2-(1-(1-benzyl-1H-pyrrol-2-yl)-4-methylpent-3-en-1-yl)malonate (4.53): 
IR (neat): 2979 (w), 2929 (w), 1750 (s), 1729 (s), 1496 (w), 1477 (w), 1452 (m), 1368 
(m), 1300 (m), 1242 (s), 1176 (s), 1146 (s), 1096 (m), 1078 (m), 1028 (s), 861 (w), 778 
(m), 705 (s), 622 (w), 613 (w), 443 (w) cm−1; 1H NMR (CDCl3, 500 MHz): δ 7.34−7.23 
(3H, m), 7.08 (1H, d, J = 7.6 Hz), 6.52−6.50 (1H, m), 6.08 (1H, t, J = 3.2 Hz), 5.98−5.97 
(1H, m), 5.20 (1H, d, J = 8.0 Hz), 5.02 (1H, d, J = 8.0 Hz), 4.79 (1H, t, J = 7.2 Hz), 4.19 
(2H, q, J = 7.2 Hz) 3.97 (2H, q, J = 7.2 Hz), 3.60−3.51 (2H, m), 2.19 (2H, d, J = 6.4 Hz), 
1.52 (3H, s), 1.41 (3H, s), 1.27 (3H, t, J = 7.2 Hz), 1.06 (3H, t, J = 7.2 Hz); 13C NMR 
(CDCl3, 100 MHz): δ 168.6, 168.3, 138.7, 133.9, 132.8, 128.68, 128.65, 127.4, 127.1, 
120.9, 107.5, 106.5, 83.6, 61.6, 61.4, 58.1, 50.4, 36.3, 32.8, 25.9, 17.7, 14.2, 14.0. HRMS 
(DART+): Calcd for C24H32O4N [M+H]+: 398.2331; Found: 398.2346. Specific rotation: 
[α]D20.0  1.69 (c 2.13, CHCl3) for an enantiomerically enriched sample of 94.5:5.5 e.r.  
Enantiomeric purity was determined by HPLC analysis in comparison with authentic 
racemic material; Chiralpak OZ–H column, 99.0:1.0 hexanes/iPrOH, 0.5 mL/min, 220 
nm. 
 
Retention Time Area Area% Retention Time Area Area% 
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12.884 5499273 47.450 12.603 355854 5.456 
21.579 6090333 52.550 20.118 6166678 94.544 
Diethyl (S)-2-(4-methyl-1-(thiophen-2-yl)pent-3-en-1-yl)malonate (4.54): IR (neat): 
2980 (w), 2930 (w), 1751 (s), 1730 (s), 1444 (w), 1368 (m), 1303 (m), 1259 (s), 1238 (s), 
1149 (s), 1113 (m), 1096 (m), 1030 (s), 852 (m), 827 (m), 695 (s), 613 (w), 533 (w) cm−1; 
1H NMR (CDCl3, 400 MHz): δ 7.14 (1H, d, J = 5.2 Hz), 6.88 (1H, d, J = 5.2, 3.6 Hz), 
6.84 (1H, d, J = 3.6 Hz), 5.01 (1H, t, J = 7.2 Hz), 4.22 (2H, q, J = 7.2 Hz) 3.98 (2H, q, J 
= 7.2 Hz), 3.78−3.72 (1H, m), 3.65 (1H, d, J = 10.4 Hz), 2.52−2.46 (1H, m), 2.38−2.30 
(1H, m), 1.63 (3H, s), 1.52 (3H, s), 1.28 (3H, t, J = 7.2 Hz), 1.06 (3H, t, J = 7.2 Hz); 13C 
NMR (CDCl3, 100 MHz): δ 168.3, 167.9, 144.5, 134.5, 126.4, 125.6, 124.0, 120.8, 61.7, 
61.4, 58.7, 41.2, 33.8, 25.9, 17.9, 14.2, 13.9. HRMS (DART+): Calcd for C17H25SO4 
[M+H]+: 325.1474; Found: 325.1473. Specific rotation: [α]D20.0  4.86 (c 1.07, CHCl3) for 
an enantiomerically enriched sample of 76:24 e.r.  
Enantiomeric purity was determined by HPLC analysis in comparison with authentic 
racemic material; Chiralpak OZ–H column, 99.0:1.0 hexanes/iPrOH, 1.0 mL/min, 220 
nm. 
 
Retention Time Area Area% Retention Time Area Area% 
7.496 4845940 53.518 7.566 901643 24.231 
11.351 4208838 46.482 11.508 2819337 75.769 
Diethyl (S)-2-(1-(furan-2-yl)-4-methylpent-3-en-1-yl)malonate (4.55): IR (neat): 2981 
(w), 2931 (w), 1752 (s), 1731 (s), 1505 (w), 1446 (w), 1368 (m), 1303 (m), 1258 (s), 
1239 (s), 1146 (s), 1112 (m), 1096 (m), 1031 (s), 1011 (s), 861 (m), 805 (m), 731 (s), 599 
(m), 438 (w) cm−1; 1H NMR (CDCl3, 400 MHz): δ 7.30 (1H, t, J = 0.8 Hz), 6.25 (1H, t, 
J = 2.0 Hz), 6.05 (1H, d, J = 3.2 Hz), 4.98 (1H, t, J = 7.2 Hz), 4.21 (2H, q, J = 7.2 Hz), 
4.01 (2H, qd, J = 7.2, 2.0 Hz), 3.70 (1H, d, J = 9.6 Hz), 3.57–3.51 (1H, m), 2.39 (1H, t, J 
= 7.2 Hz), 1.63 (3H, s), 1.51 (3H, s), 1.27 (3H, t, J = 7.2 Hz), 1.11 (3H, t, J = 7.2 Hz); 13C 
NMR (CDCl3, 100 MHz): δ 168.3, 168.1, 154.5, 142.5, 134.3, 120.7, 110.2, 107.1, 61.6, 
61.4, 56.0, 39.4, 30.5, 25.9, 17.7, 14.2, 14.0. HRMS (DART+): Calcd for C17H25O5 
[M+H]+: 309.1702; Found: 309.1712. Specific rotation: [α]D20.0 –0.72 (c 1.11, CHCl3) for 
an enantiomerically enriched sample of 78:22 e.r.  
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Enantiomeric purity was determined by HPLC analysis in comparison with authentic 
racemic material; Chiralpak OZ–H column, 99.0:1.0 hexanes/iPrOH, 1.0 mL/min, 220 
nm. 
 
Retention Time Area Area% Retention Time Area Area% 
10.004 5236899 50.101 9.376 10572351 22.190 
14.871 5215705 49.899 13.589 37072252 77.810 
Diethyl (S)-2-(1-(benzo[d][1,3]dioxol-5-yl)-4-methylpent-3-en-1-yl)malonate (4.62): 
IR (neat): 2980 (w), 2917 (w), 1751 (s), 1729 (s), 1505 (m), 1488 (s), 1441 (m), 1368 
(m), 1303 (m), 1243 (s), 1175 (s), 1147 (s), 1097 (s), 1036 (s), 934 (s), 900 (m), 859 (m), 
810 (s), 644 (m), 444 (m) cm−1; 1H NMR (CDCl3, 500 MHz): δ 6.70−6.68 (2H, m), 6.63 
(1H, dd, J = 8.0, 2.0 Hz), 5.91 (2H, s), 4.90 (1H, t, J = 7.2 Hz), 4.23 (2H, q, J = 7.2 Hz) 
3.93 (2H, q, J = 7.2 Hz), 3.59 (1H, d, J = 6.4 Hz), 3.33 (1H, dt, J = 10.0, 4.4 Hz), 
2.43−2.36 (1H, m), 2.26−2.18 (1H, m), 1.59 (3H, s), 1.49 (3H, s), 1.28 (3H, t, J = 7.2 Hz), 
1.01 (3H, t, J = 7.2 Hz); 13C NMR (CDCl3, 100 MHz): δ 168.6, 168.0, 147.5, 146.3, 
135.0, 133.8, 121.8, 121.0, 108.7, 108.0, 100.9, 61.6, 61.3, 58.3, 45.6, 32.9, 25.8, 17.9, 
14.2, 14.0. HRMS (DART+): Calcd for C20H27O6 [M+H]+: 363.1808; Found: 363.1802. 
Specific rotation: [α]D20.0  –1.01 (c 2.17, CHCl3) for an enantiomerically enriched sample 
of 95:5 e.r.  
Enantiomeric purity was determined by HPLC analysis in comparison with authentic 
racemic material; Chiralpak OZ–H column, 99.0:1.0 hexanes/iPrOH, 1.0 mL/min, 220 
nm. 
 
Retention Time Area Area% Retention Time Area Area% 
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11.755 4233342 49.325 11.759 184326 4.766 
14.539 4349167 50.675 14.497 3682896 95.234 
Ethyl (S)-3-(benzo[d][1,3]dioxol-5-yl)-6-methylhept-5-enoate (4.63): IR (neat): 2975 
(w), 2912 (w), 1730 (s), 1503 (m), 1487 (s), 1440 (s), 1375 (m), 1347 (w), 1302 (w), 
1240 (s), 1174 (s), 1142 (s), 1097 (m), 1037 (s), 935 (s), 902 (m), 857 (m), 808 (s), 727 
(w), 639 (m), 438 (w) cm−1; 1H NMR (CDCl3, 400 MHz): δ 6.72 (1H, d, J = 8.0 Hz), 
6.69 (1H, d, J = 1.6 Hz), 6.64 (1H, dd, J = 8.0, 1.6 Hz), 5.92 (2H, s), 5.02 (1H, td, J = 6.8, 
1.2 Hz), 4.03 (2H, qd, J = 6.8, 0.8 Hz) 3.06 (1H, m), 2.62 (1H, dd, J = 15.6, 6.8 Hz), 2.47 
(1H, dd, J = 15.2, 8.8 Hz), 2.31−2.19 (2H, m), 1.65 (3H, s), 1.55 (3H, s), 1.16 (3H, t, J = 
7.2 Hz); 13C NMR (CDCl3, 100 MHz): δ 172.6, 147.6, 146.0, 138.3, 133.7, 121.8, 120.6, 
108.2, 107.8, 100.9, 60.4, 42.4, 41.0, 35.3, 25.9, 18.0, 14.3. HRMS (DART+): Calcd for 
C17H23O4 [M+H]+: 291.1596; Found: 291.1601. Specific rotation: [α]D20.0  6.61 (c 1.21, 
CHCl3) for an enantiomerically enriched sample of 95:5 e.r.  
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